Rank,Score,Type,ID,Name,Description
8559,-99.37,kd,CGS001-6856,SYPL1,-
8558,-99.34,kd,CGS001-4712,NDUFB6,Mitochondrial respiratory chain complex / Complex I
8557,-99.12,cp,BRD-K49865102,PD-0325901,MEK inhibitor
8556,-99.08,kd,CGS001-23429,RYBP,-
8555,-99.01,cp,BRD-K74236984,UNC-0321,Histone lysine methyltransferase inhibitor
8554,-98.95,kd,CGS001-56834,GPR137,GPCR / Unclassified : 7TM orphan receptors
8553,-98.92,kd,CGS001-9128,PRPF4,WD repeat domain containing
8552,-98.7,cp,BRD-K62810658,PD-98059,MEK inhibitor
8550,-98.69,cc,,MEK inhibitor,-
8551,-98.69,kd,CGS001-930,CD19,CD molecules
8549,-98.66,kd,CGS001-8477,GPR65,GPCR / Class A : Orphans
8548,-98.63,cp,BRD-K12244279,MEK1-2-inhibitor,MEK inhibitor
8547,-98.53,kd,CGS001-3576,IL8,-
8546,-98.45,cp,BRD-K48722833,iloperidone,Dopamine receptor antagonist
8545,-98.37,kd,CGS001-22934,RPIA,-
8544,-98.31,cp,BRD-U73238814,QL-XI-92,DDR1 inhibitor
8543,-98.21,kd,CGS001-8148,TAF15,RNA binding motif (RRM) containing
8542,-98.13,cp,BRD-A11702965,chromomycin-a3,DNA binding agent
8541,-98,cp,BRD-U88459701,atorvastatin,HMGCR inhibitor
8540,-97.98,kd,CGS001-10336,PCGF3,Polycomb group ring fingers
8539,-97.97,kd,CGS001-4047,LSS,Lanosterol biosynthesis pathway
8538,-97.87,kd,CGS001-2920,CXCL2,Endogenous ligands
8537,-97.63,kd,CGS001-894,CCND2,-
8536,-97.59,cp,BRD-K41895714,AS-605240,PI3K inhibitor
8535,-97.57,kd,CGS001-3654,IRAK1,Interleukin-1 receptor-associated kinase (IRAK) family
8534,-97.53,kd,CGS001-9170,LPAR2,GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid
8533,-97.37,kd,CGS001-23039,XPO7,Exportins
8532,-97.36,kd,CGS001-27102,EIF2AK1,Other PEK family kinases
8531,-97.3,kd,CGS001-5029,P2RY2,"GPCR / Class A : Purinergic receptors, P2Y"
8530,-97.29,kd,CGS001-8864,PER2,-
8529,-97.18,kd,CGS001-10447,FAM3C,-
8528,-97.13,cp,BRD-A13122391,triptolide,RNA polymerase inhibitor
8527,-97.03,kd,CGS001-23636,NUP62,-
8526,-96.89,kd,CGS001-10892,MALT1,Immunoglobulin superfamily / Immunoglobulin-like domain containing
8525,-96.63,kd,CGS001-688,KLF5,Kruppel-like transcription factors
8524,-96.62,cp,BRD-U51951544,ZG-10,JNK inhibitor
8522,-96.6,kd,CGS001-1457,CSNK2A1,Casein kinase 2 (CK2) family
8523,-96.6,kd,CGS001-468,ATF4,basic leucine zipper proteins
8521,-96.48,cp,BRD-M16762496,PIK-75,DNA protein kinase inhibitor
8520,-96.43,cp,BRD-K21680192,mitoxantrone,Topoisomerase inhibitor
8519,-96.36,kd,CGS001-3373,HYAL1,-
8518,-96.35,oe,ccsbBroad304_01061,NAB2,-
8517,-96.22,cp,BRD-K53414658,tivozanib,VEGFR inhibitor
8516,-96.02,kd,CGS001-3597,IL13RA1,IL-2 receptor family
8515,-95.88,cp,BRD-K57080016,selumetinib,MEK inhibitor
8514,-95.87,cp,BRD-K29113274,ketoconazole,Sterol demethylase inhibitor
8513,-95.81,cp,BRD-K55127134,fluphenazine,Dopamine receptor antagonist
8512,-95.59,kd,CGS001-23013,SPEN,RNA binding motif (RRM) containing
8511,-95.58,kd,CGS001-10342,TFG,-
8510,-95.52,oe,ccsbBroad304_06198,FCGR2A,CD molecules
8509,-95.45,cp,BRD-K19540840,saracatinib,SRC inhibitor
8508,-95.4,cp,BRD-K68202742,trichostatin-a,HDAC inhibitor
8507,-95.26,cp,BRD-K74761218,WT-171,HDAC inhibitor
8506,-95.17,cp,BRD-U44618005,WH-4023,SRC inhibitor
8505,-95.11,cc,,SRC inhibitor,-
8504,-95.06,cp,BRD-K14965640,ibuprofen,Cyclooxygenase inhibitor
8503,-94.87,cp,BRD-K59184148,SB-216763,Glycogen synthase kinase inhibitor
8502,-94.86,kd,CGS001-25805,BAMBI,-
8501,-94.8,kd,CGS001-9124,PDLIM1,-
8500,-94.72,kd,CGS001-8835,SOCS2,SH2 domain containing
8499,-94.44,kd,CGS001-5526,PPP2R5B,"Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits"
8498,-94.27,kd,CGS001-51135,IRAK4,Interleukin-1 receptor-associated kinase (IRAK) family
8497,-94.13,kd,CGS001-5867,RAB4A,"RAB, member RAS oncogene"
8496,-94.11,kd,CGS001-9231,DLG5,-
8495,-93.94,kd,CGS001-85377,MICALL1,-
8494,-93.92,kd,CGS001-22841,RAB11FIP2,-
8493,-93.72,kd,CGS001-4352,MPL,Prolactin receptor family
8492,-93.66,cp,BRD-K15791587,L-733060,Tachykinin antagonist
8491,-93.59,kd,CGS001-29775,CARD10,-
8490,-93.34,oe,ccsbBroad304_07272,PPAP2B,Lipid phosphate phosphatases
8489,-93.15,cp,BRD-K81418486,vorinostat,HDAC inhibitor
8488,-93.13,cp,BRD-K69840642,ISOX,HDAC inhibitor
8487,-93.07,cp,BRD-A39646320,HC-toxin,HDAC inhibitor
8486,-93.01,oe,ccsbBroad304_01579,SOX2,SRY (sex determining region Y)-boxes
8485,-92.96,cp,BRD-K68756823,FR-180204,-666
8483,-92.93,oe,ccsbBroad304_06847,RBBP4,WD repeat domain containing
8484,-92.93,kd,CGS001-80025,PANK2,-
8482,-92.91,oe,ccsbBroad304_01540,SLC2A1,Solute carriers
8481,-92.88,kd,CGS001-639,PRDM1,"Zinc fingers, C2H2-type"
8480,-92.67,kd,CGS001-3459,IFNGR1,Interferon receptor family
8479,-92.61,cc,,NADH ubiquinone oxidoreductase supernumerary subunits LOF,-
8478,-92.58,kd,CGS001-200734,SPRED2,-
8477,-92.57,cp,BRD-K94176593,TWS-119,Glycogen synthase kinase inhibitor
8476,-92.52,cp,BRD-A81795050,U-18666A,Oxidosqualene cyclase inhibitor
8474,-92.45,kd,CGS001-55033,FKBP14,EF-hand domain containing
8475,-92.45,kd,CGS001-159,ADSS,-
8473,-92.39,kd,CGS001-51478,HSD17B7,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2
8472,-92.36,cp,BRD-K23875128,RHO-kinase-inhibitor-III[rockout],Rho associated kinase inhibitor
8471,-92.35,cp,BRD-K52522949,NCH-51,HDAC inhibitor
8470,-92.34,cp,BRD-K03319035,maprotiline,Norepinephrine reuptake inhibitor
8469,-92.3,kd,CGS001-10919,EHMT2,Histone methyltransferases
8468,-92.24,cp,BRD-K99964838,bosutinib,ABL inhibitor
8467,-92.15,kd,CGS001-7625,ZNF74,"Zinc fingers, C2H2-type"
8466,-92.02,kd,CGS001-91137,SLC25A46,Miscellaneous SLC25 mitochondrial transporters
8465,-92.01,cc,,Tricyclic antidepressant,-
8464,-92,kd,CGS001-2589,GALNT1,Glycosyltransferase family 2 domain containing
8463,-91.97,cp,BRD-K33583600,isoliquiritigenin,Guanylate cyclase activator
8462,-91.95,cp,BRD-K89732114,trifluoperazine,Dopamine receptor antagonist
8461,-91.87,kd,CGS001-2130,EWSR1,RNA binding motif (RRM) containing
8460,-91.81,cp,BRD-K61314889,IWR-1-ENDO,PARP inhibitor
8459,-91.73,cp,BRD-K11558771,droxinostat,HDAC inhibitor
8458,-91.69,cp,BRD-K85503079,perospirone,Dopamine receptor antagonist
8457,-91.67,kd,CGS001-7433,VIPR1,GPCR / Class B : VIP and PACAP (ADCYAP1) receptors
8456,-91.56,kd,CGS001-6453,ITSN1,Rho guanine nucleotide exchange factors
8455,-91.43,cp,BRD-K22503835,scriptaid,HDAC inhibitor
8454,-91.42,cp,BRD-K80527266,triacsin-c,Adrenergic receptor antagonist
8453,-91.41,kd,CGS001-65057,ACD,-
8452,-91.39,oe,ccsbBroad304_00529,F3,CD molecules
8451,-91.22,kd,CGS001-8859,STK19,G11 family
8450,-91.21,cp,BRD-K50720187,flupirtine,Glutamate receptor antagonist
8449,-91.13,kd,CGS001-1806,DPYD,-
8448,-91.05,kd,CGS001-6397,SEC14L1,-
8447,-91,kd,CGS001-9918,NCAPD2,-
8446,-90.75,kd,CGS001-6794,STK11,LKB subfamily
8445,-90.56,cp,BRD-K41160163,fenobam,Glutamate receptor antagonist
8444,-90.44,cp,BRD-A18579359,wiskostatin,Neural Wiskott-Aldrich syndrome protein inhibitor
8443,-90.41,kd,CGS001-6767,ST13,Tetratricopeptide (TTC) repeat domain containing
8442,-90.2,oe,ccsbBroad304_02138,TRIP10,-
8440,-90.18,kd,CGS001-2959,GTF2B,General transcription factors
8441,-90.18,cp,BRD-A16311756,profenamine,Butyrylcholinesterase inhibitor
8439,-90.05,kd,CGS001-3030,HADHA,-
370,90.23,kd,CGS001-38,ACAT1,Lanosterol biosynthesis pathway
8437,-89.83,cp,BRD-K95785537,PP-2,SRC inhibitor
369,90.25,kd,CGS001-51375,SNX7,Sorting nexins
368,90.29,kd,CGS001-9019,MPZL1,Immunoglobulin superfamily / V-set domain containing
367,90.31,kd,CGS001-9296,ATP6V1F,ATPases / V-type
8433,-89.64,cp,BRD-K43389675,daunorubicin,RNA synthesis inhibitor
8432,-89.56,cp,BRD-K05804044,AZ-628,RAF inhibitor
366,90.33,kd,CGS001-1955,MEGF9,-
8430,-89.46,cp,BRD-K12502280,TG-101348,FLT3 inhibitor
8429,-88.81,cp,BRD-K06980535,promazine,Dopamine receptor antagonist
8428,-88.75,cp,BRD-A42553870,L-152804,Neuropeptide receptor antagonist
8427,-88.62,cp,BRD-K50387473,XMD-892,MAP kinase inhibitor
8426,-88.58,cp,BRD-K27737647,H-89,PKA inhibitor
364,90.47,kd,CGS001-10014,HDAC5,Histone deacetylases
8424,-87.95,cp,BRD-K84996949,sinensetin,Cyclooxygenase inhibitor
362,90.68,kd,CGS001-7511,XPNPEP1,Methionyl aminopeptidase
360,90.79,oe,ccsbBroad304_06681,P2RY2,"GPCR / Class A : Purinergic receptors, P2Y"
359,90.86,kd,CGS001-5373,PMM2,-
8420,-87.72,cp,BRD-K87909389,alvocidib,CDK inhibitor
358,90.92,kd,CGS001-29911,HOOK2,-
357,90.96,kd,CGS001-6723,SRM,-
8417,-87.4,cp,BRD-K20285085,fostamatinib,SYK inhibitor
356,90.97,oe,ccsbBroad304_07079,TSPAN4,Tetraspanins
8415,-86.77,cp,BRD-K17743125,belinostat,HDAC inhibitor
353,91.13,oe,ccsbBroad304_06539,LSS,Lanosterol biosynthesis pathway
351,91.19,kd,CGS001-6203,RPS9,S ribosomal proteins
8412,-86.67,cp,BRD-K91263825,nortriptyline,Tricyclic antidepressant
350,91.21,kd,CGS001-1019,CDK4,"Cyclin-dependent kinases, CDK4 subfamily"
348,91.23,kd,CGS001-10482,NXF1,-
8409,-86.56,cp,BRD-K61250553,loperamide,Opioid receptor agonist
349,91.23,kd,CGS001-2936,GSR,Oxidoreductases
347,91.24,oe,ccsbBroad304_06648,CNOT3,-
8406,-86.31,cp,BRD-K84085265,CG-930,JNK inhibitor
344,91.29,kd,CGS001-51586,MED15,-
8404,-85.92,cp,BRD-K64857848,XMD-885,Leucine rich repeat kinase inhibitor
8403,-85.65,cp,BRD-K00312224,PPT,Estrogen receptor agonist
342,91.34,kd,CGS001-8894,EIF2S2,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
8400,-85.6,cp,BRD-K17743697,KB-R7943,Sodium/calcium exchange inhibitor
343,91.34,kd,CGS001-100,ADA,Adenosine turnover
340,91.37,kd,CGS001-10681,GNB5,WD repeat domain containing
338,91.47,oe,ccsbBroad304_06753,POU5F1,Homeoboxes / POU class
8397,-85.25,cp,BRD-A31159102,fluoxetine,Selective serotonin reuptake inhibitor (SSRI)
337,91.49,kd,CGS001-440387,CTRB2,-
335,91.53,oe,ccsbBroad304_04616,ORMDL3,-
8394,-85.07,cc,,Leucine rich repeat kinase inhibitor,-
336,91.53,kd,CGS001-6584,SLC22A5,Organic zwitterions/cation transporters (OCTN)
8392,-85,cp,BRD-K47598052,PP-1,SRC inhibitor
333,91.69,kd,CGS001-83743,GRWD1,WD repeat domain containing
332,91.75,oe,ccsbBroad304_01150,PCCB,Carboxylases
328,91.84,kd,CGS001-6632,SNRPD1,-
329,91.84,kd,CGS001-4245,MGAT1,-
327,91.86,oe,ccsbBroad304_00272,CDC25A,Protein tyrosine phosphatases / Class III Cys-based PTPs
326,91.97,kd,CGS001-2063,NR2F6,COUP-TF-like receptors
325,91.98,kd,CGS001-80351,TNKS2,Ankyrin repeat domain containing
319,92.23,kd,CGS001-5019,OXCT1,-
318,92.27,kd,CGS001-6657,SOX2,SRY (sex determining region Y)-boxes
317,92.33,kd,CGS001-23658,LSM5,-
8381,-84.08,cc,,HDAC inhibitor,-
313,92.46,kd,CGS001-10112,KIF20A,Kinesins
312,92.49,kd,CGS001-51727,CMPK1,-
309,92.64,kd,CGS001-6646,SOAT1,-
8377,-83.41,cp,BRD-K01436366,XMD-1150,Leucine rich repeat kinase inhibitor
306,92.69,oe,ccsbBroad304_00477,LPAR1,GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid
8375,-83.1,cp,BRD-K81376179,TCS-359,FLT3 inhibitor
8374,-82.96,cp,BRD-K18787491,U-0126,MEK inhibitor
8373,-82.94,cp,BRD-K51485625,ritonavir,HIV protease inhibitor
8372,-82.68,cp,BRD-K82941592,rosuvastatin,HMGCR inhibitor
8371,-82.65,cp,BRD-K12867552,THM-I-94,HDAC inhibitor
302,92.76,kd,CGS001-9275,BCL7B,-
301,92.85,kd,CGS001-7157,TP53,-
300,92.86,kd,CGS001-10868,USP20,Ubiquitin-specific peptidases
295,93.09,kd,CGS001-7267,TTC3,RING-type (C3HC4) zinc fingers
293,93.1,kd,CGS001-10285,SMNDC1,Tudor domain containing
294,93.1,oe,ccsbBroad304_00602,SLC37A4,SLC37 family of phosphosugar/phosphate exchangers
290,93.27,kd,CGS001-8986,RPS6KA4,MSK subfamily
289,93.28,kd,CGS001-513,ATP5D,ATPases / F-type
287,93.34,oe,ccsbBroad304_00088,FASLG,Tumour necrosis factor (TNF) receptor family
286,93.38,kd,CGS001-308,ANXA5,Annexins
283,93.49,kd,CGS001-8649,LAMTOR3,-
281,93.51,oe,ccsbBroad304_01186,PHB,-
8358,-81.34,cp,BRD-K11663430,pyroxamide,HDAC inhibitor
276,93.73,kd,CGS001-8349,HIST2H2BE,Histones / Replication-dependent
272,93.89,kd,CGS001-5257,PHKB,-
271,93.94,kd,CGS001-8607,RUVBL1,ATPases / AAA-type
8354,-80.75,cc,,Integrin subunits beta LOF,-
8353,-80.71,cp,BRD-K69650333,idarubicin,Topoisomerase inhibitor
270,93.96,kd,CGS001-50814,NSDHL,Short chain dehydrogenase/reductase superfamily / Extended SDR fold
269,93.98,kd,CGS001-9308,CD83,CD molecules
267,94.03,kd,CGS001-4191,MDH2,-
264,94.12,oe,ccsbBroad304_03232,VPS28,-
263,94.13,kd,CGS001-64746,ACBD3,A-kinase anchor proteins
260,94.27,kd,CGS001-7272,TTK,TTK family
259,94.45,kd,CGS001-8878,SQSTM1,-
258,94.46,oe,ccsbBroad304_00771,HOXA5,Homeoboxes / ANTP class : HOXL subclass
253,94.61,kd,CGS001-2067,ERCC1,-
254,94.61,oe,ccsbBroad304_05390,DUSP28,Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases
249,94.7,kd,CGS001-5910,RAP1GDS1,Armadillo repeat containing
246,94.82,kd,CGS001-6772,STAT1,SH2 domain containing
8340,-79.57,cp,BRD-K15588452,R-96544,Serotonin receptor antagonist
247,94.82,kd,CGS001-9031,BAZ1B,"Zinc fingers, PHD-type"
244,94.91,oe,ccsbBroad304_00879,IRAK2,Interleukin-1 receptor-associated kinase (IRAK) family
243,94.93,kd,CGS001-23161,SNX13,Sorting nexins
8336,-78.93,cp,BRD-K49404994,levetiracetam,Calcium channel blocker
242,94.99,kd,CGS001-3326,HSP90AB1,Heat shock proteins / HSPC
241,95.02,kd,CGS001-10298,PAK4,PAKB subfamily
239,95.06,kd,CGS001-501,ALDH7A1,Aldehyde dehydrogenases
238,95.08,kd,CGS001-5981,RFC1,ATPases / AAA-type
235,95.18,kd,CGS001-2853,GPR31,GPCR / Class A : Orphans
233,95.2,kd,CGS001-54472,TOLLIP,-
232,95.21,oe,ccsbBroad304_07117,UGCG,Glycosyltransferase family 2 domain containing
224,95.38,kd,CGS001-1528,CYB5A,Cytochrome b genes
222,95.4,kd,CGS001-2673,GFPT1,-
220,95.43,kd,CGS001-6196,RPS6KA2,RSK subfamily
218,95.46,kd,CGS001-4771,NF2,A-kinase anchor proteins
216,95.47,kd,CGS001-1314,COPA,Endogenous ligands
8323,-77.63,cp,BRD-K56957086,dacinostat,HDAC inhibitor
8321,-77.52,cp,BRD-K50168500,canertinib,EGFR inhibitor
215,95.5,kd,CGS001-283455,KSR2,RAF family
211,95.63,kd,CGS001-11157,LSM6,-
207,95.71,kd,CGS001-29110,TBK1,IKK family
206,95.72,kd,CGS001-79094,CHAC1,-
204,95.75,oe,ccsbBroad304_01203,PIM1,PIM family
8316,-77.21,cp,BRD-K49328571,dasatinib,BCR-ABL kinase inhibitor
200,95.82,kd,CGS001-6938,TCF12,Basic helix-loop-helix proteins
198,95.86,kd,CGS001-2184,FAH,-
8312,-77.05,cp,BRD-K46441700,GR-55562,Serotonin receptor antagonist
196,95.91,kd,CGS001-6428,SRSF3,RNA binding motif (RRM) containing
192,95.98,kd,CGS001-10525,HYOU1,Heat shock proteins / HSP70
191,95.99,kd,CGS001-4726,NDUFS6,Mitochondrial respiratory chain complex / Complex I
8309,-76.66,cp,BRD-K85606544,neratinib,EGFR inhibitor
187,96.11,kd,CGS001-4323,MMP14,Matrix metallopeptidase
184,96.14,kd,CGS001-1643,DDB2,WD repeat domain containing
8306,-76.47,cp,BRD-K19796430,erismodegib,Smoothened receptor antagonist
8305,-76.37,cp,BRD-K93095519,SJ-172550,MDM inhibitor
183,96.16,oe,ccsbBroad304_01291,MAP2K6,MAPKK:STE7 family
181,96.18,kd,CGS001-9016,SLC25A14,Mitochondrial uncoupling proteins
182,96.18,kd,CGS001-5531,PPP4C,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
8301,-76.2,cp,BRD-K93201660,ML-7,Myosin light chain kinase inhibitor
179,96.24,kd,CGS001-81550,TDRD3,Tudor domain containing
8299,-75.51,cp,BRD-K22009844,phenprobamate,Muscle relaxant
8298,-75.49,cp,BRD-K19352500,prochlorperazine,Dopamine receptor antagonist
178,96.26,kd,CGS001-4048,LTA4H,Hydrolases
177,96.36,kd,CGS001-204,AK2,Adenylate kinases
173,96.42,kd,CGS001-23200,ATP11B,Phospholipid-transporting ATPases
172,96.43,kd,CGS001-4782,NFIC,-
169,96.49,kd,CGS001-64170,CARD9,-
8292,-75.07,cc,,Norepinephrine reuptake inhibitor,-
164,96.6,kd,CGS001-23012,STK38L,NDR family
163,96.61,kd,CGS001-6233,RPS27A,S ribosomal proteins
162,96.63,kd,CGS001-79006,METRN,-
161,96.71,kd,CGS001-55031,USP47,Ubiquitin-specific peptidases
160,96.73,kd,CGS001-29890,RBM15B,RNA binding motif (RRM) containing
157,96.83,kd,CGS001-1871,E2F3,-
156,96.89,kd,CGS001-6259,RYK,Type XV RTKs: RYK
154,96.93,kd,CGS001-3125,HLA-DRB3,Immunoglobulin superfamily / C1-set domain containing
150,97,kd,CGS001-8644,AKR1C3,Prostaglandin synthases
8282,-74.09,cp,BRD-K11927976,ER-27319,Mediator release inhibitor
146,97.08,kd,CGS001-19,ABCA1,ATP binding cassette transporters / subfamily A
145,97.14,kd,CGS001-9276,COPB2,WD repeat domain containing
8279,-73.95,cp,BRD-M07438658,lapatinib,EGFR inhibitor
139,97.31,oe,ccsbBroad304_01093,NFKBIA,Ankyrin repeat domain containing
8277,-73.83,cp,BRD-A09467419,mebeverine,Acetylcholine receptor antagonist
138,97.32,kd,CGS001-55422,ZNF331,"Zinc fingers, C2H2-type"
8275,-73.67,cp,BRD-K77625572,etomoxir,Carnitine palmitoyltransferase inhibitor
137,97.36,kd,CGS001-3482,IGF2R,CD molecules
136,97.37,kd,CGS001-7477,WNT7B,Endogenous ligands
8272,-72.98,cp,BRD-K01192156,tyrphostin-AG-112,Protein tyrosine kinase inhibitor
133,97.51,kd,CGS001-10381,TUBB3,Tubulins
131,97.53,kd,CGS001-51385,ZNF589,"Zinc fingers, C2H2-type"
129,97.55,kd,CGS001-57616,TSHZ3,Teashirt zinc fingers
8268,-72.64,cp,BRD-K79090631,CGP-60474,CDK inhibitor
128,97.56,kd,CGS001-5184,PEPD,Methionyl aminopeptidase
8266,-72.43,cp,BRD-K99818283,PIK-90,PI3K inhibitor
8265,-72.32,cp,BRD-K60762818,desipramine,Tricyclic antidepressant
8264,-72.2,cp,BRD-K04210847,tamoxifen,Estrogen receptor antagonist
127,97.57,kd,CGS001-26472,PPP1R14B,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
126,97.6,kd,CGS001-7297,TYK2,Janus kinase (JakA) family
8261,-71.85,cp,BRD-K38615104,A-443644,AKT inhibitor
124,97.7,oe,ccsbBroad304_02012,FADD,-
123,97.81,kd,CGS001-50604,IL20,Interleukins and interleukin receptors
121,97.9,kd,CGS001-25803,SPDEF,ETS Transcription Factors
8257,-71.41,cp,BRD-A49225603,alimemazine,Histamine receptor agonist
120,97.92,kd,CGS001-1611,DAP,-
118,97.93,oe,ccsbBroad304_00532,F11,Chymotrypsin
117,98.02,kd,CGS001-6241,RRM2,Ribonucleoside-diphosphate reductases
114,98.08,kd,CGS001-4267,CD99,CD molecules
8252,-71.13,cp,BRD-A84493640,atovaquone,Mitochondrial electron transport inhibitor
111,98.11,kd,CGS001-23224,SYNE2,-
110,98.16,kd,CGS001-50810,HDGFRP3,-
107,98.21,kd,CGS001-1874,E2F4,-
8248,-70.81,cp,BRD-K99545815,PF-562271,Focal adhesion kinase inhibitor
106,98.26,kd,CGS001-5654,HTRA1,Serine peptidases / Serine peptidases
105,98.27,kd,CGS001-10267,RAMP1,Receptor (G protein-coupled) activity modifying proteins
8245,-70.57,cp,BRD-K83010055,VU-0415374-1,Glutamate receptor modulator
8244,-70.29,cp,BRD-K39944607,ochratoxin-a,Phenylalanyl tRNA synthetase inhibitor
8243,-70.28,cp,BRD-K44084986,Y-27632,Rho associated kinase inhibitor
8242,-70.22,cp,BRD-K59058766,chlorprothixene,Dopamine receptor antagonist
8241,-70.14,cp,BRD-K35430135,SR-59230A,Adrenergic receptor antagonist
103,98.34,kd,CGS001-22949,PTGR1,-
101,98.35,kd,CGS001-55837,EAPP,-
99,98.36,kd,CGS001-55604,LRRC16A,-
100,98.36,kd,CGS001-1329,COX5B,Mitochondrial respiratory chain complex
373,89.89,kd,CGS001-5423,POLB,DNA polymerases
374,89.83,kd,CGS001-84634,KISS1R,GPCR / Class A : RF amide peptide receptors
8233,-69.74,cp,BRD-K20742498,RS-39604,Serotonin receptor antagonist
375,89.83,oe,ccsbBroad304_06028,CPE,Carboxypeptidase A
8232,-69.73,cp,BRD-A15530910,carpindolol,Adrenergic receptor antagonist
377,89.63,kd,CGS001-984,CDK11B,"Cyclin-dependent kinases, PITSLRE subfamily"
378,89.56,kd,CGS001-5073,PARN,-
379,89.48,kd,CGS001-103,ADAR,-
380,89.46,oe,ccsbBroad304_07851,FAM120A,-
382,89.44,kd,CGS001-3784,KCNQ1,Voltage-gated potassium channels
383,89.2,kd,CGS001-8480,RAE1,WD repeat domain containing
8224,-69.04,cp,BRD-K38305202,domperidone,Dopamine receptor antagonist
384,89.18,kd,CGS001-10099,TSPAN3,Tetraspanins
385,89.18,kd,CGS001-54555,DDX49,DEAD-boxes
8221,-69,cp,BRD-K41859756,NVP-AUY922,HSP inhibitor
386,89.18,kd,CGS001-10109,ARPC2,Actin related protein 2/3 complex subunits
388,89.15,kd,CGS001-57178,ZMIZ1,"Zinc fingers, MIZ-type"
389,89.1,kd,CGS001-64858,DCLRE1B,-
391,89.08,kd,CGS001-3017,HIST1H2BD,Histones / Replication-dependent
392,89.02,kd,CGS001-9146,HGS,"Zinc fingers, FYVE domain containing"
8216,-68.52,cp,BRD-K06543683,bisindolylmaleimide-ix,CDK inhibitor
8215,-68.38,cp,BRD-K04548931,pidorubicine,Topoisomerase inhibitor
8214,-68.34,cp,BRD-K78084463,W-12,Calmodulin antagonist
393,89.01,kd,CGS001-55234,SMU1,WD repeat domain containing
394,88.99,kd,CGS001-3656,IRAK2,Interleukin-1 receptor-associated kinase (IRAK) family
395,88.91,kd,CGS001-5578,PRKCA,Delta subfamily
396,88.9,kd,CGS001-79712,GTDC1,Glycosyltransferase group 1 domain containing
397,88.77,oe,ccsbBroad304_01676,TLE1,WD repeat domain containing
398,88.76,kd,CGS001-5608,MAP2K6,MAPKK:STE7 family
399,88.75,oe,ccsbBroad304_03864,OVOL2,"Zinc fingers, C2H2-type"
8206,-67.35,cp,BRD-K94441233,mevastatin,HMGCR inhibitor
404,88.59,oe,ccsbBroad304_02340,SORBS3,-
405,88.51,kd,CGS001-2355,FOSL2,basic leucine zipper proteins
406,88.51,kd,CGS001-8667,EIF3H,-
407,88.5,oe,ccsbBroad304_05982,CDX2,Homeoboxes / ANTP class : HOXL subclass
8201,-67.07,cp,BRD-K47659338,EMD-386088,Serotonin receptor agonist
408,88.49,oe,ccsbBroad304_07124,UROD,-
409,88.45,kd,CGS001-7468,WHSC1,"Zinc fingers, PHD-type"
8198,-66.82,cp,BRD-K46056750,AZD-7762,CHK inhibitor
410,88.35,kd,CGS001-4172,MCM3,-
411,88.29,kd,CGS001-51776,ZAK,MLK subfamily
412,88.26,kd,CGS001-22938,SNW1,-
413,88.22,kd,CGS001-51593,SRRT,-
8193,-66.35,cp,BRD-K33483813,actarit,Interleukin receptor agonist
414,88.18,kd,CGS001-819,CAMLG,-
8192,-66.2,cp,BRD-K00317371,RITA,MDM inhibitor
8190,-66.16,cp,BRD-K74501079,azithromycin,Bacterial 50S ribosomal subunit inhibitor
415,88.1,oe,ccsbBroad304_10064,NDUFS7,Mitochondrial respiratory chain complex / Complex I
416,88.08,oe,ccsbBroad304_01013,MIF,-
417,88.07,kd,CGS001-3718,JAK3,Janus kinase (JakA) family
418,88.06,kd,CGS001-27333,GOLIM4,-
420,88.03,kd,CGS001-6676,SPAG4,-
421,88.02,kd,CGS001-5689,PSMB1,Proteasome subunits
422,87.91,oe,ccsbBroad304_02708,TRIM32,-
8182,-65.65,cp,BRD-K29178788,dictamnine,Furoquinoline alkaloid
423,87.7,kd,CGS001-23405,DICER1,-
424,87.69,kd,CGS001-79142,PHF23,"Zinc fingers, PHD-type"
425,87.65,kd,CGS001-10491,CRTAP,-
426,87.57,oe,ccsbBroad304_07569,TRIB1,Trbl family
427,87.55,oe,ccsbBroad304_00430,GADD45A,-
428,87.54,kd,CGS001-7415,VCP,ATPases / AAA-type
429,87.53,kd,CGS001-831,CAST,-
430,87.47,kd,CGS001-1747,DLX3,Homeoboxes / ANTP class : NKL subclass
433,87.38,kd,CGS001-3800,KIF5C,Kinesins
434,87.37,kd,CGS001-39,ACAT2,Lanosterol biosynthesis pathway
435,87.36,oe,ccsbBroad304_00564,FGR,Src family
436,87.35,kd,CGS001-4849,CNOT3,-
437,87.33,oe,ccsbBroad304_00496,ELF4,ETS Transcription Factors
439,87.2,kd,CGS001-5547,PRCP,Lysosomal Pro-Xaa carboxypeptidase
441,87.16,kd,CGS001-5584,PRKCI,Iota subfamily
8166,-64.48,cp,BRD-K40892394,AR-C133057XX,Nitric oxide synthase inhibitor
442,87.11,kd,CGS001-6275,S100A4,EF-hand domain containing
443,87.09,kd,CGS001-10046,MAMLD1,-
445,86.89,oe,ccsbBroad304_04691,OSR2,"Zinc fingers, C2H2-type"
446,86.84,kd,CGS001-7533,YWHAH,-
447,86.83,kd,CGS001-2523,FUT1,Fucosyltransferases
8160,-63.5,cp,BRD-A36217750,sulfinpyrazone,Uricosuric blocker
448,86.79,kd,CGS001-3421,IDH3G,-
450,86.76,kd,CGS001-7546,ZIC2,"Zinc fingers, C2H2-type"
8157,-63.23,cp,BRD-K72034655,peucedanin,Apoptosis stimulant
8156,-63.22,cp,BRD-A55369275,CGP-54626,GABA receptor antagonist
452,86.65,kd,CGS001-23528,ZNF281,"Zinc fingers, C2H2-type"
453,86.64,kd,CGS001-3397,ID1,Basic helix-loop-helix proteins
8153,-63.17,cp,BRD-K53737926,amitriptyline,Norepinephrine inhibitor
8152,-62.99,cp,BRD-K43236057,piceid,ICAM1 inhibitor
454,86.63,kd,CGS001-7323,UBE2D3,Ubiquitin-conjugating enzymes E2
455,86.63,kd,CGS001-162699,TCEB3C,-
456,86.46,kd,CGS001-64786,TBC1D15,-
8148,-62.66,cp,BRD-K70490179,rimcazole,Sigma receptor antagonist
458,86.41,kd,CGS001-79902,NUP85,-
8146,-62.59,cp,BRD-K14329163,BAY-K8644,Calcium channel activator
460,86.37,kd,CGS001-221,ALDH3B1,Aldehyde dehydrogenases
461,86.19,kd,CGS001-857,CAV1,-
462,86.17,kd,CGS001-2896,GRN,-
464,86.14,kd,CGS001-9246,UBE2L6,Ubiquitin-conjugating enzymes E2
466,86,kd,CGS001-10607,TBL3,WD repeat domain containing
468,85.99,kd,CGS001-10523,CHERP,G patch domain containing
8139,-62.07,cp,BRD-K02265150,amoxapine,Norepinephrine reuptake inhibitor
469,85.89,kd,CGS001-9988,DMTF1,-
470,85.84,kd,CGS001-9512,PMPCB,-
8136,-61.94,cp,BRD-K03642198,AY-9944,Hedgehog pathway modulator
8135,-61.91,cp,BRD-K18194590,mephentermine,Adrenergic receptor agonist
471,85.79,kd,CGS001-7004,TEAD4,-
472,85.76,oe,ccsbBroad304_00478,S1PR3,GPCR / Class A : Lysophospholipid receptors : Sphingosine 1-phosphate
473,85.7,kd,CGS001-2931,GSK3A,GSK subfamily
8131,-61.64,cp,BRD-K70881766,solanine,Acetylcholinesterase inhibitor
474,85.67,kd,CGS001-8884,SLC5A6,"Sodium iodide symporter, sodium-dependent multivitamin transporter and sodium-coupled monocarboxylate transporters"
8130,-61.62,cp,BRD-K79404599,enzastaurin,PKC inhibitor
475,85.64,kd,CGS001-1829,DSG2,Cadherins / Major cadherins
477,85.57,oe,ccsbBroad304_00280,CDK7,"Cyclin-dependent kinases, CDK7 subfamily"
478,85.51,kd,CGS001-23523,CABIN1,-
479,85.47,oe,ccsbBroad304_03382,ZAK,MLK subfamily
480,85.42,kd,CGS001-55139,ANKZF1,Ankyrin repeat domain containing
481,85.38,kd,CGS001-54469,ZFAND6,"Zinc fingers, AN1-type domain containing"
8122,-60.97,cp,BRD-A73909368,dactinomycin,RNA polymerase inhibitor
8121,-60.91,cp,BRD-K79930101,GW-583340,EGFR inhibitor
8120,-60.88,cp,BRD-K46556543,canrenoic-acid,Mineralocorticoid receptor antagonist
483,85.23,kd,CGS001-4792,NFKBIA,Ankyrin repeat domain containing
484,85.17,kd,CGS001-58472,SQRDL,-
485,85.15,oe,ccsbBroad304_01283,PRKCE,Eta subfamily
486,85.12,kd,CGS001-5438,POLR2I,RNA polymerase subunits
488,84.94,kd,CGS001-6207,RPS13,S ribosomal proteins
489,84.92,kd,CGS001-57680,CHD8,-
490,84.8,oe,ccsbBroad304_06438,IL2RB,IL-2 receptor family
8112,-60.4,cc,,Phospholipases LOF,-
8110,-60.24,cc,,MDM inhibitor,-
491,84.78,kd,CGS001-4688,NCF2,Tetratricopeptide (TTC) repeat domain containing
8109,-60.21,cp,BRD-A45889380,mepacrine,Cytokine production inhibitor
8108,-60.18,cp,BRD-K57546357,prunetin,Breast cancer resistance protein inhibitor
492,84.76,kd,CGS001-10906,TRAFD1,-
493,84.75,kd,CGS001-2194,FASN,Short chain dehydrogenase/reductase superfamily / Atypical members
8105,-60,cp,BRD-K62221994,T-98475,Gonadotropin releasing factor hormone receptor antagonist
495,84.56,kd,CGS001-120892,LRRK2,Leucine-rich repeat kinase (LRRK) family
497,84.55,kd,CGS001-54512,EXOSC4,-
8102,-59.72,cp,BRD-K13810148,givinostat,HDAC inhibitor
499,84.43,kd,CGS001-146540,ZNF785,"Zinc fingers, C2H2-type"
500,84.4,oe,ccsbBroad304_03788,LPAR5,GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid
8099,-59.48,cp,BRD-A22256192,terazosin,Adrenergic receptor antagonist
8098,-59.4,cp,BRD-U94846492,quinine,Hemozoin biocrystallization inhibitor
503,84.18,kd,CGS001-4851,NOTCH1,Ankyrin repeat domain containing
504,84.1,kd,CGS001-10327,AKR1A1,Aldo-keto reductases
505,84.05,kd,CGS001-54899,PXK,Slob family
8094,-59.03,cp,BRD-A68631409,evodiamine,ATPase inhibitor
507,83.93,kd,CGS001-6182,MRPL12,Mitochondrial ribosomal proteins / large subunits
508,83.92,oe,ccsbBroad304_08392,EXOC6,-
8090,-58.65,cp,BRD-K95992530,Cyclo-[Arg-Gly-Asp-D-Phe-Val],integrin antagonist
8091,-58.65,cp,BRD-A18043272,phensuximide,Succinimide antiepileptic
509,83.74,kd,CGS001-2817,GPC1,Proteoglycans / Cell Surface : Glypicans
510,83.69,kd,CGS001-10857,PGRMC1,-
511,83.65,kd,CGS001-6117,RPA1,-
513,83.59,kd,CGS001-7919,DDX39B,DEAD-boxes
514,83.38,oe,ccsbBroad304_01538,SKP2,F-boxes / Leucine-rich repeats
515,83.37,kd,CGS001-847,CAT,-
516,83.34,kd,CGS001-1666,DECR1,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
8082,-57.86,cp,BRD-K89687904,PKCbeta-inhibitor,PKC inhibitor
517,83.32,kd,CGS001-27076,LYPD3,-
518,83.29,kd,CGS001-5209,PFKFB3,-
519,83.25,kd,CGS001-84159,ARID5B,-
520,83.14,kd,CGS001-8795,TNFRSF10B,Tumour necrosis factor (TNF) receptor family
521,83.14,kd,CGS001-23212,RRS1,-
522,83,kd,CGS001-7764,ZNF217,"Zinc fingers, C2H2-type"
524,82.97,kd,CGS001-6924,TCEB3,-
8074,-56.61,cp,BRD-A19248578,latrunculin-b,Actin polymerization inhibitor
8073,-56.46,cp,BRD-K72541103,JAK3-inhibitor-I,JAK inhibitor
8072,-56.4,cp,BRD-K12120659,GR-144053,Integrin antagonist
525,82.96,kd,CGS001-4931,NVL,ATPases / AAA-type
8070,-56.21,cp,BRD-K16554956,PTB1,AMPK activator
526,82.95,oe,ccsbBroad304_10232,PDIA5,Protein disulfide isomerases
8068,-56.09,cp,BRD-K23922020,arecaidine,Acetylcholine receptor agonist
527,82.84,kd,CGS001-8841,HDAC3,Histone deacetylases
528,82.83,oe,ccsbBroad304_00620,GCDH,-
530,82.72,kd,CGS001-7077,TIMP2,-
8063,-55.55,cp,BRD-K05104363,PD-184352,MEK inhibitor
531,82.6,kd,CGS001-3925,STMN1,-
8061,-55.54,cp,BRD-K70914287,BIBX-1382,EGFR inhibitor
532,82.6,kd,CGS001-148479,PHF13,"Zinc fingers, PHD-type"
533,82.6,kd,CGS001-23464,GCAT,-
534,82.6,kd,CGS001-310,ANXA7,Annexins
8058,-55.21,cp,BRD-K67847053,guanabenz,Adrenergic receptor agonist
8057,-55.18,cp,BRD-K08924299,palonosetron,Serotonin receptor antagonist
535,82.41,kd,CGS001-84823,LMNB2,"Intermediate filaments type V, lamins"
537,82.4,kd,CGS001-367,AR,Nuclear hormone receptors
538,82.37,kd,CGS001-51271,UBAP1,-
542,82.09,kd,CGS001-84890,ADO,-
544,82.04,kd,CGS001-55746,NUP133,-
545,82.01,kd,CGS001-3094,HINT1,-
546,82,kd,CGS001-9688,NUP93,-
547,81.98,oe,ccsbBroad304_02560,RNPS1,RNA binding motif (RRM) containing
548,81.95,oe,ccsbBroad304_03186,GMNN,-
8047,-54.29,cp,BRD-A10070317,propranolol,Adrenergic receptor antagonist
8046,-54.2,cp,BRD-K64052750,gefitinib,EGFR inhibitor
549,81.9,kd,CGS001-8801,SUCLG2,-
550,81.89,kd,CGS001-1453,CSNK1D,Casein kinase 1 (CK1) family
552,81.84,kd,CGS001-4046,LSP1,-
553,81.79,kd,CGS001-10057,ABCC5,ATP binding cassette transporters / subfamily C
554,81.6,kd,CGS001-7444,VRK2,Vaccina related kinase (VRK) family
555,81.55,kd,CGS001-200081,TXLNA,-
8039,-53.51,cp,BRD-K99696746,fatostatin,SREBP inhibitor
8038,-53.41,cp,BRD-K86191271,cytosporone-b,NUR77 receptor agonist
8037,-53.35,cp,BRD-K64451768,GANT-58,GLI antagonist
557,81.51,oe,ccsbBroad304_03197,NDUFA13,Mitochondrial respiratory chain complex / Complex I
8035,-53.02,cp,BRD-A72703248,SKF-96365,Calcium channel blocker
558,81.47,kd,CGS001-8140,SLC7A5,SLC7 family
560,81.34,kd,CGS001-4234,METTL1,-
561,81.26,kd,CGS001-1431,CS,-
562,81.25,oe,ccsbBroad304_07094,TPMT,-
563,81.19,kd,CGS001-498,ATP5A1,ATPases / F-type
564,81.09,oe,ccsbBroad304_04690,ZNF653,"Zinc fingers, C2H2-type"
567,81.08,kd,CGS001-9966,TNFSF15,Tumor necrosis factor (ligand) superfamily
568,80.94,kd,CGS001-11344,TWF2,Twinfilin subfamily
569,80.82,kd,CGS001-9533,POLR1C,RNA polymerase subunits
8025,-52.61,cp,BRD-K40742111,baeomycesic-acid,Lipoxygenase inhibitor
570,80.81,oe,ccsbBroad304_06319,GPR35,GPCR / Class A : Orphans
571,80.8,kd,CGS001-9695,EDEM1,-
572,80.76,oe,ccsbBroad304_06837,RAF1,RAF family
573,80.63,kd,CGS001-4086,SMAD1,SMADs
8020,-52.41,cp,BRD-K47780086,penciclovir,DNA directed DNA polymerase inhibitor
8019,-52.35,cp,BRD-K37516142,idebenone,Calcium channel modulator
574,80.61,kd,CGS001-8848,TSC22D1,-
8017,-51.93,cp,BRD-K46862739,metyrapone,Cytochrome P450 inhibitor
576,80.51,oe,ccsbBroad304_06557,MAOA,Catecholamine turnover
577,80.46,kd,CGS001-8714,ABCC3,ATP binding cassette transporters / subfamily C
578,80.27,kd,CGS001-6709,SPTAN1,EF-hand domain containing
579,80.26,kd,CGS001-2230,FDX1,-
580,80.23,kd,CGS001-5711,PSMD5,"Proteasome (prosome, macropain) subunits"
8011,-51.74,cp,BRD-K19554809,MK-212,Serotonin receptor agonist
8010,-51.73,cp,BRD-K77793136,hydroxyfasudil,Rho associated kinase inhibitor
581,80.2,oe,ccsbBroad304_08055,ATP5S,-
582,80.2,kd,CGS001-64343,AZI2,-
8007,-51.59,cc,,S100 calcium binding proteins LOF,-
583,80.12,kd,CGS001-10841,FTCD,-
8005,-51.54,cp,BRD-K01253243,SB-590885,RAF inhibitor
584,80.01,kd,CGS001-2863,GPR39,GPCR / Class A : Orphans
8003,-51.25,cp,BRD-A92826379,lupanine,Sodium channel blocker
8002,-51.1,cp,BRD-K70557564,zosuquidar,P-glycoprotein inhibitor
585,80,kd,CGS001-7728,ZNF175,"Zinc fingers, C2H2-type"
7999,-50.59,cc,,HMGCR inhibitor,-
586,79.98,kd,CGS001-7167,TPI1,-
588,79.8,kd,CGS001-7572,ZNF24,"Zinc fingers, C2H2-type"
589,79.77,oe,ccsbBroad304_00348,MAP3K8,MAPKKK:STE-unique family
591,79.72,kd,CGS001-6204,RPS10,S ribosomal proteins
592,79.63,oe,ccsbBroad304_01249,PPARG,Peroxisome proliferator-activated receptors
593,79.62,kd,CGS001-196,AHR,Basic helix-loop-helix proteins
594,79.46,oe,ccsbBroad304_02509,GMEB1,-
596,79.22,kd,CGS001-6004,RGS16,Regulators of G-protein signaling
597,79.03,kd,CGS001-23361,ZNF629,"Zinc fingers, C2H2-type"
7990,-49.26,cp,BRD-A02759312,betaxolol,Adrenergic receptor antagonist
7989,-49.14,cp,BRD-K05926469,lenalidomide,Antineoplastic
599,78.95,kd,CGS001-1384,CRAT,-
602,78.74,kd,CGS001-10845,CLPX,ATPases / AAA-type
603,78.63,kd,CGS001-8317,CDC7,CDC7 family
604,78.55,kd,CGS001-8874,ARHGEF7,Rho guanine nucleotide exchange factors
7984,-48.95,cp,BRD-K85013741,auraptene,Nitric oxide production inhibitor
605,78.49,oe,ccsbBroad304_04780,GPR139,GPCR / Class A : Orphans
606,78.46,kd,CGS001-2161,F12,Chymotrypsin
607,78.45,kd,CGS001-115,ADCY9,Adenylyl cyclases
608,78.4,kd,CGS001-9112,MTA1,GATA zinc finger domain containing
7979,-48.37,cp,BRD-K31283835,tofacitinib,JAK inhibitor
609,78.38,kd,CGS001-2624,GATA2,GATA zinc finger domain containing
7976,-48.12,cp,BRD-K01638814,rilmenidine,Adrenergic receptor agonist
610,78.36,kd,CGS001-5430,POLR2A,RNA polymerase subunits
611,78.29,kd,CGS001-60493,FASTKD5,-
612,78.25,kd,CGS001-7314,UBB,-
613,78.13,kd,CGS001-1728,NQO1,-
614,78.12,kd,CGS001-8737,RIPK1,Receptor interacting protein kinase (RIPK) family
615,78.05,kd,CGS001-701,BUB1B,Bub family
616,78.03,kd,CGS001-1363,CPE,Carboxypeptidase A
619,77.88,kd,CGS001-6820,SULT2B1,"Sulfotransferases, cytosolic"
7969,-47.05,cp,BRD-A19195498,trimipramine,Norepinephrine reuptake inhibitor
620,77.87,oe,ccsbBroad304_08282,ATP6V1D,ATPases / V-type
7966,-47,cp,BRD-K83794624,pirarubicin,Topoisomerase inhibitor
7965,-46.93,cp,BRD-K73838513,cinacalcet,Calcium channel activator
621,77.83,kd,CGS001-142,PARP1,Poly (ADP-ribose) polymerases
624,77.74,oe,ccsbBroad304_00881,IRF5,-
625,77.63,kd,CGS001-8022,LHX3,Homeoboxes / LIM class
7960,-46.61,cp,BRD-K51476772,ST-638,Tyrosine kinase inhibitor
7961,-46.61,cp,BRD-A98299281,velnacrine,cholinesterase inhibitor
7959,-46.57,cp,BRD-K32610195,androstenedione,Cytochrome P450 inhibitor
627,77.58,oe,ccsbBroad304_08054,EIF2AK1,Other PEK family kinases
628,77.57,kd,CGS001-64167,ERAP2,Aminopeptidase N
629,77.55,kd,CGS001-388677,NOTCH2NL,-
630,77.38,kd,CGS001-5707,PSMD1,Proteasome subunits
631,77.37,oe,ccsbBroad304_06982,SNRNP70,RNA binding motif (RRM) containing
632,77.35,kd,CGS001-9341,VAMP3,Vesicle-associated membrane proteins
7952,-45.97,cp,BRD-K44876623,zolpidem,Benzodiazepine receptor agonist
7951,-45.92,cp,BRD-K74913225,brinzolamide,Carbonic anhydrase inhibitor
633,77.31,oe,ccsbBroad304_05902,BNIP3,-
634,77.22,kd,CGS001-8611,PPAP2A,Lipid phosphate phosphatases
635,77.15,kd,CGS001-1655,DDX5,DEAD-boxes
636,77.09,kd,CGS001-4846,NOS3,Nitric oxide synthases
637,76.99,oe,ccsbBroad304_07091,TPM1,Tropomyosins
640,76.85,kd,CGS001-9322,TRIP10,-
641,76.84,kd,CGS001-4817,NIT1,-
7943,-45.43,cp,BRD-K87573634,propylpyrazole,Estrogen receptor agonist
642,76.64,kd,CGS001-10928,RALBP1,-
7941,-45.21,cp,BRD-A90515964,guaifenesin,Expectorant
643,76.64,kd,CGS001-27243,CHMP2A,Charged multivesicular body proteins
7939,-45.02,cp,BRD-K34508425,KUC103898N,-666
645,76.58,kd,CGS001-822,CAPG,-
7937,-44.93,cp,BRD-K35573744,erbstatin-analog,EGFR inhibitor
646,76.47,oe,ccsbBroad304_01764,VDAC1,Voltage-dependent anion channels
648,76.41,kd,CGS001-4092,SMAD7,SMADs
649,76.23,kd,CGS001-26054,SENP6,Ulp1 endopeptidase
7933,-44.34,cp,BRD-K92093830,doxorubicin,Topoisomerase inhibitor
7931,-44.25,cp,BRD-A65076780,dihydroergocristine,Adrenergic receptor antagonist
650,76.23,kd,CGS001-54546,RNF186,RING-type (C3HC4) zinc fingers
7930,-44.14,cp,BRD-K76810206,nicergoline,Adrenergic receptor antagonist
7929,-44.13,cp,BRD-A41250306,cyclopenthiazide,Thiazide diuretic
651,76.14,kd,CGS001-3488,IGFBP5,insulin-like growth factor (IGF) binding proteins
652,76.12,kd,CGS001-11245,GPR176,GPCR / Class A : Orphans
7925,-44.02,cp,BRD-A73680854,PT-630,Dipeptidyl peptidase inhibitor
653,76.08,kd,CGS001-118442,GPR62,GPCR / Class A : Orphans
654,76.03,kd,CGS001-1050,CEBPA,basic leucine zipper proteins
655,76.02,kd,CGS001-301,ANXA1,Annexins
656,75.95,kd,CGS001-1642,DDB1,-
657,75.9,kd,CGS001-6804,STX1A,-
658,75.86,oe,ccsbBroad304_06301,GOT2,-
660,75.82,kd,CGS001-3313,HSPA9,Heat shock proteins / HSP70
661,75.8,kd,CGS001-8438,RAD54L,-
662,75.8,kd,CGS001-1837,DTNA,-
664,75.77,kd,CGS001-7316,UBC,-
665,75.77,kd,CGS001-1983,EIF5,-
667,75.62,oe,ccsbBroad304_01071,NDUFB5,Mitochondrial respiratory chain complex / Complex I
7913,-43.16,cp,BRD-K18779551,bifemelane,Acetylcholine release stimulant
668,75.49,kd,CGS001-6240,RRM1,Ribonucleoside-diphosphate reductases
669,75.44,kd,CGS001-8659,ALDH4A1,Aldehyde dehydrogenases
671,75.27,oe,ccsbBroad304_01054,GADD45B,-
7909,-42.88,cp,BRD-K29530284,amlexanox,Histamine receptor modulator
672,75.26,kd,CGS001-55818,KDM3A,Histone demethylases
673,75.21,kd,CGS001-2079,ERH,-
674,75.17,oe,ccsbBroad304_02425,CDIPT,-
675,75.12,kd,CGS001-4758,NEU1,-
7904,-42.83,cp,BRD-K82746043,navitoclax,BCL inhibitor
676,75.08,kd,CGS001-8837,CFLAR,Endogenous ligands
677,75.04,kd,CGS001-25839,COG4,Components of oligomeric golgi complex
680,74.92,kd,CGS001-4299,AFF1,-
681,74.91,kd,CGS001-10856,RUVBL2,ATPases / AAA-type
682,74.88,oe,ccsbBroad304_02578,EBNA1BP2,-
685,74.76,kd,CGS001-89845,ABCC10,ATP binding cassette transporters / subfamily C
686,74.66,kd,CGS001-55500,ETNK1,-
687,74.58,kd,CGS001-7358,UGDH,-
688,74.51,oe,ccsbBroad304_04240,CLPB,Ankyrin repeat domain containing
689,74.44,kd,CGS001-5471,PPAT,Phosphoribosyl pyrophosphate amidotransferase
690,74.43,kd,CGS001-163049,ZNF791,"Zinc fingers, C2H2-type"
691,74.37,kd,CGS001-7862,BRPF1,Non-enzymatic BRD containing proteins
7891,-42.26,cp,BRD-K84141129,VU-0400193-3,Glutamate receptor modulator
692,74.35,oe,ccsbBroad304_00383,SLC25A10,Mitochondrial di- and tri-carboxylic acid transporter subfamily
7889,-42.08,cp,BRD-A18497530,5-iodotubercidin,Adenosine kinase inhibitor
7888,-42.06,cp,BRD-K18895904,olanzapine,Dopamine receptor antagonist
693,74.33,kd,CGS001-5523,PPP2R3A,EF-hand domain containing
7886,-42,cp,BRD-K11630072,carmofur,Thymidylate synthase inhibitor
694,74.32,kd,CGS001-11232,POLG2,DNA polymerases
696,74.21,kd,CGS001-2849,GPR26,GPCR / Class A : Orphans
697,74.14,kd,CGS001-10574,CCT7,Heat Shock Proteins / Chaperonins
7882,-41.7,cp,BRD-K50128260,sildenafil,Phosphodiesterase inhibitor
7881,-41.65,cp,BRD-K74733595,APHA-compound-8,HDAC inhibitor
698,74.13,oe,ccsbBroad304_02306,PQBP1,-
699,74.11,kd,CGS001-10362,HMG20B,High mobility group / Non-canonical
700,74.08,kd,CGS001-7474,WNT5A,Endogenous ligands
701,73.97,kd,CGS001-126208,ZNF787,"Zinc fingers, C2H2-type"
7876,-41.27,cp,BRD-A96897502,U-74389F,Lipid peroxidase inhibitor
7875,-41.1,cp,BRD-K63195589,tipifarnib,Farnesyltransferase inhibitor
7874,-41.04,cp,BRD-K27184429,levocetirizine,Histamine receptor antagonist
702,73.93,kd,CGS001-4069,LYZ,-
7872,-40.77,cp,BRD-A09495397,bicuculline,GABA receptor antagonist
703,73.92,oe,ccsbBroad304_00747,HLF,-
704,73.9,kd,CGS001-10352,WARS2,Aminoacyl tRNA synthetases / Class I
7869,-40.3,cp,BRD-K18135438,chenodeoxycholic-acid,11-beta-HSD1 inhibitor
705,73.79,kd,CGS001-4200,ME2,-
706,73.72,kd,CGS001-2059,EPS8,-
707,73.68,kd,CGS001-7292,TNFSF4,CD molecules
7865,-39.54,cp,BRD-K32330832,VER-155008,HSP inhibitor
708,73.62,oe,ccsbBroad304_09821,TMEM154,-
709,73.56,kd,CGS001-2852,GPER,-
710,73.46,kd,CGS001-5898,RALA,-
711,73.41,oe,ccsbBroad304_03736,SUCNR1,GPCR / Class A : Orphans
712,73.32,oe,ccsbBroad304_03687,NSFL1C,UBX domain containing
7859,-39.29,cp,BRD-K77677632,SB-200646,Serotonin receptor antagonist
713,73.26,kd,CGS001-4925,NUCB2,EF-hand domain containing
714,73.21,kd,CGS001-10406,WFDC2,WAP four-disulfide core domain containing
715,73.13,kd,CGS001-6421,SFPQ,RNA binding motif (RRM) containing
716,73.12,kd,CGS001-8892,EIF2B2,-
7854,-39,cp,BRD-K26548821,quinpirole,Dopamine receptor agonist
718,73.1,kd,CGS001-23244,PDS5A,-
719,72.96,kd,CGS001-5781,PTPN11,Protein tyrosine phosphatases
720,72.94,kd,CGS001-9324,HMGN3,High-mobility group / Canonical
721,72.92,kd,CGS001-23670,TMEM2,-
7849,-38.83,cc,,Bromodomain Inhibitor,-
7848,-38.79,cp,BRD-K55424922,anpirtoline,Serotonin receptor agonist
7847,-38.64,cp,BRD-K60690191,MPEP,Glutamate receptor antagonist
722,72.91,oe,ccsbBroad304_07349,MAP7,-
7844,-38.55,cp,BRD-A57457122,VU-0400071-3,Glutamate receptor modulator
7845,-38.55,cp,BRD-K45446451,JZL-184,Monoacylglucerol lipase inhibitor
723,72.87,kd,CGS001-57167,SALL4,"Zinc fingers, C2H2-type"
724,72.85,kd,CGS001-55781,RIOK2,RIO2 subfamily
725,72.85,kd,CGS001-168374,ZNF92,"Zinc fingers, C2H2-type"
7840,-38.28,cp,BRD-A68929948,DAPT-GSI-IX,Gamma secretase inhibitor
726,72.82,kd,CGS001-5127,CDK16,"Cyclin-dependent kinases, TAIRE subfamily"
727,72.76,kd,CGS001-1845,DUSP3,Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases
730,72.57,oe,ccsbBroad304_05528,TICAM2,-
731,72.42,kd,CGS001-10412,NSA2,-
732,72.31,kd,CGS001-51005,AMDHD2,-
733,72.2,kd,CGS001-6429,SRSF4,RNA binding motif (RRM) containing
7833,-38.01,cc,,JAK inhibitor,-
734,72.09,oe,ccsbBroad304_14158,GPR87,GPCR / Class A : Orphans
7832,-37.98,cp,BRD-A09533288,verapamil,Calcium channel blocker
736,72.04,kd,CGS001-2073,ERCC5,-
7830,-37.82,cp,BRD-A51182606,chloramphenicol,Protein synthesis inhibitor
737,71.98,kd,CGS001-10010,TANK,-
738,71.98,kd,CGS001-10614,HEXIM1,-
7826,-37.73,cp,BRD-K95402279,geranylgeraniol,Farnesyltransferase inhibitor
740,71.92,oe,ccsbBroad304_02057,P4HA2,-
741,71.82,kd,CGS001-22818,COPZ1,-
742,71.76,kd,CGS001-11136,SLC7A9,SLC7 family
743,71.7,kd,CGS001-6787,NEK4,NIMA (never in mitosis gene a)- related kinase (NEK) family
7821,-37.34,cp,BRD-K49945136,GR-113808,Serotonin receptor antagonist
7820,-37.31,cp,BRD-A70449690,forskolin,Adenylyl cyclase activator
744,71.68,kd,CGS001-3225,HOXC9,Homeoboxes / ANTP class : HOXL subclass
745,71.67,kd,CGS001-23657,SLC7A11,Solute carriers
7817,-37.22,cp,BRD-A65013509,oxybutynin,Acetylcholine receptor antagonist
746,71.63,kd,CGS001-83593,RASSF5,-
747,71.49,oe,ccsbBroad304_03103,SNX11,Sorting nexins
7814,-37.04,cp,BRD-A82590476,SDZ-NKT-343,Tachykinin antagonist
748,71.46,kd,CGS001-114026,ZIM3,"Zinc fingers, C2H2-type"
7812,-36.98,cp,BRD-K28761384,zuclopenthixol,Dopamine receptor antagonist
749,71.44,oe,ccsbBroad304_00873,INPP1,Inositol polyphosphate phosphatases
750,71.38,kd,CGS001-150094,SIK1,QIK subfamily
752,71.31,oe,ccsbBroad304_05985,CFL1,-
7808,-36.86,cp,BRD-A48430263,pioglitazone,Insulin sensitizer
753,71.27,kd,CGS001-4680,CEACAM6,CD molecules
754,71.22,kd,CGS001-10694,CCT8,Heat Shock Proteins / Chaperonins
755,71.17,kd,CGS001-10933,MORF4L1,-
7803,-36.77,cp,BRD-K49519092,immethridine,Histamine receptor agonist
756,71.16,kd,CGS001-3799,KIF5B,Kinesins
757,71.15,kd,CGS001-1029,CDKN2A,-
7801,-36.7,cp,BRD-A42423104,benproperine,Antitussive
7800,-36.66,cp,BRD-K41567364,SB-334867,Orexin receptor antagonist
7799,-36.38,cp,BRD-K48722258,dilazep,Adenosine reuptake inhibitor
758,71,kd,CGS001-10953,TOMM34,Tetratricopeptide (TTC) repeat domain containing
759,70.91,kd,CGS001-7030,TFE3,Basic helix-loop-helix proteins
760,70.9,kd,CGS001-147179,WIPF2,-
761,70.84,kd,CGS001-146434,ZNF597,"Zinc fingers, C2H2-type"
763,70.78,kd,CGS001-57215,THAP11,THAP (C2CH-type zinc finger) domain containing
764,70.78,kd,CGS001-5529,PPP2R5E,"Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits"
765,70.76,oe,ccsbBroad304_06021,KLF6,Kruppel-like transcription factors
767,70.72,kd,CGS001-7264,TSTA3,Short chain dehydrogenase/reductase superfamily / Extended SDR fold
768,70.61,kd,CGS001-8295,TRRAP,TRRAP subfamily
769,70.6,kd,CGS001-126823,KLHDC9,-
7788,-35.61,cp,BRD-K68065987,MK-2206,AKT inhibitor
770,70.55,oe,ccsbBroad304_06382,HMGCL,-
771,70.53,kd,CGS001-84969,TOX2,-
772,70.51,oe,ccsbBroad304_01651,TCF7L2,-
774,70.26,kd,CGS001-5546,PRCC,-
775,70.24,kd,CGS001-5982,RFC2,ATPases / AAA-type
776,70.17,kd,CGS001-79711,IPO4,Importins
777,70.17,kd,CGS001-11129,CLASRP,-
779,70.14,kd,CGS001-3609,ILF3,-
7779,-35,cp,BRD-K59331372,SB-366791,TRPV antagonist
780,70.12,kd,CGS001-55193,PBRM1,Non-enzymatic BRD containing proteins
781,70.1,oe,ccsbBroad304_02203,MAD2L1BP,-
783,70.1,kd,CGS001-6418,SET,-
785,69.93,oe,ccsbBroad304_00980,MBNL1,"Zinc fingers, CCCH-type domain containing"
787,69.88,kd,CGS001-112812,FDX1L,-
788,69.8,oe,ccsbBroad304_03659,FOXJ2,Forkhead boxes
789,69.79,kd,CGS001-58533,SNX6,Sorting nexins
7771,-34.7,cp,BRD-K00959089,thenoyltrifluoroacetone,Chelating agent
791,69.74,oe,ccsbBroad304_06318,GPER,-
792,69.73,oe,ccsbBroad304_09420,RASGRP4,EF-hand domain containing
793,69.71,kd,CGS001-3978,LIG1,-
794,69.61,kd,CGS001-8572,PDLIM4,-
795,69.54,kd,CGS001-10827,FAM114A2,-
796,69.54,kd,CGS001-124583,CANT1,-
797,69.49,kd,CGS001-3985,LIMK2,LIMK subfamily
7763,-34.35,cp,BRD-K09764130,mead-ethanolamide,Cannabinoid receptor agonist
7762,-34.34,cp,BRD-K85925969,zalcitabine,Nucleoside reverse transcriptase inhibitor
798,69.42,oe,ccsbBroad304_00283,CDKN2C,Ankyrin repeat domain containing
7760,-33.85,cp,BRD-K60184833,tyrphostin-46,Tyrosine kinase inhibitor
801,69.34,oe,ccsbBroad304_01074,NDUFS3,Mitochondrial respiratory chain complex / Complex I
7758,-33.76,cp,BRD-A84481105,thioridazine,Dopamine receptor antagonist
7757,-33.74,cc,,Tachykinin antagonist,-
7755,-33.61,cp,BRD-A52588987,SKF-83566,Dopamine receptor antagonist
803,69.27,kd,CGS001-9014,TAF1B,-
804,69.22,kd,CGS001-10013,HDAC6,Histone deacetylases
7753,-33.56,cp,BRD-K63915849,AS-604850,PI3K inhibitor
805,69.18,kd,CGS001-23038,WDTC1,DDB1 and CUL4 associated factors
806,69.16,kd,CGS001-4482,MSRA,-
7750,-33.42,cp,BRD-A60245366,AS-601245,JNK inhibitor
7749,-33.28,cp,BRD-K41051431,mecillinam,Bacterial cell wall synthesis inhibitor
808,68.97,kd,CGS001-55165,CEP55,-
7747,-33.17,cp,BRD-K36198571,WAY-170523,Metalloproteinase inhibitor
809,68.86,kd,CGS001-10730,YME1L1,ATPases / AAA-type
7745,-33.09,cp,BRD-K59037100,oxybenzone,Lipase inhibitor
812,68.82,kd,CGS001-8824,CES2,Carboxylesterases
814,68.68,kd,CGS001-55011,PIH1D1,-
816,68.58,kd,CGS001-1462,VCAN,Immunoglobulin superfamily / V-set domain containing
7741,-32.89,cp,BRD-A01145011,zebularine,DNA methyltransferase inhibitor
7740,-32.85,cp,BRD-K92428153,mycophenolate-mofetil,Dehydrogenase inhibitor
7739,-32.77,cp,BRD-A76279427,myriocin,Serine palmitoyltransferase inhibitor
7738,-32.75,cp,BRD-K83508485,FK-888,Tachykinin antagonist
817,68.39,kd,CGS001-9133,CCNB2,-
818,68.31,kd,CGS001-11267,SNF8,-
7735,-32.54,cp,BRD-K72093121,vidarabine,Antiviral
819,68.28,kd,CGS001-3171,FOXA3,Forkhead boxes
820,68.26,kd,CGS001-3174,HNF4G,Hepatocyte nuclear factor-4 receptors
821,68.09,oe,ccsbBroad304_12492,RBM15,RNA binding motif (RRM) containing
822,68.07,kd,CGS001-56923,NMUR2,GPCR / Class A : Neuromedin U receptors
823,68.03,kd,CGS001-29959,NRBP1,NRBP family
7729,-32.33,cc,,Rho associated kinase inhibitor,-
7728,-32.25,cp,BRD-A65615053,zacopride,Serotonin receptor antagonist
824,67.93,kd,CGS001-64783,RBM15,RNA binding motif (RRM) containing
7726,-32.07,cp,BRD-K36324071,NF-449,Purinergic receptor antagonist
825,67.9,kd,CGS001-9475,ROCK2,Pleckstrin homology (PH) domain containing
826,67.9,oe,ccsbBroad304_06392,HOXB7,Homeoboxes / ANTP class : HOXL subclass
7723,-31.98,cp,BRD-K15086322,JNJ-10191584,Histamine receptor antagonist
828,67.77,kd,CGS001-3895,KTN1,-
7721,-31.93,cp,BRD-A59215453,lobelanidine,Acetylcholine receptor antagonist
7720,-31.91,cp,BRD-K63675182,triflupromazine,Dopamine receptor antagonist
7719,-31.88,cp,BRD-K82036761,sertraline,Serotonin receptor antagonist
829,67.75,kd,CGS001-9712,USP6NL,-
830,67.71,kd,CGS001-5682,PSMA1,Proteasome subunits
7716,-31.7,cp,BRD-K62206109,VUF-5681,Histamine receptor antagonist
7714,-31.68,cp,BRD-K36529613,PU-H71,HSP inhibitor
7715,-31.68,cp,BRD-A26097136,bulleyaconitine-a,Non-opiod analgesic
7713,-31.64,cp,BRD-K84266862,BRL-50481,Phosphodiesterase inhibitor
7712,-31.63,cp,BRD-A99177642,deltaline,Acetylcholine receptor antagonist
831,67.7,oe,ccsbBroad304_06398,HPN,Serine peptidases / Transmembrane
7710,-31.55,cp,BRD-A53077924,tianeptine,Selective serotonin reuptake enhancer (SSRE)
832,67.66,kd,CGS001-374291,NDUFS7,Mitochondrial respiratory chain complex / Complex I
833,67.62,kd,CGS001-7165,TPD52L2,-
7707,-31.45,cp,BRD-K91696562,orantinib,FGFR inhibitor
834,67.52,oe,ccsbBroad304_06639,NFYB,-
835,67.43,oe,ccsbBroad304_09429,FOXP4,Forkhead boxes
836,67.37,oe,ccsbBroad304_02157,MED21,-
837,67.26,kd,CGS001-23410,SIRT3,Histone deacetylases (HDACs)
838,67.23,oe,ccsbBroad304_05757,ACADS,-
7701,-31.34,cp,BRD-K19416115,sitagliptin,Dipeptidyl peptidase inhibitor
839,67.22,oe,ccsbBroad304_00401,CYB5A,Cytochrome b genes
841,67.19,kd,CGS001-6775,STAT4,SH2 domain containing
843,67.14,kd,CGS001-285268,ZNF621,"Zinc fingers, C2H2-type"
844,67.13,kd,CGS001-5771,PTPN2,Protein tyrosine phosphatases
845,67.08,kd,CGS001-670,BPHL,-
847,67.03,kd,CGS001-6917,TCEA1,General transcription factors
848,67.03,kd,CGS001-5018,OXA1L,-
849,67.01,kd,CGS001-63891,RNF123,RING-type (C3HC4) zinc fingers
7692,-30.59,cp,BRD-K56700933,phenethyl-isothiocyanate,Antineoplastic
852,66.77,kd,CGS001-55722,CEP72,-
853,66.74,oe,ccsbBroad304_04431,PHF5A,"Zinc fingers, PHD-type"
854,66.72,kd,CGS001-81621,KAZALD1,Immunoglobulin superfamily / I-set domain containing
7688,-30.27,cp,BRD-K98426715,tubacin,HDAC inhibitor
856,66.6,kd,CGS001-8193,DPF1,"Zinc fingers, PHD-type"
857,66.54,kd,CGS001-4199,ME1,-
858,66.53,kd,CGS001-2869,GRK5,GRK1/3 subfamily
7684,-29.97,cp,BRD-A20131130,"2',5'-dideoxyadenosine",Adenylyl cyclase inhibitor
7683,-29.94,cp,BRD-A94413429,NTNCB,Neuropeptide receptor antagonist
860,66.36,kd,CGS001-9784,SNX17,Sorting nexins
862,66.29,kd,CGS001-6598,SMARCB1,-
7680,-29.76,cp,BRD-K50311478,tosyl-phenylalanyl-chloromethyl-ketone,Chymotrypsin inhibitor
863,66.22,kd,CGS001-675,BRCA2,"Fanconi anemia, complementation groups"
864,66.21,kd,CGS001-8893,EIF2B5,-
865,66.14,kd,CGS001-81577,GFOD2,-
867,66.09,kd,CGS001-760,CA2,Carbonic anhydrases
868,66.04,kd,CGS001-5693,PSMB5,Proteasome subunits
869,65.91,kd,CGS001-3565,IL4,Interleukins and interleukin receptors
871,65.87,kd,CGS001-7291,TWIST1,Basic helix-loop-helix proteins
872,65.84,kd,CGS001-11019,LIAS,-
873,65.79,kd,CGS001-3690,ITGB3,Integrins
874,65.71,kd,CGS001-125950,RAVER1,RNA binding motif (RRM) containing
7669,-29.2,cp,BRD-K53561341,KIN001-220,Aurora kinase inhibitor
7668,-29.16,cp,BRD-K17868609,BRL-54443,Serotonin receptor agonist
876,65.59,kd,CGS001-6817,SULT1A1,"Sulfotransferases, cytosolic"
877,65.55,kd,CGS001-6223,RPS19,S ribosomal proteins
878,65.48,kd,CGS001-5347,PLK1,Polo-like kinase (PLK) family
879,65.46,kd,CGS001-174,AFP,-
7663,-28.93,cp,BRD-K41337261,ZM-306416,ABL inhibitor
7662,-28.91,cp,BRD-A65280694,molindone,Dopamine receptor antagonist
7660,-28.9,cc,,Serotonin receptor antagonist,-
880,65.43,kd,CGS001-23566,LPAR3,GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid
881,65.42,kd,CGS001-5832,ALDH18A1,Aldehyde dehydrogenases
883,65.41,kd,CGS001-2260,FGFR1,Type V RTKs: FGF (fibroblast growth factor) receptor family
884,65.39,kd,CGS001-143,PARP4,Poly (ADP-ribose) polymerases
885,65.38,kd,CGS001-5810,RAD1,-
886,65.37,oe,ccsbBroad304_06518,LDHA,-
888,65.26,kd,CGS001-93594,WDR67,-
889,65.22,kd,CGS001-9488,PIGB,Dolichyl D-mannosyl phosphate dependent mannosyltransferases
890,65.17,kd,CGS001-3566,IL4R,IL-2 receptor family
7651,-28.65,cp,BRD-K17378184,prestwick-559,Dopamine receptor agonist
892,65.08,oe,ccsbBroad304_06191,FABP6,Fatty acid binding protein family
894,65.05,kd,CGS001-9868,TOMM70A,Tetratricopeptide (TTC) repeat domain containing
896,64.9,kd,CGS001-79960,PHF17,-
7647,-28.49,cp,BRD-A84389091,L-655708,GABA receptor inverse agonist
897,64.85,kd,CGS001-26993,AKAP8L,-
898,64.82,kd,CGS001-9788,MTSS1,-
899,64.78,kd,CGS001-9289,GPR56,Adhesion Class GPCRs
900,64.76,kd,CGS001-26511,CHIC2,-
7642,-27.99,cp,BRD-K89162000,tandutinib,FLT3 inhibitor
901,64.74,kd,CGS001-9738,CCP110,-
7640,-27.89,cp,BRD-K64890080,BI-2536,PLK inhibitor
903,64.64,kd,CGS001-350,APOH,Apolipoproteins
904,64.59,kd,CGS001-3339,HSPG2,Immunoglobulin superfamily / Immunoglobulin-like domain containing
7637,-27.76,cp,BRD-K89014967,AS-703026,MEK inhibitor
7636,-27.75,cp,BRD-A87125127,3-matida,Glutamate receptor antagonist
905,64.49,kd,CGS001-403,ARL3,ADP-ribosylation factors
7635,-27.73,cp,BRD-A67373739,AICA-ribonucleotide,AMPK activator
906,64.47,kd,CGS001-10329,TMEM5,-
907,64.41,kd,CGS001-5427,POLE2,DNA polymerases
908,64.4,oe,ccsbBroad304_02398,LANCL1,-
909,64.34,kd,CGS001-54623,PAF1,-
910,64.29,kd,CGS001-10206,TRIM13,RING-type (C3HC4) zinc fingers
7628,-27.38,cp,BRD-K86873305,piperacillin,Bacterial cell wall synthesis inhibitor
7627,-27.32,cp,BRD-K08554278,bisbenzimide,DNA binding agent
911,64.25,oe,ccsbBroad304_05890,BHMT,-
912,64.13,kd,CGS001-5873,RAB27A,"RAB, member RAS oncogene"
913,64.04,kd,CGS001-65264,UBE2Z,Ubiquitin-conjugating enzymes E2
914,64.02,kd,CGS001-10765,KDM5B,Histone demethylases
915,63.97,kd,CGS001-159296,NKX2-3,Homeoboxes / ANTP class : NKL subclass
7621,-26.99,cp,BRD-K73319509,PF-04217903,c-Met inhibitor
7620,-26.95,cp,BRD-A79803969,memantine,Glutamate receptor antagonist
917,63.91,kd,CGS001-24138,IFIT5,Tetratricopeptide (TTC) repeat domain containing
918,63.87,oe,ccsbBroad304_00081,APOC3,Apolipoproteins
7617,-26.81,cp,BRD-A10977446,carvedilol,Adrenergic receptor antagonist
919,63.86,kd,CGS001-57693,ZNF317,"Zinc fingers, C2H2-type"
7615,-26.73,cp,BRD-A80574334,oxalomalic-acid,Isocitrate dehydrogenase inhibitor
920,63.68,kd,CGS001-7381,UQCRB,Mitochondrial respiratory chain complex / Complex III
7613,-26.55,cp,BRD-A75455249,kavain,Calcium channel modulator
921,63.65,kd,CGS001-84290,CAPNS2,EF-hand domain containing
922,63.63,kd,CGS001-7840,ALMS1,-
923,63.59,oe,ccsbBroad304_01858,FOSL1,basic leucine zipper proteins
924,63.54,kd,CGS001-10092,ARPC5,Actin related protein 2/3 complex subunits
925,63.47,kd,CGS001-26986,PABPC1,RNA binding motif (RRM) containing
926,63.46,kd,CGS001-53343,NUDT9,Nudix motif containing
927,63.45,kd,CGS001-8853,ASAP2,Ankyrin repeat domain containing
7605,-26.21,cp,BRD-A99571536,dubinidine,Anti-epileptic
7604,-26.11,cp,BRD-A74771556,nikkomycin,Chitin inhibitor
929,63.43,kd,CGS001-9887,SMG7,-
930,63.42,oe,ccsbBroad304_03396,FGFRL1,Immunoglobulin superfamily / I-set domain containing
931,63.38,kd,CGS001-29998,GLTSCR1,-
932,63.37,oe,ccsbBroad304_00433,DECR1,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
933,63.34,kd,CGS001-84288,EFCAB2,EF-hand domain containing
934,63.33,kd,CGS001-1719,DHFR,Oxidoreductases
935,63.12,oe,ccsbBroad304_05881,BCL2L2,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
936,63.01,oe,ccsbBroad304_04190,CCDC92,-
7595,-25.49,cp,BRD-K81169441,cerivastatin,HMGCR inhibitor
7594,-25.48,cp,BRD-K89997465,chlorpromazine,Dopamine receptor antagonist
937,62.95,kd,CGS001-7186,TRAF2,RING-type (C3HC4) zinc fingers
938,62.93,kd,CGS001-10613,ERLIN1,-
940,62.83,kd,CGS001-955,ENTPD6,-
942,62.79,kd,CGS001-3226,HOXC10,Homeoboxes / ANTP class : HOXL subclass
943,62.74,kd,CGS001-8985,PLOD3,-
944,62.64,kd,CGS001-5337,PLD1,Phosphatidylcholine-specific phospholipase D
7587,-25.11,cp,BRD-K52394958,GR-159897,Tachykinin antagonist
7585,-25.06,cp,BRD-A85587465,bemesetron,Serotonin receptor antagonist
945,62.61,oe,ccsbBroad304_01279,PRKAG1,AMPK subfamily
946,62.58,oe,ccsbBroad304_00521,ETV5,ETS Transcription Factors
947,62.48,kd,CGS001-3093,UBE2K,Ubiquitin-conjugating enzymes E2
948,62.38,kd,CGS001-1727,CYB5R3,-
950,62.35,kd,CGS001-5591,PRKDC,Other PIKK family kinases
951,62.33,kd,CGS001-3127,HLA-DRB5,Immunoglobulin superfamily / C1-set domain containing
7579,-24.88,cp,BRD-K70487031,flupentixol,Dopamine receptor antagonist
952,62.14,kd,CGS001-84365,MKI67IP,-
953,62.06,oe,ccsbBroad304_01466,RRM2,Ribonucleoside-diphosphate reductases
954,62,kd,CGS001-54505,DHX29,DEAH-boxes
7575,-24.75,cp,BRD-A93206962,L-755507,Adrenergic receptor agonist
7572,-24.68,cp,BRD-A84134924,pancuronium,Acetylcholine receptor antagonist
955,61.97,kd,CGS001-9847,KIAA0528,-
956,61.96,oe,ccsbBroad304_04398,MRPL43,Mitochondrial ribosomal proteins / large subunits
7570,-24.66,cp,BRD-K98493452,honokiol,AKT inhibitor
959,61.7,oe,ccsbBroad304_06424,IFI16,-
7568,-24.57,cp,BRD-K55677650,CO-101244,Ionotropic glutamate receptor antagonist
960,61.68,kd,CGS001-7693,ZNF134,"Zinc fingers, C2H2-type"
961,61.65,oe,ccsbBroad304_00389,CTBP1,-
962,61.63,kd,CGS001-11168,PSIP1,-
963,61.6,kd,CGS001-80204,FBXO11,Protein arginine N-methyltransferases
964,61.59,kd,CGS001-929,CD14,CD molecules
965,61.54,kd,CGS001-1852,DUSP9,Protein tyrosine phosphatases / Class I Cys-based PTPs : MAP kinase phosphatases
967,61.42,kd,CGS001-8720,MBTPS1,Subtilisin
7560,-24.15,cp,BRD-K61737877,VEGF-receptor-2-kinase-inhibitor-IV,VEGFR inhibitor
969,61.36,kd,CGS001-478,ATP1A3,ATPases / P-type
971,61.31,kd,CGS001-2925,GRPR,GPCR / Class A : Bombesin receptors
972,61.26,kd,CGS001-7994,KAT6A,Histone acetyltransferases (HATs)
7556,-23.98,cp,BRD-A21723284,naltriben,Opioid receptor antagonist
973,61.22,oe,ccsbBroad304_03418,ZFAND6,"Zinc fingers, AN1-type domain containing"
7555,-23.94,cp,BRD-K94512704,spiramide,Dopamine receptor antagonist
974,61.11,kd,CGS001-26064,RAI14,Ankyrin repeat domain containing
975,61.1,kd,CGS001-4691,NCL,RNA binding motif (RRM) containing
7552,-23.78,cp,BRD-K18909381,CGS-12066B,Serotonin receptor agonist
976,61.09,kd,CGS001-865,CBFB,-
7550,-23.7,cp,BRD-K21565985,xylazine,Adrenergic receptor agonist
977,61.08,kd,CGS001-644,BLVRA,-
979,61,kd,CGS001-5775,PTPN4,Protein tyrosine phosphatases
980,60.95,kd,CGS001-5188,PET112,-
981,60.93,kd,CGS001-27201,GPR78,GPCR / Class A : Orphans
982,60.69,kd,CGS001-9886,RHOBTB1,BTB/POZ domain containing
983,60.69,kd,CGS001-56647,BCCIP,-
984,60.65,kd,CGS001-2119,ETV5,ETS Transcription Factors
985,60.6,kd,CGS001-10943,MSL3,-
7541,-23.29,cp,BRD-A26334849,propafenone,Antiarrhythmic
986,60.58,kd,CGS001-7159,TP53BP2,Ankyrin repeat domain containing
987,60.5,kd,CGS001-4850,CNOT4,RNA binding motif (RRM) containing
988,60.42,kd,CGS001-51070,NOSIP,-
989,60.42,kd,CGS001-8804,CREG1,-
991,60.39,oe,ccsbBroad304_06828,PYCR1,-
7535,-23.04,cp,BRD-K46384212,o-3M3FBS,phospholipase activator
7534,-23.02,cp,BRD-A98702003,carbenoxolone,11-beta-HSD1 inhibitor
7533,-23,cp,BRD-K28029915,dolasetron,Serotonin receptor antagonist
7532,-22.97,cp,BRD-K85871428,SC-68376,p38 MAPK inhibitor
992,60.29,kd,CGS001-9955,HS3ST3A1,"Sulfotransferases, membrane-bound"
993,60.25,kd,CGS001-47,ACLY,-
7529,-22.91,cp,BRD-K60219430,serdemetan,MDM inhibitor
7528,-22.88,cp,BRD-K10852020,tolcapone,Catechol O methyltransferase inhibitor
7527,-22.83,cp,BRD-K40619305,larixinic-acid,Compound that interacts with metal centers
7526,-22.82,cp,BRD-K30570479,VU-0400195-3,Glutamate receptor modulator
7525,-22.75,cp,BRD-K23913458,coumarin,Vitamin K antagonist
7524,-22.71,cp,BRD-A67981824,cefotaxime,Bacterial cell wall synthesis inhibitor
994,60.22,oe,ccsbBroad304_02751,SATB2,Homeoboxes / CUT class
7520,-22.56,cp,BRD-K87696786,LY-456236,Glutamate receptor antagonist
995,60.22,kd,CGS001-5710,PSMD4,"Proteasome (prosome, macropain) subunits"
996,60.2,kd,CGS001-22823,MTF2,"Zinc fingers, PHD-type"
997,60.17,kd,CGS001-7321,UBE2D1,Ubiquitin-conjugating enzymes E2
998,60.15,kd,CGS001-5293,PIK3CD,Phosphatidylinositol kinases
999,60.05,kd,CGS001-1854,DUT,-
7515,-22.42,cp,BRD-K96319534,phentermine,Dopamine uptake inhibitor
7516,-22.42,cp,BRD-K48692744,NU-1025,PARP inhibitor
1000,60.01,kd,CGS001-7189,TRAF6,RING-type (C3HC4) zinc fingers
1001,59.85,kd,CGS001-4144,MAT2A,-
7512,-22.28,cp,BRD-K23192422,lestaurtinib,FLT3 inhibitor
1002,59.79,oe,ccsbBroad304_00945,LMNA,"Intermediate filaments type V, lamins"
7511,-22.19,cp,BRD-A68039575,liquiritigenin,Aromatase inhibitor
7509,-22.18,cp,BRD-K91900765,VX-745,p38 MAPK inhibitor
7508,-22.17,cp,BRD-A81772229,simvastatin,HMGCR inhibitor
7507,-22.14,cp,BRD-K80738081,resveratrol,Cytochrome P450 inhibitor
7506,-22.09,cp,BRD-A25004090,erastin,Ion channel antagonist
1003,59.76,kd,CGS001-140609,NEK7,NIMA (never in mitosis gene a)- related kinase (NEK) family
7503,-22.04,cp,BRD-K60923938,veratridine,Sodium channel activator
1004,59.74,kd,CGS001-9212,AURKB,Aurora kinase
1005,59.66,kd,CGS001-388,RHOB,-
7501,-22.01,cp,BRD-K14696368,"9-methyl-5H-6-thia-4,5-diaza-chrysene-6,6-dioxide",NFkB pathway inhibitor
1006,59.65,kd,CGS001-93134,ZNF561,"Zinc fingers, C2H2-type"
1007,59.64,kd,CGS001-11124,FAF1,UBX domain containing
7499,-21.91,cp,BRD-K24994810,androstenol,GABA receptor modulator
1008,59.3,kd,CGS001-66008,TRAK2,-
1009,59.27,kd,CGS001-4860,PNP,-
1010,59.19,oe,ccsbBroad304_03310,LCMT1,-
1011,59.14,kd,CGS001-55038,CDCA4,-
1012,59.05,kd,CGS001-53632,PRKAG3,AMPK subfamily
7492,-21.64,cp,BRD-K53123955,niridazole,Phosphofructokinase inhibitor
1013,59.04,kd,CGS001-340371,NRBP2,NRBP family
1014,58.89,kd,CGS001-1386,ATF2,basic leucine zipper proteins
1015,58.78,oe,ccsbBroad304_06236,XRCC6,XRCC DNA Repair
1016,58.71,kd,CGS001-5901,RAN,-
1017,58.66,kd,CGS001-8777,MPDZ,-
7486,-21.09,cp,BRD-K82795137,loratadine,Histamine receptor antagonist
1018,58.65,kd,CGS001-10544,PROCR,CD molecules
1021,58.42,kd,CGS001-8435,SOAT2,-
1022,58.39,kd,CGS001-1605,DAG1,-
7482,-20.94,cp,BRD-A87387433,cefpodoxime,Bacterial cell wall synthesis inhibitor
7481,-20.78,cp,BRD-K20995441,U-54494A,Opioid receptor agonist
7480,-20.75,cp,BRD-K31491153,1-phenylbiguanide,Serotonin receptor agonist
1023,58.35,kd,CGS001-5469,MED1,-
1024,58.31,kd,CGS001-283078,MKX,Homeoboxes / TALE class
1025,58.16,kd,CGS001-115950,ZNF653,"Zinc fingers, C2H2-type"
7476,-20.5,cp,BRD-A29644307,nomifensine,Dopamine uptake inhibitor
1026,58.14,oe,ccsbBroad304_01974,RNASET2,-
1027,58.07,kd,CGS001-6617,SNAPC1,-
1028,58,kd,CGS001-875,CBS,Hydrogen sulphide synthesis
1029,57.97,kd,CGS001-6597,SMARCA4,Non-enzymatic BRD containing proteins
1030,57.9,kd,CGS001-6389,SDHA,Mitochondrial respiratory chain complex
1032,57.78,kd,CGS001-7541,ZFP161,-
1033,57.78,kd,CGS001-89884,LHX4,Homeoboxes / LIM class
7468,-20.08,cp,BRD-K15262564,mupirocin,Isoleucyl-tRNA synthetase inhibitor
7467,-20.07,cp,BRD-K59574735,ubenimex,Leukotriene inhibitor
1034,57.66,kd,CGS001-2647,BLOC1S1,Biogenesis of lysosomal organelles complex-1 subunits
1035,57.64,kd,CGS001-7490,WT1,"Zinc fingers, C2H2-type"
1036,57.59,kd,CGS001-92595,ZNF764,"Zinc fingers, C2H2-type"
1037,57.53,kd,CGS001-1399,CRKL,SH2 domain containing
7462,-19.82,cp,BRD-K52911425,GDC-0941,PI3K inhibitor
7460,-19.8,cp,BRD-K69556541,ryanodine,Calcium channel blocker
7461,-19.8,cp,BRD-K06926592,tretinoin,Retinoid receptor agonist
7459,-19.78,cp,BRD-K68103045,CGS-20625,Benzodiazepine receptor agonist
7458,-19.76,cp,BRD-A38747044,KU-14R,Imidazoline receptor ligand
1038,57.42,kd,CGS001-56139,PCDHA10,Cadherins / Protocadherins : Clustered
7456,-19.57,cp,BRD-K26657438,imiquimod,TLR agonist
7455,-19.53,cp,BRD-K20714604,RS-56812,Serotonin receptor partial agonist
1039,57.42,kd,CGS001-10898,CPSF4,-
1040,57.39,kd,CGS001-5518,PPP2R1A,"Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits"
1041,57.37,kd,CGS001-23321,TRIM2,RING-type (C3HC4) zinc fingers
1042,57.36,kd,CGS001-117581,TWIST2,Basic helix-loop-helix proteins
1043,57.33,kd,CGS001-89849,ATG16L2,WD repeat domain containing
1044,57.31,oe,ccsbBroad304_03939,RNF25,RING-type (C3HC4) zinc fingers
7448,-19.16,cp,BRD-U66370498,androstanol,CAR antagonist
1047,57.26,kd,CGS001-219333,USP12,Ubiquitin-specific peptidases
7447,-19.12,cp,BRD-K93280214,gabazine,GABA receptor antagonist
1048,57.25,kd,CGS001-55278,QRSL1,-
1049,57.23,kd,CGS001-8891,EIF2B3,-
7443,-19.02,cp,BRD-A07780951,orciprenaline,Adrenergic receptor agonist
7442,-18.9,cp,BRD-K48923948,BMS-641988,Androgen receptor antagonist
1054,57.01,kd,CGS001-1123,CHN1,Rho GTPase activating proteins
1056,56.82,kd,CGS001-3104,ZBTB48,BTB/POZ domain containing
1057,56.78,kd,CGS001-23786,BCL2L13,-
1058,56.73,kd,CGS001-25801,GCA,EF-hand domain containing
7437,-18.86,cp,BRD-K85242180,beta-CCP,"Indoleamine 2,3-dioxygenase inhibitor"
1059,56.71,oe,ccsbBroad304_06855,RDX,-
1060,56.7,kd,CGS001-51015,ISOC1,-
1061,56.69,oe,ccsbBroad304_01593,SRP14,-
1062,56.66,kd,CGS001-10971,YWHAQ,-
1063,56.64,kd,CGS001-6210,RPS15A,S ribosomal proteins
1067,56.51,kd,CGS001-9697,TRAM2,-
1068,56.44,kd,CGS001-801,CALM1,EF-hand domain containing
7429,-18.47,cp,BRD-K06234293,LY-364947,TGF beta receptor inhibitor
1069,56.42,kd,CGS001-6217,RPS16,S ribosomal proteins
7427,-18.43,cp,BRD-K56509348,BMS-182874,Endothelin receptor antagonist
7426,-18.38,cp,BRD-K42098891,protriptyline,Tricyclic antidepressant
1070,56.36,kd,CGS001-9897,KIAA0196,-
1072,56.34,oe,ccsbBroad304_02625,SLC7A9,SLC7 family
7424,-18.33,cp,BRD-A52660433,tetrindole,Monoamine oxidase inhibitor
7422,-18.31,cp,BRD-K40656405,L-165041,PPAR receptor agonist
7421,-18.29,cp,BRD-K08703257,3-amino-benzamide,PARP inhibitor
7420,-18.28,cp,BRD-A36267905,buphenine,Adrenergic receptor agonist
1073,56.33,kd,CGS001-6566,SLC16A1,SLC16 family of monocarboxylate transporters
1074,56.31,oe,ccsbBroad304_07814,SACM1L,-
1075,56.3,kd,CGS001-4043,LRPAP1,-
1077,55.95,kd,CGS001-7357,UGCG,Glycosyltransferase family 2 domain containing
7415,-18.15,cp,BRD-K04887706,AKT-inhibitor-1-2,AKT inhibitor
7414,-18.12,cp,BRD-K26373640,IKK-2-inhibitor,IKK inhibitor
1079,55.79,kd,CGS001-3303,HSPA1A,Heat shock proteins / HSP70
1080,55.76,kd,CGS001-5690,PSMB2,Proteasome subunits
1081,55.76,oe,ccsbBroad304_05787,ADRBK1,BARK/GRK2 subfamily
1082,55.74,kd,CGS001-5300,PIN1,-
7410,-18,cp,BRD-A22707317,SB-205384,GABA receptor modulator
1084,55.69,oe,ccsbBroad304_13912,NDUFB1,Mitochondrial respiratory chain complex / Complex I
7407,-17.95,cp,BRD-K46937689,phenazone,Cyclooxygenase inhibitor
1085,55.64,kd,CGS001-4926,NUMA1,-
1086,55.6,kd,CGS001-1606,DGKA,EF-hand domain containing
7404,-17.86,cp,BRD-K05181463,L-741626,Dopamine receptor antagonist
1087,55.59,kd,CGS001-10632,ATP5L,ATPases / F-type
1089,55.46,oe,ccsbBroad304_01992,B4GALT3,Beta 4-glycosyltransferases
7401,-17.71,cp,BRD-A27489425,rolitetracycline,Bacterial 30S ribosomal subunit inhibitor
7400,-17.7,cp,BRD-K93176058,AC-55649,Retinoid receptor agonist
1090,55.28,kd,CGS001-10559,SLC35A1,SLC35 family of nucleotide sugar transporters
7398,-17.56,cp,BRD-A12016240,LY-278584,Serotonin receptor antagonist
1091,55.25,kd,CGS001-7405,UVRAG,-
7396,-17.51,cp,BRD-A02333338,cyclopamine,Smoothened receptor antagonist
7394,-17.44,cp,BRD-K43245338,MDL-28170,Calpain inhibitor
1092,55.23,kd,CGS001-2831,NPBWR1,GPCR / Class A : Neuropeptide receptors : W/B
1093,55.19,kd,CGS001-23475,QPRT,-
1094,55.16,oe,ccsbBroad304_06394,HOXC9,Homeoboxes / ANTP class : HOXL subclass
1095,55.15,oe,ccsbBroad304_02619,PRSS23,Serine peptidases / Serine peptidases
1096,55.14,oe,ccsbBroad304_02257,ZBTB24,BTB/POZ domain containing
1098,55.02,kd,CGS001-7486,WRN,-
7387,-17.28,cp,BRD-K30990140,FR-122047,Cyclooxygenase inhibitor
1099,54.99,kd,CGS001-54915,YTHDF1,-
7386,-17.18,cp,BRD-K86600316,RS-79948,Adrenergic receptor antagonist
7385,-17.14,cp,BRD-K53570330,carbofuran,Cholinesterase inhibitor
1100,54.95,oe,ccsbBroad304_00030,ADORA2B,GPCR / Class A : Adenosine receptors
1101,54.95,kd,CGS001-10007,GNPDA1,-
7381,-16.99,cp,BRD-K17306061,aprepitant,Tachykinin antagonist
1103,54.93,oe,ccsbBroad304_00305,CHRM3,Cholinergic receptors
1104,54.78,kd,CGS001-5106,PCK2,-
1105,54.78,kd,CGS001-4853,NOTCH2,Ankyrin repeat domain containing
1106,54.73,kd,CGS001-2744,GLS,Ankyrin repeat domain containing
1107,54.72,kd,CGS001-901,CCNG2,-
1110,54.69,kd,CGS001-5777,PTPN6,Protein tyrosine phosphatases
1111,54.69,oe,ccsbBroad304_00174,BRAF,RAF family
7373,-16.81,cp,BRD-K41260949,valproic-acid,HDAC inhibitor
1112,54.67,kd,CGS001-1209,CLPTM1,-
1113,54.65,kd,CGS001-4067,LYN,Src family
7369,-16.67,cp,BRD-A52172093,VU-0413807-2,Calcium channel blocker
1114,54.62,kd,CGS001-256364,EML3,WD repeat domain containing
1115,54.61,kd,CGS001-2767,GNA11,-
1116,54.58,kd,CGS001-286075,ZNF707,"Zinc fingers, C2H2-type"
1117,54.58,kd,CGS001-4916,NTRK3,Type VII RTKs: Neurotrophin receptor/Trk family
1118,54.56,kd,CGS001-11041,B3GNT1,-
1119,54.46,kd,CGS001-137209,ZNF572,"Zinc fingers, C2H2-type"
1120,54.4,oe,ccsbBroad304_02674,STK38,NDR family
1121,54.31,kd,CGS001-7917,BAG6,-
1122,54.27,kd,CGS001-1020,CDK5,"Cyclin-dependent kinases, CDK5 subfamily"
7361,-16.5,cp,BRD-K33572481,taurodeoxycholic-acid,Bile acid
7360,-16.49,cp,BRD-A10355991,norketamine,Glutamate receptor antagonist
1123,54.26,kd,CGS001-811,CALR,-
1125,54.15,kd,CGS001-1515,CTSL2,-
1126,54.09,kd,CGS001-10472,ZNF238,-
1128,54.01,kd,CGS001-7360,UGP2,-
7355,-16.33,cp,BRD-K99029477,prometon,Photosynthesis inhibitor
1130,53.94,kd,CGS001-375318,AQP12A,Ion channels / Aquaporins
1131,53.92,kd,CGS001-10538,BATF,basic leucine zipper proteins
1137,53.76,kd,CGS001-163059,ZNF433,"Zinc fingers, C2H2-type"
7351,-16.27,cp,BRD-K47693913,evoxine,Furoquinoline alkaloid
7350,-16.22,cp,BRD-A48809242,IB-MECA,Adenosine receptor agonist
7349,-16.21,cp,BRD-K79437791,acetyl-farnesyl-cysteine,Inhibitor of methylation of endogenous isoprenylated proteins
7348,-16.2,cp,BRD-K47539947,tetradecylthioacetic-acid,Lipid peroxidase inhibitor
1138,53.74,kd,CGS001-9915,ARNT2,Basic helix-loop-helix proteins
7346,-16.13,cp,BRD-K97309399,thiothixene,Dopamine receptor antagonist
1139,53.72,oe,ccsbBroad304_04775,NTAN1,-
1140,53.45,kd,CGS001-8325,FZD8,GPCR / Class F : Frizzled receptors
7344,-16.09,cp,BRD-K88560311,rucaparib,PARP inhibitor
7341,-16.08,cp,BRD-A10715913,sulpiride,Dopamine receptor antagonist
1141,53.4,kd,CGS001-1994,ELAVL1,RNA binding motif (RRM) containing
7340,-16.07,cp,BRD-A00993607,alprenolol,Adrenergic receptor antagonist
1143,53.34,kd,CGS001-10444,ZER1,ZYG11 cell cycle regulator family
1144,53.2,kd,CGS001-2109,ETFB,-
7337,-15.92,cp,BRD-K73290745,ICI-199441,Opioid receptor agonist
7336,-15.9,cp,BRD-K92984783,melperone,Serotonin receptor antagonist
7335,-15.89,cp,BRD-K97564742,mepyramine,Histamine receptor antagonist
1145,53.17,kd,CGS001-3775,KCNK1,Two-P potassium channels
1146,53.17,kd,CGS001-27241,BBS9,-
7332,-15.77,cp,BRD-A03623303,metoprolol,Adrenergic receptor antagonist
1147,53.08,kd,CGS001-5111,PCNA,-
1149,53.03,kd,CGS001-4718,NDUFC2,Mitochondrial respiratory chain complex / Complex I
7329,-15.69,cp,BRD-K77925998,quipazine,Serotonin receptor agonist
7328,-15.67,cp,BRD-A25576662,streptozotocin,DNA alkylating agent
7327,-15.63,cp,BRD-K33396764,alpha-linolenic-acid,Omega 3 fatty acid stimulant
1150,53,oe,ccsbBroad304_03926,SLC39A8,SLC39 family of metal ion transporters
7326,-15.61,cp,BRD-K54330070,SB-202190,p38 MAPK inhibitor
1153,52.8,kd,CGS001-1844,DUSP2,Protein tyrosine phosphatases / Class I Cys-based PTPs : MAP kinase phosphatases
7323,-15.56,cp,BRD-K16551401,PNU-22394,Serotonin receptor agonist
7322,-15.55,cp,BRD-A69917777,aminopentamide,Acetylcholine receptor antagonist
1154,52.79,kd,CGS001-4763,NF1,-
1156,52.68,kd,CGS001-11073,TOPBP1,-
7319,-15.52,cp,BRD-K09186807,KIN001-244,Phosphoinositide dependent kinase inhibitor
1157,52.63,kd,CGS001-10987,COPS5,-
7317,-15.47,cp,BRD-K32398298,alprazolam,Benzodiazepine receptor agonist
1158,52.6,oe,ccsbBroad304_02497,YKT6,-
1159,52.6,oe,ccsbBroad304_06820,PTS,-
1160,52.59,kd,CGS001-5327,PLAT,Chymotrypsin
7313,-15.38,cp,BRD-K09499853,KU-0060648,DNA dependent protein kinase inhibitor
1161,52.55,kd,CGS001-8996,NOL3,-
1162,52.52,kd,CGS001-641,BLM,-
1163,52.48,kd,CGS001-55129,ANO10,Calcium activated chloride channel
1164,52.46,kd,CGS001-5763,PTMS,-
7308,-15.23,cp,BRD-K70976396,cefoxitin,Bacterial cell wall synthesis inhibitor
1165,52.43,kd,CGS001-51181,DCXR,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
1166,52.43,oe,ccsbBroad304_04064,PRR15L,-
1167,52.39,kd,CGS001-2837,UTS2R,Urotensin receptor
7304,-15.09,cp,BRD-A41112154,oleanolic-acid,G protein-coupled receptor agonist
1169,52.21,kd,CGS001-226,ALDOA,-
1170,52.19,oe,ccsbBroad304_00746,HLA-DRB5,Immunoglobulin superfamily / C1-set domain containing
7302,-15.01,cp,BRD-K98530306,clonidine,Adrenergic receptor agonist
1171,52.07,kd,CGS001-2274,FHL2,-
7300,-15,cp,BRD-K38055836,etamivan,Respiratory stimulant
7296,-14.89,cp,BRD-K61097567,SB-218795,Tachykinin antagonist
7297,-14.89,cp,BRD-K36638830,anabasine,Acetylcholine receptor agonist
1172,52.06,kd,CGS001-116443,GRIN3A,Glutamate receptors
1173,52.02,kd,CGS001-8800,PEX11A,-
1176,51.87,kd,CGS001-7391,USF1,Basic helix-loop-helix proteins
7293,-14.83,cp,BRD-K82357231,desloratadine,Histamine receptor antagonist
1177,51.82,kd,CGS001-9817,KEAP1,Kelch-like proteins
1179,51.75,oe,ccsbBroad304_01650,TCEA1,General transcription factors
1180,51.72,oe,ccsbBroad304_01985,EIF3H,-
1181,51.72,kd,CGS001-26191,PTPN22,Protein tyrosine phosphatases / Class I Cys-based PTPs : Non-receptor
1182,51.64,oe,ccsbBroad304_01580,SOX10,SRY (sex determining region Y)-boxes
1183,51.62,kd,CGS001-7001,PRDX2,-
7286,-14.61,cp,BRD-K67783091,haloperidol,Dopamine receptor antagonist
1184,51.62,kd,CGS001-2581,GALC,-
7283,-14.57,cp,BRD-K95763993,trapidil,PDGFR receptor inhibitor
7284,-14.57,cp,BRD-A38898897,GW-311616,Leukocyte elastase inhibitor
1185,51.6,kd,CGS001-8061,FOSL1,basic leucine zipper proteins
1186,51.59,kd,CGS001-51096,UTP18,WD repeat domain containing
1188,51.46,kd,CGS001-64407,RGS18,Regulators of G-protein signaling
1189,51.45,kd,CGS001-6714,SRC,Src family
7278,-14.47,cp,BRD-K68558722,deracoxib,Cyclooxygenase inhibitor
1190,51.39,kd,CGS001-10320,IKZF1,IKAROS zinc fingers
1191,51.37,oe,ccsbBroad304_04202,MED28,-
7275,-14.37,cp,BRD-K50464341,berbamine,Calmodulin antagonist
7274,-14.33,cp,BRD-K76064317,tyrphostin-AG-1296,FLT3 inhibitor
1192,51.37,kd,CGS001-27242,TNFRSF21,Tumour necrosis factor (TNF) receptor family
1193,51.26,kd,CGS001-8028,MLLT10,"Zinc fingers, PHD-type"
1194,51.19,kd,CGS001-170302,ARX,Homeoboxes / PRD class
7270,-14.27,cp,BRD-K53979406,ALX-5407,Glycine transporter inhibitor
7268,-14.25,cp,BRD-K08502430,angiogenesis-inhibitor,Angiogenesis inhibitor
1195,51.11,oe,ccsbBroad304_06992,SRC,Src family
1196,51.07,kd,CGS001-6777,STAT5B,SH2 domain containing
1200,51.03,kd,CGS001-11044,PAPD7,-
1201,50.99,kd,CGS001-7227,TRPS1,GATA zinc finger domain containing
1203,50.85,kd,CGS001-9143,SYNGR3,-
7263,-13.99,cp,BRD-A49370193,RO-60-0175,Serotonin receptor agonist
1204,50.84,kd,CGS001-26039,SS18L1,-
7261,-13.86,cp,BRD-A01787639,naftopidil,Adrenergic receptor antagonist
1205,50.82,kd,CGS001-2746,GLUD1,-
7259,-13.81,cp,BRD-K04111260,raclopride,Dopamine receptor antagonist
1206,50.81,kd,CGS001-57761,TRIB3,Trbl family
1208,50.73,oe,ccsbBroad304_01976,EIF4EBP3,-
7256,-13.76,cp,BRD-K71731651,PNU-120596,Acetylcholine receptor agonist
1209,50.6,kd,CGS001-56998,CTNNBIP1,Catenins
1210,50.55,oe,ccsbBroad304_02451,HOXB13,Homeoboxes / ANTP class : HOXL subclass
1211,50.54,kd,CGS001-10488,CREB3,basic leucine zipper proteins
1212,50.52,oe,ccsbBroad304_09177,EFCAB2,EF-hand domain containing
1214,50.43,oe,ccsbBroad304_01641,TAF13,-
7250,-13.61,cp,BRD-K10136726,tosyllysyl-chloromethyl-ketone,Chymotrypsin inhibitor
1215,50.4,kd,CGS001-81570,CLPB,Ankyrin repeat domain containing
7248,-13.59,cp,BRD-A96255180,ribavirin,Antiviral
1216,50.37,kd,CGS001-10153,CEBPZ,-
1217,50.36,kd,CGS001-154,ADRB2,GPCR / Class A : Adrenoceptors : beta
1218,50.33,kd,CGS001-9924,PAN2,Ubiquitin-specific peptidases
1219,50.29,kd,CGS001-54998,AURKAIP1,-
7243,-13.37,cp,BRD-K23623876,decafluorobutane,Contrast agent
1220,50.25,kd,CGS001-6605,SMARCE1,-
1221,50.25,kd,CGS001-79891,ZNF671,"Zinc fingers, C2H2-type"
7240,-13.28,cp,BRD-K22828899,TUL-XXI039,Serine/threonine kinase inhibitor
7239,-13.23,cp,BRD-K49456190,prima-1-met,thioredoxin inhibitor
7238,-13.22,cp,BRD-K54472332,elvitegravir,HIV integrase inhibitor
1222,50.15,oe,ccsbBroad304_07596,DLC1,Rho GTPase activating proteins
7235,-13.18,cp,BRD-K09485525,GANT-61,GLI antagonist
7236,-13.18,cp,BRD-K02130563,panobinostat,HDAC inhibitor
1223,50.14,kd,CGS001-26137,ZBTB20,BTB/POZ domain containing
7233,-13.11,cp,BRD-K96263742,GW-7647,PPAR receptor agonist
1226,50.07,kd,CGS001-51172,NAGPA,-
7231,-13.06,cp,BRD-A20239487,atenolol,Adrenergic receptor antagonist
1227,50.02,kd,CGS001-6857,SYT1,Synaptotagmins
1228,50.02,kd,CGS001-64223,MLST8,WD repeat domain containing
1229,49.99,kd,CGS001-4671,NAIP,Inhibitors of apoptosis (IAP) protein family
7227,-13,cp,BRD-A69636825,diltiazem,Calcium channel blocker
1230,49.89,kd,CGS001-9270,ITGB1BP1,-
1231,49.86,oe,ccsbBroad304_02392,PAK4,PAKB subfamily
1233,49.79,kd,CGS001-55107,ANO1,Calcium activated chloride channel
7223,-12.88,cp,BRD-K32906660,bis-tyrphostin,EGFR inhibitor
7222,-12.87,cp,BRD-K34098590,tienilic-acid,Sodium/potassium/chloride transporter inhibitor
7220,-12.86,cp,BRD-K21971034,OM-137,Aurora kinase inhibitor
1234,49.77,kd,CGS001-6927,HNF1A,Homeoboxes / HNF class
1235,49.76,kd,CGS001-339403,RXFP4,GPCR / Class A : Relaxin family peptide receptors
7218,-12.83,cp,BRD-K93325701,damnacanthal,SRC inhibitor
7214,-12.82,cp,BRD-A32164164,methyllycaconitine,Acetylcholine receptor antagonist
1236,49.68,oe,ccsbBroad304_03544,FAIM,-
1237,49.66,kd,CGS001-51466,EVL,-
1238,49.65,kd,CGS001-7353,UFD1L,-
7213,-12.81,cp,BRD-K08109516,L-701324,Glutamate receptor antagonist
7211,-12.79,cp,BRD-K54665485,R-59022,Diacylglycerol kinase inhibitor
1239,49.56,kd,CGS001-79258,MMEL1,-
1240,49.55,oe,ccsbBroad304_02448,UBE2E3,Ubiquitin-conjugating enzymes E2
7209,-12.76,cp,BRD-K92731339,perindopril,ACE inhibitor
1241,49.54,kd,CGS001-5433,POLR2D,RNA polymerase subunits
1243,49.36,kd,CGS001-10954,PDIA5,Protein disulfide isomerases
7206,-12.67,cp,BRD-K87991767,umbelliferone,Cyclooxygenase inhibitor
1244,49.31,oe,ccsbBroad304_10438,LGALS8,"Lectins, galactoside-binding"
1245,49.31,kd,CGS001-55127,HEATR1,-
1248,49.16,oe,ccsbBroad304_02321,ARL4C,ADP-ribosylation factors
1250,49.15,kd,CGS001-2583,B4GALNT1,Beta 4-glycosyltransferases
1251,49.13,kd,CGS001-22955,SCMH1,Sterile alpha motif (SAM) domain containing
7200,-12.56,cp,BRD-K46469693,SCH-442416,Adenosine receptor antagonist
7199,-12.54,cp,BRD-A27143604,DPN,Estrogen receptor agonist
1252,49.09,kd,CGS001-8974,P4HA2,-
7197,-12.49,cp,BRD-K28806945,L-750667,Dopamine receptor antagonist
1253,49.07,oe,ccsbBroad304_06621,NDUFA8,Mitochondrial respiratory chain complex / Complex I
1254,49.05,kd,CGS001-3660,IRF2,-
1255,49.05,kd,CGS001-2146,EZH2,Chromatin-modifying enzymes / K-methyltransferases
7193,-12.34,cp,BRD-K10016611,pyridine-2-aldoxime,Acetylcholinesterase inhibitor
1256,48.94,kd,CGS001-10287,RGS19,Regulators of G-protein signaling
7191,-12.32,cp,BRD-K28470988,L-690330,Inositol monophosphatase inhibitor
1257,48.94,kd,CGS001-3554,IL1R1,Interleukins and interleukin receptors
1258,48.82,kd,CGS001-6774,STAT3,SH2 domain containing
7188,-12.29,cp,BRD-K89152108,liothyronine,Thyroid hormone stimulant
7186,-12.28,cp,BRD-K20197062,SA-94315,Caspase inhibitor
1260,48.77,kd,CGS001-5371,PML,RING-type (C3HC4) zinc fingers
1261,48.77,kd,CGS001-51752,ERAP1,Aminopeptidase N
7183,-12.21,cp,BRD-K10176267,L-701252,Glutamate receptor antagonist
1262,48.73,kd,CGS001-3087,HHEX,Homeoboxes / ANTP class : NKL subclass
1264,48.72,oe,ccsbBroad304_03961,SMURF2,-
1266,48.63,kd,CGS001-596,BCL2,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
1267,48.45,kd,CGS001-6194,RPS6,S ribosomal proteins
1268,48.38,kd,CGS001-23499,MACF1,EF-hand domain containing
1269,48.35,kd,CGS001-166793,ZBTB49,BTB/POZ domain containing
7177,-11.97,cp,BRD-K64994968,progesterone,Progesterone receptor agonist
7175,-11.94,cp,BRD-A74500471,ethambutol,Bacterial cell wall synthesis inhibitor
1270,48.3,kd,CGS001-9928,KIF14,Kinesins
7173,-11.86,cp,BRD-A48720949,testosterone,androgen receptor agonist
7174,-11.86,cp,BRD-K35531059,molsidomine,Guanylyl cyclase activator
7172,-11.84,cp,BRD-K05396879,15-delta-prostaglandin-j2,PPAR receptor agonist
1271,48.29,oe,ccsbBroad304_02045,BUD31,-
7170,-11.8,cp,BRD-K08273968,griseofulvin,Tubulin inhibitor
1273,48.2,kd,CGS001-84433,CARD11,-
1274,48.15,kd,CGS001-9653,HS2ST1,"Sulfotransferases, membrane-bound"
1275,48.1,kd,CGS001-7867,MAPKAPK3,MAPKAPK subfamily
1276,48.1,kd,CGS001-2010,EMD,-
1277,48.08,kd,CGS001-4055,LTBR,Tumor necrosis factor receptor superfamily
1278,48.04,oe,ccsbBroad304_02239,RASSF2,-
7162,-11.73,cp,BRD-K68873215,phosphodiesterase-V-inhibitor-II,Phosphodiesterase inhibitor
1279,47.98,oe,ccsbBroad304_02447,ATP5H,ATPases / F-type
7160,-11.69,cp,BRD-K26134695,calpeptin,Calpain inhibitor
1280,47.98,kd,CGS001-7088,TLE1,WD repeat domain containing
1281,47.98,oe,ccsbBroad304_00533,FABP4,Fatty acid binding protein family
7158,-11.61,cp,BRD-K88849294,lobaric-acid,Tyrosine phosphatase inhibitor
7157,-11.59,cc,,Serpin peptidase inhibitors LOF,-
7156,-11.55,cp,BRD-K02275692,cefotiam,Bacterial cell wall synthesis inhibitor
1282,47.98,oe,ccsbBroad304_06133,TOR1A,-
7154,-11.53,cp,BRD-A53131506,epitestosterone,Inactive testosterone analog
1283,47.97,kd,CGS001-4149,MAX,Basic helix-loop-helix proteins
1284,47.97,oe,ccsbBroad304_03340,LSR,Immunoglobulin superfamily / Immunoglobulin-like domain containing
1285,47.9,oe,ccsbBroad304_05947,CCNC,-
7150,-11.41,cp,BRD-K24538644,KUC104502N,-666
1288,47.84,kd,CGS001-5607,MAP2K5,MAPKK:STE7 family
7146,-11.34,cp,BRD-U97083655,teicoplanin,Bacterial cell wall synthesis inhibitor
7147,-11.34,cp,BRD-K05737787,isoeugenol,Nitric oxide production inhibitor
1289,47.81,kd,CGS001-7076,TIMP1,-
1290,47.81,kd,CGS001-10641,NPRL2,-
1291,47.78,kd,CGS001-5021,OXTR,GPCR / Class A : Vasopressin and oxytocin receptors
1292,47.64,kd,CGS001-4088,SMAD3,SMADs
7141,-11.29,cp,BRD-K53878242,MMPX,Phosphodiesterase inhibitor
1293,47.63,kd,CGS001-79722,ANKRD55,Ankyrin repeat domain containing
1295,47.59,kd,CGS001-5613,PRKX,Protein kinase A
7139,-11.23,cp,BRD-K73109821,diazoxide,Potassium channel activator
7138,-11.22,cp,BRD-K35498378,alrestatin,Aldose reductase inhibitor
1296,47.58,oe,ccsbBroad304_06159,CTTN,-
1297,47.57,oe,ccsbBroad304_06288,GMDS,Short chain dehydrogenase/reductase superfamily / Extended SDR fold
7134,-11.16,cp,BRD-A43930669,L-368899,Oxytocin receptor antagonist
1298,47.55,kd,CGS001-22796,COG2,Components of oligomeric golgi complex
1299,47.54,kd,CGS001-25966,C2CD2,-
7132,-11.14,cp,BRD-K50891186,GR-103691,Dopamine receptor antagonist
1300,47.5,kd,CGS001-1962,EHHADH,-
7130,-11.11,cp,BRD-K27351809,nomegestrol,Progesterone receptor agonist
7129,-11.1,cp,BRD-K29733039,deforolimus,MTOR inhibitor
7128,-11.07,cp,BRD-A55393291,testosterone,Androgen receptor agonist
1301,47.49,kd,CGS001-2524,FUT2,Fucosyltransferases
7126,-11.04,cp,BRD-A65282128,cefazolin,Bacterial cell wall synthesis inhibitor
1302,47.48,kd,CGS001-132,ADK,Adenosine turnover
1305,47.39,kd,CGS001-9891,NUAK1,NuaK subfamily
7123,-10.99,cp,BRD-K93618743,ipriflavone,Bone resorption inhibitor
7122,-10.95,cp,BRD-A32836748,leu-enkephalin,Opioid receptor agonist
1306,47.37,kd,CGS001-114904,C1QTNF6,-
7120,-10.93,cp,BRD-A85025557,NCS-382,GABA receptor antagonist
7119,-10.91,cp,BRD-K82846253,repaglinide,Insulin secretagogue
7118,-10.89,cp,BRD-K04412738,tramadol,Norepinephrine reuptake inhibitor
7117,-10.85,cp,BRD-A91866971,SQ-29548,Thromboxane receptor antagonist
7115,-10.81,cp,BRD-A62890442,3-methyl-GABA,GABA aminotransferase activator
1308,47.27,kd,CGS001-56997,ADCK3,ABC1-B subfamily
7114,-10.8,cp,BRD-K08287586,butylparaben,DNA synthesis inhibitor
1310,47.2,kd,CGS001-10797,MTHFD2,-
1311,47.18,kd,CGS001-4204,MECP2,-
7110,-10.6,cp,BRD-K30677119,PP-30,RAF inhibitor
7111,-10.6,cp,BRD-A85472596,L-670596,Prostanoid receptor antagonist
7109,-10.56,cp,BRD-K05464208,JX-401,p38 MAPK inhibitor
1312,47.15,kd,CGS001-3945,LDHB,-
7106,-10.54,cp,BRD-K63874012,thioperamide,Histamine receptor antagonist
1314,47.14,kd,CGS001-51182,HSPA14,Heat shock proteins / HSP70
1315,47.13,kd,CGS001-5049,PAFAH1B2,-
7104,-10.49,cp,BRD-K93480852,KN-93,Calcium-calmodulin dependent protein kinase inhibitor
7103,-10.48,cp,BRD-K50660797,epicatechin,Bacterial DNA gyrase inhibitor
1316,47.06,oe,ccsbBroad304_07238,STK24,YSK subfamily
1317,47.05,kd,CGS001-10914,PAPOLA,-
1318,46.99,kd,CGS001-60528,ELAC2,-
1321,46.85,kd,CGS001-1949,EFNB3,Ephrins
7098,-10.36,cp,BRD-K19525698,ozagrel,Thromboxane synthase inhibitor
1322,46.81,kd,CGS001-8702,B4GALT4,Beta 4-glycosyltransferases
7093,-10.32,cp,BRD-K96527333,dehydroisoandosterone,GABA receptor modulator
7094,-10.32,cp,BRD-A90311807,cilastatin,Dehydropeptidase inhibitor
1323,46.81,oe,ccsbBroad304_06449,ILF3,-
7096,-10.32,cp,BRD-K40645748,mefloquine,Adenosine receptor antagonist
1324,46.73,kd,CGS001-9925,ZBTB5,BTB/POZ domain containing
7090,-10.28,cp,BRD-K70883034,nimetazepam,GABA receptor agonist
7091,-10.28,cp,BRD-K87048468,RS-102221,Serotonin receptor antagonist
7092,-10.28,cp,BRD-A83326220,brazilin,Nitric oxide production inhibitor
7088,-10.23,cp,BRD-K15519488,CS-110266,Dopamine receptor agonist
1325,46.73,oe,ccsbBroad304_00519,ETFB,-
1326,46.58,oe,ccsbBroad304_00212,CAMLG,-
1328,46.46,kd,CGS001-10202,DHRS2,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
7084,-10.2,cp,BRD-K61691971,avrainvillamide-analog-1,nucleophosmin inhibitor
7083,-10.16,cp,BRD-A08877921,cephalotaxine,Protein synthesis inhibitor
7082,-10.12,cp,BRD-A43940795,tetrahydropalmatine,Serotonin release inhibitor
1329,46.42,kd,CGS001-7280,TUBB2A,Tubulins
1330,46.42,kd,CGS001-29915,HCFC2,-
7080,-10.05,cp,BRD-A10523515,GSK-429286A,Rho associated kinase inhibitor
7078,-10.04,cp,BRD-A15493168,tetracycline,Bacterial 30S ribosomal subunit inhibitor
1331,46.42,kd,CGS001-9831,ZNF623,"Zinc fingers, C2H2-type"
1332,46.41,kd,CGS001-1649,DDIT3,-
1333,46.41,kd,CGS001-1488,CTBP2,-
1335,46.38,oe,ccsbBroad304_01025,ALDH6A1,Aldehyde dehydrogenases
1336,46.33,oe,ccsbBroad304_09657,PHF13,"Zinc fingers, PHD-type"
7073,-9.93,cp,BRD-A18620900,estriol,Estrogen receptor agonist
1337,46.3,kd,CGS001-9851,KIAA0753,-
7069,-9.87,cp,BRD-K23335153,AMN-082,Glutamate receptor modulator
1338,46.28,kd,CGS001-6509,SLC1A4,Alanine/serine/cysteine transporter subfamily
1341,46.05,kd,CGS001-191,AHCY,Adenosine turnover
1342,46.04,kd,CGS001-8766,RAB11A,"RAB, member RAS oncogene"
1344,46.01,kd,CGS001-2683,B4GALT1,Beta 4-glycosyltransferases
1346,45.92,kd,CGS001-6256,RXRA,Retinoid X receptors
1347,45.89,kd,CGS001-51441,YTHDF2,-
1349,45.86,kd,CGS001-5744,PTHLH,Endogenous ligands
1350,45.85,kd,CGS001-9867,PJA2,RING-type (C3HC4) zinc fingers
1351,45.85,kd,CGS001-90861,HN1L,-
1352,45.83,kd,CGS001-54205,CYCS,-
1353,45.83,kd,CGS001-5321,PLA2G4A,Phospholipase A2
7057,-9.67,cc,,Structural maintenance of chromosomes proteins LOF,-
1354,45.75,oe,ccsbBroad304_05980,CDKN1B,-
7056,-9.66,cp,BRD-K79602928,metformin,Insulin sensitizer
7054,-9.62,cp,BRD-K50214219,CS-1657,PARP inhibitor
1355,45.72,kd,CGS001-10096,ACTR3,-
1357,45.67,oe,ccsbBroad304_01350,PVRL2,Immunoglobulin superfamily / C2-set domain containing
7052,-9.56,cp,BRD-K67831364,ZM-323881,VEGFR inhibitor
7051,-9.55,cp,BRD-K03670461,tyrphostin-AG-82,EGFR inhibitor
7050,-9.54,cp,BRD-A72758037,asiatic-acid,Apoptosis stimulant
1358,45.63,oe,ccsbBroad304_06450,ILK,Ankyrin repeat domain containing
7048,-9.45,cp,BRD-K35559145,levomepromazine,Dopamine receptor antagonist
1360,45.48,kd,CGS001-2224,FDPS,Lanosterol biosynthesis pathway
1361,45.4,kd,CGS001-53340,SPA17,-
7045,-9.4,cp,BRD-K48115423,2-(4-methoxybenzylthio)-6-methylpyrimidin-4-ol,Matrix metalloprotease inhibitor
1362,45.26,kd,CGS001-5747,PTK2,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
7042,-9.32,cp,BRD-K90333595,phentolamine,Adrenergic receptor antagonist
1363,45.23,kd,CGS001-51079,NDUFA13,Mitochondrial respiratory chain complex / Complex I
7041,-9.31,cp,BRD-K13390322,AT-7519,CDK inhibitor
1364,45.23,kd,CGS001-4214,MAP3K1,MAPKKK:STE11 family
7038,-9.28,cp,BRD-A97730597,hexylcaine,Sodium channel blocker
7039,-9.28,cp,BRD-K95609758,BMS-191011,Potassium channel activator
1366,45.13,oe,ccsbBroad304_08325,LIPT1,-
7036,-9.22,cp,BRD-K27721098,clopidogrel,Purinergic receptor antagonist
7035,-9.18,cp,BRD-K14920963,erythrosine,Coloring agent
1367,45.09,kd,CGS001-3791,KDR,Type IV RTKs: VEGF (vascular endothelial growth factor) receptor family
7034,-9.16,cp,BRD-K12102668,nialamide,Monoamine oxidase inhibitor
7031,-9.11,cp,BRD-A71262238,nafadotride,Dopamine receptor antagonist
1368,45.09,oe,ccsbBroad304_06338,GTF2A2,General transcription factors
1369,45.07,kd,CGS001-1906,EDN1,Endogenous ligands
1370,45.04,kd,CGS001-7020,TFAP2A,-
1371,45.01,oe,ccsbBroad304_00501,EMD,-
7028,-9.06,cp,BRD-K75532464,FTI-276,Farnesyltransferase inhibitor
1372,44.96,kd,CGS001-8204,NRIP1,-
1373,44.95,oe,ccsbBroad304_04154,DENND2D,DENN/MADD domain containing
1374,44.94,kd,CGS001-23466,CBX6,-
7023,-9.02,cp,BRD-K42142750,retrorsine,Antimitotic
7022,-9.01,cp,BRD-K19360254,ergocornine,Dopamine receptor agonist
1375,44.93,kd,CGS001-339327,ZNF546,"Zinc fingers, C2H2-type"
1376,44.88,kd,CGS001-94235,GNG8,-
1377,44.85,oe,ccsbBroad304_13934,PTK2,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
1378,44.84,kd,CGS001-192286,HIGD2A,-
1379,44.79,kd,CGS001-122618,PLD4,-
7015,-8.85,cp,BRD-K59597909,phenothiazine,Dopamine receptor antagonist
1380,44.71,kd,CGS001-2882,GPX7,-
1381,44.69,oe,ccsbBroad304_00328,CLK3,CDC-like kinases
1382,44.67,kd,CGS001-22889,KIAA0907,-
7014,-8.84,cp,BRD-K88568253,iproniazid,Monoamine oxidase inhibitor
1383,44.67,kd,CGS001-3419,IDH3A,-
1384,44.64,oe,ccsbBroad304_00105,ARNTL,Basic helix-loop-helix proteins
1385,44.64,oe,ccsbBroad304_02746,FBXW11,F-boxes / WD-40 domains
7007,-8.79,cp,BRD-K37792168,denbufylline,Phosphodiesterase inhibitor
1386,44.63,kd,CGS001-444,ASPH,-
1387,44.6,kd,CGS001-3455,IFNAR2,Interferon receptor family
1388,44.56,kd,CGS001-147807,ZNF524,"Zinc fingers, C2H2-type"
1389,44.53,oe,ccsbBroad304_02956,EHF,-
1390,44.5,kd,CGS001-3635,INPP5D,Inositol polyphosphate phosphatases
1391,44.5,oe,ccsbBroad304_06894,RPS6,S ribosomal proteins
7000,-8.64,cp,BRD-A14395271,mesoridazine,Dopamine receptor antagonist
1393,44.43,kd,CGS001-7690,ZNF131,BTB/POZ domain containing
6998,-8.63,cp,BRD-K93258693,GW-9662,PPAR receptor antagonist
1394,44.37,kd,CGS001-10600,USP16,Ubiquitin-specific peptidases
6997,-8.59,cp,BRD-K05395900,nicotine,Acetylcholine receptor agonist
6996,-8.58,cp,BRD-K42748308,XE-991,Potassium channel blocker
1396,44.3,kd,CGS001-2071,ERCC3,General transcription factors
6994,-8.56,cp,BRD-K01493881,apigenin,Casein kinase inhibitor
6995,-8.56,cp,BRD-K82983861,GW-0742,PPAR receptor agonist
1398,44.19,kd,CGS001-55163,PNPO,-
1401,44.14,kd,CGS001-149233,IL23R,IL-12 receptor family
6989,-8.47,cp,BRD-K99946902,hexylresorcinol,Local anesthetic
1402,44.13,oe,ccsbBroad304_05394,ZNF621,"Zinc fingers, C2H2-type"
6987,-8.46,cp,BRD-K45068323,W-13,Calmodulin antagonist
6988,-8.46,cp,BRD-A42167015,carteolol,Adrenergic receptor antagonist
1403,44.13,kd,CGS001-204219,CERS3,Homeoboxes / CERS class
6984,-8.44,cc,,Non Homologous End Joining LOF,-
1404,44.09,kd,CGS001-5351,PLOD1,-
1405,44.06,kd,CGS001-6599,SMARCC1,-
6981,-8.4,cp,BRD-A59808129,guggulsterone,Cholesterol inhibitor
1406,44.03,kd,CGS001-9686,VGLL4,-
1407,43.98,kd,CGS001-5720,PSME1,"Proteasome (prosome, macropain) subunits"
1408,43.96,kd,CGS001-6119,RPA3,-
6978,-8.37,cp,BRD-K92413528,thiazolidinecarboxylic-acid,Reducing agent
6976,-8.36,cp,BRD-K07888196,tyrphostin-AG-538,IGF-1 inhibitor
1409,43.93,kd,CGS001-23435,TARDBP,RNA binding motif (RRM) containing
1410,43.91,kd,CGS001-26353,HSPB8,Heat shock proteins / HSPB
1411,43.82,kd,CGS001-3934,LCN2,Lipocalins
6972,-8.34,cp,BRD-A83855350,naltrexone,Opioid receptor antagonist
1412,43.76,kd,CGS001-65123,INTS3,-
6971,-8.3,cp,BRD-K63165456,norcyclobenzaprine,Adrenergic receptor agonist
1413,43.68,kd,CGS001-22921,MSRB2,-
6969,-8.24,cp,BRD-K43887077,dopamine,Dopamine receptor agonist
1415,43.61,oe,ccsbBroad304_02058,PLOD3,-
1417,43.61,kd,CGS001-11180,WDR6,WD repeat domain containing
6964,-8.19,cp,BRD-A65550283,ginsenoside,Steroid hormone receptor agonist
6965,-8.19,cp,BRD-A01295252,trans-7-hydroxy-pipat,Dopamine receptor ligand
1418,43.57,oe,ccsbBroad304_10231,SETDB1,Histone methyltransferases (HMTs)
6963,-8.18,cp,BRD-K00615600,AG-14361,PARP inhibitor
1420,43.55,kd,CGS001-10400,PEMT,-
1421,43.44,oe,ccsbBroad304_02279,RBX1,RING-type (C3HC4) zinc fingers
1422,43.37,oe,ccsbBroad304_00578,FLI1,ETS Transcription Factors
6959,-8.12,cp,BRD-K48735772,PD-158780,EGFR inhibitor
6957,-8.1,cp,BRD-K09859624,methantheline,Acetylcholine receptor antagonist
6958,-8.1,cp,BRD-K64341947,CFM-1571,Guanylate cyclase activator
6955,-8.09,cp,BRD-A49734948,foliosidine,Plant alkaloid
1423,43.35,kd,CGS001-84923,FAM104A,-
1425,43.18,kd,CGS001-593,BCKDHA,-
6953,-8.06,cp,BRD-A37776212,ICI-204448,Opioid receptor agonist
1427,43.15,kd,CGS001-5378,PMS1,-
1428,43.14,kd,CGS001-8651,SOCS1,SH2 domain containing
6950,-8.02,cp,BRD-K68246049,TTNPB,Retinoid receptor agonist
1429,43.11,oe,ccsbBroad304_01455,RPS16,S ribosomal proteins
1430,43.11,kd,CGS001-9748,SLK,SLK subfamily
1433,42.98,kd,CGS001-5888,RAD51,-
6946,-7.95,cp,BRD-K40782193,QX-222,Sodium channel blocker
1434,42.93,kd,CGS001-23461,ABCA5,ATP binding cassette transporters / subfamily A
1435,42.89,kd,CGS001-7056,THBD,CD molecules
6942,-7.89,cp,BRD-K29582115,ziprasidone,Dopamine receptor antagonist
6943,-7.89,cp,BRD-K95885906,quercetagetin,PIM inhibitor
6939,-7.88,cp,BRD-A82656074,naltrindole,Opioid receptor antagonist
6940,-7.88,cp,BRD-K33193182,methylnorlichexanthone,Aurora kinase inhibitor
6941,-7.88,cp,BRD-K45542189,diethylcarbamazine,Lipoxygenase inhibitor
1436,42.89,kd,CGS001-387509,GPR153,GPCR / Class A : Orphans
1439,42.77,oe,ccsbBroad304_00115,ASPH,-
1441,42.71,oe,ccsbBroad304_03903,ABHD4,Abhydrolase domain containing
1442,42.67,kd,CGS001-22,ABCB7,ATP binding cassette transporters / subfamily B
1443,42.67,kd,CGS001-10250,SRRM1,-
6933,-7.77,cp,BRD-K37814297,acepromazine,Dopamine receptor antagonist
6932,-7.75,cc,,Sterol demethylase inhibitor,-
6931,-7.72,cp,BRD-K78373679,RO-3306,CDK inhibitor
1444,42.66,kd,CGS001-5292,PIM1,PIM family
6929,-7.65,cp,BRD-K74763371,bosentan,Endothelin receptor antagonist
1445,42.61,oe,ccsbBroad304_02136,COPS2,-
1446,42.61,kd,CGS001-892,CCNC,-
6928,-7.63,cp,BRD-K55191674,benzylpenicillin,Penicillin binding protein inhibitor
1447,42.58,kd,CGS001-6146,RPL22,L ribosomal proteins
1449,42.38,kd,CGS001-1604,CD55,CD molecules
6922,-7.6,cp,BRD-K30867024,SB-216641,Serotonin receptor antagonist
1450,42.37,kd,CGS001-5684,PSMA3,Proteasome subunits
1451,42.37,kd,CGS001-5624,PROC,Endogenous ligands
1452,42.32,oe,ccsbBroad304_05941,CBR3,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
1453,42.32,kd,CGS001-3376,IARS,Aminoacyl tRNA synthetases / Class I
1454,42.26,kd,CGS001-3663,IRF5,-
6917,-7.48,cp,BRD-K01624546,docosatrienoic-acid,LTB4 inhibitor
6915,-7.47,cp,BRD-K27499107,carbacyclin,IP receptor activator
1455,42.25,kd,CGS001-5934,RBL2,-
1456,42.24,oe,ccsbBroad304_05002,ZNF563,"Zinc fingers, C2H2-type"
6912,-7.43,cp,BRD-K08219523,5-nonyloxytryptamine,Serotonin receptor agonist
1457,42.22,kd,CGS001-116113,FOXP4,Forkhead boxes
6910,-7.41,cp,BRD-K60038276,irbesartan,Angiotensin receptor antagonist
1458,42.19,kd,CGS001-5053,PAH,Amino acid hydroxylases
6909,-7.38,cp,BRD-K86595100,chlordiazepoxide,Benzodiazepine receptor agonist
1459,42.15,kd,CGS001-210,ALAD,-
1460,42.15,kd,CGS001-1645,AKR1C1,Aldo-keto reductases
6905,-7.29,cp,BRD-A35338386,NECA,Adenosine receptor agonist
1461,42.1,kd,CGS001-29937,NENF,-
6904,-7.28,cp,BRD-K05901394,terguride,Dopamine receptor agonist
1462,42.08,oe,ccsbBroad304_03591,ETNK1,-
6901,-7.26,cp,BRD-A00758722,noretynodrel,Progestogen hormone
6902,-7.26,cp,BRD-A59303141,quinethazone,Thiazide diuretic
1463,42.05,kd,CGS001-8717,TRADD,-
1464,42.03,oe,ccsbBroad304_08684,CXCR7,-
6898,-7.19,cp,BRD-K77133231,PD-169316,p38 MAPK inhibitor
1465,41.93,oe,ccsbBroad304_02213,TRAF4,RING-type (C3HC4) zinc fingers
6895,-7.16,cp,BRD-K45435259,SCH-23390,Dopamine receptor antagonist
1466,41.89,kd,CGS001-3329,HSPD1,Heat Shock Proteins / Chaperonins
1467,41.89,oe,ccsbBroad304_06976,SMARCE1,-
1468,41.87,kd,CGS001-8935,SKAP2,Pleckstrin homology (PH) domain containing
1469,41.81,kd,CGS001-10365,KLF2,Kruppel-like transcription factors
1470,41.79,kd,CGS001-54788,DNAJB12,Heat shock proteins / DNAJ (HSP40)
1472,41.75,kd,CGS001-27109,ATP5S,-
1474,41.65,oe,ccsbBroad304_07667,CGRRF1,RING-type (C3HC4) zinc fingers
6888,-7.08,cp,BRD-K63150726,JTE-907,Cannabinoid receptor inverse agonist
1475,41.59,kd,CGS001-150,ADRA2A,GPCR / Class A : Adrenoceptors : alpha
6886,-7.05,cp,BRD-K23204545,busulfan,DNA inhibitor
1476,41.41,kd,CGS001-4174,MCM5,-
6882,-7,cc,,Serotonin receptor agonist,-
6883,-7,cp,BRD-K68402494,ML-9,Myosin light chain kinase inhibitor
1477,41.37,kd,CGS001-10127,ZNF263,"Zinc fingers, C2H2-type"
1478,41.32,kd,CGS001-8566,PDXK,-
1479,41.29,oe,ccsbBroad304_00626,GDI1,-
6881,-6.99,cp,BRD-K17349619,HLI-373,MDM inhibitor
1480,41.29,oe,ccsbBroad304_02002,RNMT,-
1482,41.25,kd,CGS001-27032,ATP2C1,Calcium-ATPases
6878,-6.98,cp,BRD-A25067867,benzatropine,Acetylcholine receptor antagonist
1483,41.05,kd,CGS001-7040,TGFB1,Endogenous ligands
1484,41,kd,CGS001-7089,TLE2,WD repeat domain containing
1486,40.95,kd,CGS001-27035,NOX1,-
1487,40.93,kd,CGS001-2147,F2,Endogenous ligands
1488,40.92,kd,CGS001-57406,ABHD6,Abhydrolase domain containing
1489,40.87,kd,CGS001-1508,CTSB,Cathepsins
6869,-6.91,cp,BRD-K01095011,finasteride,5-alpha reductase inhibitor
1490,40.82,kd,CGS001-7074,TIAM1,Rho guanine nucleotide exchange factors
6867,-6.87,cp,BRD-K03440695,boldine,Acetylcholine receptor antagonist
1491,40.78,oe,ccsbBroad304_07311,HDAC3,Histone deacetylases
1492,40.75,oe,ccsbBroad304_02853,QPCT,Aminopeptidase Y
1493,40.73,kd,CGS001-1503,CTPS,-
1495,40.66,kd,CGS001-4698,NDUFA5,Mitochondrial respiratory chain complex / Complex I
1496,40.66,kd,CGS001-3336,HSPE1,Heat Shock Proteins / Chaperonins
1497,40.63,kd,CGS001-7874,USP7,Ubiquitin-specific peptidases
1498,40.58,kd,CGS001-4719,NDUFS1,Mitochondrial respiratory chain complex / Complex I
1499,40.58,oe,ccsbBroad304_03237,LEF1,-
6858,-6.78,cp,BRD-K45033733,famciclovir,DNA polymerase inhibitor
6857,-6.72,cp,BRD-K68190965,GR-46611,Serotonin receptor agonist
6856,-6.71,cp,BRD-K16444452,ibudilast,Leukotriene receptor antagonist
6855,-6.69,cp,BRD-A89672324,CGP-55845,GABA receptor antagonist
1500,40.57,kd,CGS001-124961,ZFP3,"Zinc fingers, C2H2-type"
1501,40.54,kd,CGS001-24149,ZNF318,"Zinc fingers, C2H2-type"
6851,-6.65,cp,BRD-A16444946,acarbose,Glucosidase inhibitor
6852,-6.65,cp,BRD-K48427617,U-0124,MEK inhibitor
1502,40.47,oe,ccsbBroad304_02110,VAPB,-
1503,40.43,oe,ccsbBroad304_05944,CCBL1,Hydrogen sulphide synthesis
1505,40.41,kd,CGS001-1616,DAXX,-
1506,40.4,oe,ccsbBroad304_14066,CHEK2,CHK1 subfamily
6847,-6.56,cp,BRD-K73196317,urapidil,Adrenergic receptor antagonist
6844,-6.55,cp,BRD-K65503129,HSP90-inhibitor,HSP inhibitor
1507,40.35,kd,CGS001-83448,PUS7L,-
1508,40.31,kd,CGS001-2582,GALE,Short chain dehydrogenase/reductase superfamily / Extended SDR fold
1509,40.25,kd,CGS001-3177,SLC29A2,SLC29 family
6841,-6.52,cp,BRD-M40783228,mesna,Antioxidant
1511,40.12,kd,CGS001-6595,SMARCA2,Non-enzymatic BRD containing proteins
6838,-6.45,cp,BRD-K04010869,prostaglandin-a1,HSP inducer
1512,40.08,kd,CGS001-283450,C12ORF51,-
6837,-6.41,cp,BRD-A42571354,cetirizine,Histamine receptor antagonist
1513,40.07,kd,CGS001-6721,SREBF2,Basic helix-loop-helix proteins
1514,40.01,kd,CGS001-10497,UNC13B,-
6833,-6.37,cp,BRD-K01779529,fluoropyruvate,Pyruvate dehydrogenase kinase inhibitor
1515,39.97,kd,CGS001-4329,ALDH6A1,Aldehyde dehydrogenases
1516,39.96,kd,CGS001-53831,GPR84,GPCR / Class A : Fatty acid receptors
6829,-6.34,cp,BRD-K14791739,fluticasone,Glucocorticoid receptor agonist
6830,-6.34,cp,BRD-K32526544,DCEBIO,Potassium channel activator
6831,-6.34,cp,BRD-A09472452,flecainide,Sodium channel blocker
1518,39.95,kd,CGS001-5585,PKN1,Protein kinase N (PKN) family
6827,-6.26,cp,BRD-K62056274,quipazine,Serotonin receptor agonist
6826,-6.25,cc,,General transcription factors group 1 LOF,-
6825,-6.24,cp,BRD-K30240666,clemastine,Histamine receptor antagonist
6823,-6.23,cp,BRD-K47192521,icosapent,Platelet aggregation inhibitor
1519,39.92,kd,CGS001-6648,SOD2,-
1520,39.87,kd,CGS001-56654,NPDC1,-
6819,-6.2,cp,BRD-A24543851,nornicotine,Acetylcholine receptor agonist
1521,39.85,kd,CGS001-27,ABL2,Abl family
1522,39.77,oe,ccsbBroad304_07140,XPC,-
1523,39.76,kd,CGS001-5824,PEX19,-
1524,39.66,kd,CGS001-4363,ABCC1,ATP binding cassette transporters / subfamily C
1526,39.62,oe,ccsbBroad304_02351,DHRS2,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
1527,39.6,oe,ccsbBroad304_02772,ICMT,-
6815,-6.11,cp,BRD-K32584078,BML-257,AKT inhibitor
6813,-6.1,cp,BRD-K21520694,sulfacetamide,PABA antagonist
1528,39.6,kd,CGS001-10245,TIMM17B,-
1529,39.56,kd,CGS001-6335,SCN9A,Voltage-gated sodium channels
1530,39.55,kd,CGS001-51422,PRKAG2,AMPK subfamily
1531,39.47,kd,CGS001-2944,GSTM1,Glutathione S-transferases / Soluble
6807,-6.03,cp,BRD-A34706053,CGP-12177,Adrenergic receptor agonist
1533,39.43,kd,CGS001-109,ADCY3,Adenylyl cyclases
1534,39.41,kd,CGS001-1025,CDK9,"Cyclin-dependent kinases, CDK9 subfamily"
1535,39.31,kd,CGS001-7421,VDR,Vitamin D receptors
6804,-5.97,cp,BRD-A01317026,"7,8-dihydro-L-biopterin",Dihydroneopterin aldolase inhibitor
1536,39.28,kd,CGS001-23650,TRIM29,-
1537,39.22,kd,CGS001-6821,SUOX,-
1538,39.14,kd,CGS001-2760,GM2A,-
1540,38.96,oe,ccsbBroad304_01819,ZNF213,"Zinc fingers, C2H2-type"
1541,38.94,kd,CGS001-3725,JUN,basic leucine zipper proteins
1543,38.86,kd,CGS001-10901,DHRS4,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
1544,38.83,oe,ccsbBroad304_02376,RAMP1,Receptor (G protein-coupled) activity modifying proteins
1546,38.8,kd,CGS001-64215,DNAJC1,Heat shock proteins / DNAJ (HSP40)
6796,-5.87,cp,BRD-K12762134,XAV-939,Tankyrase inhibitor
1548,38.79,kd,CGS001-79885,HDAC11,Histone deacetylases
1549,38.79,kd,CGS001-118738,ZNF488,"Zinc fingers, C2H2-type"
1551,38.74,kd,CGS001-4602,MYB,-
6793,-5.83,cp,BRD-A61470182,n-formylmethionylalanine,macrophage activator
6790,-5.81,cp,BRD-K59650319,YM-298198,Glutamate receptor antagonist
1552,38.72,kd,CGS001-9670,IPO13,Importins
1554,38.69,oe,ccsbBroad304_00696,CXCL2,Endogenous ligands
1555,38.68,kd,CGS001-7965,AIMP2,-
6786,-5.78,cp,BRD-K16195444,oxymetazoline,Adrenergic receptor agonist
1557,38.6,kd,CGS001-51001,MTERFD1,-
6784,-5.76,cp,BRD-K36740062,GSK-1070916,Aurora kinase inhibitor
1558,38.59,kd,CGS001-5411,PNN,-
1559,38.59,kd,CGS001-57819,LSM2,-
6781,-5.68,cp,BRD-K32311154,nifekalant,Potassium channel blocker
6780,-5.67,cp,BRD-K83636919,entacapone,Catechol O methyltransferase inhibitor
1560,38.57,oe,ccsbBroad304_00079,APOA1,Apolipoproteins
1561,38.53,kd,CGS001-5577,PRKAR2B,Protein kinase A
6776,-5.61,cp,BRD-K24201553,SB-269970,Serotonin receptor antagonist
6777,-5.61,cp,BRD-A22844106,tenoxicam,Cyclooxygenase inhibitor
1562,38.52,kd,CGS001-64147,KIF9,Kinesins
1563,38.47,kd,CGS001-998,CDC42,-
6773,-5.57,cp,BRD-A10969569,ambelline,Plant alkaloid
6772,-5.56,cp,BRD-A80960055,celastrol,Anti-inflammatory
1564,38.43,kd,CGS001-8493,PPM1D,"Serine/threonine phosphatases / Protein phosphatases, Mg2+/Mn2+ dependent"
1565,38.43,kd,CGS001-586,BCAT1,-
1567,38.35,oe,ccsbBroad304_07529,AKT3,Akt (Protein kinase B)
1568,38.27,kd,CGS001-2731,GLDC,-
1569,38.26,kd,CGS001-515,ATP5F1,ATPases / F-type
6765,-5.5,cp,BRD-K32645441,dipropyl-5ct,Serotonin receptor agonist
1570,38.24,kd,CGS001-823,CAPN1,EF-hand domain containing
1571,38.22,oe,ccsbBroad304_00415,CYP24A1,Cytochrome P450s
1572,38.15,kd,CGS001-56889,TM9SF3,-
6762,-5.46,cp,BRD-K70301876,escitalopram,Selective serotonin reuptake inhibitor (SSRI)
1573,38.14,oe,ccsbBroad304_02572,SERINC3,-
1574,38.12,kd,CGS001-3065,HDAC1,Histone deacetylases
6760,-5.42,cp,BRD-K26801045,pipamperone,Dopamine receptor antagonist
6757,-5.4,cp,BRD-K52930707,rescinnamine,ACE inhibitor
6758,-5.4,cp,BRD-K68407802,KIN001-055,EGFR inhibitor
1575,38.04,kd,CGS001-2908,NR3C1,3-Ketosteroid receptors
1576,38,kd,CGS001-7078,TIMP3,-
1577,37.99,kd,CGS001-481,ATP1B1,ATPases / P-type
1578,37.91,oe,ccsbBroad304_06777,PRNP,CD molecules
6753,-5.32,cp,BRD-K93460210,lamotrigine,Serotonin receptor antagonist
6751,-5.29,cp,BRD-K50388907,fenofibrate,PPAR receptor agonist
1579,37.91,kd,CGS001-153830,RNF145,RING-type (C3HC4) zinc fingers
6747,-5.25,cp,BRD-K33226500,indinavir,HIV protease inhibitor
6748,-5.25,cp,BRD-A00267231,hemado,Adenosine receptor agonist
6749,-5.25,cp,BRD-A94669766,naringenin,Aromatase inhibitor
1580,37.86,kd,CGS001-8678,BECN1,-
1581,37.85,oe,ccsbBroad304_06048,CRYZ,-
1582,37.83,kd,CGS001-9063,PIAS2,"Zinc fingers, MIZ-type"
6740,-5.21,cp,BRD-K24859147,KIN001-242,Protein kinase inhibitor
6741,-5.21,cp,BRD-A68888262,azelastine,Histamine receptor antagonist
6742,-5.21,cp,BRD-K60174629,z-prolyl-prolinal,Prolyl endopeptidase inhibitor
6743,-5.21,cp,BRD-K07325606,hispidin,PKC inhibitor
6738,-5.18,cp,BRD-K32107296,temozolomide,DNA alkylating agent
1586,37.75,oe,ccsbBroad304_02467,AGPAT1,1-acylglycerol-3-phosphate O-acyltransferases
1587,37.55,kd,CGS001-9919,SEC16A,-
1588,37.53,oe,ccsbBroad304_06079,CYP51A1,Cytochrome P450s
6734,-5.14,cp,BRD-K69600043,thiethylperazine,Dopamine receptor antagonist
1589,37.47,kd,CGS001-5641,LGMN,Legumain
1591,37.32,oe,ccsbBroad304_06257,GATA2,GATA zinc finger domain containing
1593,37.28,oe,ccsbBroad304_00447,DLD,-
6732,-5.11,cp,BRD-K01292756,pimozide,Dopamine receptor antagonist
6730,-5.1,cc,,Dopamine receptor antagonist,-
1594,37.28,oe,ccsbBroad304_01870,CHAF1B,WD repeat domain containing
1595,37.24,oe,ccsbBroad304_06102,DLX3,Homeoboxes / ANTP class : NKL subclass
1596,37.17,kd,CGS001-11140,CDC37,-
1597,37.11,kd,CGS001-11188,NISCH,-
1598,37.09,kd,CGS001-4700,NDUFA6,LYR motif containing
1600,36.98,oe,ccsbBroad304_06038,CRK,SH2 domain containing
1602,36.9,kd,CGS001-5387,PMS2P3,-
6722,-5.01,cp,BRD-K27141178,SB-203186,Serotonin receptor antagonist
1603,36.85,kd,CGS001-400,ARL1,ADP-ribosylation factors
1604,36.8,kd,CGS001-2547,XRCC6,XRCC DNA Repair
1605,36.74,kd,CGS001-238,ALK,Leukocyte tyrosine kinase (LTK) receptor family
6716,-4.97,cp,BRD-K00610438,altanserin,Serotonin receptor antagonist
6717,-4.97,cp,BRD-A11135865,nor-binaltorphimine,Opioid receptor antagonist
1606,36.69,kd,CGS001-4287,ATXN3,Ataxins
1607,36.67,kd,CGS001-9612,NCOR2,-
1608,36.67,oe,ccsbBroad304_02324,TRAP1,Heat shock proteins / HSPC
1609,36.58,kd,CGS001-10138,YAF2,-
1610,36.57,kd,CGS001-55120,FANCL,"Fanconi anemia, complementation groups"
6710,-4.86,cp,BRD-K52172416,anastrozole,Aromatase inhibitor
1611,36.55,kd,CGS001-1509,CTSD,Cathepsins
6708,-4.83,cp,BRD-K33818169,GW-3965,LXR agonist
6709,-4.83,cp,BRD-A05186015,bupropion,Dopamine uptake inhibitor
1613,36.47,kd,CGS001-163081,ZNF567,"Zinc fingers, C2H2-type"
1614,36.36,oe,ccsbBroad304_02436,ZER1,ZYG11 cell cycle regulator family
1615,36.33,kd,CGS001-5581,PRKCE,Eta subfamily
6703,-4.79,cp,BRD-K49372556,mofezolac,Cyclooxygenase inhibitor
1616,36.32,oe,ccsbBroad304_03097,CNOT7,-
1617,36.28,kd,CGS001-1500,CTNND1,Catenins
1618,36.21,kd,CGS001-79600,TCTN1,Tectonic proteins
1619,36.17,kd,CGS001-64376,IKZF5,IKAROS zinc fingers
1620,36.14,kd,CGS001-11186,RASSF1,-
6697,-4.76,cp,BRD-K76908866,CP-724714,EGFR inhibitor
6698,-4.76,cp,BRD-A01320529,salmeterol,Adrenergic receptor agonist
1622,36.04,kd,CGS001-3726,JUNB,basic leucine zipper proteins
1623,36.02,oe,ccsbBroad304_04891,TMEM174,-
6694,-4.69,cp,BRD-K21450440,benzthiazide,Carbonic anhydrase inhibitor
6692,-4.68,cp,BRD-K63516691,T-0156,Phosphodiesterase inhibitor
1624,36.01,kd,CGS001-1490,CTGF,-
6691,-4.62,cp,BRD-K66175015,afatinib,EGFR inhibitor
1625,35.99,kd,CGS001-85236,HIST1H2BK,Histones / Replication-dependent
6688,-4.59,cp,BRD-K68997413,PF-3845,FAAH inhibitor
1626,35.98,oe,ccsbBroad304_07565,RBM6,G patch domain containing
6687,-4.56,cp,BRD-K22385716,LY-303511,Casein kinase inhibitor
6686,-4.55,cp,BRD-K39569857,avrainvillamide-analog-3,nucleophosmin inhibitor
1627,35.97,kd,CGS001-8660,IRS2,Pleckstrin homology (PH) domain containing
6685,-4.54,cp,BRD-K01612348,meropenem,Bacterial cell wall synthesis inhibitor
1629,35.94,kd,CGS001-8444,DYRK3,Dyrk2 subfamily
1631,35.89,kd,CGS001-1062,CENPE,Kinesins
1632,35.88,kd,CGS001-2181,ACSL3,Acyl-CoA synthetase family
1633,35.87,oe,ccsbBroad304_07326,EIF2B2,-
6677,-4.51,cp,BRD-K52850071,JAK3-Inhibitor-II,JAK inhibitor
6678,-4.51,cp,BRD-K59753853,MDL-29951,Glutamate receptor antagonist
1635,35.8,kd,CGS001-8565,YARS,Aminoacyl tRNA synthetases / Class I
6676,-4.5,cp,BRD-K06080977,eicosatetraynoic-acid,Cyclooxygenase inhibitor
6672,-4.49,cp,BRD-K64606589,apicidin,HDAC inhibitor
6673,-4.49,cp,BRD-K52080565,rilmenidine,Imidazoline receptor agonist
6674,-4.49,cp,BRD-K10065684,dantron,Laxative
1636,35.74,kd,CGS001-1786,DNMT1,Methyltransferases
6671,-4.48,cp,BRD-K10995081,perphenazine,Dopamine receptor antagonist
6665,-4.47,cp,BRD-K10177585,PSB-11,Adenosine receptor antagonist
6666,-4.47,cp,BRD-A41145729,methoprene-acid,Retinoid receptor agonist
1637,35.66,kd,CGS001-1594,CYP27B1,Cytochrome P450s
1639,35.62,oe,ccsbBroad304_00933,LDHB,-
1640,35.56,oe,ccsbBroad304_08010,FBXO5,F-boxes / other
6670,-4.47,cp,BRD-K33453211,levocabastine,Histamine receptor antagonist
6660,-4.45,cp,BRD-K79877282,PF-543,Sphingosine kinase inhibitor
1642,35.54,kd,CGS001-28964,GIT1,Ankyrin repeat domain containing
1643,35.53,kd,CGS001-29928,TIMM22,-
1644,35.5,kd,CGS001-183,AGT,Endogenous ligands
1645,35.43,kd,CGS001-2548,GAA,Glycosidases
1646,35.35,kd,CGS001-3669,ISG20,-
6658,-4.44,cp,BRD-K68341547,W-9,Calmodulin antagonist
6659,-4.44,cp,BRD-A07440155,labetalol,Adrenergic receptor antagonist
6656,-4.4,cp,BRD-K25311561,KU-55933,ATM kinase inhibitor
1647,35.31,kd,CGS001-2737,GLI3,"Zinc fingers, C2H2-type"
1648,35.3,kd,CGS001-84636,GPR174,GPCR / Class A : Orphans
6653,-4.38,cp,BRD-A16478930,amcinonide,Glucocorticoid receptor agonist
1649,35.16,kd,CGS001-4886,NPY1R,GPCR / Class A : Neuropeptide receptors : Y
1650,35.12,kd,CGS001-7090,TLE3,WD repeat domain containing
1652,35.08,kd,CGS001-665,BNIP3L,-
1653,35.07,kd,CGS001-351,APP,Endogenous ligands
1654,35.04,kd,CGS001-6455,SH3GL1,-
1655,35.04,kd,CGS001-23549,DNPEP,Aminopeptidase I
1657,34.96,kd,CGS001-2052,EPHX1,-
6641,-4.26,cp,BRD-K28428262,brivanib,FGFR inhibitor
6642,-4.26,cp,BRD-K74212935,ergocryptine,Dopamine agonist
1658,34.93,kd,CGS001-10557,RPP38,-
1659,34.88,kd,CGS001-5243,ABCB1,ATP binding cassette transporters / subfamily B
1660,34.87,kd,CGS001-11325,DDX42,DEAD-boxes
6639,-4.23,cp,BRD-K28137194,loreclezole,GABA receptor agonist
6640,-4.23,cp,BRD-A84174393,meloxicam,Cyclooxygenase inhibitor
1661,34.86,kd,CGS001-2877,GPX2,-
1662,34.84,kd,CGS001-10691,GMEB1,-
1663,34.8,kd,CGS001-292,SLC25A5,Mitochondrial nucleotide transporter subfamily
1664,34.67,kd,CGS001-79174,CRELD2,-
1665,34.65,kd,CGS001-58499,ZNF462,"Zinc fingers, C2H2-type"
6633,-4.15,cc,,X linked mental retardation group 2 LOF,-
6632,-4.12,cp,BRD-K33459542,ditolylguanidine,Sigma receptor agonist
1666,34.65,oe,ccsbBroad304_01832,PAX8,Paired boxes
1668,34.62,kd,CGS001-9618,TRAF4,RING-type (C3HC4) zinc fingers
6628,-4.09,cp,BRD-K54708045,nTZDpa,PPAR receptor agonist
1669,34.6,kd,CGS001-1454,CSNK1E,Casein kinase 1 (CK1) family
1670,34.6,oe,ccsbBroad304_06255,LRRC32,-
6627,-4.07,cp,BRD-K69032158,diprotin-a,Dipeptidyl peptidase inhibitor
1671,34.57,kd,CGS001-10771,ZMYND11,"Zinc fingers, MYND-type"
1672,34.52,kd,CGS001-79618,HMBOX1,Homeoboxes / HNF class
1673,34.43,kd,CGS001-3920,LAMP2,CD molecules
6622,-4,cp,BRD-K32536677,AGK-2,SIRT inhibitor
6621,-3.99,cp,BRD-K99451608,lopinavir,HIV protease inhibitor
1674,34.42,oe,ccsbBroad304_09391,DTX2,RING-type (C3HC4) zinc fingers
6619,-3.98,cp,BRD-K22631935,neurodazine,Neurogenesis of non-pluripotent C2C12 myoblast inducer
6620,-3.98,cp,BRD-K52020312,metronidazole,DNA inhibitor
1675,34.42,kd,CGS001-678,ZFP36L2,RING-type (C3HC4) zinc fingers
6615,-3.95,cp,BRD-K67174588,toremifene,Estrogen receptor antagonist
1676,34.42,oe,ccsbBroad304_00078,BIRC2,Inhibitors of apoptosis (IAP) protein family
1677,34.41,kd,CGS001-85027,C5ORF62,-
1678,34.35,kd,CGS001-7832,BTG2,-
6612,-3.91,cp,BRD-K09631521,thiotepa,Cytochrome P450 inhibitor
6613,-3.91,cp,BRD-K92778217,mefenamic-acid,Cyclooxygenase inhibitor
1679,34.31,oe,ccsbBroad304_00282,CDKN1A,-
1680,34.31,kd,CGS001-23408,SIRT5,Histone deacetylases
1681,34.31,kd,CGS001-56882,CDC42SE1,-
1682,34.3,kd,CGS001-9961,MVP,-
1683,34.28,kd,CGS001-148103,ZNF599,"Zinc fingers, C2H2-type"
1684,34.25,kd,CGS001-4175,MCM6,-
1685,34.25,oe,ccsbBroad304_01880,LAGE3,-
1687,34.21,oe,ccsbBroad304_03215,MRPS2,Mitochondrial ribosomal proteins / small subunits
1689,34.16,oe,ccsbBroad304_02080,USP14,Ubiquitin-specific peptidases
1690,34.15,kd,CGS001-55617,TASP1,Glycosylasparaginase precursor
6599,-3.84,cp,BRD-K61341215,vecuronium,Acetylcholine receptor antagonist
1691,34.11,kd,CGS001-1662,DDX10,DEAD-boxes
6596,-3.83,cp,BRD-K06753942,nobiletin,MEK inhibitor
1692,34.1,kd,CGS001-5198,PFAS,-
1694,34,kd,CGS001-23266,LPHN2,Adhesion Class GPCRs
6595,-3.81,cp,BRD-K66615216,moxifloxacin,Bacterial DNA gyrase inhibitor
1695,33.86,kd,CGS001-328,APEX1,-
1696,33.85,kd,CGS001-6643,SNX2,Sorting nexins
1697,33.81,oe,ccsbBroad304_03510,FKBP14,EF-hand domain containing
1698,33.79,kd,CGS001-2958,GTF2A2,General transcription factors
1699,33.78,kd,CGS001-94103,ORMDL3,-
6590,-3.79,cp,BRD-A41995253,brucine,Glycine receptor antagonist
6588,-3.78,cp,BRD-A02710418,meptazinol,Opioid receptor agonist
6587,-3.77,cp,BRD-K55430733,WAY-629,Serotonin receptor agonist
1700,33.73,kd,CGS001-84527,ZNF559,"Zinc fingers, C2H2-type"
1702,33.64,kd,CGS001-5868,RAB5A,"RAB, member RAS oncogene"
1703,33.63,oe,ccsbBroad304_01677,TLE2,WD repeat domain containing
1704,33.61,oe,ccsbBroad304_06957,SLC1A5,Alanine/serine/cysteine transporter subfamily
1706,33.56,kd,CGS001-22930,RAB3GAP1,-
1707,33.55,oe,ccsbBroad304_00836,IGF2,-
6577,-3.74,cp,BRD-K55591206,epigallocatechin,Nitric oxide synthase inhibitor
1708,33.55,kd,CGS001-7753,ZNF202,"Zinc fingers, C2H2-type"
1709,33.54,oe,ccsbBroad304_09471,CSNK1A1L,Casein kinase 1 (CK1) family
1710,33.53,kd,CGS001-6548,SLC9A1,SLC9 family of sodium/hydrogen exchangers
1711,33.52,kd,CGS001-140465,MYL6B,EF-hand domain containing
1712,33.51,oe,ccsbBroad304_00001,NAT1,-
6572,-3.7,cp,BRD-K87510569,RS-504393,CC chemokine receptor antagonist
1713,33.46,oe,ccsbBroad304_02834,GABARAPL1,-
1714,33.43,kd,CGS001-29082,CHMP4A,Charged multivesicular body proteins
1716,33.14,kd,CGS001-8655,DYNLL1,Cytoplasmic dyneins
1717,33.07,kd,CGS001-10733,PLK4,Polo-like kinase (PLK) family
6569,-3.67,cp,BRD-K37691127,hinokitiol,Tyrosinase inhibitor
6566,-3.66,cp,BRD-K26429091,J-104129,Acetylcholine receptor antagonist
1719,33.05,kd,CGS001-1595,CYP51A1,Cytochrome P450s
1720,33.02,kd,CGS001-190,NR0B1,DAX-like receptors
6565,-3.64,cp,BRD-A33084410,5'-guanidinonaltrindole,Opioid receptor antagonist
6562,-3.63,cc,,Trace amine receptors LOF,-
6563,-3.63,cp,BRD-K78692225,leflunomide,Dihydroorotate dehydrogenase inhibitor
1721,32.99,kd,CGS001-246778,IL27,Interleukins and interleukin receptors
6560,-3.62,cp,BRD-K99411983,lumicolchicine,"Colchicine isomer, non-binder of microtubules"
6561,-3.62,cp,BRD-K06014311,DH-97,Melatonin receptor antagonist
1722,32.98,kd,CGS001-2678,GGT1,CD molecules
6553,-3.58,cp,BRD-A79465854,auranofin,NFkB pathway inhibitor
6554,-3.58,cp,BRD-K90789829,nefazodone,Adrenergic inhibitor
1723,32.96,kd,CGS001-284312,ZSCAN1,"Zinc fingers, C2H2-type"
1725,32.91,kd,CGS001-151126,ZNF385B,-
1726,32.89,kd,CGS001-5359,PLSCR1,-
1728,32.85,kd,CGS001-5264,PHYH,-
1730,32.8,kd,CGS001-7852,CXCR4,Chemokine receptors
1731,32.8,kd,CGS001-642,BLMH,-
1733,32.76,kd,CGS001-22794,CASC3,-
6549,-3.52,cp,BRD-K26674531,GR-235,Estrogen receptor agonist
6548,-3.49,cp,BRD-K41170226,deoxycholic-acid,G protein-coupled receptor agonist
1734,32.64,kd,CGS001-6890,TAP1,ATP binding cassette transporters / subfamily B
6546,-3.46,cp,BRD-A13807286,HA-14-1,BCL inhibitor
6544,-3.45,cp,BRD-K18059238,gamma-linolenic-acid,Cyclooxygenase inhibitor
1735,32.63,kd,CGS001-10318,TNIP1,-
1737,32.56,kd,CGS001-6915,TBXA2R,GPCR / Class A : Prostanoid receptors
6542,-3.41,cp,BRD-A73368467,fexofenadine,Histamine receptor antagonist
6539,-3.39,cp,BRD-K91904471,SD-169,p38 MAPK inhibitor
1738,32.55,oe,ccsbBroad304_03858,SRPRB,-
1740,32.47,oe,ccsbBroad304_01351,PEX19,-
1742,32.42,kd,CGS001-84936,ZFYVE19,"Zinc fingers, FYVE domain containing"
1743,32.41,kd,CGS001-1382,CRABP2,Fatty acid-binding proteins
6538,-3.38,cp,BRD-K08115555,tyrphostin-AG-1288,TNF production inhibitor
1744,32.41,kd,CGS001-220,ALDH1A3,Aldehyde dehydrogenases
6535,-3.37,cp,BRD-A50311610,meclozine,CAR agonist
6532,-3.36,cp,BRD-A15914070,4-hydroxy-2-nonenal,Cytotoxic lipid peroxidation product
6533,-3.36,cp,BRD-K13664374,dichloroacetic-acid,Pyruvate dehydrogenase kinase inhibitor
6528,-3.35,cp,BRD-A83892713,rifampicin,RNA polymerase inhibitor
6529,-3.35,cp,BRD-A95696066,nisoxetine,Norepinephrine reuptake inhibitor
6530,-3.35,cp,BRD-A17428743,BW-723C86,Serotonin receptor agonist
6531,-3.35,cp,BRD-K11801786,trimidox,Ribonucleotide reductase inhibitor
1746,32.39,kd,CGS001-80218,NAA50,N(alpha)-acetyltransferase subunits
1748,32.37,kd,CGS001-8613,PPAP2B,Lipid phosphate phosphatases
1749,32.37,kd,CGS001-56922,MCCC1,-
1750,32.31,oe,ccsbBroad304_06126,TSC22D3,-
6521,-3.31,cp,BRD-A77118605,BML-ST330,Phospholipase inhibitor
6522,-3.31,cp,BRD-K94832621,Y-134,Estrogen receptor antagonist
6523,-3.31,cp,BRD-K32755366,reserpic-acid,Norepinephrine transporter inhibitor
1751,32.25,oe,ccsbBroad304_08267,KLF3,Kruppel-like transcription factors
6520,-3.3,cp,BRD-K12513978,fenbufen,Cyclooxygenase inhibitor
1752,32.25,kd,CGS001-6868,ADAM17,ADAM metallopeptidase domain containing
6516,-3.28,cp,BRD-A84389633,"tropanyl-3,5-dimethylbenzoate",Serotonin receptor antagonist
1753,32.24,kd,CGS001-7016,TESK1,TESK subfamily
1756,32.13,kd,CGS001-84328,LZIC,-
1758,31.98,kd,CGS001-1633,DCK,-
1759,31.92,kd,CGS001-1153,CIRBP,RNA binding motif (RRM) containing
1761,31.88,oe,ccsbBroad304_08292,IP6K2,-
6509,-3.24,cp,BRD-A25775766,securinine,GABA receptor antagonist
1762,31.82,kd,CGS001-2593,GAMT,-
1763,31.81,oe,ccsbBroad304_07918,CBLC,RING-type (C3HC4) zinc fingers
1764,31.8,kd,CGS001-27095,TRAPPC3,Trafficking protein particle complex
6507,-3.22,cp,BRD-K61993165,niacin,NAD precursor with lipid lowering effects
1765,31.79,oe,ccsbBroad304_01371,RALA,-
1766,31.76,kd,CGS001-563,AZGP1,Immunoglobulin superfamily / C1-set domain containing
1767,31.75,kd,CGS001-340385,ZNF517,"Zinc fingers, C2H2-type"
1768,31.74,oe,ccsbBroad304_10024,ZNF680,"Zinc fingers, C2H2-type"
1769,31.73,kd,CGS001-93487,MAPK1IP1L,-
1770,31.68,oe,ccsbBroad304_07680,NEK6,NIMA (never in mitosis gene a)- related kinase (NEK) family
6498,-3.14,cp,BRD-K92678294,irilin-a,Isoflavone
6499,-3.14,cp,BRD-K87919739,tyrphostin-AG-825,Receptor tyrosine protein kinase inhibitor
6500,-3.14,cp,BRD-A25234499,aminoglutethimide,Glucocorticoid receptor antagonist
1772,31.61,oe,ccsbBroad304_02919,KIAA1279,-
1773,31.58,oe,ccsbBroad304_02487,TXNIP,-
6492,-3.1,cp,BRD-K07996107,harpagoside,Acetylcholinesterase inhibitor
6493,-3.1,cp,BRD-A06390036,hydroquinidine,Antiarrhythmic
1774,31.57,kd,CGS001-9406,ZRANB2,"Zinc fingers, RAN-binding domain containing"
1776,31.47,oe,ccsbBroad304_06748,POLE2,DNA polymerases
1778,31.43,kd,CGS001-6897,TARS,Aminoacyl tRNA synthetases / Class II
6489,-3.07,cp,BRD-K04430056,7-nitroindazole,nitric oxide synthase inhibitor
6490,-3.07,cp,BRD-A79981887,midodrine,Adrenergic receptor agonist
1779,31.35,kd,CGS001-4613,MYCN,Basic helix-loop-helix proteins
6487,-3.06,cp,BRD-K52397688,amperozide,Dopamine receptor antagonist
6488,-3.06,cp,BRD-K56558538,ambroxol,Sodium channel blocker
6485,-3.04,cp,BRD-K24656285,farnesol,FXR agonist
6483,-3.03,cp,BRD-K43736954,cortisone,Glucocorticoid receptor agonist
1780,31.34,kd,CGS001-1389,CREBL2,basic leucine zipper proteins
6482,-3.02,cp,BRD-A09925278,etilefrine,Adrenergic receptor agonist
6479,-3.01,cp,BRD-K69690935,curcumin,Cyclooxygenase inhibitor
1781,31.32,kd,CGS001-3567,IL5,Interleukins and interleukin receptors
1782,31.27,kd,CGS001-3815,KIT,"Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family"
1783,31.27,oe,ccsbBroad304_06494,KLRC1,CD molecules
1784,31.25,kd,CGS001-6929,TCF3,Basic helix-loop-helix proteins
1785,31.25,kd,CGS001-84722,PSRC1,-
6476,-2.97,cp,BRD-K41143549,BRD-K41143549,Glutamate receptor antagonist
6471,-2.96,cp,BRD-K83972459,JWE-035,Aurora kinase inhibitor
1786,31.25,kd,CGS001-4615,MYD88,-
1787,31.24,kd,CGS001-6193,RPS5,S ribosomal proteins
6474,-2.96,cp,BRD-A29734509,disopyramide,Sodium channel blocker
1788,31.22,kd,CGS001-8639,AOC3,Oxidoreductases
1789,31.18,kd,CGS001-355,FAS,Tumour necrosis factor (TNF) receptor family
1790,31.12,kd,CGS001-5883,RAD9A,-
1791,31.1,kd,CGS001-23635,SSBP2,-
1792,31.07,oe,ccsbBroad304_01450,RPS10,S ribosomal proteins
6470,-2.92,cp,BRD-K68507560,dicycloverine,Acetylcholine receptor antagonist
6462,-2.91,cc,,Integrin subunits alpha LOF,-
6463,-2.91,cp,BRD-K51541829,RO-25-6981,Ionotropic glutamate receptor antagonist
1793,31.06,kd,CGS001-7126,TNFAIP1,BTB/POZ domain containing
6461,-2.9,cc,,Calmodulin antagonist,-
6458,-2.89,cp,BRD-K82255054,propofol,GABA receptor agonist
6459,-2.89,cp,BRD-K99595596,salsolinol,Monoamine oxidase inhibitor
1794,30.96,kd,CGS001-7569,ZNF182,"Zinc fingers, C2H2-type"
1795,30.93,kd,CGS001-22926,ATF6,basic leucine zipper proteins
6456,-2.85,cp,BRD-K36864847,BD-1047,Adrenergic receptor antagonist
1796,30.87,kd,CGS001-53347,UBASH3A,-
1797,30.84,kd,CGS001-23710,GABARAPL1,-
6452,-2.82,cp,BRD-K17896185,FIT,Opioid receptor agonist
1798,30.8,kd,CGS001-167465,ZNF366,"Zinc fingers, C2H2-type"
6454,-2.82,cp,BRD-K37289225,clozapine,Dopamine receptor antagonist
1799,30.79,kd,CGS001-474354,LRRC18,-
1801,30.74,oe,ccsbBroad304_09233,GPR128,Adhesion Class GPCRs
6445,-2.78,cp,BRD-K78278890,NM-PP1,Mutant kinase inhibitor
6446,-2.78,cp,BRD-K95851186,CGP-13501,GABA receptor modulator
1802,30.72,oe,ccsbBroad304_10047,GPR148,GPCR / Class A : Orphans
1803,30.71,oe,ccsbBroad304_00067,SLC25A4,Mitochondrial nucleotide transporter subfamily
1804,30.67,kd,CGS001-3636,INPPL1,Inositol polyphosphate phosphatases
6443,-2.77,cc,,FXR antagonist,-
6440,-2.75,cp,BRD-K91733562,secoisolariciresinol,Antioxidant
6441,-2.75,cp,BRD-K52721684,PCO-400,Potassium channel activator
6442,-2.75,cp,BRD-K12002134,megestrol,progesterone receptor agonist
1805,30.64,kd,CGS001-5332,PLCB4,Phosphoinositide-specific phospholipase C
1807,30.6,kd,CGS001-1746,DLX2,Homeoboxes / ANTP class : NKL subclass
1808,30.55,oe,ccsbBroad304_01278,PRKACB,Protein kinase A
6433,-2.71,cp,BRD-A02990301,lofexidine,Adrenergic receptor agonist
6434,-2.71,cp,BRD-A14574269,UB-165,Acetylcholine receptor agonist
6435,-2.71,cp,BRD-K06221026,DUP-697,Cyclooxygenase inhibitor
6436,-2.71,cp,BRD-K78485176,olmesartan,Angiotensin receptor antagonist
6432,-2.69,cp,BRD-A91008255,bepridil,Calcium channel blocker
6430,-2.68,cp,BRD-K95921201,reserpine,Vesicular monoamine transporter inhibitor
1809,30.54,oe,ccsbBroad304_00446,DKC1,-
6428,-2.67,cp,BRD-K91243525,SR-142948,Neurotensin receptor antagonist
1810,30.52,kd,CGS001-5562,PRKAA1,AMPK subfamily
6420,-2.64,cp,BRD-K74430258,"1,2-dichlorobenzene",Hepatotoxicant
6421,-2.64,cp,BRD-A93000692,ciglitazone,PPAR receptor agonist
1811,30.51,oe,ccsbBroad304_05876,AZGP1,Immunoglobulin superfamily / C1-set domain containing
1813,30.44,kd,CGS001-471,ATIC,-
1814,30.4,oe,ccsbBroad304_00250,CD19,CD molecules
1815,30.31,kd,CGS001-2353,FOS,basic leucine zipper proteins
6426,-2.64,cp,BRD-A53952395,prilocaine,Local anesthetic
6427,-2.64,cp,BRD-K06335600,tizanidine,Adrenergic receptor agonist
6419,-2.63,cp,BRD-A28422058,L-689560,Glutamate receptor antagonist
6418,-2.62,cp,BRD-A31575449,CGP-20712,Adrenergic receptor antagonist
6413,-2.61,cp,BRD-A17448384,beclometasone,Glucocorticoid receptor agonist
6414,-2.61,cp,BRD-A77349281,RK-682,Tyrosine phosphatase inhibitor
1817,30.26,kd,CGS001-657,BMPR1A,Type I receptor serine/threonine kinases
1819,30.24,kd,CGS001-54407,SLC38A2,System A-like transporters
6417,-2.61,cp,BRD-K35458079,edaravone,Nootropic agent
1822,30.17,kd,CGS001-2494,NR5A2,Fushi tarazu F1-like receptors
1823,30.15,oe,ccsbBroad304_02139,HMGN3,High-mobility group / Canonical
1824,30.14,kd,CGS001-4651,MYO10,Pleckstrin homology (PH) domain containing
1826,30.13,kd,CGS001-6697,SPR,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
6412,-2.59,cp,BRD-A47494775,dipivefrine,Adrenergic receptor agonist
1829,30,kd,CGS001-9,NAT1,-
1830,29.99,kd,CGS001-8850,KAT2B,Histone acetyltransferases (HATs)
6406,-2.57,cp,BRD-A88282067,delcorine,Antiarrhythmic
6407,-2.57,cp,BRD-K75089421,procainamide,Sodium channel blocker
1831,29.96,kd,CGS001-6282,S100A11,EF-hand domain containing
1832,29.92,kd,CGS001-527,ATP6V0C,ATPases / V-type
1835,29.76,kd,CGS001-9797,TATDN2,-
1836,29.74,kd,CGS001-4605,MYBL2,-
1838,29.67,kd,CGS001-6201,RPS7,S ribosomal proteins
6398,-2.55,cp,BRD-K49671696,ketanserin,Serotonin receptor antagonist
1839,29.66,kd,CGS001-7188,TRAF5,RING-type (C3HC4) zinc fingers
1841,29.65,kd,CGS001-6097,RORC,Retinoic acid-related orphans
1842,29.58,kd,CGS001-27154,BRPF3,Non-enzymatic BRD containing proteins
1843,29.57,kd,CGS001-84878,ZBTB45,BTB/POZ domain containing
6392,-2.54,cp,BRD-K40965114,cyanopindolol,Adrenergic receptor antagonist
6393,-2.54,cp,BRD-A77291778,cyclopentolate,Acetylcholine receptor antagonist
1844,29.57,oe,ccsbBroad304_07017,SUOX,-
1846,29.5,kd,CGS001-91949,COG7,Components of oligomeric golgi complex
6386,-2.5,cp,BRD-A43882281,pinacidil,ATP channel activator
6387,-2.5,cp,BRD-K73589491,nizatidine,Histamine receptor antagonist
6388,-2.5,cp,BRD-K40990712,hexamethyleneamiloride,Sodium/hydrogen antiport inhibitor
1848,29.4,kd,CGS001-5434,POLR2E,RNA polymerase subunits
1849,29.39,kd,CGS001-9184,BUB3,WD repeat domain containing
1850,29.33,kd,CGS001-23061,TBC1D9B,EF-hand domain containing
6381,-2.47,cp,BRD-A34751532,homosalate,HSP inducer
6382,-2.47,cp,BRD-K71103788,duloxetine,Serotonin reuptake inhibitor
1852,29.29,kd,CGS001-6886,TAL1,Basic helix-loop-helix proteins
1854,29.24,kd,CGS001-8520,HAT1,Histone acetyltransferases (HATs)
1856,29.18,kd,CGS001-572,BAD,-
1857,29.14,kd,CGS001-2623,GATA1,GATA zinc finger domain containing
6377,-2.43,cp,BRD-K75181824,acetyl-geranygeranyl-cysteine,Inhibitor of methyl esterification of geranylgeranylated proteins
1858,29.13,oe,ccsbBroad304_03117,CERS2,Homeoboxes / CERS class
1859,29.13,kd,CGS001-6818,SULT1A3,"Sulfotransferases, cytosolic"
1860,29.07,oe,ccsbBroad304_08418,FBXL12,F-boxes / Leucine-rich repeats
1861,29.06,kd,CGS001-23118,TAB2,-
1862,29.06,kd,CGS001-2115,ETV1,ETS Transcription Factors
1864,29.02,oe,ccsbBroad304_00759,HMOX2,Haem oxygenase
6368,-2.4,cp,BRD-A72596465,GW-6471,PPAR receptor antagonist
6369,-2.4,cp,BRD-K26573499,DMAB-anabaseine,Adrenergic receptor agonist
1865,29.01,kd,CGS001-23029,RBM34,RNA binding motif (RRM) containing
6363,-2.37,cc,,HRH1 antagonist,-
1866,29,kd,CGS001-8553,BHLHE40,Basic helix-loop-helix proteins
1867,28.97,kd,CGS001-27113,BBC3,-
1868,28.85,oe,ccsbBroad304_01632,SYPL1,-
6367,-2.37,cp,BRD-A42759514,ornidazole,Antiprotozoal
1869,28.83,kd,CGS001-11116,FGFR1OP,-
6359,-2.36,cp,BRD-K80672993,M2-PK-activator,-666
6360,-2.36,cp,BRD-K59522102,piperine,Monoamine oxidase inhibitor
1870,28.77,kd,CGS001-11243,PMF1,-
6362,-2.36,cp,BRD-K76205745,losartan,Angiotensin receptor antagonist
1872,28.71,kd,CGS001-23014,FBXO21,F-boxes / other
1873,28.69,oe,ccsbBroad304_01066,NDUFA4,-
6354,-2.33,cp,BRD-K48300629,zonisamide,Sodium channel blocker
1874,28.65,kd,CGS001-8872,CDC123,-
1875,28.65,kd,CGS001-10097,ACTR2,-
1876,28.54,kd,CGS001-55256,ADI1,-
1877,28.53,oe,ccsbBroad304_01284,PRKCZ,Iota subfamily
6349,-2.29,cp,BRD-K52735702,cefdinir,Bacterial cell wall synthesis inhibitor
1879,28.49,oe,ccsbBroad304_03164,MTERFD1,-
6348,-2.28,cp,BRD-K82688027,RG-13022,PDGFR receptor inhibitor
1880,28.46,oe,ccsbBroad304_00063,AMPD2,-
1881,28.37,kd,CGS001-95,ACY1,-
1882,28.36,kd,CGS001-3221,HOXC4,Homeoboxes / ANTP class : HOXL subclass
6339,-2.26,cp,BRD-K61217870,n-(3-acetamidophenyl)-3-chlorobenzamide,Glutamate receptor antagonist
6340,-2.26,cp,BRD-K54759182,dosulepin,Norepinephrine reuptake inhibitor
6341,-2.26,cp,BRD-A92537424,danazol,Estrogen receptor antagonist
6342,-2.26,cp,BRD-K30020243,aliskiren,Antihypertensive
1883,28.35,kd,CGS001-9249,DHRS3,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3
1886,28.22,kd,CGS001-7003,TEAD1,-
6338,-2.25,cp,BRD-K72222507,quinapril,ACE inhibitor
1887,28.12,kd,CGS001-54583,EGLN1,2-oxoglutarate oxygenases
6332,-2.22,cp,BRD-K74141488,naftifine,Fungal squalene epoxidase inhibitor
6333,-2.22,cp,BRD-K95309561,dienestrol,Estrogen receptor agonist
1888,28.1,kd,CGS001-5891,MOK,RCK family
1890,28.08,kd,CGS001-994,CDC25B,Protein tyrosine phosphatases / Class III Cys-based PTPs
1891,28.08,oe,ccsbBroad304_05937,CASP7,Caspases
1892,28.06,kd,CGS001-124626,ZPBP2,Immunoglobulin superfamily / Immunoglobulin-like domain containing
1893,28.02,kd,CGS001-51684,SUFU,-
1894,28.02,oe,ccsbBroad304_02592,KIF2C,Kinesins
6328,-2.18,cp,BRD-K98684188,GSK-0660,PPAR receptor antagonist
6329,-2.18,cp,BRD-A72988804,tiaprofenic-acid,Cyclooxygenase inhibitor
6330,-2.18,cp,BRD-A79672927,tropicamide,Acetylcholine receptor antagonist
1895,27.99,kd,CGS001-10671,DCTN6,-
1897,27.97,kd,CGS001-5950,RBP4,Lipocalins
1898,27.96,kd,CGS001-54957,TXNL4B,-
6321,-2.15,cp,BRD-K00675675,CL-82198,Metalloproteinase inhibitor
6322,-2.15,cp,BRD-K54704028,BAY-36-7620,Glutamate receptor antagonist
1900,27.9,kd,CGS001-1827,RCAN1,-
1901,27.9,kd,CGS001-51203,NUSAP1,-
6317,-2.11,cp,BRD-K80725821,RS-16566,Serotonin receptor antagonist
1902,27.86,kd,CGS001-51284,TLR7,Toll-like receptor family
1903,27.81,oe,ccsbBroad304_00490,EIF4EBP1,-
6310,-2.08,cp,BRD-K11540476,EMF-BCA1-64,Caspase inhibitor
6311,-2.08,cp,BRD-K51751936,alfadolone,GABA receptor agonist
6312,-2.08,cp,BRD-K20482099,rutin,Antioxidant
1906,27.72,kd,CGS001-9709,HERPUD1,-
1908,27.7,kd,CGS001-10161,LPAR6,GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid
1909,27.67,kd,CGS001-3176,HNMT,-
6309,-2.06,cp,BRD-A02189320,met-leu-phe,-666
1910,27.67,kd,CGS001-2152,F3,CD molecules
1911,27.65,kd,CGS001-162239,ZFP1,"Zinc fingers, C2H2-type"
1912,27.62,kd,CGS001-115509,ZNF689,"Zinc fingers, C2H2-type"
6304,-2.04,cp,BRD-K06854232,AM-580,Retinoid receptor agonist
1913,27.62,kd,CGS001-3162,HMOX1,Haem oxygenase
1916,27.49,oe,ccsbBroad304_07976,RNF167,RING-type (C3HC4) zinc fingers
1917,27.49,kd,CGS001-5894,RAF1,RAF family
1918,27.47,kd,CGS001-9354,UBE4A,U-box domain containing
1919,27.45,kd,CGS001-3776,KCNK2,Two-P potassium channels
6296,-2.01,cp,BRD-K57033106,tripelennamine,Histamine receptor antagonist
6297,-2.01,cp,BRD-K02715688,hydrastine,Tyrosine hydroxylase inhibitor
6298,-2.01,cp,BRD-K78280988,anandamide,Cannabinoid receptor agonist
6299,-2.01,cp,BRD-K55344148,BU-224,Imidazoline receptor ligand
1921,27.36,kd,CGS001-406,ARNTL,Basic helix-loop-helix proteins
1922,27.31,kd,CGS001-6493,SIM2,Basic helix-loop-helix proteins
1923,27.31,oe,ccsbBroad304_01648,SERPINA7,Serine (or cysteine) peptidase inhibitors
1924,27.3,oe,ccsbBroad304_04379,LZIC,-
1925,27.27,oe,ccsbBroad304_09578,PASD1,-
1926,27.23,oe,ccsbBroad304_02862,CCRN4L,-
6289,-1.98,cp,BRD-K72903603,zidovudine,Reverse transcriptase inhibitor
6287,-1.97,cp,BRD-A03359064,ICI-89406,Adrenergic receptor antagonist
6288,-1.97,cp,BRD-K66788707,fludarabine,DNA synthesis inhibitor
6286,-1.96,cp,BRD-K14536225,piceid,Glucosidase inhibitor
1927,27.21,oe,ccsbBroad304_07172,ZNF195,"Zinc fingers, C2H2-type"
1928,27.17,kd,CGS001-2950,GSTP1,Glutathione S-transferases
1929,27.17,kd,CGS001-29994,BAZ2B,"Zinc fingers, PHD-type"
6279,-1.94,cp,BRD-A33711280,metixene,Acetylcholine receptor antagonist
1930,27.16,kd,CGS001-4216,MAP3K4,MAPKKK:STE11 family
1932,27.14,kd,CGS001-3265,HRAS,RAS subfamily
1934,27.09,kd,CGS001-8318,CDC45,-
1935,27.03,kd,CGS001-5605,MAP2K2,MAPKK:STE7 family
1936,27.03,kd,CGS001-3476,IGBP1,-
1937,27.01,kd,CGS001-151742,PPM1L,"Serine/threonine phosphatases / Protein phosphatases, Mg2+/Mn2+ dependent"
1938,27,oe,ccsbBroad304_09006,RPF1,-
1939,27,oe,ccsbBroad304_06384,HMOX1,Haem oxygenase
1940,27,kd,CGS001-8899,PRPF4B,PRP4 subfamily
1941,26.99,kd,CGS001-3420,IDH3B,-
6273,-1.9,cp,BRD-A69960130,bromocriptine,Dopamine receptor agonist
6274,-1.9,cp,BRD-A47144777,dihydro-7-desacetyldeoxygedunin,HSP inhibitor
6267,-1.87,cp,BRD-K11399644,phenformin,AMPK activator
1942,26.95,kd,CGS001-4835,NQO2,-
6269,-1.87,cp,BRD-A01826957,xanthinol,Vasodilator
1943,26.92,kd,CGS001-11035,RIPK3,Receptor interacting protein kinase (RIPK) family
1945,26.76,kd,CGS001-5447,POR,-
1948,26.68,kd,CGS001-57657,HCN3,Cyclic nucleotide-regulated channels
1949,26.67,kd,CGS001-6337,SCNN1A,Epithelial sodium channels (ENaC)
1951,26.6,oe,ccsbBroad304_06172,EPS8,-
6261,-1.83,cp,BRD-K72676686,fluvoxamine,Selective serotonin reuptake inhibitor (SSRI)
1952,26.58,oe,ccsbBroad304_06765,PRCC,-
1953,26.57,kd,CGS001-1465,CSRP1,-
1954,26.57,kd,CGS001-23647,ARFIP2,-
6256,-1.8,cp,BRD-K45479396,BP-554,Serotonin receptor agonist
6257,-1.8,cp,BRD-K12219985,glipizide,Sulfonylurea
1955,26.56,kd,CGS001-3856,KRT8,"Intermediate filaments type II, keratins (basic)"
1956,26.56,oe,ccsbBroad304_02086,PDLIM1,-
1958,26.53,kd,CGS001-56033,BARX1,Homeoboxes / ANTP class : NKL subclass
1959,26.5,kd,CGS001-900,CCNG1,-
1960,26.46,kd,CGS001-6016,RIT1,-
6245,-1.76,cp,BRD-K37561857,zardaverine,Phosphodiesterase inhibitor
6246,-1.76,cp,BRD-A45499626,UBP-302,Glutamate receptor antagonist
6247,-1.76,cp,BRD-K89375097,pirenzepine,Acetylcholine receptor antagonist
6248,-1.76,cp,BRD-K16508793,diazepam,Benzodiazepine receptor agonist
1961,26.46,kd,CGS001-3364,HUS1,-
1962,26.45,kd,CGS001-89766,UMODL1,-
1963,26.42,kd,CGS001-54386,TERF2IP,-
6239,-1.73,cp,BRD-K12260308,xanthoxyline,Antifungal
6240,-1.73,cp,BRD-K19533706,tranilast,Angiogenesis inhibitor
6241,-1.73,cp,BRD-K50018155,RS-67506,Serotonin receptor partial agonist
6242,-1.73,cp,BRD-A19661776,mianserin,Serotonin receptor antagonist
6243,-1.73,cp,BRD-K20152659,gamma-homolinolenic-acid,Cholesterol inhibitor
1964,26.41,kd,CGS001-1482,NKX2-5,Homeoboxes / ANTP class : NKL subclass
1966,26.36,kd,CGS001-9587,MAD2L1BP,-
1967,26.34,kd,CGS001-64324,NSD1,Histone methyltransferases (HMTs)
1968,26.34,kd,CGS001-64241,ABCG8,ATP binding cassette transporters / subfamily G
1972,26.23,oe,ccsbBroad304_05887,CFB,Complement system
1973,26.22,oe,ccsbBroad304_03177,FIS1,-
1974,26.2,kd,CGS001-89882,TPD52L3,-
1975,26.14,kd,CGS001-6300,MAPK12,MAPK:p38 subfamily
6228,-1.69,cp,BRD-K52751261,TAK-715,p38 MAPK inhibitor
6229,-1.69,cp,BRD-K20141153,atomoxetine,Norepinephrine transporter inhibitor
6230,-1.69,cp,BRD-A09056319,alfuzosin,Adrenergic receptor antagonist
1976,26.14,kd,CGS001-2771,GNAI2,-
6227,-1.68,cp,BRD-A39230911,chlorphensin,Muscle relaxant
1977,26.13,oe,ccsbBroad304_09284,UBE3B,-
1978,26.12,kd,CGS001-3832,KIF11,Kinesins
1979,26.11,oe,ccsbBroad304_00655,GNB2,WD repeat domain containing
6223,-1.67,cp,BRD-K76534306,enrofloxacin,Bacterial DNA gyrase inhibitor
1980,26.1,kd,CGS001-139760,GPR119,GPCR / Class A : Orphans
1981,26.05,kd,CGS001-203523,ZNF449,"Zinc fingers, C2H2-type"
6212,-1.66,cp,BRD-A04327189,synephrine,Adrenergic receptor agonist
6213,-1.66,cp,BRD-K66944906,fraxidin,Carbonic anhydrase inhibitor
6214,-1.66,cp,BRD-K34820100,tebuthiuron,Photosynthesis inhibitor
6215,-1.66,cp,BRD-K93441486,diphemanil,Acetylcholine receptor antagonist
1982,26.05,kd,CGS001-4297,MLL,-
1984,25.98,kd,CGS001-965,CD58,CD molecules
1985,25.88,kd,CGS001-3337,DNAJB1,Heat shock proteins / DNAJ (HSP40)
1986,25.87,kd,CGS001-10254,STAM2,-
1987,25.85,kd,CGS001-4696,NDUFA3,Mitochondrial respiratory chain complex / Complex I
1988,25.81,kd,CGS001-9221,NOLC1,-
6204,-1.62,cp,BRD-M41783010,acamprosate,Glutamate receptor antagonist
6205,-1.62,cp,BRD-K99291625,SB-203580,p38 MAPK inhibitor
6206,-1.62,cp,BRD-A51820102,econazole,Bacterial cell wall synthesis inhibitor
6207,-1.62,cp,BRD-K65639003,icariin,Phosphodiesterase inhibitor
1989,25.8,oe,ccsbBroad304_07704,SUB1,-
1990,25.79,kd,CGS001-6988,TCTA,-
1991,25.78,kd,CGS001-222611,GPR111,Adhesion Class GPCRs
6198,-1.59,cp,BRD-K31471398,dihydrexidine,Dopamine receptor agonist
6199,-1.59,cp,BRD-A20968261,WAY-213613,Glutamate inhibitor
6200,-1.59,cp,BRD-K27871032,lysergol,Ergoline alkaloid
6201,-1.59,cp,BRD-K51918615,iodophenpropit,Histamine receptor antagonist
6202,-1.59,cp,BRD-A15435692,BMY-14802,Sigma receptor antagonist
1993,25.74,kd,CGS001-10257,ABCC4,ATP binding cassette transporters / subfamily C
1994,25.71,kd,CGS001-6810,STX4,-
1995,25.68,kd,CGS001-22859,LPHN1,Adhesion Class GPCRs
1997,25.66,kd,CGS001-5566,PRKACA,Protein kinase A
1998,25.64,kd,CGS001-2222,FDFT1,Lanosterol biosynthesis pathway
1999,25.56,oe,ccsbBroad304_03533,CDCA8,-
2000,25.53,kd,CGS001-3485,IGFBP2,insulin-like growth factor (IGF) binding proteins
6185,-1.55,cp,BRD-A41692738,TGX-221,PI3K inhibitor
6186,-1.55,cp,BRD-K09635134,l-erythro-MAPP,negative control for D-erythro-MAPP
6187,-1.55,cp,BRD-A96882008,L-732138,Tachykinin antagonist
6188,-1.55,cp,BRD-K91315211,betahistine,Histamine receptor agonist
2001,25.52,kd,CGS001-5997,RGS2,Endogenous ligands
2003,25.47,kd,CGS001-9467,SH3BP5,-
6182,-1.52,cp,BRD-K53913732,SB-408124,Orexin receptor antagonist
6183,-1.52,cp,BRD-A29289453,PCA-4248,Platelet activating factor receptor antagonist
6184,-1.52,cp,BRD-K52662033,lidocaine,Histamine receptor agonist
2004,25.45,oe,ccsbBroad304_01664,TGFA,-
2005,25.44,oe,ccsbBroad304_02825,POLA2,DNA polymerases
2006,25.43,oe,ccsbBroad304_00526,EZH2,Chromatin-modifying enzymes / K-methyltransferases
2009,25.4,kd,CGS001-8558,CDK10,"Cyclin-dependent kinases, CDK10 subfamily"
6175,-1.48,cp,BRD-K68437527,EMF-bca1-60,caspase inhibitor
6176,-1.48,cp,BRD-A18202423,CPCCOEt,Glutamate receptor antagonist
6177,-1.48,cp,BRD-K41996876,tyrphostin-1,EGFR inhibitor
6178,-1.48,cp,BRD-K25224017,pirenperone,Serotonin receptor antagonist
2010,25.37,kd,CGS001-9290,GPR55,GPCR / Class A : Orphans
2012,25.34,kd,CGS001-27316,RBMX,RNA binding motif (RRM) containing
6181,-1.48,cp,BRD-K09907482,PRL-3-inhibitor-I,Tyrosine phosphatase inhibitor
2013,25.32,kd,CGS001-115650,TNFRSF13C,Tumour necrosis factor (TNF) receptor family
2014,25.28,kd,CGS001-7534,YWHAZ,-
2015,25.28,kd,CGS001-6788,STK3,MST subfamily
2016,25.27,kd,CGS001-253260,RICTOR,-
2017,25.27,kd,CGS001-5985,RFC5,ATPases / AAA-type
2018,25.25,kd,CGS001-9813,KIAA0494,-
2019,25.21,kd,CGS001-7295,TXN,-
2020,25.18,kd,CGS001-5478,PPIA,Cis-trans-isomerases
6169,-1.44,cp,BRD-A74980173,gatifloxacin,Bacterial DNA gyrase inhibitor
2021,25.11,kd,CGS001-2247,FGF2,Endogenous ligands
6160,-1.43,cp,BRD-K97764662,PD-173074,FGFR inhibitor
6161,-1.43,cp,BRD-A09094913,strychnine,Acetylcholine receptor antagonist
2023,25.09,kd,CGS001-5524,PPP2R4,"Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits"
2028,25.05,oe,ccsbBroad304_01607,STAT1,SH2 domain containing
6152,-1.41,cp,BRD-K43149758,myricetin,Androgen receptor agonist
6153,-1.41,cp,BRD-K19605405,ZM-241385,Adenosine receptor antagonist
6154,-1.41,cp,BRD-K68620903,dydrogesterone,Progesterone receptor agonist
6155,-1.41,cp,BRD-K31987754,oleylethanolamide,Cannabinoid receptor agonist
2029,25.03,kd,CGS001-7570,ZNF22,"Zinc fingers, C2H2-type"
2030,25,oe,ccsbBroad304_02596,KDELR3,-
2033,24.91,oe,ccsbBroad304_02140,ZNHIT3,"Zinc fingers, HIT-type"
2035,24.87,kd,CGS001-5134,PDCD2,"Zinc fingers, MYND-type"
2036,24.83,kd,CGS001-8027,STAM,-
2040,24.78,kd,CGS001-51495,PTPLAD1,-
6144,-1.37,cp,BRD-A48261811,argatroban,Thrombin inhibitor
6145,-1.37,cp,BRD-K20313525,rosmarinic-acid,GABA transaminase inhibitor
6146,-1.37,cp,BRD-A30590053,MR-16728,Acetylcholine release enhancer
6143,-1.36,cp,BRD-A08187463,racecadotril,Enkephalinase inhibitor
2041,24.74,kd,CGS001-221393,GPR115,Adhesion Class GPCRs
6142,-1.35,cp,BRD-K77695569,tiabendazole,Angiogenesis inhibitor
2042,24.71,kd,CGS001-3113,HLA-DPA1,Immunoglobulin superfamily / C1-set domain containing
2043,24.68,kd,CGS001-8536,CAMK1,CAMK1 family
2045,24.62,kd,CGS001-128674,PROKR2,GPCR / Class A : Prokineticin receptors
2046,24.59,kd,CGS001-9871,SEC24D,-
6131,-1.34,cp,BRD-A06726973,dibutyrylcyclic-gmp,cGMP analog
6132,-1.34,cp,BRD-K06208435,YS-035,Calcium channel blocker
6133,-1.34,cp,BRD-K96862998,pirfenidone,TGF beta receptor inhibitor
6134,-1.34,cp,BRD-K98521173,desoxycortone,Mineralocorticoid receptor agonist
6135,-1.34,cp,BRD-A91699651,chloroquine,Antimalarial
2048,24.55,oe,ccsbBroad304_04794,ZFP3,"Zinc fingers, C2H2-type"
2051,24.49,kd,CGS001-10450,PPIE,RNA binding motif (RRM) containing
2052,24.48,oe,ccsbBroad304_02459,KAT5,Histone acetyltransferases (HATs)
6139,-1.34,cp,BRD-A80213327,NSC-23766,Ras GTPase inhibitor
6140,-1.34,cp,BRD-A93255169,thalidomide,TNF production inhibitor
6125,-1.33,cc,,HSP inhibitor,-
2053,24.46,oe,ccsbBroad304_00705,GTF2A1,General transcription factors
2054,24.43,kd,CGS001-6258,RXRG,Retinoid X receptors
6124,-1.32,cp,BRD-A92161634,scopoline,Acetylcholine receptor antagonist
6122,-1.31,cp,BRD-K77947974,fluspirilene,Dopamine receptor antagonist
2055,24.38,oe,ccsbBroad304_03450,TMED9,-
2056,24.38,kd,CGS001-1445,CSK,Csk family
6116,-1.3,cp,BRD-A80641450,FR-139317,Endothelin receptor antagonist
6117,-1.3,cp,BRD-K08132273,tyrphostin,EGFR inhibitor
6118,-1.3,cp,BRD-A72483914,spiroxatrine,Serotonin receptor antagonist
2057,24.37,oe,ccsbBroad304_12008,NLK,nmo subfamily
2058,24.36,kd,CGS001-25989,ULK3,Unc-51-like kinase (ULK) family
2059,24.36,kd,CGS001-3399,ID3,Basic helix-loop-helix proteins
6113,-1.29,cp,BRD-K22193694,dioxybenzone,Topical sunscreen agent
6108,-1.27,cp,BRD-K62996583,lidoflazine,Calcium channel blocker
6109,-1.27,cp,BRD-K38323065,phenacetin,Cyclooxygenase inhibitor
6110,-1.27,cp,BRD-A85234536,N6-cyclopentyladenosine,Adenosine receptor agonist
6111,-1.27,cp,BRD-K09991945,GSK-3-inhibitor-II,PKC inhibitor
6112,-1.27,cp,BRD-K37991163,paroxetine,Selective serotonin reuptake inhibitor (SSRI)
2060,24.31,oe,ccsbBroad304_03264,UBAP1,-
2061,24.29,kd,CGS001-85315,PAQR8,-
2062,24.27,kd,CGS001-7301,TYRO3,"Type XI RTKs: TAM (TYRO3-, AXL- and MER-TK) receptor family"
2064,24.26,kd,CGS001-10558,SPTLC1,Serine palmitoyltransferase
2065,24.24,kd,CGS001-8323,FZD6,GPCR / Class F : Frizzled receptors
2066,24.2,kd,CGS001-55536,CDCA7L,-
6101,-1.24,cp,BRD-K33308633,INCA-6,Calcineurin inhibitor
6098,-1.23,cp,BRD-K44353683,nateglinide,Insulin secretagogue
6099,-1.23,cp,BRD-A83695761,chromanol,Potassium channel blocker
2067,24.13,kd,CGS001-5265,SERPINA1,Serine (or cysteine) peptidase inhibitors
2068,24.12,oe,ccsbBroad304_00857,IL10,Interleukins and interleukin receptors
2071,23.99,kd,CGS001-6727,SRP14,-
2072,23.98,kd,CGS001-5226,PGD,-
6092,-1.18,cp,BRD-A10303790,talampicillin,Bacterial cell wall synthesis inhibitor
2073,23.93,oe,ccsbBroad304_00515,ERH,-
2075,23.89,kd,CGS001-3398,ID2,Basic helix-loop-helix proteins
2076,23.85,kd,CGS001-7780,SLC30A2,SLC30 zinc transporter family
6084,-1.16,cp,BRD-K87142802,veliparib,PARP inhibitor
6085,-1.16,cp,BRD-K67352070,TC-2559,Acetylcholine receptor agonist
6086,-1.16,cp,BRD-K85015012,NNC-05-2090,GAT inhibitor
6087,-1.16,cp,BRD-A43974575,tranylcypromine,Monoamine oxidase inhibitor
6088,-1.16,cp,BRD-K13819402,desoxypeganine,Acetylcholinesterase inhibitor
2078,23.81,kd,CGS001-199777,ZNF626,"Zinc fingers, C2H2-type"
2079,23.81,kd,CGS001-5879,RAC1,Endogenous ligands
2080,23.81,kd,CGS001-10142,AKAP9,A-kinase anchor proteins
6082,-1.14,cp,BRD-A89175223,bisoprolol,Adrenergic receptor antagonist
6076,-1.13,cp,BRD-K09549677,mibefradil,T-type calcium channel blocker
2081,23.8,oe,ccsbBroad304_01242,POLR2I,RNA polymerase subunits
6078,-1.13,cp,BRD-K92428232,GSK-461364,PLK inhibitor
6079,-1.13,cp,BRD-K59369769,tozasertib,Aurora kinase inhibitor
6080,-1.13,cp,BRD-A97437073,rosiglitazone,Insulin sensitizer
6081,-1.13,cp,BRD-K11129031,gemfibrozil,Lipoprotein lipase activator
6075,-1.12,cp,BRD-K44067360,flufenamic-acid,Chloride channel blocker
2083,23.78,kd,CGS001-6832,SUPV3L1,-
2084,23.73,kd,CGS001-55082,ARGLU1,-
2085,23.71,kd,CGS001-3294,HSD17B2,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2
6070,-1.1,cp,BRD-A44551378,LFM-A12,EGFR inhibitor
2086,23.71,kd,CGS001-780,DDR1,Type XVI RTKs: DDR (collagen receptor) family
6066,-1.09,cp,BRD-K12932420,YM-976,Phosphodiesterase inhibitor
6067,-1.09,cp,BRD-K09416995,lovastatin,HMGCR inhibitor
6068,-1.09,cp,BRD-K28578425,cilostamide,Phosphodiesterase inhibitor
6069,-1.09,cp,BRD-A44090213,indoprofen,Cyclooxygenase inhibitor
2087,23.67,kd,CGS001-55793,FAM63A,-
6064,-1.08,cp,BRD-K81916719,triclabendazole,Microtubule inhibitor
2088,23.59,oe,ccsbBroad304_04496,LHX4,Homeoboxes / LIM class
6060,-1.06,cp,BRD-K26521938,dinoprostone,Prostanoid receptor agonist
6061,-1.06,cp,BRD-A54236247,racephedrine,Adrenergic receptor agonist
2090,23.54,oe,ccsbBroad304_03615,ZNF673,-
2091,23.53,oe,ccsbBroad304_00752,HMGB3,High-mobility group / Canonical
2095,23.49,kd,CGS001-4856,NOV,-
2096,23.48,kd,CGS001-11000,SLC27A3,SLC27 family of fatty acid transporters
6055,-1.02,cp,BRD-K68332390,ponalrestat,Aldose reductase inhibitor
2097,23.43,kd,CGS001-5499,PPP1CA,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
2098,23.4,oe,ccsbBroad304_02612,DUSP14,Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases
2101,23.33,kd,CGS001-5034,P4HB,Protein disulfide isomerases
6051,-1,cp,BRD-K64402243,ivachtin,Caspase inhibitor
2102,23.32,oe,ccsbBroad304_12106,PXK,Slob family
6041,-0.99,cp,BRD-K71499074,diclofenamide,Carbonic anhydrase inhibitor
6042,-0.99,cp,BRD-K29555132,arachidonamide,Cannabinoid receptor agonist
6043,-0.99,cp,BRD-K89055274,alverine,Muscle relaxant
6044,-0.99,cp,BRD-K00603606,ticlopidine,Purinergic receptor antagonist
6045,-0.99,cp,BRD-A54596827,solifenacin,Acetylcholine receptor antagonist
6046,-0.99,cp,BRD-K21733600,rofecoxib,Cyclooxygenase inhibitor
6047,-0.99,cp,BRD-K47936004,piribedil,Dopamine receptor agonist
6048,-0.99,cp,BRD-A61793559,metolazone,Carbonic anhydrase inhibitor
6049,-0.99,cp,BRD-K10974103,diloxanide,Protein synthesis inhibitor
6050,-0.99,cp,BRD-K35723520,darinaparsin,Apoptosis stimulant
2103,23.31,oe,ccsbBroad304_00225,CAT,-
2104,23.3,kd,CGS001-7554,ZNF8,"Zinc fingers, C2H2-type"
2105,23.28,kd,CGS001-9589,WTAP,-
2106,23.28,kd,CGS001-4709,NDUFB3,Mitochondrial respiratory chain complex / Complex I
2107,23.26,kd,CGS001-10589,DRAP1,-
6032,-0.95,cp,BRD-K97118047,"4,5,6,7-tetrabromobenzotriazole",Casein kinase inhibitor
6033,-0.95,cp,BRD-K14282469,LY-165163,Serotonin receptor antagonist
6034,-0.95,cp,BRD-K05434375,HA-1004,Calcium channel blocker
6035,-0.95,cp,BRD-A96485169,EBPC,Aldose reductase inhibitor
2108,23.24,kd,CGS001-2580,GAK,Heat shock proteins / DNAJ (HSP40)
2109,23.23,kd,CGS001-23492,CBX7,-
2110,23.22,oe,ccsbBroad304_06928,SDHB,Mitochondrial respiratory chain complex / Complex II
6031,-0.93,cp,BRD-K32247306,primidone,GABA receptor antagonist
6022,-0.92,cp,BRD-K24675965,LY-288513,CCK receptor antagonist
6023,-0.92,cp,BRD-K00662280,CL-218872,GABA receptor agonist
2111,23.21,kd,CGS001-2002,ELK1,ETS Transcription Factors
6025,-0.92,cp,BRD-A95939040,sertaconazole,Sterol demethylase inhibitor
6026,-0.92,cp,BRD-K47323024,methapyrilene,Histamine receptor antagonist
6027,-0.92,cp,BRD-A19736161,ondansetron,Serotonin receptor antagonist
2112,23.2,kd,CGS001-23512,SUZ12,"Zinc fingers, C2H2-type"
6020,-0.89,cp,BRD-K47328134,lysylphenylalanyl-tyrosine,Heparin activation inhibitor
2113,23.17,kd,CGS001-29880,ALG5,Glycosyltransferase family 2 domain containing
6015,-0.88,cp,BRD-K49890030,gavestinel,Glutamate receptor antagonist
6016,-0.88,cp,BRD-K46766488,S-14506,Serotonin receptor agonist
2115,23.08,kd,CGS001-79947,DHDDS,-
2119,22.95,kd,CGS001-122011,CSNK1A1L,Casein kinase 1 (CK1) family
6019,-0.88,cp,BRD-A70407468,PSB-36,Adenosine receptor antagonist
2120,22.93,kd,CGS001-1070,CETN3,EF-hand domain containing
6010,-0.85,cp,BRD-K54416256,methimazole,Antithyroid
6011,-0.85,cp,BRD-K17796732,JWH-015,Cannabinoid receptor agonist
6012,-0.85,cp,BRD-K87158025,benzamil,Sodium channel blocker
6006,-0.83,cc,,PARP inhibitor,-
2122,22.9,kd,CGS001-51170,HSD17B11,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3
2123,22.83,kd,CGS001-29916,SNX11,Sorting nexins
2124,22.82,kd,CGS001-6472,SHMT2,-
2126,22.74,kd,CGS001-2167,FABP4,Fatty acid binding protein family
6001,-0.81,cp,BRD-K80725632,lavendustin-c,EGFR inhibitor
6002,-0.81,cp,BRD-A24381660,zeranol,Estrogen receptor agonist
6003,-0.81,cp,BRD-K93332168,isocarboxazid,Monoamine oxidase inhibitor
6004,-0.81,cp,BRD-A48257147,PHCCC,Glutamate receptor agonist
2129,22.67,kd,CGS001-8522,GAS7,-
2130,22.65,kd,CGS001-5315,PKM2,-
2131,22.55,kd,CGS001-8503,PIK3R3,Phosphatidylinositol kinases
2132,22.52,oe,ccsbBroad304_05758,ACADSB,-
2133,22.51,kd,CGS001-5170,PDPK1,PDK1 family
2134,22.48,kd,CGS001-389421,LIN28B,-
5993,-0.78,cp,BRD-K32412559,morphothebaine,Adrenergic receptor antagonist
5994,-0.78,cp,BRD-A63667919,methylergometrine,Dopamine receptor antagonist
5992,-0.77,cp,BRD-A77299732,salubrinal,Eukaryotic translation initiation factor inhibitor
2135,22.43,kd,CGS001-4143,MAT1A,-
2136,22.39,kd,CGS001-3845,KRAS,RAS subfamily
5988,-0.75,cc,,FGFR inhibitor,-
5989,-0.75,cp,BRD-K14888893,minoxidil,KATP activator
2137,22.35,oe,ccsbBroad304_03005,HCAR1,GPCR / Class A : Hydroxy-carboxylic acid receptors
5985,-0.74,cp,BRD-K08996725,zolantidine,Histamine receptor antagonist
5986,-0.74,cp,BRD-K89210380,biotin,Vitamin B
2138,22.33,kd,CGS001-5716,PSMD10,Ankyrin repeat domain containing
5979,-0.7,cc,,EGFR inhibitor,-
5980,-0.7,cp,BRD-K89125793,tinidazole,Antiprotozoal
5981,-0.7,cp,BRD-K44779798,miglitol,Glucosidase inhibitor
5982,-0.7,cp,BRD-K33211335,dextromethorphan,Glutamate receptor antagonist
5983,-0.7,cp,BRD-K53857191,risperidone,Dopamine receptor antagonist
2142,22.29,oe,ccsbBroad304_07078,TSPAN6,Tetraspanins
2144,22.28,kd,CGS001-3930,LBR,Tudor domain containing
2145,22.22,oe,ccsbBroad304_00645,GCLM,-
2147,22.1,kd,CGS001-1577,CYP3A5,Cytochrome P450s
5971,-0.67,cp,BRD-A04352665,maraviroc,CC chemokine receptor antagonist
5972,-0.67,cp,BRD-K07691486,roscovitine,CDK inhibitor
5973,-0.67,cp,BRD-K47639036,flavoxate,Acetylcholine receptor antagonist
5974,-0.67,cp,BRD-K07888107,depudecin,HDAC inhibitor
2148,22.08,kd,CGS001-8031,NCOA4,-
2149,22.06,kd,CGS001-29947,DNMT3L,-
5961,-0.63,cp,BRD-K67298865,SB-431542,TGF beta receptor inhibitor
5962,-0.63,cp,BRD-K60060639,methyllidocaine,antiarrhythmic medication
5963,-0.63,cp,BRD-K96144918,mead-acid,KPL-1 tumor suppressor
5964,-0.63,cp,BRD-K71534238,GW-9508,Free fatty acid receptor agonist
5965,-0.63,cp,BRD-K15715913,fluperlapine,Serotonin receptor antagonist
5966,-0.63,cp,BRD-K52989797,clomipramine,Serotonin transporter inhibitor (SERT)
5967,-0.63,cp,BRD-K39746403,erythromycin,NFkB pathway inhibitor
5968,-0.63,cp,BRD-K79116891,proxymetacaine,Sodium channel blocker
2150,22.05,oe,ccsbBroad304_00023,ADA,Adenosine turnover
2151,22.04,oe,ccsbBroad304_00122,ATP1B1,ATPases / P-type
2152,22.04,kd,CGS001-637,BID,Endogenous ligands
2153,21.98,kd,CGS001-50,ACO2,-
2154,21.97,oe,ccsbBroad304_06728,PIK3R1,Phosphatidylinositol kinases
5954,-0.6,cp,BRD-A70268693,PG-9,Acetylcholine receptor agonist
5955,-0.6,cp,BRD-K18574842,nafcillin,Bacterial cell wall synthesis inhibitor
5956,-0.6,cp,BRD-A49358627,ciprofibrate,PPAR receptor agonist
5957,-0.6,cp,BRD-K94379058,BML-190,Cannabinoid receptor inverse agonist
5958,-0.6,cp,BRD-K56343971,vemurafenib,RAF inhibitor
2155,21.92,kd,CGS001-57541,ZNF398,"Zinc fingers, C2H2-type"
2156,21.91,kd,CGS001-4664,NAB1,-
2160,21.77,kd,CGS001-5087,PBX1,Homeoboxes / TALE class
2161,21.71,kd,CGS001-201799,TMEM154,-
5944,-0.56,cp,BRD-A41941932,vitexin,Antioxidant
5945,-0.56,cp,BRD-K06147391,telenzepine,Acetylcholine receptor antagonist
5946,-0.56,cp,BRD-K43330982,JTE-013,Lysophospholipid receptor antagonist
5947,-0.56,cp,BRD-K25905511,buddleoflavonoloside,Acetylcholinesterase inhibitor
5948,-0.56,cp,BRD-A02367930,ethinyl-estradiol,DNA directed DNA polymerase stimulant
5939,-0.53,cp,BRD-K64610608,EMF-bca1-57,caspase inhibitor
5940,-0.53,cp,BRD-K02581333,protein-tyrosine-phosphatase-inhibitor-IV,Tyrosine phosphatase inhibitor
5941,-0.53,cp,BRD-K36927236,glibenclamide,Sulfonylurea
2162,21.7,oe,ccsbBroad304_00397,CTSK,Cathepsins
5936,-0.51,cp,BRD-K73999723,telmisartan,Angiotensin receptor antagonist
2164,21.67,kd,CGS001-5522,PPP2R2C,"Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits"
2167,21.6,kd,CGS001-11336,EXOC3,-
5932,-0.5,cc,,Mitogen activated protein kinases LOF,-
2168,21.6,oe,ccsbBroad304_01421,RPL11,L ribosomal proteins
2169,21.56,kd,CGS001-10923,SUB1,-
5930,-0.49,cp,BRD-A93659613,GR-89696,Opioid receptor agonist
5931,-0.49,cp,BRD-K32830106,guanfacine,Adrenergic receptor agonist
5929,-0.47,cc,,HIV protease inhibitor,-
5925,-0.46,cc,,GABA receptor antagonist,-
5926,-0.46,cp,BRD-K27665173,D-64406,PDGFR receptor inhibitor
5927,-0.46,cp,BRD-K60770992,pergolide,Dopamine receptor agonist
5928,-0.46,cp,BRD-K39915878,loxapine,Dopamine receptor antagonist
2170,21.53,kd,CGS001-25793,FBXO7,F-boxes / other
5923,-0.43,cc,,Aminoacyl tRNA synthetases class II LOF,-
2173,21.45,kd,CGS001-8050,PDHX,-
2174,21.44,kd,CGS001-51655,RASD1,-
2175,21.43,kd,CGS001-55143,CDCA8,-
5918,-0.42,cp,BRD-K45401373,betulinic-acid,Apoptosis stimulant
5919,-0.42,cp,BRD-K54314721,zolmitriptan,Serotonin receptor agonist
5920,-0.42,cp,BRD-K66296774,fluvastatin,HMGCR inhibitor
2176,21.42,kd,CGS001-23522,KAT6B,Histone acetyltransferases (HATs)
5922,-0.42,cp,BRD-A23072235,pheniramine,Histamine receptor antagonist
5914,-0.41,cp,BRD-K96354014,nifedipine,Calcium channel blocker
5909,-0.39,cp,BRD-A31195449,TCB2,Serotonin receptor agonist
5910,-0.39,cp,BRD-K92015269,GBR-12783,Dopamine uptake inhibitor
5911,-0.39,cp,BRD-K76133116,benzydamine,Membrane integrity inhibitor
5912,-0.39,cp,BRD-K71430621,clobenpropit,Histamine receptor antagonist
5913,-0.39,cp,BRD-A92670106,tocainide,Sodium channel blocker
2177,21.4,kd,CGS001-375133,PI4KAP2,-
2178,21.36,kd,CGS001-9218,VAPA,-
2180,21.33,kd,CGS001-55748,CNDP2,Carnosine dipeptidase
2181,21.33,kd,CGS001-427,ASAH1,Acid ceramidase
5904,-0.36,cp,BRD-K97354755,SU-6656,SRC inhibitor
5898,-0.35,cp,BRD-K95202259,ML-3163,p38 MAPK inhibitor
5899,-0.35,cp,BRD-K47717570,NBQX,Glutamate receptor antagonist
5900,-0.35,cp,BRD-K13032584,procarbazine,Monoamine oxidase inhibitor
5901,-0.35,cp,BRD-A44008656,doxylamine,Histamine receptor antagonist
5902,-0.35,cp,BRD-K95237249,probenecid,Uricosuric blocker
5903,-0.35,cp,BRD-A75769826,SDM25N,Opioid receptor antagonist
5897,-0.34,cc,,Potassium channel activator,-
5896,-0.33,cc,,Imidazoline ligand,-
2182,21.32,kd,CGS001-116535,MRGPRF,GPCR / Class A : Orphans
5890,-0.32,cp,BRD-K04170657,psoromic-acid,Ras GTPase inhibitor
5891,-0.32,cp,BRD-K80315159,DPPE,Histamine receptor antagonist
5892,-0.32,cp,BRD-A54880345,etomidate,GABA receptor modulator
2183,21.31,kd,CGS001-55699,IARS2,Aminoacyl tRNA synthetases / Class I
2184,21.23,kd,CGS001-51131,PHF11,"Zinc fingers, PHD-type"
2185,21.21,oe,ccsbBroad304_13848,EGFR,Type I RTKs: ErbB (epidermal growth factor) receptor family
5888,-0.29,cp,BRD-K05350981,oligomycin-c,ATPase inhibitor
2186,21.2,kd,CGS001-4038,LRP4,Low density lipoprotein receptors
5880,-0.28,cp,BRD-K59962020,CHEMBL-374350,NFkB pathway inhibitor
5881,-0.28,cp,BRD-K88871508,lisuride,Dopamine receptor agonist
5882,-0.28,cp,BRD-K73391359,quinisocaine,Local anesthetic
5883,-0.28,cp,BRD-K55468218,spiperone,Dopamine receptor antagonist
5884,-0.28,cp,BRD-K35941380,methysergide,Serotonin receptor antagonist
5885,-0.28,cp,BRD-A65145453,ATPA,Glutamate receptor agonist
5886,-0.28,cp,BRD-A29485665,bicalutamide,Androgen receptor antagonist
5887,-0.28,cp,BRD-K29458283,chlorambucil,DNA inhibitor
5875,-0.25,cp,BRD-K94887716,TFMPP,Serotonin receptor agonist
5876,-0.25,cp,BRD-K39965020,doconexent,PPAR receptor agonist
5877,-0.25,cp,BRD-K12994359,valdecoxib,Cyclooxygenase inhibitor
5878,-0.25,cp,BRD-K51575138,TPCA-1,IKK inhibitor
5871,-0.21,cc,,PPAR receptor agonist,-
5872,-0.21,cp,BRD-K50135270,GBR-12935,Dopamine uptake inhibitor
5873,-0.21,cp,BRD-A26711594,nicardipine,Calcium channel blocker
5874,-0.21,cp,BRD-A64092382,mexiletine,Sodium channel blocker
5870,-0.19,cp,BRD-K89348303,ramipril,ACE inhibitor
5865,-0.18,cp,BRD-K62374253,rufloxacin,Bacterial DNA gyrase inhibitor
5866,-0.18,cp,BRD-A75935363,atracurium,Acetylcholine receptor antagonist
5867,-0.18,cp,BRD-A63043573,cabergoline,Dopamine receptor agonist
5868,-0.18,cp,BRD-K51677086,erythromycin,NFkB pathway inhibitor
2187,21.1,oe,ccsbBroad304_07805,SCAF8,RNA binding motif (RRM) containing
5864,-0.17,cc,,P38 MAPK inhibitor,-
5861,-0.14,cc,,Bacterial DNA gyrase inhibitor,-
5862,-0.14,cp,BRD-K67100011,pivmecillinam,Bacterial cell wall synthesis inhibitor
5863,-0.14,cp,BRD-A43671941,oxprenolol,Adrenergic receptor antagonist
5858,-0.11,cp,BRD-K62965247,tipifarnib-P2,farnesyltransferase inhibitor
5859,-0.11,cp,BRD-A16332958,modafinil,Adrenergic receptor agonist
5860,-0.11,cp,BRD-K17561142,amiodarone,Potassium channel blocker
5856,-0.07,cc,,Canonical high mobility group proteins LOF,-
5857,-0.07,cp,BRD-A97674275,ranolazine,Sodium channel blocker
5855,-0.06,cp,BRD-A53576514,orphenadrine,Acetylcholine receptor antagonist
5854,-0.04,cp,BRD-K28936863,ketotifen,Histamine receptor agonist
5852,-0.03,cp,BRD-K60511616,pravastatin,HMGCR inhibitor
5853,-0.03,cp,BRD-K62200014,anagrelide,Phosphodiesterase inhibitor
5849,-0.02,cc,,GPCR Subset GOF,-
5850,-0.02,cc,,Sodium channel blocker,-
5851,-0.02,cp,BRD-K00627859,tubastatin-a,HDAC inhibitor
5847,-0.01,cc,,Phospholipases GOF,-
5848,-0.01,cc,,Sigma receptor antagonist,-
4722,0,cc,,General transcription factors group 2 LOF,-
2188,21.08,oe,ccsbBroad304_06609,MYL6,EF-hand domain containing
2189,21.02,kd,CGS001-3932,LCK,Src family
2190,21.02,kd,CGS001-1080,CFTR,ATP binding cassette transporters / subfamily C
2192,20.91,kd,CGS001-163071,ZNF114,"Zinc fingers, C2H2-type"
2193,20.89,kd,CGS001-10955,SERINC3,-
2194,20.89,kd,CGS001-3242,HPD,Oxidoreductases
2195,20.88,oe,ccsbBroad304_02242,SNX17,Sorting nexins
2196,20.82,oe,ccsbBroad304_06278,GK,Glycerol kinases
2197,20.75,oe,ccsbBroad304_01812,ZNF175,"Zinc fingers, C2H2-type"
2199,20.74,oe,ccsbBroad304_04465,RERG,-
2202,20.73,kd,CGS001-873,CBR1,Prostaglandin synthases
2203,20.71,oe,ccsbBroad304_11503,MERTK,"Type XI RTKs: TAM (TYRO3-, AXL- and MER-TK) receptor family"
2204,20.7,oe,ccsbBroad304_03235,TUBD1,Tubulins
2205,20.67,kd,CGS001-3400,ID4,Basic helix-loop-helix proteins
2206,20.6,kd,CGS001-1984,EIF5A,-
2207,20.59,oe,ccsbBroad304_01327,PSPH,-
2208,20.58,kd,CGS001-5160,PDHA1,-
2209,20.57,kd,CGS001-5310,PKD1,Voltage-gated ion channels / Transient receptor potential cation channels
2210,20.54,oe,ccsbBroad304_06770,PRKAA1,AMPK subfamily
2211,20.54,kd,CGS001-2645,GCK,Hexokinases
2213,20.51,kd,CGS001-1027,CDKN1B,-
2214,20.51,oe,ccsbBroad304_02053,BTRC,F-boxes / WD-40 domains
2217,20.46,kd,CGS001-23223,RRP12,-
2219,20.43,kd,CGS001-230,ALDOC,-
2220,20.41,kd,CGS001-6038,RNASE4,"Ribonucleases, RNase A"
2221,20.37,kd,CGS001-2189,FANCG,"Fanconi anemia, complementation groups"
2223,20.3,oe,ccsbBroad304_02163,MED7,-
2224,20.29,oe,ccsbBroad304_07875,SPECC1L,-
2225,20.28,kd,CGS001-9097,USP14,Ubiquitin-specific peptidases
2226,20.25,kd,CGS001-3214,HOXB4,Homeoboxes / ANTP class : HOXL subclass
2228,20.24,kd,CGS001-2155,F7,Chymotrypsin
2230,20.23,kd,CGS001-23770,FKBP8,Tetratricopeptide (TTC) repeat domain containing
2231,20.23,oe,ccsbBroad304_05773,ADCY9,Adenylyl cyclases
2232,20.22,oe,ccsbBroad304_00889,JUNB,basic leucine zipper proteins
2233,20.22,oe,ccsbBroad304_00865,ILF2,-
2235,20.19,kd,CGS001-2321,FLT1,Type IV RTKs: VEGF (vascular endothelial growth factor) receptor family
2238,20.14,kd,CGS001-10111,RAD50,-
2239,20.13,kd,CGS001-64863,METTL4,-
2240,20.11,kd,CGS001-11340,EXOSC8,-
2241,20.09,oe,ccsbBroad304_13822,CALM3,EF-hand domain containing
2243,20.01,kd,CGS001-3622,ING2,"Zinc fingers, PHD-type"
2244,20.01,kd,CGS001-34,ACADM,-
2245,20.01,oe,ccsbBroad304_06339,GTF2F2,General transcription factors
2246,19.98,kd,CGS001-3479,IGF1,Endogenous ligands
2248,19.93,oe,ccsbBroad304_01469,RSU1,-
2249,19.92,kd,CGS001-8802,SUCLG1,-
2250,19.9,kd,CGS001-23326,USP22,Ubiquitin-specific peptidases
2255,19.82,oe,ccsbBroad304_01844,HSD17B8,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
2256,19.77,oe,ccsbBroad304_03761,LHX9,Homeoboxes / LIM class
2257,19.72,kd,CGS001-5686,PSMA5,Proteasome subunits
2259,19.65,kd,CGS001-2621,GAS6,-
2260,19.64,kd,CGS001-874,CBR3,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
2261,19.64,oe,ccsbBroad304_07887,GCAT,-
2263,19.59,kd,CGS001-1026,CDKN1A,-
2264,19.59,kd,CGS001-64333,ARHGAP9,Rho GTPase activating proteins
2265,19.58,oe,ccsbBroad304_06897,RPS6KB2,p70 subfamily
2266,19.57,kd,CGS001-7276,TTR,-
2267,19.57,kd,CGS001-56916,SMARCAD1,-
2268,19.56,oe,ccsbBroad304_00055,AKR1B1,Aldo-keto reductases
2270,19.55,kd,CGS001-523,ATP6V1A,ATPases / V-type
2273,19.46,kd,CGS001-64326,RFWD2,RING-type (C3HC4) zinc fingers
2275,19.39,oe,ccsbBroad304_03080,C16ORF80,-
2276,19.38,oe,ccsbBroad304_00677,GPR34,GPCR / Class A : Orphans
2278,19.34,oe,ccsbBroad304_02786,ZNF281,"Zinc fingers, C2H2-type"
2280,19.31,kd,CGS001-9159,PCSK7,Subtilisin
2281,19.3,kd,CGS001-10413,YAP1,Hippo Signaling
2285,19.18,kd,CGS001-5754,PTK7,Type VI RTKs: PTK7/CCK4
2286,19.16,kd,CGS001-4221,MEN1,-
2287,19.14,kd,CGS001-23097,CDK19,"Cyclin-dependent kinases, CDK8 subfamily"
2288,19.13,kd,CGS001-5947,RBP1,Fatty acid binding protein family
2289,19.03,kd,CGS001-1525,CXADR,Immunoglobulin superfamily / Immunoglobulin-like domain containing
2292,18.99,kd,CGS001-1504,CTRB1,-
2293,18.97,oe,ccsbBroad304_06173,NR2F6,COUP-TF-like receptors
2294,18.96,oe,ccsbBroad304_00550,FDXR,-
2297,18.94,kd,CGS001-4841,NONO,RNA binding motif (RRM) containing
2298,18.92,kd,CGS001-6664,SOX11,SRY (sex determining region Y)-boxes
2299,18.91,kd,CGS001-7181,NR2C1,Testicular receptors
2301,18.9,oe,ccsbBroad304_00214,CAPN1,EF-hand domain containing
2303,18.88,oe,ccsbBroad304_05936,CASP2,Caspases
2304,18.87,kd,CGS001-9093,DNAJA3,Heat shock proteins / DNAJ (HSP40)
2307,18.79,kd,CGS001-871,SERPINH1,Serine (or cysteine) peptidase inhibitors
2308,18.78,kd,CGS001-2542,SLC37A4,SLC37 family of phosphosugar/phosphate exchangers
2309,18.74,oe,ccsbBroad304_00232,SERPINA6,Serine (or cysteine) peptidase inhibitors
2311,18.74,kd,CGS001-293,SLC25A6,Mitochondrial nucleotide transporter subfamily
2312,18.71,kd,CGS001-152,ADRA2C,GPCR / Class A : Adrenoceptors : alpha
2314,18.66,kd,CGS001-123803,NTAN1,-
2315,18.66,oe,ccsbBroad304_00739,ZBTB48,BTB/POZ domain containing
2316,18.65,oe,ccsbBroad304_00572,FKBP3,-
2317,18.65,kd,CGS001-57822,GRHL3,-
2318,18.56,kd,CGS001-7384,UQCRC1,Mitochondrial respiratory chain complex / Complex III
2319,18.53,kd,CGS001-23030,KDM4B,Histone demethylases
2320,18.52,kd,CGS001-57804,POLD4,DNA polymerases
2322,18.49,kd,CGS001-2195,FAT1,Cadherins / Cadherin-related
2323,18.48,kd,CGS001-10020,GNE,-
2325,18.45,kd,CGS001-3692,EIF6,-
2326,18.44,kd,CGS001-2264,FGFR4,Type V RTKs: FGF (fibroblast growth factor) receptor family
2327,18.44,oe,ccsbBroad304_02036,ARHGEF7,Rho guanine nucleotide exchange factors
2328,18.4,kd,CGS001-1326,MAP3K8,MAPKKK:STE-unique family
2329,18.34,kd,CGS001-3198,HOXA1,Homeoboxes / ANTP class : HOXL subclass
2332,18.29,kd,CGS001-8669,EIF3J,-
2333,18.28,oe,ccsbBroad304_05931,CAPG,-
2335,18.26,oe,ccsbBroad304_06718,PFN2,-
2336,18.26,kd,CGS001-83999,KREMEN1,-
2338,18.25,kd,CGS001-11108,PRDM4,"Zinc fingers, C2H2-type"
2339,18.25,kd,CGS001-10645,CAMKK2,Meta subfamily
2340,18.24,kd,CGS001-27148,STK36,Unc-51-like kinase (ULK) family
2341,18.19,kd,CGS001-25799,ZNF324,"Zinc fingers, C2H2-type"
2343,18.13,oe,ccsbBroad304_00665,GOT1,-
2344,18.13,kd,CGS001-64400,AKTIP,Ubiquitin-conjugating enzymes E2
2345,18.12,oe,ccsbBroad304_00534,FABP1,Fatty acid-binding proteins
2346,18.11,kd,CGS001-7100,TLR5,Toll-like receptor family
2347,18.1,kd,CGS001-80349,WDR61,WD repeat domain containing
2349,18.03,kd,CGS001-6576,SLC25A1,Mitochondrial di- and tri-carboxylic acid transporter subfamily
2350,18.03,kd,CGS001-51750,RTEL1,-
2351,18.01,kd,CGS001-863,CBFA2T3,A-kinase anchor proteins
2352,18,kd,CGS001-11113,CIT,Other DMPK family kinases
2353,18,kd,CGS001-5525,PPP2R5A,"Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits"
2355,17.99,kd,CGS001-545,ATR,ATR subfamily
2356,17.98,kd,CGS001-2966,GTF2H2,General transcription factors
2357,17.98,oe,ccsbBroad304_01146,PARN,-
2358,17.94,kd,CGS001-51715,RAB23,"RAB, member RAS oncogene"
2359,17.94,kd,CGS001-4701,NDUFA7,Mitochondrial respiratory chain complex / Complex I
2360,17.93,oe,ccsbBroad304_00150,BAX,-
2361,17.93,kd,CGS001-9318,COPS2,-
2362,17.93,kd,CGS001-6387,CXCL12,Endogenous ligands
2364,17.92,kd,CGS001-8833,GMPS,-
2365,17.89,kd,CGS001-27161,EIF2C2,-
2366,17.88,kd,CGS001-9869,SETDB1,Histone methyltransferases (HMTs)
2367,17.88,oe,ccsbBroad304_05547,TMEM110,-
2368,17.87,kd,CGS001-92609,TIMM50,Serine/threonine phosphatases / CTD aspartate-based phosphatases
2369,17.86,oe,ccsbBroad304_06745,PNN,-
2371,17.77,kd,CGS001-113451,ADC,-
2372,17.76,kd,CGS001-7389,UROD,-
2380,17.65,kd,CGS001-23210,JMJD6,-
2382,17.62,oe,ccsbBroad304_00087,FAS,Tumour necrosis factor (TNF) receptor family
2383,17.61,oe,ccsbBroad304_09316,ISX,Homeoboxes / PRD class
2384,17.61,oe,ccsbBroad304_04626,EGLN3,-
2385,17.6,kd,CGS001-2145,EZH1,Chromatin-modifying enzymes / K-methyltransferases
2387,17.52,kd,CGS001-51588,PIAS4,"Zinc fingers, MIZ-type"
2388,17.52,kd,CGS001-8550,MAPKAPK5,MAPKAPK subfamily
2389,17.43,kd,CGS001-147183,KRT25,"Intermediate filaments type I, keratins (acidic)"
2390,17.42,oe,ccsbBroad304_05309,OR52B2,GPCR / Class A : Olfactory receptors
2391,17.41,oe,ccsbBroad304_09676,ZSWIM2,"Zinc fingers, SWIM-type"
2392,17.4,kd,CGS001-661,POLR3D,RNA polymerase subunits
2393,17.4,oe,ccsbBroad304_09020,RUFY1,"Zinc fingers, FYVE domain containing"
2394,17.39,kd,CGS001-1111,CHEK1,CHK1 subfamily
2395,17.33,kd,CGS001-55890,GPRC5C,GPCR / Class C : Orphans
2397,17.19,kd,CGS001-10555,AGPAT2,1-acylglycerol-3-phosphate O-acyltransferases
2400,17.11,oe,ccsbBroad304_03623,ZNF692,"Zinc fingers, C2H2-type"
2403,17.07,oe,ccsbBroad304_04678,GPR146,GPCR / Class A : Orphans
2404,17.06,kd,CGS001-7484,WNT9B,Wingless-type MMTV integration sites
2405,16.99,kd,CGS001-54490,UGT2B28,UDP glucuronosyltransferases
2407,16.97,kd,CGS001-375346,TMEM110,-
2408,16.97,oe,ccsbBroad304_00783,HPRT1,-
2409,16.95,kd,CGS001-538,ATP7A,ATPases / P-type
2411,16.92,oe,ccsbBroad304_01724,TTR,-
2413,16.9,oe,ccsbBroad304_02032,TSC22D1,-
2414,16.84,kd,CGS001-23596,OPN3,GPCR / Class A : Opsin receptors
2415,16.84,kd,CGS001-83550,GPR101,GPCR / Class A : Orphans
2416,16.84,oe,ccsbBroad304_01981,DYNLL1,Cytoplasmic dyneins
2418,16.81,kd,CGS001-5993,RFX5,-
2420,16.77,kd,CGS001-340273,ABCB5,ATP binding cassette transporters / subfamily B
2421,16.75,oe,ccsbBroad304_02756,RRP8,-
2422,16.74,kd,CGS001-1644,DDC,Catecholamine turnover
2423,16.71,kd,CGS001-3556,IL1RAP,Immunoglobulin superfamily / Immunoglobulin-like domain containing
2424,16.68,kd,CGS001-57504,MTA3,GATA zinc finger domain containing
2425,16.68,kd,CGS001-2828,GPR4,GPCR / Class A : Orphans
2426,16.62,kd,CGS001-51022,GLRX2,-
2427,16.62,kd,CGS001-11215,AKAP11,A-kinase anchor proteins
2428,16.61,kd,CGS001-8543,LMO4,-
2429,16.59,oe,ccsbBroad304_00975,MAT2A,-
2430,16.59,kd,CGS001-3416,IDE,Pitrilysin
2431,16.58,kd,CGS001-7803,PTP4A1,Protein tyrosine phosphatases / Class I Cys-based PTPs : PRLs
2433,16.56,kd,CGS001-91133,L3MBTL4,Sterile alpha motif (SAM) domain containing
2434,16.55,kd,CGS001-7984,ARHGEF5,Rho guanine nucleotide exchange factors
2435,16.51,kd,CGS001-25819,CCRN4L,-
2436,16.49,kd,CGS001-22933,SIRT2,Histone deacetylases
2437,16.48,kd,CGS001-10745,PHTF1,-
2438,16.44,kd,CGS001-11112,HIBADH,-
2439,16.43,kd,CGS001-7296,TXNRD1,-
2440,16.41,kd,CGS001-348,APOE,Apolipoproteins
2441,16.41,oe,ccsbBroad304_01701,TPI1,-
2442,16.39,oe,ccsbBroad304_00745,HLA-DRB4,Immunoglobulin superfamily / C1-set domain containing
2446,16.33,kd,CGS001-10461,MERTK,"Type XI RTKs: TAM (TYRO3-, AXL- and MER-TK) receptor family"
2447,16.32,oe,ccsbBroad304_00704,GSTZ1,Glutathione S-transferases / Soluble
2451,16.26,kd,CGS001-4609,MYC,Basic helix-loop-helix proteins
2452,16.23,oe,ccsbBroad304_13931,PSMA3,Proteasome subunits
2454,16.2,kd,CGS001-290,ANPEP,Aminopeptidase N
2455,16.19,kd,CGS001-55847,CISD1,CDGSH iron sulfur domain containing
2456,16.18,oe,ccsbBroad304_06183,EWSR1,RNA binding motif (RRM) containing
2458,16.18,oe,ccsbBroad304_02370,HRSP12,-
2459,16.16,kd,CGS001-1491,CTH,Hydrogen sulphide synthesis
2460,16.14,kd,CGS001-8428,STK24,YSK subfamily
2461,16.14,kd,CGS001-217,ALDH2,Aldehyde dehydrogenases
2464,16.03,oe,ccsbBroad304_00072,ANXA7,Annexins
2465,16.03,kd,CGS001-5054,SERPINE1,Serine (or cysteine) peptidase inhibitors
2466,16.03,oe,ccsbBroad304_02551,CPSF4,-
2470,15.95,kd,CGS001-29074,MRPL18,Mitochondrial ribosomal proteins / large subunits
2471,15.94,oe,ccsbBroad304_08782,SNX6,Sorting nexins
2472,15.9,kd,CGS001-55897,MESP1,Basic helix-loop-helix proteins
2473,15.89,kd,CGS001-378,ARF4,ADP-ribosylation factors
2476,15.85,kd,CGS001-4801,NFYB,-
2478,15.84,kd,CGS001-5163,PDK1,-
2479,15.83,kd,CGS001-2149,F2R,Protease activated receptors
2482,15.76,kd,CGS001-2057,EPOR,Prolactin receptor family
2483,15.74,kd,CGS001-6364,CCL20,Chemokine ligands
2484,15.73,oe,ccsbBroad304_06654,NPM1,-
2486,15.71,kd,CGS001-23057,NMNAT2,-
2487,15.7,kd,CGS001-23576,DDAH1,Dimethylarginine dimethylaminohydrolases
2489,15.68,oe,ccsbBroad304_03683,APOM,Apolipoproteins
2490,15.65,kd,CGS001-54541,DDIT4,-
2491,15.62,oe,ccsbBroad304_06735,PLAU,Chymotrypsin
2492,15.59,kd,CGS001-7079,TIMP4,-
2493,15.56,oe,ccsbBroad304_01281,PRKCA,Delta subfamily
2494,15.53,kd,CGS001-6936,C2ORF3,-
2495,15.52,oe,ccsbBroad304_07294,TNFSF10,CD molecules
2497,15.52,oe,ccsbBroad304_05152,SSBP4,-
2498,15.48,kd,CGS001-7026,NR2F2,COUP-TF-like receptors
2499,15.47,oe,ccsbBroad304_10441,PEPD,Methionyl aminopeptidase
2500,15.47,oe,ccsbBroad304_02601,RAB31,"RAB, member RAS oncogene"
2501,15.44,kd,CGS001-3217,HOXB7,Homeoboxes / ANTP class : HOXL subclass
2502,15.44,kd,CGS001-9451,EIF2AK3,PEK subfamily
2503,15.42,oe,ccsbBroad304_01333,PTGFR,GPCR / Class A : Prostanoid receptors
2505,15.39,kd,CGS001-51174,TUBD1,Tubulins
2506,15.39,kd,CGS001-3298,HSF2,-
2507,15.38,kd,CGS001-147686,ZNF418,"Zinc fingers, C2H2-type"
2508,15.34,kd,CGS001-64116,SLC39A8,SLC39 family of metal ion transporters
2511,15.3,kd,CGS001-2064,ERBB2,Type I RTKs: ErbB (epidermal growth factor) receptor family
2512,15.3,kd,CGS001-6622,SNCA,Parkinson disease
2514,15.28,kd,CGS001-7037,TFRC,CD molecules
2515,15.28,kd,CGS001-51268,PIPOX,-
2516,15.27,oe,ccsbBroad304_03071,CHMP4A,Charged multivesicular body proteins
2517,15.26,kd,CGS001-89910,UBE3B,-
2519,15.21,oe,ccsbBroad304_07288,B4GALT4,Beta 4-glycosyltransferases
2520,15.16,kd,CGS001-60,ACTB,-
2523,15.1,oe,ccsbBroad304_08670,DUSP22,Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases
2524,15.1,kd,CGS001-30,ACAA1,-
2526,15.09,oe,ccsbBroad304_00614,GAMT,-
2527,15.08,kd,CGS001-8829,NRP1,CD molecules
2530,15.06,kd,CGS001-6928,HNF1B,Homeoboxes / HNF class
2531,15.06,oe,ccsbBroad304_07314,ASAP2,Ankyrin repeat domain containing
2532,15.05,kd,CGS001-5058,PAK1,PAKA subfamily
2533,15.04,kd,CGS001-4090,SMAD5,SMADs
2534,15.02,kd,CGS001-7031,TFF1,-
2535,15.02,kd,CGS001-2034,EPAS1,Basic helix-loop-helix proteins
2536,15.02,oe,ccsbBroad304_00106,ARRB1,-
2537,15,oe,ccsbBroad304_09035,COASY,-
2538,14.96,kd,CGS001-7471,WNT1,Endogenous ligands
2539,14.96,kd,CGS001-10395,DLC1,Rho GTPase activating proteins
2540,14.96,oe,ccsbBroad304_00993,MDM4,-
2541,14.95,kd,CGS001-51719,CAB39,-
2543,14.87,oe,ccsbBroad304_09992,VN1R2,"GPCR / Unclassified : Vomeronasal receptors, type 1"
2544,14.87,kd,CGS001-1841,DTYMK,-
2545,14.85,oe,ccsbBroad304_02396,TCIRG1,ATPases / V-type
2547,14.84,kd,CGS001-342357,ZKSCAN2,"Zinc fingers, C2H2-type"
2548,14.84,kd,CGS001-25842,ASF1A,-
2549,14.8,kd,CGS001-1855,DVL1,Dishevelled homologs
2550,14.79,oe,ccsbBroad304_07466,VGLL4,-
2551,14.78,kd,CGS001-29956,CERS2,Homeoboxes / CERS class
2552,14.75,kd,CGS001-7431,VIM,Intermediate filaments type III
2553,14.74,kd,CGS001-117154,DACH2,-
2555,14.72,oe,ccsbBroad304_01263,PPP2R1A,"Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits"
2556,14.7,oe,ccsbBroad304_07260,LGR5,GPCR / Class A : Orphans
2557,14.69,oe,ccsbBroad304_03405,CHRAC1,-
2560,14.64,oe,ccsbBroad304_00471,E2F6,-
2561,14.63,kd,CGS001-9700,ESPL1,-
2562,14.61,kd,CGS001-8495,PPFIBP2,Sterile alpha motif (SAM) domain containing
2563,14.6,oe,ccsbBroad304_06013,CLPTM1,-
2564,14.59,kd,CGS001-91304,C19ORF6,-
2565,14.59,kd,CGS001-7846,TUBA1A,Tubulins
2568,14.54,kd,CGS001-54749,EPDR1,-
2569,14.52,kd,CGS001-10651,MTX2,-
2570,14.51,oe,ccsbBroad304_01478,S100A11,EF-hand domain containing
2571,14.49,oe,ccsbBroad304_06335,GSTP1,Glutathione S-transferases
2573,14.47,kd,CGS001-3034,HAL,-
2574,14.44,kd,CGS001-4077,NBR1,-
2575,14.43,kd,CGS001-5573,PRKAR1A,Protein kinase A
2576,14.41,kd,CGS001-716,C1S,Complement system
2578,14.39,kd,CGS001-598,BCL2L1,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
2579,14.32,oe,ccsbBroad304_00789,HSBP1,-
2580,14.32,kd,CGS001-2773,GNAI3,-
2581,14.29,kd,CGS001-9404,LPXN,-
2582,14.29,kd,CGS001-2859,GPR35,GPCR / Class A : Orphans
2584,14.22,kd,CGS001-6626,SNRPA,RNA binding motif (RRM) containing
2585,14.22,kd,CGS001-607,BCL9,-
2588,14.2,kd,CGS001-25800,SLC39A6,SLC39 family of metal ion transporters
2589,14.19,kd,CGS001-23753,SDF2L1,-
2590,14.16,kd,CGS001-7543,ZFX,"Zinc fingers, C2H2-type"
2592,14.11,kd,CGS001-83881,MIXL1,Homeoboxes / PRD class
2593,14.1,oe,ccsbBroad304_00099,ARG2,Arginase
2594,14.1,oe,ccsbBroad304_02217,FEZ1,-
2596,14.08,kd,CGS001-51547,SIRT7,Histone deacetylases (HDACs)
2597,14.07,kd,CGS001-231,AKR1B1,Aldo-keto reductases
2600,14.05,oe,ccsbBroad304_00003,ABAT,GABA turnover
2601,14.04,kd,CGS001-5144,PDE4D,Phosphodiesterases
5018,0,cp,BRD-K82216340,medroxyprogesterone,progesterone receptor agonist
5019,0,cp,BRD-K94070024,depomedrol,Glucocorticoid receptor agonist
5020,0,cp,BRD-K88701661,dimercaptosuccinic-acid,Chelating agent
5021,0,cp,BRD-K63784565,BRD-K63784565,Topoisomerase inhibitor
5022,0,cp,BRD-K56450366,NSC-94258,Antineoplastic
5023,0,cp,BRD-A79314293,cephalosporanic-acid,Bacterial cell wall synthesis inhibitor
5024,0,cp,BRD-A20589515,dihydroxyphenylglycine,Glutamate receptor agonist
5025,0,cp,BRD-K15891719,tenofovir,Reverse transcriptase inhibitor
5026,0,cp,BRD-M72442222,vicriviroc,CC chemokine receptor antagonist
5027,0,cp,BRD-K09436313,prostaglandin,Prostanoid receptor antagonist
5028,0,cp,BRD-K70401845,erlotinib,EGFR inhibitor
5029,0,cp,BRD-K00337317,NU-7441,DNA dependent protein kinase inhibitor
5030,0,cp,BRD-K58772419,AZD-6482,PI3K inhibitor
5031,0,cp,BRD-K63343048,orlistat,Lipase inhibitor
5032,0,cp,BRD-K01649396,indatraline,Norepinephrine transporter inhibitor
5033,0,cp,BRD-K10860596,granisetron,Serotonin receptor antagonist
5034,0,cp,BRD-K48932581,cetraxate,Mucus protecting agent
5035,0,cp,BRD-K51967704,BIIB021,HSP inhibitor
5036,0,cp,BRD-K16621777,enobosarm,Androgen receptor modulator
5037,0,cp,BRD-K64310881,MW-STK33-3B,Potassium channel activator
5038,0,cp,BRD-K54987996,CAY-10578,Casein kinase inhibitor
5039,0,cp,BRD-K59633790,VU-0420363-1,SARS coronavirus 3C-like protease inhibitor
5040,0,cp,BRD-K97509413,coumestrol,Estrogen receptor agonist
5041,0,cp,BRD-K90259198,W-7,Calmodulin antagonist
5042,0,cp,BRD-K70281171,U-99194,Dopamine receptor antagonist
5043,0,cp,BRD-K02607075,tubocurarine,Acetylcholine receptor antagonist
5044,0,cp,BRD-A11605036,thiocolchicoside,GABA receptor antagonist
5045,0,cp,BRD-K11158509,tyrphostin-B44,EGFR inhibitor
5046,0,cp,BRD-K34415467,trimethobenzamide,Histamine receptor antagonist
5047,0,cp,BRD-K45988865,tetramethylsilane,Internal standard for NMR spectroscopy
5048,0,cp,BRD-K31843556,T-0070907,PPAR receptor antagonist
5049,0,cp,BRD-K14200658,syrosingopine,Vesicular monoamine transporter inhibitor
5050,0,cp,BRD-K25875056,SC-9,Protein tyrosine kinase activator
5051,0,cp,BRD-K14807180,SB-221284,Serotonin receptor antagonist
5052,0,cp,BRD-K26160755,RS-45041-190,Imidazoline receptor agonist
5053,0,cp,BRD-K70505054,ranitidine,Histamine receptor antagonist
5054,0,cp,BRD-K68095457,palmitoylethanolamide,Cannabinoid receptor agonist
5055,0,cp,BRD-K84175871,pseudoephedrine,Adrenergic receptor agonist
5056,0,cp,BRD-A95096829,PNU-96415E,Dopamine receptor antagonist
5057,0,cp,BRD-K00206590,P-1075,ATP channel activator
5058,0,cp,BRD-K10042277,desmethylclozapine,Acetylcholine receptor agonist
5059,0,cp,BRD-K84987553,MDM2-inhibitor,MDM inhibitor
5060,0,cp,BRD-K76274772,MAPP-D-erythro,Ceramidase inhibitor
5061,0,cp,BRD-K78637815,LY-320135,Cannabinoid receptor antagonist
5062,0,cp,BRD-K38903228,hesperidin,Flavanone glycoside
5063,0,cp,BRD-K02283807,GR-32191,Thromboxane receptor antagonist
5064,0,cp,BRD-K96402602,farnesylthiotriazole,PPMTase inhibitor
5065,0,cp,BRD-K30296925,flavokavain-b,Antineoplastic
5066,0,cp,BRD-K31699485,DMEOB,glutamate receptor modulator
5067,0,cp,BRD-K54142781,cirazoline,Adrenergic receptor agonist
5068,0,cp,BRD-K65786282,CGP-7930,GABA receptor modulator
5069,0,cp,BRD-K04185004,oxybuprocaine,Local anesthetic
5070,0,cp,BRD-K07507905,BRL-37344,Adrenergic receptor agonist
5071,0,cp,BRD-A51829654,BRL-15572,Serotonin receptor antagonist
5072,0,cp,BRD-K29668683,BD-1063,Sigma receptor antagonist
5073,0,cp,BRD-K15164005,apoptosis-activator-II,Carboxylesterase inhibitor
5074,0,cp,BRD-K39670393,amthamine,Histamine receptor agonist
5075,0,cp,BRD-K95739795,tetrabenazine,Vesicular monoamine transporter inhibitor
5076,0,cp,BRD-K27710560,splitomycin,SIRT inhibitor
5077,0,cp,BRD-K58299615,RO-90-7501,Beta amyloid inhibitor
5078,0,cp,BRD-K38251852,paxilline,Potassium channel blocker
5079,0,cp,BRD-A97479839,piperidolate,Acetylcholine receptor antagonist
5080,0,cp,BRD-A66563878,medetomidine,Adrenergic receptor agonist
5081,0,cp,BRD-A62057054,MDL-11939,Serotonin receptor antagonist
5082,0,cp,BRD-A71157293,fursultiamine,Vitamin B
5083,0,cp,BRD-K66093087,FGIN-1-43,Benzodiazepine receptor agonist
5084,0,cp,BRD-K45330754,diethylstilbestrol,Estrogen receptor agonist
5085,0,cp,BRD-A37347161,BRL-52537,Opioid receptor agonist
5086,0,cp,BRD-K49294207,BIBU-1361,EGFR inhibitor
5087,0,cp,BRD-A85280935,quinpirole,Dopamine receptor agonist
2602,14.03,kd,CGS001-94233,OPN4,GPCR / Class A : Opsin receptors
2603,14,kd,CGS001-3709,ITPR2,Ion channels / Inositol triphosphate receptors
2604,14,kd,CGS001-1975,EIF4B,RNA binding motif (RRM) containing
2605,14,kd,CGS001-1675,CFD,Complement system
2606,13.97,kd,CGS001-51097,SCCPDH,-
2608,13.96,kd,CGS001-4728,NDUFS8,Mitochondrial respiratory chain complex / Complex I
2609,13.96,kd,CGS001-56993,TOMM22,-
2610,13.96,kd,CGS001-126626,GABPB2,Ankyrin repeat domain containing
2611,13.94,kd,CGS001-57026,PDXP,-
2612,13.93,oe,ccsbBroad304_00755,HMGCR,Lanosterol biosynthesis pathway
2613,13.92,oe,ccsbBroad304_00033,ADSS,-
2614,13.91,oe,ccsbBroad304_14439,OPN5,GPCR / Class A : Opsin receptors
2616,13.87,kd,CGS001-148327,CREB3L4,basic leucine zipper proteins
2618,13.86,kd,CGS001-9448,MAP4K4,MAPKKKK:MSN subfamily
2619,13.84,kd,CGS001-7298,TYMS,Methyltransferases
2620,13.82,kd,CGS001-140735,DYNLL2,Cytoplasmic dyneins
2623,13.79,kd,CGS001-169270,ZNF596,"Zinc fingers, C2H2-type"
2624,13.79,kd,CGS001-51295,ECSIT,Mitochondrial respiratory chain complex assembly factors
2626,13.72,kd,CGS001-7150,TOP1,DNA Topoisomerases
2628,13.71,kd,CGS001-8727,CTNNAL1,Catenins
2629,13.7,oe,ccsbBroad304_01101,NME1,-
2630,13.69,kd,CGS001-84619,ZGPAT,G patch domain containing
2631,13.67,kd,CGS001-8681,JMJD7-PLA2G4B,-
2632,13.66,kd,CGS001-6773,STAT2,SH2 domain containing
2633,13.66,kd,CGS001-259249,MRGPRX1,GPCR / Class A : Orphans
2636,13.64,oe,ccsbBroad304_07427,PIGB,Dolichyl D-mannosyl phosphate dependent mannosyltransferases
2637,13.63,kd,CGS001-597,BCL2A1,-
2640,13.62,kd,CGS001-6491,STIL,-
2641,13.62,kd,CGS001-79017,GGCT,Leukotriene and lipoxin metabolism
2642,13.59,kd,CGS001-4927,NUP88,-
2643,13.57,kd,CGS001-5708,PSMD2,Proteasome subunits
2645,13.55,kd,CGS001-2768,GNA12,-
2646,13.54,kd,CGS001-7913,DEK,-
2648,13.5,kd,CGS001-6050,RNH1,-
2649,13.49,kd,CGS001-9443,MED7,-
2652,13.48,kd,CGS001-80237,ELL3,-
2653,13.48,oe,ccsbBroad304_02322,ZNF263,"Zinc fingers, C2H2-type"
2654,13.47,kd,CGS001-6757,SSX2,-
2656,13.46,kd,CGS001-405,ARNT,Basic helix-loop-helix proteins
2657,13.41,kd,CGS001-64080,RBKS,-
2658,13.4,kd,CGS001-11083,DIDO1,"Zinc fingers, PHD-type"
2659,13.39,kd,CGS001-6660,SOX5,SRY (sex determining region Y)-boxes
2660,13.39,kd,CGS001-23,ABCF1,ATP binding cassette transporters / subfamily F
2662,13.37,kd,CGS001-27244,SESN1,-
2663,13.34,oe,ccsbBroad304_09615,LACC1,-
2665,13.29,kd,CGS001-2050,EPHB4,Type XIII RTKs: Ephrin receptor family
2666,13.28,kd,CGS001-4141,MARS,Aminoacyl tRNA synthetases / Class I
2667,13.28,kd,CGS001-4000,LMNA,"Intermediate filaments type V, lamins"
2668,13.27,kd,CGS001-2037,EPB41L2,-
2669,13.26,kd,CGS001-516,ATP5G1,ATPases / F-type
2670,13.22,kd,CGS001-1345,COX6C,Mitochondrial respiratory chain complex
2673,13.19,kd,CGS001-80777,CYB5B,-
2674,13.19,oe,ccsbBroad304_01448,RPS7,S ribosomal proteins
2676,13.15,kd,CGS001-6655,SOS2,Rho guanine nucleotide exchange factors
2677,13.13,kd,CGS001-7013,TERF1,-
2678,13.13,kd,CGS001-2241,FER,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
2679,13.13,oe,ccsbBroad304_01659,TERF1,-
2681,13.11,kd,CGS001-9761,MLEC,-
2683,13.09,kd,CGS001-124641,OVCA2,-
2685,13.05,kd,CGS001-51465,UBE2J1,Ubiquitin-conjugating enzymes E2
2687,13.03,kd,CGS001-3320,HSP90AA1,Heat shock proteins / HSPC
2689,13.01,kd,CGS001-776,CACNA1D,Calcium channel subunits
2691,12.99,kd,CGS001-64429,ZDHHC6,"Zinc fingers, DHHC-type"
2692,12.98,kd,CGS001-6790,AURKA,Aurora kinase
2693,12.98,oe,ccsbBroad304_07358,DNAJA3,Heat shock proteins / DNAJ (HSP40)
2694,12.96,kd,CGS001-10125,RASGRP1,EF-hand domain containing
2695,12.96,kd,CGS001-9643,MORF4L2,-
2697,12.92,kd,CGS001-10988,METAP2,Methionyl aminopeptidase
2699,12.86,kd,CGS001-23509,POFUT1,Fucosyltransferases
2700,12.84,kd,CGS001-10755,GIPC1,-
2704,12.74,kd,CGS001-3560,IL2RB,IL-2 receptor family
2705,12.72,kd,CGS001-55654,TMEM127,-
2707,12.69,kd,CGS001-6208,RPS14,S ribosomal proteins
2708,12.67,kd,CGS001-5515,PPP2CA,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
2709,12.66,oe,ccsbBroad304_02367,CALCOCO2,-
2713,12.63,kd,CGS001-165140,OXER1,GPCR / Class A : Leukotriene receptors
2715,12.6,oe,ccsbBroad304_02979,RNF11,RING-type (C3HC4) zinc fingers
2717,12.58,oe,ccsbBroad304_00998,MEIS2,Homeoboxes / TALE class
2718,12.55,kd,CGS001-10725,NFAT5,Nuclear factor of activated T-cells
2720,12.5,kd,CGS001-102,ADAM10,ADAM metallopeptidase domain containing
2722,12.49,oe,ccsbBroad304_10014,RXFP4,GPCR / Class A : Relaxin family peptide receptors
2725,12.45,kd,CGS001-10736,SIX2,Homeoboxes / SINE class
2726,12.45,kd,CGS001-5629,PROX1,Homeoboxes / PROS class
2728,12.43,kd,CGS001-399664,MEX3D,Mex-3 homologs
2729,12.41,oe,ccsbBroad304_06645,NQO2,-
2731,12.37,kd,CGS001-6427,SRSF2,RNA binding motif (RRM) containing
2733,12.33,kd,CGS001-6184,RPN1,-
2734,12.33,oe,ccsbBroad304_06401,HRH1,Histamine receptors
2735,12.32,kd,CGS001-23335,WDR7,WD repeat domain containing
2736,12.32,oe,ccsbBroad304_03433,DDIT4,-
2738,12.31,kd,CGS001-23368,PPP1R13B,Ankyrin repeat domain containing
2739,12.3,kd,CGS001-344,APOC2,Apolipoproteins
2740,12.29,kd,CGS001-9774,BCLAF1,-
2743,12.27,kd,CGS001-79894,ZNF672,"Zinc fingers, C2H2-type"
2744,12.26,kd,CGS001-54108,CHRAC1,-
2745,12.25,oe,ccsbBroad304_03940,RFWD2,RING-type (C3HC4) zinc fingers
2747,12.23,kd,CGS001-8784,TNFRSF18,Tumour necrosis factor (TNF) receptor family
2749,12.18,kd,CGS001-5516,PPP2CB,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
2750,12.17,kd,CGS001-5253,PHF2,Histone demethylases
2751,12.17,oe,ccsbBroad304_02243,DLGAP5,-
2753,12.16,kd,CGS001-65975,STK33,CAMK-unique family
2754,12.15,oe,ccsbBroad304_00561,FGFR1,Type V RTKs: FGF (fibroblast growth factor) receptor family
2755,12.15,kd,CGS001-54106,TLR9,Toll-like receptor family
2756,12.13,kd,CGS001-10135,NAMPT,-
2757,12.13,kd,CGS001-2015,EMR1,Adhesion Class GPCRs
2758,12.12,oe,ccsbBroad304_00486,EFNB2,Ephrins
2762,12.08,kd,CGS001-347736,NME9,-
2763,12.08,kd,CGS001-3598,IL13RA2,IL-2 receptor family
2764,12.08,kd,CGS001-8527,DGKD,Pleckstrin homology (PH) domain containing
2765,12.06,kd,CGS001-5328,PLAU,Chymotrypsin
2766,12.05,oe,ccsbBroad304_06565,MB,-
2767,12.05,kd,CGS001-6304,SATB1,Homeoboxes / CUT class
2768,12.05,kd,CGS001-3670,ISL1,Homeoboxes / LIM class
2769,12.03,kd,CGS001-8226,HDHD1,-
2770,12.03,kd,CGS001-9637,FEZ2,-
2773,11.98,kd,CGS001-2171,FABP5,Fatty acid-binding proteins
2774,11.94,kd,CGS001-124535,HSF5,-
2775,11.89,kd,CGS001-3428,IFI16,-
2776,11.89,kd,CGS001-3172,HNF4A,Hepatocyte nuclear factor-4 receptors
2777,11.87,kd,CGS001-6257,RXRB,Retinoid X receptors
2779,11.84,kd,CGS001-219,ALDH1B1,Aldehyde dehydrogenases
2782,11.81,oe,ccsbBroad304_02683,COG2,Components of oligomeric golgi complex
2784,11.79,oe,ccsbBroad304_01560,SNAPC1,-
2785,11.76,kd,CGS001-6934,TCF7L2,-
2786,11.75,oe,ccsbBroad304_00867,IMPDH2,Oxidoreductases
2787,11.75,kd,CGS001-6502,SKP2,F-boxes / Leucine-rich repeats
2790,11.72,kd,CGS001-6919,TCEA2,-
2791,11.71,kd,CGS001-10775,POP4,-
2792,11.69,kd,CGS001-5966,REL,NFkappaB transcription factor family
2794,11.65,kd,CGS001-3091,HIF1A,Basic helix-loop-helix proteins
2796,11.62,kd,CGS001-386724,AMIGO3,Immunoglobulin superfamily / Immunoglobulin-like domain containing
2797,11.58,kd,CGS001-23066,CAND2,-
2799,11.54,kd,CGS001-59352,LGR6,GPCR / Class A : Orphans
2800,11.54,kd,CGS001-10023,FRAT1,-
2801,11.53,kd,CGS001-4616,GADD45B,-
2803,11.52,kd,CGS001-10524,KAT5,Histone acetyltransferases (HATs)
2805,11.51,kd,CGS001-4869,NPM1,-
2806,11.49,oe,ccsbBroad304_07053,TFPI,-
2807,11.46,kd,CGS001-5695,PSMB7,Proteasome subunits
2808,11.46,kd,CGS001-5446,PON3,Paraoxonases
2809,11.45,kd,CGS001-10673,TNFSF13B,CD molecules
2812,11.42,kd,CGS001-2138,EYA1,Protein tyrosine phosphatases / Asp-based PTPs
2813,11.39,kd,CGS001-140685,ZBTB46,BTB/POZ domain containing
2814,11.38,oe,ccsbBroad304_07676,PLK2,Polo-like kinase (PLK) family
2815,11.34,oe,ccsbBroad304_00032,ADSL,-
2818,11.31,kd,CGS001-5255,PHKA1,-
2819,11.3,kd,CGS001-5859,QARS,Aminoacyl tRNA synthetases / Class I
2820,11.29,oe,ccsbBroad304_06220,FOS,basic leucine zipper proteins
2821,11.29,kd,CGS001-58495,OVOL2,"Zinc fingers, C2H2-type"
2822,11.27,kd,CGS001-9568,GABBR2,GABA receptors
2823,11.26,kd,CGS001-7597,ZBTB25,BTB/POZ domain containing
2824,11.25,kd,CGS001-26149,ZNF658,"Zinc fingers, C2H2-type"
2825,11.25,kd,CGS001-7923,HSD17B8,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
2826,11.18,oe,ccsbBroad304_06304,GPC1,Proteoglycans / Cell Surface : Glypicans
2827,11.18,oe,ccsbBroad304_04565,COG7,Components of oligomeric golgi complex
2828,11.17,oe,ccsbBroad304_02209,RNF14,RING-type (C3HC4) zinc fingers
2830,11.17,kd,CGS001-23386,NUDCD3,-
2833,11.15,kd,CGS001-221895,JAZF1,"Zinc fingers, C2H2-type"
2834,11.15,kd,CGS001-2730,GCLM,-
2835,11.11,oe,ccsbBroad304_07145,ZFP161,-
2836,11.11,kd,CGS001-5962,RDX,-
2838,11.07,kd,CGS001-4677,NARS,Aminoacyl tRNA synthetases / Class II
2840,11.06,kd,CGS001-8915,BCL10,-
2841,11.06,kd,CGS001-558,AXL,Fibronectin type III domain containing
2842,11.05,kd,CGS001-57721,METTL14,-
2844,11.03,kd,CGS001-5108,PCM1,-
2845,11.03,kd,CGS001-6307,MSMO1,Fatty acid hydroxylase domain containing
2846,11.01,kd,CGS001-182,JAG1,CD molecules
2847,10.98,kd,CGS001-23211,ZC3H4,"Zinc fingers, CCCH-type domain containing"
2848,10.98,kd,CGS001-567,B2M,Immunoglobulin superfamily / C1-set domain containing
2850,10.96,kd,CGS001-3315,HSPB1,Heat shock proteins / HSPB
2856,10.88,kd,CGS001-79073,TMEM109,-
2857,10.86,kd,CGS001-3590,IL11RA,IL-6 receptor family
2858,10.79,kd,CGS001-64121,RRAGC,-
2860,10.73,kd,CGS001-53836,GPR87,GPCR / Class A : Orphans
2861,10.72,oe,ccsbBroad304_07605,LYPLA1,-
2862,10.71,kd,CGS001-4798,NFRKB,INO80 complex subunits
2864,10.68,kd,CGS001-9650,MTFR1,-
2865,10.67,kd,CGS001-223,ALDH9A1,Aldehyde dehydrogenases
2868,10.61,kd,CGS001-390980,ZNF805,"Zinc fingers, C2H2-type"
2871,10.54,kd,CGS001-2099,ESR1,Estrogen receptors
2872,10.54,kd,CGS001-11151,CORO1A,Coronins
2873,10.5,kd,CGS001-1244,ABCC2,ATP binding cassette transporters / subfamily C
2874,10.48,oe,ccsbBroad304_01268,PPP3CB,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
2877,10.47,kd,CGS001-8462,KLF11,Kruppel-like transcription factors
2878,10.45,kd,CGS001-3783,KCNN4,Calcium-activated potassium channels
2880,10.44,kd,CGS001-5335,PLCG1,Phosphoinositide-specific phospholipase C
2881,10.44,oe,ccsbBroad304_00053,ALDOA,-
2882,10.43,oe,ccsbBroad304_06675,SLC22A18,Orphan or poorly characterized SLC22 family members
2884,10.41,kd,CGS001-10972,TMED10,-
2885,10.41,kd,CGS001-638,BIK,-
2886,10.4,kd,CGS001-57057,TBX20,T-boxes
2887,10.39,kd,CGS001-55612,FERMT1,Fermitins
2888,10.37,kd,CGS001-327,APEH,Prolyl oligopeptidase
2890,10.35,kd,CGS001-4893,NRAS,RAS subfamily
2892,10.34,kd,CGS001-4189,DNAJB9,Heat shock proteins / DNAJ (HSP40)
2893,10.33,kd,CGS001-10325,RRAGB,-
2894,10.31,oe,ccsbBroad304_07401,TXNL1,-
2895,10.29,kd,CGS001-91464,ISX,Homeoboxes / PRD class
2896,10.27,kd,CGS001-338,APOB,Apolipoproteins
2897,10.25,oe,ccsbBroad304_07354,ASH2L,"Zinc fingers, PHD-type"
2898,10.25,oe,ccsbBroad304_02087,PRPF4,WD repeat domain containing
2901,10.21,kd,CGS001-51292,GMPR2,-
2902,10.18,kd,CGS001-8771,TNFRSF6B,Tumour necrosis factor (TNF) receptor family
2903,10.18,kd,CGS001-26001,RNF167,RING-type (C3HC4) zinc fingers
2905,10.17,oe,ccsbBroad304_00171,BNIP3L,-
2906,10.15,oe,ccsbBroad304_02311,ARPC3,Actin related protein 2/3 complex subunits
2907,10.15,oe,ccsbBroad304_01163,PDHA1,-
2908,10.14,kd,CGS001-891,CCNB1,-
2909,10.12,kd,CGS001-3708,ITPR1,Ion channels / Inositol triphosphate receptors
2911,10.11,kd,CGS001-56005,C19ORF10,-
2913,10.08,kd,CGS001-7976,FZD3,GPCR / Class F : Frizzled receptors
2916,10.05,oe,ccsbBroad304_07582,NET1,Rho guanine nucleotide exchange factors
2917,10.04,oe,ccsbBroad304_08898,TRAK2,-
2918,10.03,kd,CGS001-1173,AP2M1,-
2919,10,kd,CGS001-899,CCNF,F-boxes / other
2920,9.99,kd,CGS001-6446,SGK1,SGK family
2922,9.97,kd,CGS001-462,SERPINC1,Serine (or cysteine) peptidase inhibitors
2924,9.95,kd,CGS001-2242,FES,Fer family
2925,9.94,oe,ccsbBroad304_06975,SMARCC2,-
2928,9.9,oe,ccsbBroad304_03512,ATG16L1,WD repeat domain containing
2929,9.9,kd,CGS001-4864,NPC1,-
2930,9.89,kd,CGS001-9374,PPT2,-
2931,9.89,kd,CGS001-29078,NDUFAF4,Mitochondrial respiratory chain complex assembly factors
2932,9.87,kd,CGS001-89765,RSPH1,-
2933,9.87,kd,CGS001-3912,LAMB1,Laminins
2938,9.83,kd,CGS001-7750,ZMYM2,"Zinc fingers, MYM type"
2940,9.78,kd,CGS001-1128,CHRM1,Cholinergic receptors
2942,9.76,kd,CGS001-2042,EPHA3,Type XIII RTKs: Ephrin receptor family
2943,9.74,kd,CGS001-10616,RBCK1,RING-type (C3HC4) zinc fingers
2944,9.73,kd,CGS001-83463,MXD3,Basic helix-loop-helix proteins
2945,9.72,kd,CGS001-8650,NUMB,-
2946,9.72,oe,ccsbBroad304_01102,NMT1,-
2947,9.72,oe,ccsbBroad304_07045,TEAD4,-
2948,9.69,kd,CGS001-5916,RARG,Retinoic acid receptors
2949,9.69,kd,CGS001-4552,MTRR,-
2952,9.66,kd,CGS001-6443,SGCB,-
2953,9.65,kd,CGS001-3275,PRMT2,Protein arginine N-methyltransferases
2954,9.64,kd,CGS001-55229,PANK4,-
2955,9.64,kd,CGS001-11007,CCDC85B,-
2956,9.63,kd,CGS001-8826,IQGAP1,-
2957,9.63,kd,CGS001-84435,GPR123,Adhesion Class GPCRs
2958,9.63,kd,CGS001-2100,ESR2,Estrogen receptors
2960,9.61,kd,CGS001-2810,SFN,-
2961,9.6,kd,CGS001-7398,USP1,Ubiquitin-specific peptidases
2962,9.57,kd,CGS001-2770,GNAI1,-
2964,9.51,oe,ccsbBroad304_03647,CNDP2,Carnosine dipeptidase
2965,9.49,kd,CGS001-5091,PC,Carboxylases
2966,9.49,oe,ccsbBroad304_08888,ACD,-
2967,9.48,oe,ccsbBroad304_02266,RHOBTB1,BTB/POZ domain containing
2973,9.42,kd,CGS001-23536,ADAT1,-
2975,9.38,oe,ccsbBroad304_13850,EIF4A2,DEAD-boxes
2977,9.37,kd,CGS001-11162,NUDT6,Nudix motif containing
2978,9.36,kd,CGS001-8324,FZD7,GPCR / Class F : Frizzled receptors
2979,9.35,oe,ccsbBroad304_04046,ZNF426,"Zinc fingers, C2H2-type"
2980,9.34,kd,CGS001-6778,STAT6,SH2 domain containing
2983,9.32,oe,ccsbBroad304_00738,HINT1,-
2985,9.26,oe,ccsbBroad304_08775,SQRDL,-
2986,9.26,oe,ccsbBroad304_04189,FBXO11,Protein arginine N-methyltransferases
2987,9.25,kd,CGS001-7538,ZFP36,RING-type (C3HC4) zinc fingers
2988,9.25,kd,CGS001-9053,MAP7,-
2989,9.22,oe,ccsbBroad304_01078,NDUFV2,Mitochondrial respiratory chain complex / Complex I
2990,9.22,oe,ccsbBroad304_04786,CANT1,-
2991,9.21,kd,CGS001-10902,BRD8,Bromodomain kinase (BRDK) family
2992,9.21,oe,ccsbBroad304_05425,SNAI3,Snail homologs
2994,9.19,kd,CGS001-3767,KCNJ11,Inwardly rectifying potassium channels
2995,9.16,kd,CGS001-23378,RRP8,-
2996,9.16,kd,CGS001-3601,IL15RA,IL-2 receptor family
2997,9.14,kd,CGS001-6647,SOD1,-
2998,9.13,kd,CGS001-9261,MAPKAPK2,MAPKAPK subfamily
2999,9.11,kd,CGS001-4303,FOXO4,Forkhead boxes
3000,9.1,kd,CGS001-57147,SCYL3,-
3001,9.09,kd,CGS001-353,APRT,-
3003,9.06,kd,CGS001-147948,ZNF582,"Zinc fingers, C2H2-type"
3004,9.06,kd,CGS001-55832,CAND1,-
3005,9.04,kd,CGS001-677,ZFP36L1,RING-type (C3HC4) zinc fingers
3006,9.04,kd,CGS001-23271,CAMSAP2,-
3008,9.01,kd,CGS001-1981,EIF4G1,Parkinson disease
3009,9,kd,CGS001-9360,PPIG,-
3010,8.98,oe,ccsbBroad304_07245,PPFIBP2,Sterile alpha motif (SAM) domain containing
3011,8.98,kd,CGS001-51741,WWOX,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2
3012,8.95,kd,CGS001-7226,TRPM2,Transient Receptor Potential channels
3013,8.95,oe,ccsbBroad304_01768,VEGFA,Cytokines and growth factors
3014,8.94,kd,CGS001-23743,BHMT2,-
3018,8.89,kd,CGS001-5721,PSME2,"Proteasome (prosome, macropain) subunits"
3019,8.89,kd,CGS001-1997,ELF1,ETS Transcription Factors
3020,8.89,kd,CGS001-56616,DIABLO,-
3022,8.88,kd,CGS001-4833,NME4,-
3025,8.85,oe,ccsbBroad304_07884,RYBP,-
3026,8.85,kd,CGS001-57798,GATAD1,GATA zinc finger domain containing
3027,8.85,kd,CGS001-6301,SARS,Aminoacyl tRNA synthetases / Class II
3028,8.85,kd,CGS001-51635,DHRS7,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3
3030,8.82,kd,CGS001-1468,SLC25A10,Mitochondrial di- and tri-carboxylic acid transporter subfamily
3032,8.79,kd,CGS001-140690,CTCFL,"Zinc fingers, C2H2-type"
3034,8.77,kd,CGS001-1021,CDK6,"Cyclin-dependent kinases, CDK4 subfamily"
3035,8.76,kd,CGS001-10465,PPIH,-
3036,8.75,oe,ccsbBroad304_02576,MLLT11,-
3038,8.74,kd,CGS001-3956,LGALS1,Endogenous ligands
3040,8.72,kd,CGS001-8089,YEATS4,-
3041,8.72,oe,ccsbBroad304_00130,ATP5F1,ATPases / F-type
3043,8.69,kd,CGS001-6696,SPP1,Endogenous ligands
3045,8.67,kd,CGS001-2909,ARHGAP35,Rho GTPase activating proteins
3046,8.66,kd,CGS001-115992,RNF166,RING-type (C3HC4) zinc fingers
3047,8.65,kd,CGS001-79751,SLC25A22,Mitochondrial amino acid transporter subfamily
3048,8.65,kd,CGS001-5167,ENPP1,-
3049,8.65,oe,ccsbBroad304_00960,SMAD1,SMADs
3051,8.63,kd,CGS001-1534,CYB561,Cytochrome b genes
3052,8.62,kd,CGS001-1284,COL4A2,Collagens
3059,8.58,kd,CGS001-1456,CSNK1G3,Casein kinase 1 (CK1) family
3060,8.58,oe,ccsbBroad304_02408,HMG20B,High mobility group / Non-canonical
3061,8.57,kd,CGS001-23062,GGA2,-
3062,8.55,kd,CGS001-7465,WEE1,WEE family
3063,8.55,kd,CGS001-9978,RBX1,RING-type (C3HC4) zinc fingers
3065,8.54,kd,CGS001-645,BLVRB,Short chain dehydrogenase/reductase superfamily / Atypical members
3066,8.53,kd,CGS001-6188,RPS3,S ribosomal proteins
3067,8.51,kd,CGS001-4947,OAZ2,-
3069,8.45,kd,CGS001-3249,HPN,Serine peptidases / Transmembrane
3070,8.44,oe,ccsbBroad304_01609,STAT3,SH2 domain containing
3071,8.44,kd,CGS001-3308,HSPA4,Heat shock proteins / HSP70
3072,8.44,kd,CGS001-1196,CLK2,CDC-like kinases
3073,8.43,oe,ccsbBroad304_07109,TUBB2A,Tubulins
3075,8.42,kd,CGS001-7915,ALDH5A1,Aldehyde dehydrogenases
3076,8.4,oe,ccsbBroad304_13598,NRBP2,NRBP family
3078,8.4,kd,CGS001-121549,ASCL4,Basic helix-loop-helix proteins
3080,8.39,oe,ccsbBroad304_06383,HMMR,CD molecules
3081,8.38,kd,CGS001-4804,NGFR,Tumour necrosis factor (TNF) receptor family
3083,8.34,kd,CGS001-63948,DMRTB1,-
3084,8.32,kd,CGS001-5869,RAB5B,"RAB, member RAS oncogene"
3085,8.31,kd,CGS001-8797,TNFRSF10A,Tumour necrosis factor (TNF) receptor family
3087,8.24,oe,ccsbBroad304_09648,ZNF548,"Zinc fingers, C2H2-type"
3089,8.24,kd,CGS001-134288,TMEM174,-
3090,8.23,kd,CGS001-5291,PIK3CB,Phosphatidylinositol kinases
3091,8.21,kd,CGS001-117289,TAGAP,Rho GTPase activating proteins
3092,8.21,oe,ccsbBroad304_03179,BOLA1,-
3094,8.2,kd,CGS001-54498,SMOX,-
3096,8.11,kd,CGS001-3205,HOXA9,Homeoboxes / ANTP class : HOXL subclass
3100,8.08,oe,ccsbBroad304_00527,F2RL1,GPCR / Class A : Protease activated receptors
3102,8.07,kd,CGS001-84515,MCM8,-
3103,8.06,kd,CGS001-5688,PSMA7,Proteasome subunits
3104,8.06,oe,ccsbBroad304_00651,GNAI3,-
3105,8.06,oe,ccsbBroad304_02958,HSPB8,Heat shock proteins / HSPB
3106,8.05,oe,ccsbBroad304_01769,VEGFB,-
3107,8.05,kd,CGS001-4967,OGDH,-
3108,8.05,oe,ccsbBroad304_03739,NRIP3,-
3110,8.01,oe,ccsbBroad304_05901,POLR3D,RNA polymerase subunits
3112,8.01,oe,ccsbBroad304_05779,ADK,Adenosine turnover
3113,7.96,kd,CGS001-56521,DNAJC12,Heat shock proteins / DNAJ (HSP40)
3116,7.95,kd,CGS001-3276,PRMT1,Protein arginine N-methyltransferases
3117,7.93,kd,CGS001-2786,GNG4,-
3118,7.91,kd,CGS001-9687,GREB1,-
3119,7.9,kd,CGS001-51460,SFMBT1,Sterile alpha motif (SAM) domain containing
3120,7.89,kd,CGS001-51545,ZNF581,"Zinc fingers, C2H2-type"
3123,7.88,kd,CGS001-8396,PIP4K2B,1-phosphatidylinositol-5-phosphate 4-kinase family
3124,7.87,kd,CGS001-2113,ETS1,ETS Transcription Factors
3125,7.86,kd,CGS001-7097,TLR2,Toll-like receptor family
3127,7.84,kd,CGS001-5055,SERPINB2,Serine (or cysteine) peptidase inhibitors
3131,7.82,oe,ccsbBroad304_01923,UXT,-
3134,7.79,kd,CGS001-2769,GNA15,-
3136,7.76,kd,CGS001-7342,UBP1,-
3137,7.76,kd,CGS001-151306,GPBAR1,Bile acid receptor
3140,7.73,oe,ccsbBroad304_04235,TDRD3,Tudor domain containing
3142,7.72,oe,ccsbBroad304_03817,NMRAL1,Short chain dehydrogenase/reductase superfamily / Atypical members
3143,7.69,kd,CGS001-29102,DROSHA,-
3144,7.66,kd,CGS001-10489,LRRC41,-
3145,7.64,kd,CGS001-833,CARS,Aminoacyl tRNA synthetases / Class I
3146,7.64,kd,CGS001-2535,FZD2,GPCR / Class F : Frizzled receptors
3147,7.63,kd,CGS001-1936,EEF1D,-
3148,7.61,kd,CGS001-54815,GATAD2A,GATA zinc finger domain containing
3149,7.61,kd,CGS001-2212,FCGR2A,CD molecules
3152,7.58,kd,CGS001-213,ALB,-
3155,7.55,oe,ccsbBroad304_03880,RXFP1,GPCR / Class A : Relaxin family peptide receptors
3156,7.55,kd,CGS001-55312,RFK,-
3157,7.55,oe,ccsbBroad304_02990,LYPD3,-
3158,7.52,kd,CGS001-10390,CEPT1,-
3159,7.51,kd,CGS001-663,BNIP2,-
3160,7.5,oe,ccsbBroad304_00969,MAGEA10,-
3161,7.5,oe,ccsbBroad304_10431,HADHB,-
3162,7.5,oe,ccsbBroad304_02019,IL18RAP,CD molecules
3163,7.49,kd,CGS001-4087,SMAD2,SMADs
3167,7.41,oe,ccsbBroad304_07641,CCT7,Heat Shock Proteins / Chaperonins
3168,7.4,kd,CGS001-10078,TSSC4,-
3169,7.37,kd,CGS001-2000,ELF4,ETS Transcription Factors
3173,7.35,kd,CGS001-7319,UBE2A,Ubiquitin-conjugating enzymes E2
3174,7.34,oe,ccsbBroad304_06055,CSNK1A1,Casein kinase 1 (CK1) family
3175,7.32,kd,CGS001-22827,PUF60,RNA binding motif (RRM) containing
3176,7.31,oe,ccsbBroad304_00615,GAPDH,-
3179,7.29,kd,CGS001-23530,NNT,-
3180,7.27,kd,CGS001-29978,UBQLN2,Ubiquilin family
3182,7.26,oe,ccsbBroad304_01324,PSMD10,Ankyrin repeat domain containing
3184,7.26,kd,CGS001-22877,MLXIP,Basic helix-loop-helix proteins
3185,7.25,kd,CGS001-4194,MDM4,-
3186,7.24,kd,CGS001-10397,NDRG1,-
3187,7.23,oe,ccsbBroad304_07515,GFPT2,-
3189,7.21,kd,CGS001-2132,EXT2,Exostosin glycosyltransferase family
3191,7.19,kd,CGS001-7443,VRK1,Vaccina related kinase (VRK) family
3193,7.18,kd,CGS001-2629,GBA,-
3194,7.18,kd,CGS001-283150,FOXR1,Forkhead boxes
3195,7.18,oe,ccsbBroad304_06750,POLR2H,RNA polymerase subunits
3196,7.17,oe,ccsbBroad304_01930,CUL2,-
3197,7.14,kd,CGS001-143187,VTI1A,-
3198,7.13,oe,ccsbBroad304_00070,ANXA5,Annexins
3199,7.1,kd,CGS001-1613,DAPK3,Death-associated kinase (DAPK) family
3200,7.09,kd,CGS001-890,CCNA2,-
3203,7.07,kd,CGS001-5236,PGM1,-
3204,7.05,kd,CGS001-7386,UQCRFS1,Mitochondrial respiratory chain complex / Complex III
3206,7.03,kd,CGS001-9770,RASSF2,-
3207,7.03,kd,CGS001-1163,CKS1B,-
3210,6.99,oe,ccsbBroad304_06624,NDUFC2,Mitochondrial respiratory chain complex / Complex I
3212,6.95,oe,ccsbBroad304_02030,CFLAR,Endogenous ligands
3213,6.94,kd,CGS001-1718,DHCR24,-
3214,6.93,oe,ccsbBroad304_07075,TLR5,Toll-like receptor family
3215,6.92,kd,CGS001-5921,RASA1,Pleckstrin homology (PH) domain containing
3216,6.91,kd,CGS001-8531,CSDA,-
3217,6.89,kd,CGS001-4734,NEDD4,-
3218,6.89,kd,CGS001-2625,GATA3,GATA zinc finger domain containing
3219,6.89,kd,CGS001-64240,ABCG5,ATP binding cassette transporters / subfamily G
3220,6.88,oe,ccsbBroad304_03072,GTPBP8,-
3224,6.87,kd,CGS001-26523,EIF2C1,-
3225,6.87,kd,CGS001-8313,AXIN2,-
3226,6.85,kd,CGS001-3161,HMMR,CD molecules
3227,6.84,oe,ccsbBroad304_10489,CSF3,Endogenous ligands
3228,6.83,kd,CGS001-6672,SP100,"Zinc fingers, PHD-type"
3229,6.83,oe,ccsbBroad304_01376,RARB,Retinoic acid receptors
3230,6.82,oe,ccsbBroad304_07071,TKT,-
3233,6.81,oe,ccsbBroad304_03625,HIF1AN,-
3234,6.81,oe,ccsbBroad304_00744,HLA-DRB3,Immunoglobulin superfamily / C1-set domain containing
3236,6.78,oe,ccsbBroad304_00773,HOXA9,Homeoboxes / ANTP class : HOXL subclass
3237,6.77,kd,CGS001-59343,SENP2,-
3238,6.77,kd,CGS001-8554,PIAS1,"Zinc fingers, MIZ-type"
3239,6.76,kd,CGS001-29984,RHOD,-
3240,6.76,kd,CGS001-10105,PPIF,-
3241,6.76,kd,CGS001-57396,CLK4,CDC-like kinases
3242,6.76,oe,ccsbBroad304_02297,DNAJB6,Heat shock proteins / DNAJ (HSP40)
3243,6.75,kd,CGS001-2030,SLC29A1,SLC29 family
3244,6.74,kd,CGS001-5105,PCK1,-
3245,6.74,kd,CGS001-976,CD97,Adhesion Class GPCRs
3249,6.72,kd,CGS001-23369,PUM2,-
3250,6.71,kd,CGS001-9156,EXO1,-
3251,6.71,oe,ccsbBroad304_06521,LGALS3,Endogenous ligands
3253,6.7,kd,CGS001-4487,MSX1,Homeoboxes / ANTP class : NKL subclass
3254,6.69,oe,ccsbBroad304_00611,GALE,Short chain dehydrogenase/reductase superfamily / Extended SDR fold
3256,6.69,oe,ccsbBroad304_06481,KCNJ11,Inwardly rectifying potassium channels
3259,6.68,kd,CGS001-25825,BACE2,Pepsin
3260,6.67,kd,CGS001-8834,TMEM11,-
3261,6.67,kd,CGS001-3119,HLA-DQB1,Immunoglobulin superfamily / C1-set domain containing
3262,6.66,kd,CGS001-9519,TBPL1,-
3263,6.66,oe,ccsbBroad304_04396,ZNF559,"Zinc fingers, C2H2-type"
3264,6.65,kd,CGS001-5245,PHB,-
3265,6.63,oe,ccsbBroad304_00290,CEBPG,basic leucine zipper proteins
3266,6.63,kd,CGS001-54658,UGT1A1,UDP glucuronosyltransferases
3267,6.63,kd,CGS001-6189,RPS3A,S ribosomal proteins
3269,6.61,kd,CGS001-10460,TACC3,-
3273,6.58,kd,CGS001-10452,TOMM40,-
3275,6.57,kd,CGS001-5289,PIK3C3,Phosphatidylinositol 3-kinase family
3276,6.57,oe,ccsbBroad304_03812,PBXIP1,-
3277,6.56,kd,CGS001-5217,PFN2,-
3278,6.56,oe,ccsbBroad304_02029,GGH,Gamma-glutamyl hydrolase
3279,6.55,oe,ccsbBroad304_01809,ZNF136,"Zinc fingers, C2H2-type"
3282,6.54,kd,CGS001-6663,SOX10,SRY (sex determining region Y)-boxes
3283,6.53,kd,CGS001-4601,MXI1,Basic helix-loop-helix proteins
3285,6.5,kd,CGS001-54101,RIPK4,Receptor interacting protein kinase (RIPK) family
3287,6.48,kd,CGS001-6871,TADA2A,-
3288,6.48,oe,ccsbBroad304_10227,ZNF85,"Zinc fingers, C2H2-type"
3292,6.44,kd,CGS001-57521,RPTOR,WD repeat domain containing
3293,6.44,oe,ccsbBroad304_06150,EIF4E,Translation Initiation Factor 4E
3294,6.44,oe,ccsbBroad304_00860,IL13,Interleukins and interleukin receptors
3297,6.41,oe,ccsbBroad304_02100,BUB3,WD repeat domain containing
3300,6.39,oe,ccsbBroad304_01131,OXCT1,-
3301,6.39,oe,ccsbBroad304_03311,EVL,-
3302,6.39,kd,CGS001-2783,GNB2,WD repeat domain containing
3303,6.39,kd,CGS001-8900,CCNA1,-
3304,6.38,kd,CGS001-7024,TFCP2,-
3305,6.37,kd,CGS001-4722,NDUFS3,Mitochondrial respiratory chain complex / Complex I
3307,6.34,oe,ccsbBroad304_10240,CROT,-
3309,6.34,kd,CGS001-7855,FZD5,GPCR / Class F : Frizzled receptors
3314,6.3,kd,CGS001-1615,DARS,Aminoacyl tRNA synthetases / Class II
3315,6.29,kd,CGS001-2232,FDXR,-
3317,6.27,kd,CGS001-5575,PRKAR1B,Protein kinase A
3319,6.26,kd,CGS001-10421,CD2BP2,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
3320,6.26,oe,ccsbBroad304_07291,RNGTT,Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases
3321,6.25,oe,ccsbBroad304_01139,PA2G4,-
3322,6.25,oe,ccsbBroad304_09309,CREB3L1,basic leucine zipper proteins
3324,6.19,kd,CGS001-4258,MGST2,Glutathione S-transferases / Microsomal
3325,6.19,oe,ccsbBroad304_01640,TAF12,-
3330,6.15,kd,CGS001-55300,PI4K2B,Phosphatidylinositol kinases
3333,6.13,kd,CGS001-51347,TAOK3,TAO subfamily
3334,6.13,kd,CGS001-170463,SSBP4,-
3335,6.12,oe,ccsbBroad304_06149,EIF4B,RNA binding motif (RRM) containing
3336,6.11,oe,ccsbBroad304_08113,DNAJC15,Heat shock proteins / DNAJ (HSP40)
3337,6.1,kd,CGS001-324,APC,Armadillo repeat containing
3338,6.08,kd,CGS001-51002,TPRKB,-
3339,6.08,kd,CGS001-9377,COX5A,Mitochondrial respiratory chain complex
3341,6.06,kd,CGS001-2048,EPHB2,Type XIII RTKs: Ephrin receptor family
3343,6.05,kd,CGS001-3486,IGFBP3,insulin-like growth factor (IGF) binding proteins
3344,6.04,oe,ccsbBroad304_00060,AMBP,Lipocalins
3345,6.04,kd,CGS001-4668,NAGA,-
3346,6.04,kd,CGS001-1875,E2F5,-
3347,6.03,kd,CGS001-2664,GDI1,-
3348,6.02,kd,CGS001-32,ACACB,Carboxylases
3349,6.01,kd,CGS001-5031,P2RY6,"GPCR / Class A : Purinergic receptors, P2Y"
3350,6.01,oe,ccsbBroad304_02686,COPZ1,-
3351,6,kd,CGS001-4176,MCM7,-
3354,5.98,oe,ccsbBroad304_00412,CYP3A5,Cytochrome P450s
3355,5.98,kd,CGS001-3122,HLA-DRA,Immunoglobulin superfamily / C1-set domain containing
3356,5.97,oe,ccsbBroad304_01894,HIST1H2AC,Histones / Replication-dependent
3357,5.97,kd,CGS001-7849,PAX8,Paired boxes
3358,5.97,kd,CGS001-57594,HOMEZ,Homeoboxes / ZF class
3360,5.93,oe,ccsbBroad304_03950,ATG3,-
3361,5.92,kd,CGS001-6603,SMARCD2,-
3362,5.91,kd,CGS001-1120,CHKB,-
3365,5.89,kd,CGS001-7748,ZNF195,"Zinc fingers, C2H2-type"
3367,5.87,kd,CGS001-337867,UBAC2,-
3368,5.85,kd,CGS001-11142,PKIG,-
3369,5.84,kd,CGS001-3673,ITGA2,Integrins
3370,5.84,kd,CGS001-2735,GLI1,"Zinc fingers, C2H2-type"
3373,5.83,oe,ccsbBroad304_00809,HUS1,-
3377,5.8,oe,ccsbBroad304_06587,MMP1,Matrix metallopeptidase
3379,5.8,kd,CGS001-81894,SLC25A28,Miscellaneous SLC25 mitochondrial transporters
3380,5.79,oe,ccsbBroad304_00617,GBA,-
3382,5.78,kd,CGS001-54821,ERCC6L,-
3384,5.77,kd,CGS001-8573,CASK,CASK family
3385,5.76,oe,ccsbBroad304_01180,PFKFB3,-
3386,5.75,oe,ccsbBroad304_00563,FGG,Endogenous ligands
3388,5.74,kd,CGS001-58497,PRUNE,-
3389,5.74,kd,CGS001-29940,DSE,-
3390,5.74,kd,CGS001-602,BCL3,Ankyrin repeat domain containing
3391,5.72,oe,ccsbBroad304_02621,PRDM7,"Zinc fingers, C2H2-type"
3392,5.71,kd,CGS001-55239,OGFOD1,-
3393,5.7,kd,CGS001-5567,PRKACB,Protein kinase A
3395,5.68,kd,CGS001-57491,AHRR,Basic helix-loop-helix proteins
3396,5.67,oe,ccsbBroad304_06469,KARS,Aminoacyl tRNA synthetases / Class II
3397,5.67,oe,ccsbBroad304_00237,CCND3,-
3400,5.65,oe,ccsbBroad304_01395,RFX5,-
3401,5.65,oe,ccsbBroad304_00774,HOXA10,Homeoboxes / ANTP class : HOXL subclass
3402,5.65,oe,ccsbBroad304_03469,ANKRD49,Ankyrin repeat domain containing
3404,5.63,oe,ccsbBroad304_00963,SMAD5,SMADs
3407,5.61,kd,CGS001-6098,ROS1,Type XVII RTKs: ROS receptors
3408,5.61,kd,CGS001-3880,KRT19,"Intermediate filaments type I, keratins (acidic)"
3409,5.61,kd,CGS001-2627,GATA6,GATA zinc finger domain containing
3410,5.58,kd,CGS001-3706,ITPKA,"Inositol 1,4,5-trisphosphate 3-kinases"
3413,5.56,oe,ccsbBroad304_09345,TIMM50,Serine/threonine phosphatases / CTD aspartate-based phosphatases
3414,5.55,kd,CGS001-10084,PQBP1,-
3415,5.55,kd,CGS001-2952,GSTT1,Glutathione S-transferases / Soluble
3421,5.52,kd,CGS001-26277,TINF2,-
3422,5.52,kd,CGS001-2634,GBP2,-
3424,5.51,oe,ccsbBroad304_07738,ABHD2,Abhydrolase domain containing
3427,5.48,oe,ccsbBroad304_00118,ATIC,-
3428,5.47,kd,CGS001-83637,ZMIZ2,"Zinc fingers, MIZ-type"
3429,5.47,kd,CGS001-10939,AFG3L2,ATPases / AAA-type
3430,5.46,kd,CGS001-11230,PRAF2,-
3431,5.45,oe,ccsbBroad304_01949,CAMK1,CAMK1 family
3432,5.45,kd,CGS001-8525,DGKZ,-
3433,5.45,kd,CGS001-18,ABAT,GABA turnover
3435,5.42,kd,CGS001-51222,ZNF219,"Zinc fingers, C2H2-type"
3436,5.42,kd,CGS001-257397,TAB3,-
3437,5.39,kd,CGS001-7423,VEGFB,-
3438,5.39,kd,CGS001-2324,FLT4,Type IV RTKs: VEGF (vascular endothelial growth factor) receptor family
3440,5.37,oe,ccsbBroad304_01699,TPD52L2,-
3441,5.37,kd,CGS001-28960,DCPS,-
3442,5.34,kd,CGS001-7071,KLF10,Kruppel-like transcription factors
3443,5.33,kd,CGS001-169436,C9ORF96,-
3445,5.32,kd,CGS001-5261,PHKG2,Phosphorylase kinase (PHK) family
3446,5.32,oe,ccsbBroad304_00778,HOXC10,Homeoboxes / ANTP class : HOXL subclass
3447,5.29,kd,CGS001-9641,IKBKE,IKK family
3448,5.28,oe,ccsbBroad304_09446,MRGPRX4,GPCR / Class A : Orphans
3452,5.25,kd,CGS001-5612,PRKRIR,THAP (C2CH-type zinc finger) domain containing
3454,5.24,kd,CGS001-54861,SNRK,SNRK subfamily
3455,5.24,kd,CGS001-29883,CNOT7,-
3456,5.23,oe,ccsbBroad304_00161,BID,Endogenous ligands
3458,5.23,kd,CGS001-5355,PLP2,-
3459,5.23,oe,ccsbBroad304_05439,O3FAR1,-
3461,5.22,kd,CGS001-207,AKT1,Akt (Protein kinase B)
3462,5.21,kd,CGS001-6591,SNAI2,Snail homologs
3463,5.21,kd,CGS001-4914,NTRK1,Type VII RTKs: Neurotrophin receptor/Trk family
3464,5.21,kd,CGS001-10962,MLLT11,-
3465,5.19,oe,ccsbBroad304_00510,EPHX2,-
3467,5.18,oe,ccsbBroad304_01833,IL1R2,Immunoglobulin-like family of IL-1 receptors
3469,5.17,kd,CGS001-5534,PPP3R1,EF-hand domain containing
3470,5.17,kd,CGS001-4998,ORC1,ATPases / AAA-type
3471,5.17,kd,CGS001-353288,KRT26,"Intermediate filaments type I, keratins (acidic)"
3473,5.15,oe,ccsbBroad304_09258,MYLK2,Myosin Light Chain Kinase (MLCK) family
3474,5.14,oe,ccsbBroad304_00657,GNG4,-
3477,5.14,kd,CGS001-3588,IL10RB,IL-10 receptor family
3478,5.14,oe,ccsbBroad304_06453,ING2,"Zinc fingers, PHD-type"
3479,5.13,kd,CGS001-27125,AFF4,-
3481,5.11,kd,CGS001-85442,KNDC1,-
3482,5.11,kd,CGS001-63933,CCDC90A,-
3483,5.1,kd,CGS001-2674,GFRA1,GDNF receptor family
3484,5.09,oe,ccsbBroad304_05523,KRT26,"Intermediate filaments type I, keratins (acidic)"
3485,5.09,oe,ccsbBroad304_00706,GTF2B,General transcription factors
3486,5.09,oe,ccsbBroad304_06575,MEF2A,Myocyte enhancer factors
3490,5.07,kd,CGS001-84617,TUBB6,Tubulins
3493,5,oe,ccsbBroad304_03937,MLST8,WD repeat domain containing
3494,5,kd,CGS001-10474,TADA3,-
3495,5,kd,CGS001-5920,RARRES3,-
3496,5,kd,CGS001-23581,CASP14,Caspases
3497,5,oe,ccsbBroad304_01485,SC5DL,-
3498,5,oe,ccsbBroad304_06372,HLA-DPB1,Immunoglobulin superfamily / C1-set domain containing
3499,4.99,kd,CGS001-79716,NPEPL1,Leucyl aminopeptidase
3500,4.95,oe,ccsbBroad304_02419,NDRG1,-
3501,4.95,oe,ccsbBroad304_01673,TIMP3,-
3505,4.92,kd,CGS001-1198,CLK3,CDC-like kinases
3506,4.91,kd,CGS001-6741,SSB,La ribonucleoprotein domain containing
3508,4.89,kd,CGS001-5887,RAD23B,-
3509,4.89,kd,CGS001-79581,GPR172A,-
3510,4.89,kd,CGS001-54850,FBXL12,F-boxes / Leucine-rich repeats
3511,4.87,kd,CGS001-63929,XPNPEP3,Methionyl aminopeptidase
3512,4.87,kd,CGS001-835,CASP2,Caspases
3513,4.87,kd,CGS001-160,AP2A1,-
3516,4.84,kd,CGS001-10776,ARPP19,-
3519,4.83,kd,CGS001-1956,EGFR,Type I RTKs: ErbB (epidermal growth factor) receptor family
3520,4.82,kd,CGS001-7103,TSPAN8,Tetraspanins
3521,4.82,kd,CGS001-5604,MAP2K1,MAPKK:STE7 family
3522,4.82,kd,CGS001-896,CCND3,-
3523,4.82,kd,CGS001-818,CAMK2G,CAMK2 family
3526,4.78,oe,ccsbBroad304_01289,MAPK13,MAPK:p38 subfamily
3527,4.78,kd,CGS001-5052,PRDX1,-
3528,4.78,kd,CGS001-144811,LACC1,-
3533,4.75,kd,CGS001-5649,RELN,-
3534,4.75,kd,CGS001-4697,NDUFA4,-
3535,4.74,kd,CGS001-26271,FBXO5,F-boxes / other
3536,4.74,kd,CGS001-1952,CELSR2,Cadherins / Major cadherins
3537,4.74,oe,ccsbBroad304_10423,BMPR1A,Type I receptor serine/threonine kinases
3539,4.73,kd,CGS001-54677,CROT,-
3540,4.72,oe,ccsbBroad304_07450,RNF7,RING-type (C3HC4) zinc fingers
3541,4.71,kd,CGS001-9217,VAPB,-
3542,4.7,oe,ccsbBroad304_11054,PRKAR2A,Protein kinase A
3544,4.68,oe,ccsbBroad304_00580,FLT1,Type IV RTKs: VEGF (vascular endothelial growth factor) receptor family
3545,4.68,oe,ccsbBroad304_08724,CYP20A1,Cytochrome P450s
3546,4.68,kd,CGS001-5663,PSEN1,Presenilin
3547,4.68,kd,CGS001-10769,PLK2,Polo-like kinase (PLK) family
3549,4.66,kd,CGS001-1154,CISH,SH2 domain containing
3550,4.66,kd,CGS001-384,ARG2,Arginase
3554,4.65,oe,ccsbBroad304_02857,BAMBI,-
3556,4.64,kd,CGS001-7520,XRCC5,XRCC DNA Repair
3557,4.63,kd,CGS001-6659,SOX4,SRY (sex determining region Y)-boxes
3558,4.63,kd,CGS001-10891,PPARGC1A,RNA binding motif (RRM) containing
3559,4.63,oe,ccsbBroad304_02719,SWAP70,EF-hand domain containing
3560,4.62,oe,ccsbBroad304_03773,CIAPIN1,-
3565,4.61,kd,CGS001-2717,GLA,-
3566,4.61,kd,CGS001-1974,EIF4A2,DEAD-boxes
3567,4.58,kd,CGS001-6715,SRD5A1,-
3568,4.58,kd,CGS001-2289,FKBP5,Tetratricopeptide (TTC) repeat domain containing
3569,4.58,oe,ccsbBroad304_07906,DDAH2,Dimethylarginine dimethylaminohydrolases
3571,4.57,oe,ccsbBroad304_13830,FOXN3,Forkhead boxes
3572,4.56,kd,CGS001-6416,MAP2K4,MAPKK:STE7 family
3573,4.55,kd,CGS001-51026,GOLT1B,-
3574,4.55,kd,CGS001-133690,CAPSL,EF-hand domain containing
3576,4.54,oe,ccsbBroad304_07006,ST14,Serine peptidases / Transmembrane
3577,4.54,oe,ccsbBroad304_00844,IL1R1,Interleukins and interleukin receptors
3578,4.54,oe,ccsbBroad304_00226,CAV1,-
3579,4.53,kd,CGS001-6477,SIAH1,-
3580,4.53,kd,CGS001-4097,MAFG,-
3581,4.53,kd,CGS001-64422,ATG3,-
3582,4.53,oe,ccsbBroad304_06679,OXTR,GPCR / Class A : Vasopressin and oxytocin receptors
3585,4.51,kd,CGS001-80746,TSEN2,tRNA splicing endonuclease subunits
3586,4.5,kd,CGS001-10793,ZNF273,"Zinc fingers, C2H2-type"
3587,4.5,kd,CGS001-64135,IFIH1,-
3588,4.5,kd,CGS001-1959,EGR2,"Zinc fingers, C2H2-type"
3589,4.5,oe,ccsbBroad304_01617,STX4,-
3591,4.49,oe,ccsbBroad304_06742,PML,RING-type (C3HC4) zinc fingers
3593,4.49,oe,ccsbBroad304_06642,NIT1,-
3594,4.49,oe,ccsbBroad304_00112,ASNA1,-
3595,4.47,oe,ccsbBroad304_02386,EIF1B,-
3596,4.47,kd,CGS001-63892,THADA,-
3597,4.47,kd,CGS001-5709,PSMD3,"Proteasome (prosome, macropain) subunits"
3598,4.47,kd,CGS001-55631,LRRC40,-
3600,4.45,kd,CGS001-126375,ZNF792,"Zinc fingers, C2H2-type"
3601,4.45,kd,CGS001-51444,RNF138,RING-type (C3HC4) zinc fingers
3602,4.45,kd,CGS001-3976,LIF,-
3603,4.44,oe,ccsbBroad304_04404,TUBB6,Tubulins
3605,4.43,kd,CGS001-11212,PROSC,-
3606,4.42,kd,CGS001-4154,MBNL1,"Zinc fingers, CCCH-type domain containing"
3607,4.42,kd,CGS001-3710,ITPR3,Ion channels / Inositol triphosphate receptors
3608,4.4,oe,ccsbBroad304_09054,EGFL8,-
3609,4.4,oe,ccsbBroad304_02843,FTSJ1,-
3611,4.38,kd,CGS001-26574,AATF,-
3612,4.37,kd,CGS001-5437,POLR2H,RNA polymerase subunits
3613,4.37,kd,CGS001-23139,MAST2,MAST family
3614,4.36,kd,CGS001-1044,CDX1,Homeoboxes / ANTP class : HOXL subclass
3615,4.35,oe,ccsbBroad304_06761,PPP3CC,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
3616,4.35,oe,ccsbBroad304_00888,ITPK1,-
3617,4.35,oe,ccsbBroad304_06329,GRPR,GPCR / Class A : Bombesin receptors
3619,4.34,kd,CGS001-125919,ZNF543,"Zinc fingers, C2H2-type"
3620,4.34,kd,CGS001-7010,TEK,Type XII RTKs: TIE family of angiopoietin receptors
3623,4.32,kd,CGS001-5723,PSPH,-
3624,4.31,oe,ccsbBroad304_06665,OAT,-
3625,4.31,kd,CGS001-1499,CTNNB1,Catenins
3627,4.29,kd,CGS001-30849,PIK3R4,Phosphatidylinositol kinases
3628,4.29,kd,CGS001-57157,PHTF2,-
3629,4.29,kd,CGS001-57211,GPR126,Adhesion Class GPCRs
3630,4.29,kd,CGS001-30836,DNTTIP2,-
3632,4.28,kd,CGS001-2729,GCLC,-
3634,4.26,kd,CGS001-1512,CTSH,Cathepsins
3635,4.26,kd,CGS001-120103,SLC36A4,SLC36 family of proton-coupled amino acid transporters
3636,4.26,kd,CGS001-8635,RNASET2,-
3637,4.26,kd,CGS001-4968,OGG1,-
3640,4.25,kd,CGS001-84844,PHF5A,"Zinc fingers, PHD-type"
3642,4.21,oe,ccsbBroad304_03696,C19ORF10,-
3643,4.21,kd,CGS001-3593,IL12B,Interleukins and interleukin receptors
3644,4.21,oe,ccsbBroad304_10212,GRHL3,-
3645,4.2,kd,CGS001-7528,YY1,INO80 complex subunits
3646,4.18,kd,CGS001-3156,HMGCR,Lanosterol biosynthesis pathway
3647,4.18,kd,CGS001-84971,ATG4D,-
3648,4.17,oe,ccsbBroad304_07328,PRPF4B,PRP4 subfamily
3649,4.16,kd,CGS001-57787,MARK4,MARK subfamily
3650,4.16,kd,CGS001-1725,DHPS,-
3653,4.14,kd,CGS001-271,AMPD2,-
3654,4.14,kd,CGS001-55324,ABCF3,ATP binding cassette transporters / subfamily F
3656,4.13,kd,CGS001-1497,CTNS,-
3657,4.12,oe,ccsbBroad304_06386,HNMT,-
3660,4.1,oe,ccsbBroad304_01787,YES1,Src family
3663,4.08,kd,CGS001-5063,PAK3,PAKA subfamily
3664,4.08,kd,CGS001-8322,FZD4,GPCR / Class F : Frizzled receptors
3666,4.07,oe,ccsbBroad304_06836,RAD23B,-
3668,4.06,oe,ccsbBroad304_00146,BAD,-
3671,4.05,kd,CGS001-87,ACTN1,EF-hand domain containing
3672,4.04,oe,ccsbBroad304_03056,MCTS1,-
3673,4.03,oe,ccsbBroad304_04054,PHF23,"Zinc fingers, PHD-type"
3674,4.03,oe,ccsbBroad304_02887,CLIC4,Ion channels / Chloride channels : Intracellular
3675,4.03,oe,ccsbBroad304_00036,AFP,-
3676,4.03,kd,CGS001-4780,NFE2L2,basic leucine zipper proteins
3677,4.03,kd,CGS001-3575,IL7R,IL-2 receptor family
3678,4.03,kd,CGS001-35,ACADS,-
3679,4.03,oe,ccsbBroad304_01292,EIF2AK2,Other PEK family kinases
3685,4.01,kd,CGS001-7083,TK1,-
3686,4,kd,CGS001-6654,SOS1,Rho guanine nucleotide exchange factors
3687,4,kd,CGS001-9355,LHX2,Homeoboxes / LIM class
3688,3.99,oe,ccsbBroad304_01831,TUBA1A,Tubulins
3693,3.97,kd,CGS001-54941,RNF125,RING-type (C3HC4) zinc fingers
3694,3.97,kd,CGS001-4830,NME1,-
3695,3.97,kd,CGS001-10095,ARPC1B,Actin related protein 2/3 complex subunits
3696,3.97,kd,CGS001-83440,ADPGK,-
5821,0,cp,BRD-A83937277,mephenytoin,Hydantoin antiepileptic
5822,0,cp,BRD-K19111024,clofibric-acid,PPAR receptor agonist
5823,0,cp,BRD-K28912512,nicotinamide,Protein synthesis stimulant
5824,0,cp,BRD-K01663662,diphenidol,Acetylcholine receptor agonist
5825,0,cp,BRD-K32318651,acyclovir,DNA polymerase inhibitor
5826,0,cp,BRD-A31800922,procyclidine,Acetylcholine receptor antagonist
5827,0,cp,BRD-K82381502,acetylcholine,Acetylcholine receptor agonist
5828,0,cp,BRD-A80638690,floxuridine,DNA synthesis inhibitor
5829,0,cp,BRD-K02123250,JNJ-38877605,Tyrosine kinase inhibitor
5830,0,cp,BRD-A88774919,doxycycline,Bacterial 30S ribosomal subunit inhibitor
5831,0,cp,BRD-K94830329,ataluren,CFTR channel agonist
5832,0,cp,BRD-K67102207,phenylbutyrate,HDAC inhibitor
5833,0,cp,BRD-A50157456,terbutaline,Adrenergic receptor agonist
5834,0,cp,BRD-K63828191,raloxifene,Estrogen receptor antagonist
5835,0,cp,BRD-K81128206,edrophonium,Acetylcholinesterase inhibitor
5836,0,cp,BRD-A16754160,ampicillin,Bacterial cell wall synthesis inhibitor
5837,0,cp,BRD-K71926323,marbofloxacin,Bacterial DNA gyrase inhibitor
5838,0,cp,BRD-K47679368,bromfenac,Cyclooxygenase inhibitor
5839,0,cp,BRD-A64479082,quinidine,Sodium channel blocker
5840,0,cp,BRD-A32161980,carbetocin,Oxytocin receptor agonist
5841,0,cp,BRD-K00656370,6-aminochrysene,Transferase inhibitor
5842,0,cp,BRD-K67637637,olopatadine,Histamine receptor antagonist
5843,0,cp,BRD-A69512159,carbidopa,Aromatic L-amino acid decarboxylase inhibitor
5844,0,cp,BRD-A19500257,geldanamycin,HSP inhibitor
5845,0,cp,BRD-K26979635,NS-3694,Glutamate receptor antagonist
5846,0,cp,BRD-A30435184,metergoline,Dopamine receptor agonist
4721,0.01,cc,,PI3K Signaling LOF,-
4719,0.02,cc,,Progesterone receptor agonist,-
4720,0.02,cp,BRD-K91290917,amodiaquine,Histamine receptor agonist
4716,0.03,cc,,Estrogen receptor agonist,-
4717,0.03,cp,BRD-A24191444,ifenprodil,Adrenergic receptor antagonist
4718,0.03,cp,BRD-A78942461,ICI-118551,Adrenergic receptor antagonist
3698,3.95,kd,CGS001-5992,RFX4,-
4710,0.07,cc,,Supressors of cytokine signaling GOF,-
4711,0.07,cp,BRD-A34817987,itraconazole,Cytochrome P450 inhibitor
4712,0.07,cp,BRD-K54094468,remoxipride,Dopamine receptor antagonist
4713,0.07,cp,BRD-K54771420,glycocholic-acid,Cholesterol inhibitor
4714,0.07,cp,BRD-A92177080,betamethasone,Glucocorticoid receptor agonist
3701,3.94,oe,ccsbBroad304_06637,NFKB1,NFkappaB transcription factor family
4708,0.1,cc,,Cyclins LOF,-
3702,3.94,oe,ccsbBroad304_08825,LHPP,-
4703,0.11,cp,BRD-A35912562,pregnenolone,Glutamate receptor modulator
4704,0.11,cp,BRD-K75958195,pizotifen,Serotonin receptor antagonist
4705,0.11,cp,BRD-A68723818,brompheniramine,Histamine receptor antagonist
4706,0.11,cp,BRD-A36074203,remacemide,Glutamate receptor antagonist
4707,0.11,cp,BRD-K92000912,AM-251,Cannabinoid receptor antagonist
4700,0.13,cc,,Potassium channel blocker,-
3703,3.94,oe,ccsbBroad304_02761,SIRT3,Histone deacetylases (HDACs)
3705,3.92,kd,CGS001-6500,SKP1,-
3708,3.89,oe,ccsbBroad304_00624,GCK,Hexokinases
4695,0.14,cp,BRD-K64245000,GW-4064,FXR agonist
4696,0.14,cp,BRD-A16694057,bisphenol-a,PPAR receptor antagonist
3709,3.89,oe,ccsbBroad304_00695,CXCL1,Endogenous ligands
4698,0.14,cp,BRD-K52313696,tacedinaline,HDAC inhibitor
4699,0.14,cp,BRD-K86509404,iso-olomoucine,CDK inhibitor
3710,3.89,kd,CGS001-10606,PAICS,-
4691,0.18,cp,BRD-A33168282,sotalol,Adrenergic receptor antagonist
4686,0.19,cc,,PKA inhibitor,-
4687,0.19,cc,,Cyclooxygenase inhibitor,-
3711,3.89,kd,CGS001-3109,HLA-DMB,Immunoglobulin superfamily / C1-set domain containing
3712,3.89,kd,CGS001-790,CAD,-
3713,3.88,kd,CGS001-2969,GTF2I,General transcription factors
4684,0.2,cc,,VEGFR inhibitor,-
4685,0.2,cc,,Na-K-Cl transporter inhibitor,-
4680,0.21,cp,BRD-K02113016,olaparib,PARP inhibitor
4681,0.21,cp,BRD-K57718010,pentylenetetrazol,GABA receptor antagonist
4682,0.21,cp,BRD-A87719232,naproxen,Cyclooxygenase inhibitor
4683,0.21,cp,BRD-K41713976,E-4031,Potassium channel blocker
4679,0.22,cp,BRD-K93034159,cladribine,Adenosine deaminase inhibitor
3715,3.86,kd,CGS001-25,ABL1,Abl family
3716,3.86,oe,ccsbBroad304_01744,UCHL1,Ubiquitin C-terminal hydrolase
4671,0.25,cc,,Estrogen receptor antagonist,-
4672,0.25,cp,BRD-K30197592,5-methoxytryptamine,Serotonin receptor agonist
4673,0.25,cp,BRD-K40992116,parachlorophenol,Anti-infective
4674,0.25,cp,BRD-K17008822,BD-1008,Sigma receptor antagonist
4675,0.25,cp,BRD-K76587808,fraxetin,Antioxidant
4676,0.25,cp,BRD-K96084870,DMBI,PDGFR receptor inhibitor
3717,3.84,oe,ccsbBroad304_02840,PISD,Decarboxylases
4667,0.28,cp,BRD-K09635314,M-3M3FBS,phospholipase activator
4668,0.28,cp,BRD-A30655177,LFM-A13,BTK inhibitor
4669,0.28,cp,BRD-K04046242,equilin,Estrogen receptor agonist
4670,0.28,cp,BRD-A24817035,laudanosine,Central nervous system agent
4665,0.3,cc,,Wnt family GOF,-
4657,0.32,cc,,Progesterone receptor antagonist,-
3719,3.84,oe,ccsbBroad304_01927,NR0B2,DAX-like receptors
4659,0.32,cp,BRD-K66874953,pifithrin-alpha,TP53 inhibitor
4660,0.32,cp,BRD-K77771411,moxonidine,Imidazoline receptor agonist
4661,0.32,cp,BRD-K34170797,fexaramine,FXR agonist
4662,0.32,cp,BRD-K13544237,r(-)-propylnorapomorphine,Dopamine receptor agonist
4663,0.32,cp,BRD-K59332007,linopirdine,Potassium channel blocker
4664,0.32,cp,BRD-K40901640,cinanserin,Serotonin receptor antagonist
4655,0.34,cc,,Angiotensin receptor antagonist,-
3720,3.83,kd,CGS001-10975,UQCR11,Mitochondrial respiratory chain complex / Complex III
4652,0.35,cp,BRD-K84663978,trequinsin,Phosphodiesterase inhibitor
4653,0.35,cp,BRD-K50495309,SRC-kinase-inhibitor-I,SRC inhibitor
4654,0.35,cp,BRD-A95869247,indapamide,Thiazide diuretic
4648,0.36,cc,,Kruppel like transcription factors LOF,-
4649,0.36,cc,,HOXL subclass homeoboxes LOF,-
4650,0.36,cc,,DNA synthesis inhibitor,-
4651,0.36,cc,,Bacterial cell wall synthesis inhibitor,-
3721,3.83,kd,CGS001-23395,LARS2,Aminoacyl tRNA synthetases / Class I
3722,3.82,kd,CGS001-390,RND3,-
3723,3.82,kd,CGS001-673,BRAF,RAF family
3728,3.8,oe,ccsbBroad304_11186,TGFBR2,Type II receptor serine/threonine kinases
3729,3.8,oe,ccsbBroad304_08266,PIPOX,-
4641,0.38,cc,,Cannabinoid receptor agonist,-
4642,0.38,cp,BRD-K95676198,JAK3-inhibitor-V,JAK inhibitor
4637,0.39,cp,BRD-K88429204,pyrimethamine,Dihydrofolate reductase inhibitor
4638,0.39,cp,BRD-A99449986,MT-21,Caspase activator
4639,0.39,cp,BRD-K46317332,proadifen,Nitric oxide synthase inhibitor
3730,3.8,oe,ccsbBroad304_00977,MAX,Basic helix-loop-helix proteins
3731,3.8,kd,CGS001-5610,EIF2AK2,Other PEK family kinases
3732,3.79,kd,CGS001-439,ASNA1,-
3734,3.77,kd,CGS001-51520,LARS,Aminoacyl tRNA synthetases / Class I
4630,0.42,cp,BRD-K90976994,dehydrocholic-acid,Bile acid
4631,0.42,cp,BRD-K09963420,saquinavir,HIV protease inhibitor
4632,0.42,cp,BRD-K18742343,H-8,PKA inhibitor
4633,0.42,cp,BRD-K62310379,fluticasone,Glucocorticoid receptor agonist
4634,0.42,cp,BRD-K40887525,ritanserin,Serotonin receptor antagonist
3735,3.77,oe,ccsbBroad304_05802,ALDH1B1,Aldehyde dehydrogenases
4636,0.42,cp,BRD-A67799922,phenoxybenzamine,Adrenergic receptor antagonist
4625,0.45,cp,BRD-K23383398,T-0901317,LXR agonist
4626,0.45,cp,BRD-A25143711,hydrocortisone,Glucocorticoid receptor agonist
4618,0.46,cp,BRD-K00673382,famotidine,Histamine receptor antagonist
4619,0.46,cp,BRD-A19633847,perhexiline,Carnitine palmitoyltransferase inhibitor
4620,0.46,cp,BRD-K48367671,febuxostat,Xanthine oxidase inhibitor
4621,0.46,cp,BRD-K05906022,limonin,HIV protease inhibitor
3737,3.75,oe,ccsbBroad304_05006,ZNF583,"Zinc fingers, C2H2-type"
3738,3.75,oe,ccsbBroad304_07383,STK17A,Death-associated kinase (DAPK) family
3740,3.74,kd,CGS001-2254,FGF9,Endogenous ligands
4617,0.47,cc,,Nucleophosmin inhibitor,-
4614,0.49,cc,,G2 M Checkpoint LOF,-
4615,0.49,cp,BRD-A81402010,KU-C103443N,CDC inhibitor
4616,0.49,cp,BRD-K09397065,SR-57227A,Serotonin receptor agonist
3741,3.73,kd,CGS001-8202,NCOA3,Histone acetyltransferases
3742,3.71,kd,CGS001-6722,SRF,-
4607,0.53,cp,BRD-A58955223,sulforaphane,Antineoplastic
4608,0.53,cp,BRD-K24132293,piperlongumine,Glutathione transferase inhibitor
3743,3.7,oe,ccsbBroad304_00941,LIG3,-
4610,0.53,cp,BRD-K86204871,terconazole,Sterol demethylase inhibitor
4611,0.53,cp,BRD-K90027355,spironolactone,Mineralocorticoid receptor antagonist
3744,3.7,oe,ccsbBroad304_00207,CALM2,EF-hand domain containing
4603,0.56,cp,BRD-K63792901,arecaidine,Acetylcholine receptor agonist
4604,0.56,cp,BRD-A43150328,penicillic-acid,other antibiotic
4605,0.56,cp,BRD-A50675702,fipronil,GABA gated chloride channel blocker
3746,3.7,oe,ccsbBroad304_02063,SLC25A14,Mitochondrial uncoupling proteins
4600,0.58,cc,,Ribonucleotide reductase inhibitor,-
3747,3.67,oe,ccsbBroad304_07678,ZNF266,"Zinc fingers, C2H2-type"
3748,3.66,oe,ccsbBroad304_03707,PCDHA10,Cadherins / Protocadherins : Clustered
4592,0.6,cp,BRD-K96134740,kitasamycin,Protein synthesis inhibitor
4593,0.6,cp,BRD-K46742498,alosetron,Serotonin receptor antagonist
4594,0.6,cp,BRD-A68281735,REV-5901,Leukotriene receptor antagonist
3749,3.66,kd,CGS001-1978,EIF4EBP1,-
3751,3.65,kd,CGS001-51734,SEPX1,-
3753,3.64,kd,CGS001-8408,ULK1,Unc-51-like kinase (ULK) family
3754,3.63,kd,CGS001-3146,HMGB1,High-mobility group / Canonical
3755,3.63,kd,CGS001-6799,SULT1A2,"Sulfotransferases, cytosolic"
3757,3.61,kd,CGS001-6510,SLC1A5,Alanine/serine/cysteine transporter subfamily
4587,0.63,cp,BRD-K63913457,eicosatrienoic-acid,Vasodilator
4588,0.63,cp,BRD-K75615183,talipexole,Adrenergic receptor agonist
4589,0.63,cp,BRD-K15563106,phloretin,Sodium/glucose cotransporter inhibitor
4578,0.65,cc,,Interleukins GOF,-
3758,3.58,kd,CGS001-80230,RUFY1,"Zinc fingers, FYVE domain containing"
3759,3.58,kd,CGS001-5223,PGAM1,-
3760,3.56,oe,ccsbBroad304_01418,RPL7,L ribosomal proteins
3761,3.56,oe,ccsbBroad304_03121,NRBF2,-
3762,3.56,oe,ccsbBroad304_00294,CETN3,EF-hand domain containing
3764,3.55,kd,CGS001-9252,RPS6KA5,MSK subfamily
3765,3.55,kd,CGS001-54438,GFOD1,-
3766,3.53,kd,CGS001-2188,FANCF,"Fanconi anemia, complementation groups"
4570,0.67,cc,,C2 domain containing protein kinases LOF,-
4571,0.67,cp,BRD-A39052811,mosapride,Serotonin receptor agonist
4572,0.67,cp,BRD-K36009368,NNC-63-0532,Opioid receptor agonist
4573,0.67,cp,BRD-K02404261,caffeine,Adenosine receptor antagonist
4574,0.67,cp,BRD-K49111258,prazosin,Adrenergic receptor antagonist
4575,0.67,cp,BRD-A31521121,methocarbamol,Muscle relaxant
4576,0.67,cp,BRD-A97701745,pindolol,Adrenergic receptor antagonist
4577,0.67,cp,BRD-K68264559,brimonidine,Adrenergic receptor agonist
3767,3.53,kd,CGS001-3992,FADS1,Fatty acid desaturases
3768,3.53,kd,CGS001-8703,B4GALT3,Beta 4-glycosyltransferases
3769,3.52,oe,ccsbBroad304_00349,COX4I1,Mitochondrial respiratory chain complex
3771,3.52,oe,ccsbBroad304_13929,PRKACA,Protein kinase A
3772,3.52,oe,ccsbBroad304_11024,PDGFRA,"Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family"
3773,3.5,kd,CGS001-4637,MYL6,EF-hand domain containing
4562,0.7,cp,BRD-K99107520,felbamate,Glutamate receptor antagonist
4563,0.7,cp,BRD-K04877770,FTase-inhibitor-B581,Farnesyltransferase inhibitor
3774,3.5,kd,CGS001-79139,DERL1,-
4552,0.74,cp,BRD-K25741894,skimmianine,Acetylcholinesterase inhibitor
4553,0.74,cp,BRD-A13650332,flucloxacillin,Bacterial cell wall synthesis inhibitor
4554,0.74,cp,BRD-A58157837,butabindide,Tripeptidyl peptidase inhibitor
4555,0.74,cp,BRD-K80451230,zamifenacin,Acetylcholine receptor antagonist
3778,3.47,kd,CGS001-4638,MYLK,Myosin Light Chain Kinase (MLCK) family
3779,3.47,oe,ccsbBroad304_08461,CDCA4,-
3780,3.45,kd,CGS001-3117,HLA-DQA1,Immunoglobulin superfamily / C1-set domain containing
3782,3.44,oe,ccsbBroad304_02671,ECD,-
4560,0.74,cp,BRD-A75552914,isoxicam,Cyclooxygenase inhibitor
4561,0.74,cp,BRD-K05653692,DL-PDMP,Glucosyltransferase inhibitor
4550,0.75,cp,BRD-A47598013,citalopram,Serotonin reuptake inhibitor
3786,3.42,kd,CGS001-4173,MCM4,-
3787,3.42,oe,ccsbBroad304_00270,CDK1,"Cyclin-dependent kinases, CDK1 subfamily"
4543,0.78,cp,BRD-K34330170,rotenonic-acid,Retinoid receptor antagonist
4544,0.78,cp,BRD-K56047318,RHC-80267,Triacylglycerol lipase inhibitor
4545,0.78,cp,BRD-K81839095,estrone,Estrogen receptor agonist
4546,0.78,cp,BRD-K33860217,CP-94253,Serotonin receptor agonist
4547,0.78,cp,BRD-K56115039,BU-226,Imidazoline receptor ligand
4548,0.78,cp,BRD-A86044036,flurbiprofen,Cyclooxygenase inhibitor
3788,3.42,oe,ccsbBroad304_01091,NFIB,-
3789,3.41,kd,CGS001-6621,SNAPC4,-
4537,0.81,cp,BRD-A73581086,ergometrine,Adrenergic receptor agonist
4538,0.81,cp,BRD-K27305650,LY-294002,MTOR inhibitor
4539,0.81,cp,BRD-A22769835,homochlorcyclizine,Antihistamine
3792,3.39,kd,CGS001-26520,TIMM9,-
3793,3.39,kd,CGS001-8604,SLC25A12,Mitochondrial amino acid transporter subfamily
3794,3.39,kd,CGS001-84875,PARP10,Poly (ADP-ribose) polymerases
3795,3.39,kd,CGS001-3682,ITGAE,Integrins
3796,3.39,kd,CGS001-57512,GPR158,GPCR / Class C : Orphans
3797,3.39,oe,ccsbBroad304_09758,APOBEC3H,Apolipoprotein B mRNA editing enzymes
3799,3.38,oe,ccsbBroad304_00376,CSK,Csk family
3800,3.38,oe,ccsbBroad304_02804,KLHDC2,-
3801,3.38,oe,ccsbBroad304_06179,ERG,ETS Transcription Factors
3803,3.38,kd,CGS001-5595,MAPK3,MAPK:ERK subfamily
3804,3.38,oe,ccsbBroad304_06588,MMP2,Matrix metallopeptidase
4523,0.85,cp,BRD-A22380646,pantoprazole,ATPase inhibitor
4524,0.85,cp,BRD-A50928468,norgestrel,Progesterone receptor agonist
4525,0.85,cp,BRD-K59256312,gabexate,Serine protease inhibitor
3805,3.37,kd,CGS001-3163,HMOX2,Haem oxygenase
3806,3.37,kd,CGS001-55662,HIF1AN,-
4513,0.88,cc,,Androgen receptor modulator,-
4514,0.88,cp,BRD-K28667793,pyrazinamide,Fatty acid synthase inhibitor
4515,0.88,cp,BRD-K83144676,olmesartan,Angiotensin antagonist
4516,0.88,cp,BRD-K13261168,LY-16350,Dopamine receptor agonist
4517,0.88,cp,BRD-K63945320,dihydrosamidin,Phospholipase inhibitor
3807,3.37,kd,CGS001-116519,APOA5,Apolipoproteins
3810,3.34,kd,CGS001-10000,AKT3,Akt (Protein kinase B)
3811,3.34,kd,CGS001-4089,SMAD4,SMADs
4512,0.9,cc,,Dihydrofolate reductase inhibitor,-
4511,0.91,cc,,Thymidylate synthase inhibitor,-
4506,0.92,cp,BRD-K06159959,CCMQ,Inhibitor of the binding of homoquinolinic acid to non-NMDA sensitive sites
4507,0.92,cp,BRD-A04553218,chlorphenamine,Histamine receptor antagonist
3812,3.34,kd,CGS001-10284,SAP18,-
3813,3.34,kd,CGS001-23242,COBL,-
3814,3.34,oe,ccsbBroad304_07208,NRIP1,-
4499,0.93,cc,,IMPDH inhibitor,-
3815,3.33,oe,ccsbBroad304_00964,SMAD7,SMADs
3818,3.29,oe,ccsbBroad304_02446,TADA3,-
3819,3.29,kd,CGS001-6935,ZEB1,"Zinc fingers, C2H2-type"
3820,3.29,kd,CGS001-23102,TBC1D2B,-
3821,3.29,kd,CGS001-28511,NKIRAS2,-
3822,3.29,kd,CGS001-533,ATP6V0B,ATPases / V-type
4493,0.95,cp,BRD-K79684402,RO-10-5824,Dopamine receptor agonist
4494,0.95,cp,BRD-K05528470,L-745870,Dopamine receptor antagonist
4495,0.95,cp,BRD-K70327191,benzoxiquine,Anti-infective
3825,3.26,kd,CGS001-23011,RAB21,"RAB, member RAS oncogene"
4497,0.95,cp,BRD-K14993104,bemegride,Chemoreceptor agonist
4498,0.95,cp,BRD-K71799949,carbamazepine,Carboxamide antiepileptic
3827,3.24,oe,ccsbBroad304_11109,RPS6KB1,p70 subfamily
3831,3.24,kd,CGS001-1543,CYP1A1,Cytochrome P450s
3832,3.24,oe,ccsbBroad304_00689,GRB7,Pleckstrin homology (PH) domain containing
3835,3.21,kd,CGS001-389114,ZNF662,"Zinc fingers, C2H2-type"
3836,3.21,kd,CGS001-9491,PSMF1,"Proteasome (prosome, macropain) subunits"
3837,3.21,kd,CGS001-11164,NUDT5,Nudix motif containing
3842,3.19,kd,CGS001-3300,DNAJB2,Heat shock proteins / DNAJ (HSP40)
3843,3.19,oe,ccsbBroad304_02715,WDTC1,DDB1 and CUL4 associated factors
4478,0.99,cp,BRD-K13926615,vardenafil,Phosphodiesterase inhibitor
4479,0.99,cp,BRD-A50684349,fenoldopam,Dopamine receptor agonist
4480,0.99,cp,BRD-K39339537,epirizole,Cyclooxygenase inhibitor
4481,0.99,cp,BRD-K31633810,DAU-5884,Acetylcholine receptor antagonist
4482,0.99,cp,BRD-K50417881,eticlopride,Dopamine receptor antagonist
4483,0.99,cp,BRD-K32821942,azathioprine,Dehydrogenase inhibitor
4484,0.99,cp,BRD-A05352148,ipratropium,Acetylcholine receptor antagonist
3844,3.18,kd,CGS001-7422,VEGFA,Cytokines and growth factors
3845,3.18,kd,CGS001-5096,PCCB,Carboxylases
3846,3.18,kd,CGS001-5599,MAPK8,MAPK:JNK subfamily
3852,3.16,kd,CGS001-10781,ZNF266,"Zinc fingers, C2H2-type"
3853,3.16,kd,CGS001-7466,WFS1,-
3854,3.15,oe,ccsbBroad304_05796,AK1,Adenylate kinases
4473,1.02,cp,BRD-A72441487,stiripentol,GABA uptake inhibitor
4474,1.02,cp,BRD-A65671304,candesartan,Angiotensin receptor antagonist
3858,3.13,oe,ccsbBroad304_10428,ETS2,ETS Transcription Factors
4476,1.02,cp,BRD-K79145749,dibenzepin,Norepinephrine reuptake inhibitor
4466,1.03,cp,BRD-K83023055,GR-135531,Melatonin receptor agonist
3862,3.1,oe,ccsbBroad304_00956,LYZ,-
3863,3.1,oe,ccsbBroad304_00164,BLMH,-
3867,3.08,kd,CGS001-10049,DNAJB6,Heat shock proteins / DNAJ (HSP40)
3870,3.06,oe,ccsbBroad304_04909,ZNF572,"Zinc fingers, C2H2-type"
3873,3.05,kd,CGS001-221188,GPR114,Adhesion Class GPCRs
3874,3.05,kd,CGS001-2821,GPI,-
4460,1.06,cp,BRD-A26845397,isamoltan,Adrenergic receptor antagonist
4461,1.06,cp,BRD-K15196155,IBC-293,Hydroxycarboxylic acid receptor agonist
4462,1.06,cp,BRD-K15025317,BAY-11-7821,NFkB pathway inhibitor
3875,3.05,kd,CGS001-57154,SMURF1,-
4464,1.06,cp,BRD-K36616567,doxepin,Histamine receptor antagonist
3876,3.05,kd,CGS001-222894,FERD3L,Basic helix-loop-helix proteins
3879,3.03,kd,CGS001-5025,P2RX4,"Ligand-gated ion channels / Purinergic receptors, ionotropic"
3880,3.02,oe,ccsbBroad304_01052,MYB,-
4452,1.09,cp,BRD-A31801025,formestane,Aromatase inhibitor
4451,1.1,cc,,Thromboxane receptor antagonist,-
3881,3.01,kd,CGS001-3312,HSPA8,Heat shock proteins / HSP70
3882,3.01,oe,ccsbBroad304_00269,CD97,Adhesion Class GPCRs
3884,3,kd,CGS001-205,AK4,Adenylate kinases
3886,2.97,oe,ccsbBroad304_08152,PSAT1,-
3887,2.97,kd,CGS001-116931,MED12L,-
3888,2.97,kd,CGS001-10644,IGF2BP2,RNA binding motif (RRM) containing
3889,2.96,oe,ccsbBroad304_00985,MCL1,-
3891,2.96,oe,ccsbBroad304_08045,NOX1,-
3892,2.96,oe,ccsbBroad304_06088,AKR1C1,Aldo-keto reductases
3895,2.95,kd,CGS001-7248,TSC1,-
4440,1.12,cp,BRD-K13211965,L-741742,Dopamine receptor antagonist
4431,1.13,cp,BRD-K02965346,SU-11274,Hepatocyte growth factor receptor inhibitor
4432,1.13,cp,BRD-K39391626,ethylestrenol,Progesterone receptor agonist
4433,1.13,cp,BRD-K63923597,barasertib,Aurora kinase inhibitor
4434,1.13,cp,BRD-A19053259,pseudopelletierine,Anthelmintic
4435,1.13,cp,BRD-K26241953,piceatannol,SYK inhibitor
4436,1.13,cp,BRD-K18816859,L-694247,Serotonin receptor agonist
3896,2.95,kd,CGS001-29965,C16ORF5,-
3897,2.93,kd,CGS001-6601,SMARCC2,-
4439,1.13,cp,BRD-K11853856,PJ-34,PARP inhibitor
4430,1.15,cp,BRD-K72029282,probucol,Atherogenesis inhibitor
4425,1.16,cp,BRD-K80778372,RO-19-4605,GABA benzodiazepine site receptor inverse agonist
4426,1.16,cp,BRD-A62021152,WAY-161503,Serotonin receptor agonist
3902,2.92,kd,CGS001-9474,ATG5,-
3903,2.92,oe,ccsbBroad304_06057,CSNK1G3,Casein kinase 1 (CK1) family
4429,1.16,cp,BRD-K87226815,cycloserine,Bacterial cell wall synthesis inhibitor
4424,1.17,cc,,Beta-adrenergic receptor agonist,-
4423,1.18,cp,BRD-A76093993,cromakalim,Potassium channel activator
3904,2.92,oe,ccsbBroad304_00929,LBR,Tudor domain containing
3909,2.89,kd,CGS001-6519,SLC3A1,SLC3 family
3910,2.89,kd,CGS001-24148,PRPF6,-
3911,2.89,kd,CGS001-23047,PDS5B,-
4412,1.2,cp,BRD-K71035033,masitinib,KIT inhibitor
4413,1.2,cp,BRD-A62035778,scopolamine,Acetylcholine receptor antagonist
4414,1.2,cp,BRD-K77171813,proxyfan,Histamine receptor modulator
4415,1.2,cp,BRD-K70241288,L-692585,Growth hormone releasing peptide ligand agonist
4416,1.2,cp,BRD-K34608650,BRD-K34608650,Cannabinoid receptor agonist
4417,1.2,cp,BRD-K48869804,icilin,TRPV agonist
4418,1.2,cp,BRD-A78295502,hydroquinine,Antiarrhythmic
4419,1.2,cp,BRD-K51290057,SA-792709,Retinoid receptor agonist
3912,2.89,kd,CGS001-2919,CXCL1,Endogenous ligands
3915,2.88,kd,CGS001-6625,SNRNP70,RNA binding motif (RRM) containing
3916,2.87,oe,ccsbBroad304_00880,IRF2,-
3917,2.87,oe,ccsbBroad304_06178,ERCC5,-
3918,2.87,oe,ccsbBroad304_10758,CTBP2,-
3919,2.87,kd,CGS001-23443,SLC35A3,SLC35 family of nucleotide sugar transporters
4401,1.23,cp,BRD-K14681867,somatostatin,Somatostatin receptor agonist
4402,1.23,cp,BRD-K24526313,levcromakalim,Potassium channel activator
4403,1.23,cp,BRD-K21936341,oxotremorine,Acetylcholine receptor agonist
4404,1.23,cp,BRD-K99922388,DPO-1,Potassium channel blocker
3920,2.87,kd,CGS001-51027,BOLA1,-
3921,2.87,kd,CGS001-624,BDKRB2,Bradykinin receptors
3922,2.87,oe,ccsbBroad304_01774,WARS,Aminoacyl tRNA synthetases / Class I
3923,2.87,oe,ccsbBroad304_03573,BRF2,-
3924,2.87,oe,ccsbBroad304_01302,KLK6,Chymotrypsin
3925,2.87,oe,ccsbBroad304_02415,TUBB3,Tubulins
4392,1.26,cp,BRD-K48029790,OBAA,Phospholipase inhibitor
4393,1.26,cp,BRD-K75641298,metoclopramide,Dopamine receptor antagonist
3926,2.85,oe,ccsbBroad304_07656,TRIM16,Tripartite motif containing
4387,1.27,cp,BRD-M47937986,cefatrizine,Bacterial cell wall synthesis inhibitor
4388,1.27,cp,BRD-A41301928,bongkrek-acid,"Mitochondrial ADP, ATP translocase inhibitor"
4389,1.27,cp,BRD-A78377521,monastrol,Kinesin-like spindle protein inhibitor
4390,1.27,cp,BRD-K92492521,LY-255283,Leukotriene receptor antagonist
4391,1.27,cp,BRD-K28307902,flutamide,Androgen receptor antagonist
4385,1.28,cp,BRD-K46424862,hymecromone,Monoamine oxidase inhibitor
4386,1.28,cp,BRD-K67043667,altretamine,DNA synthesis inhibitor
3928,2.85,oe,ccsbBroad304_07780,POLG2,DNA polymerases
3929,2.84,kd,CGS001-51282,SCAND1,-
3930,2.84,kd,CGS001-10123,ARL4C,ADP-ribosylation factors
3932,2.83,oe,ccsbBroad304_01038,MSRA,-
3933,2.82,oe,ccsbBroad304_06862,RGS3,-
3934,2.82,oe,ccsbBroad304_03351,DHRS7,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3
4380,1.3,cp,BRD-A66927094,nemonapride,Dopamine receptor antagonist
3935,2.82,kd,CGS001-1999,ELF3,ETS Transcription Factors
3936,2.79,oe,ccsbBroad304_02414,IRF9,-
3939,2.78,oe,ccsbBroad304_00038,AGL,-
3940,2.78,oe,ccsbBroad304_08862,SMYD3,Chromatin-modifying enzymes / K-methyltransferases
3941,2.78,oe,ccsbBroad304_02018,SUCLA2,-
3946,2.74,kd,CGS001-8805,TRIM24,TIF1 family
3947,2.74,kd,CGS001-26227,PHGDH,-
4359,1.34,cc,,KCNJ11 modulator,-
3948,2.74,kd,CGS001-4793,NFKBIB,Ankyrin repeat domain containing
3949,2.74,kd,CGS001-10149,GPR64,Adhesion Class GPCRs
3950,2.74,kd,CGS001-388650,FAM69A,-
3951,2.74,oe,ccsbBroad304_00472,EBF1,-
3953,2.73,oe,ccsbBroad304_02455,CREB3,basic leucine zipper proteins
4365,1.34,cp,BRD-K37846922,"3,3'-diindolylmethane",CHK inhibitor
4366,1.34,cp,BRD-K25310650,ormetoprim,Bacterial antifolate
4367,1.34,cp,BRD-K32696739,noreleagnine,Monoamine oxidase inhibitor
3954,2.73,oe,ccsbBroad304_06902,RRM1,Ribonucleoside-diphosphate reductases
3955,2.73,oe,ccsbBroad304_00987,MCM3,-
3957,2.71,kd,CGS001-3939,LDHA,-
3958,2.71,kd,CGS001-10682,EBP,-
4349,1.37,cc,,Adenosine receptor agonist,-
4350,1.37,cp,BRD-K04833372,GSK-1904529A,IGF-1 inhibitor
4351,1.37,cp,BRD-K46142322,RS-67333,Serotonin receptor partial agonist
4352,1.37,cp,BRD-K46068882,eugenitol,Bacterial quorum sensing inhibitor
4353,1.37,cp,BRD-K65146499,nabumetone,Cyclooxygenase inhibitor
4354,1.37,cp,BRD-A04706586,bucladesine,Adenosine receptor agonist
3960,2.7,oe,ccsbBroad304_01287,MAPK8,MAPK:JNK subfamily
3961,2.69,oe,ccsbBroad304_05183,TXLNA,-
4357,1.37,cp,BRD-K76723084,isotretinoin,Retinoid receptor agonist
3962,2.69,oe,ccsbBroad304_08873,P2RY12,"GPCR / Class A : Purinergic receptors, P2Y"
3964,2.69,oe,ccsbBroad304_07135,WNT10B,Wingless-type MMTV integration sites
3965,2.69,oe,ccsbBroad304_02659,SLC6A14,Glycine transporter subfamily
3966,2.69,oe,ccsbBroad304_05054,DTX3L,RING-type (C3HC4) zinc fingers
3968,2.68,kd,CGS001-8312,AXIN1,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
3970,2.66,oe,ccsbBroad304_08089,MAT2B,Short chain dehydrogenase/reductase superfamily / Extended SDR fold
3971,2.66,kd,CGS001-178,AGL,-
3973,2.64,oe,ccsbBroad304_07320,SQSTM1,-
3978,2.61,kd,CGS001-8780,RIOK3,RIO3 subfamily
3979,2.61,kd,CGS001-10398,MYL9,EF-hand domain containing
3980,2.59,oe,ccsbBroad304_00152,BCAT2,-
4334,1.41,cp,BRD-K68488863,ENMD-2076,FLT3 inhibitor
4335,1.41,cp,BRD-K08619574,thioproperazine,Dopamine receptor antagonist
4336,1.41,cp,BRD-A24429032,HEAT,Adrenergic receptor antagonist
4337,1.41,cp,BRD-K65417056,meprylcaine,Local anesthetic
3981,2.59,oe,ccsbBroad304_00273,CDC25B,Protein tyrosine phosphatases / Class III Cys-based PTPs
3982,2.59,oe,ccsbBroad304_01779,WNT5A,Endogenous ligands
3983,2.58,oe,ccsbBroad304_00459,DPYD,-
4331,1.43,cp,BRD-K81272440,dantrolene,Calcium channel blocker
4324,1.44,cc,,Sirtuins GOF,-
4325,1.44,cp,BRD-A61856038,tremulacin,Lipoxygenase inhibitor
4326,1.44,cp,BRD-A56987319,SQ-22536,Adenylyl cyclase inhibitor
4327,1.44,cp,BRD-K42679050,Y-27152,Potassium channel activator
3990,2.55,oe,ccsbBroad304_03772,CCNL1,-
3991,2.55,kd,CGS001-2834,PRLHR,GPCR / Class A : RF amide peptide receptors
4321,1.45,cp,BRD-A43082555,loxoprofen,Cyclooxygenase inhibitor
4322,1.45,cp,BRD-K52512893,SC-19220,Prostanoid receptor antagonist
3992,2.55,kd,CGS001-3032,HADHB,-
4318,1.46,cp,BRD-K43468059,byssochlamic-acid,Mycotoxin
3993,2.55,kd,CGS001-29083,GTPBP8,-
3994,2.55,oe,ccsbBroad304_06535,LPL,-
3999,2.53,kd,CGS001-10732,TCFL5,Basic helix-loop-helix proteins
4000,2.53,kd,CGS001-9380,GRHPR,-
4001,2.53,kd,CGS001-5045,FURIN,Subtilisin
4003,2.5,oe,ccsbBroad304_01276,PRKAB1,AMPK subfamily
4004,2.5,oe,ccsbBroad304_02219,MORF4L2,-
4309,1.48,cp,BRD-K65910366,KUC103904N,-666
4310,1.48,cp,BRD-K69195780,NAN-190,Serotonin receptor agonist
4311,1.48,cp,BRD-A99411506,esculin,Antioxidant
4312,1.48,cp,BRD-K06467078,corynanthine,Adrenergic receptor antagonist
4007,2.5,kd,CGS001-10253,SPRY2,-
4008,2.5,kd,CGS001-23483,TGDS,Short chain dehydrogenase/reductase superfamily / Extended SDR fold
4009,2.5,kd,CGS001-94234,FOXQ1,Forkhead boxes
4305,1.51,cp,BRD-K81876028,CP-93129,Serotonin receptor agonist
4301,1.52,cp,BRD-K50324045,avrainvillamide-analog-6,nucleophosmin inhibitor
4302,1.52,cp,BRD-K18250272,propoxycaine,Local anesthetic
4303,1.52,cp,BRD-A41451487,PK-11195,Benzodiazepine receptor antagonist
4304,1.52,cp,BRD-A11813248,AM-92016,Potassium channel blocker
4010,2.5,kd,CGS001-506,ATP5B,ATPases / F-type
4011,2.5,oe,ccsbBroad304_00551,FECH,-
4012,2.5,oe,ccsbBroad304_03309,RNF138,RING-type (C3HC4) zinc fingers
4013,2.5,oe,ccsbBroad304_02554,TRAFD1,-
4014,2.5,oe,ccsbBroad304_01952,MAPKAPK5,MAPKAPK subfamily
4015,2.49,oe,ccsbBroad304_05612,GPR152,GPCR / Class A : Orphans
4291,1.55,cp,BRD-K83837640,JNJ-26854165,HDAC inhibitor
4292,1.55,cp,BRD-K29673530,hypericin,Tyrosine kinase inhibitor
4019,2.48,oe,ccsbBroad304_06774,PRKCQ,Delta subfamily
4023,2.47,kd,CGS001-115560,ZNF501,"Zinc fingers, C2H2-type"
4024,2.47,kd,CGS001-1052,CEBPD,basic leucine zipper proteins
4025,2.46,kd,CGS001-285220,EPHA6,Type XIII RTKs: Ephrin receptor family
4026,2.45,oe,ccsbBroad304_06448,IL18,Interleukins and interleukin receptors
4027,2.45,oe,ccsbBroad304_01685,TNFAIP1,BTB/POZ domain containing
4028,2.43,kd,CGS001-23649,POLA2,DNA polymerases
4030,2.42,kd,CGS001-6118,RPA2,-
4031,2.42,kd,CGS001-3667,IRS1,Pleckstrin homology (PH) domain containing
4032,2.41,oe,ccsbBroad304_00454,DNMT3A,Methyltransferases
4281,1.59,cp,BRD-K36153907,KU-C103885,Cystic fibrosis transmembrane conductance regulator inhibitor
4282,1.59,cp,BRD-K71860425,CDK2-5-inhibitor,CDK inhibitor
4033,2.41,oe,ccsbBroad304_07616,ZNF238,-
4036,2.39,kd,CGS001-10468,FST,-
4037,2.39,kd,CGS001-8772,FADD,-
4038,2.39,oe,ccsbBroad304_08167,DNTTIP2,-
4041,2.38,kd,CGS001-4254,KITLG,-
4042,2.38,kd,CGS001-9267,CYTH1,Pleckstrin homology (PH) domain containing
4273,1.62,cp,BRD-K85402309,dovitinib,EGFR inhibitor
4274,1.62,cp,BRD-K89274813,DMP-543,Acetylcholine release stimulant
4044,2.37,kd,CGS001-10493,VAT1,-
4045,2.37,kd,CGS001-7039,TGFA,-
4046,2.37,kd,CGS001-3612,IMPA1,Inositol monophosphatase
4047,2.37,kd,CGS001-613,BCR,Rho guanine nucleotide exchange factors
4048,2.36,oe,ccsbBroad304_04001,ZNF747,"Zinc fingers, C2H2-type"
4267,1.63,cp,BRD-K77641333,naphazoline,Adrenergic receptor agonist
4053,2.34,kd,CGS001-2122,MECOM,"Zinc fingers, C2H2-type"
4261,1.66,cp,BRD-A49046702,SKF-89976A,GABA uptake inhibitor
4262,1.66,cp,BRD-K98769987,flumazenil,Benzodiazepine receptor antagonist
4263,1.66,cp,BRD-K78633253,EXO-1,ARF inhibitor
4264,1.66,cp,BRD-A42831637,tetrahydrocannabinol-7-oic-acid,Anti-inflammatory
4054,2.34,kd,CGS001-112858,TP53RK,Bud32 family
4055,2.34,kd,CGS001-4836,NMT1,-
4056,2.34,kd,CGS001-9500,MAGED1,-
4057,2.34,kd,CGS001-64077,LHPP,-
4063,2.32,kd,CGS001-84547,PGBD1,-
4064,2.32,kd,CGS001-57326,PBXIP1,-
4065,2.31,oe,ccsbBroad304_00936,LGALS1,Endogenous ligands
4252,1.69,cp,BRD-K64785675,TG100-115,-666
4253,1.69,cp,BRD-K40902647,vincamine,Adrenergic receptor antagonist
4254,1.69,cp,BRD-K25394294,oxaprozin,Cyclooxygenase inhibitor
4066,2.31,oe,ccsbBroad304_03641,ASF1B,-
4251,1.7,cp,BRD-A18763547,BAX-channel-blocker,Cytochrome C release inhibitor
4068,2.29,kd,CGS001-3053,SERPIND1,Serine (or cysteine) peptidase inhibitors
4069,2.27,oe,ccsbBroad304_07922,TRIM29,-
4070,2.27,oe,ccsbBroad304_01266,PPP3CA,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
4071,2.27,oe,ccsbBroad304_13880,IDH3G,-
4073,2.26,kd,CGS001-3033,HADH,-
4075,2.24,kd,CGS001-216,ALDH1A1,Aldehyde dehydrogenases
4076,2.22,oe,ccsbBroad304_00520,ETV1,ETS Transcription Factors
4077,2.22,oe,ccsbBroad304_08307,ZC3HC1,"Zinc fingers, C3HC-type"
4078,2.22,oe,ccsbBroad304_03332,SIRT6,Histone deacetylases (HDACs)
4238,1.73,cp,BRD-A84327315,calcitriol,Vitamin D receptor agonist
4239,1.73,cp,BRD-K28346421,rifapentine,RNA polymerase inhibitor
4240,1.73,cp,BRD-A16700644,isoxsuprine,Adrenergic receptor agonist
4079,2.22,oe,ccsbBroad304_01789,SF1,"Zinc fingers, CCHC domain containing"
4080,2.22,oe,ccsbBroad304_02864,PRDX5,-
4081,2.22,oe,ccsbBroad304_00902,KCNN4,Calcium-activated potassium channels
4087,2.22,oe,ccsbBroad304_05417,P2RY8,"GPCR / Class A : Purinergic receptors, P2Y"
4089,2.21,kd,CGS001-7775,ZNF232,"Zinc fingers, C2H2-type"
4237,1.74,cp,BRD-K22031190,diflunisal,Prostanoid receptor antagonist
4227,1.76,cp,BRD-A39969961,eplerenone,Cytochrome P450 inhibitor
4090,2.21,kd,CGS001-5899,RALB,-
4091,2.21,kd,CGS001-5737,PTGFR,GPCR / Class A : Prostanoid receptors
4230,1.76,cp,BRD-K50859149,sulfafurazole,Bacterial antifolate
4231,1.76,cp,BRD-K39823328,VU-0366037-2,Glutamate receptor modulator
4092,2.21,kd,CGS001-3716,JAK1,Janus kinase (JakA) family
4226,1.77,cp,BRD-K02992638,lamivudine,Nucleoside reverse transcriptase inhibitor
4093,2.21,kd,CGS001-1024,CDK8,"Cyclin-dependent kinases, CDK8 subfamily"
4094,2.21,kd,CGS001-868,CBLB,RING-type (C3HC4) zinc fingers
4096,2.19,oe,ccsbBroad304_00763,HNF4A,Hepatocyte nuclear factor-4 receptors
4097,2.19,kd,CGS001-5164,PDK2,PDHK family
4221,1.8,cp,BRD-K04466929,Merck60,HDAC inhibitor
4098,2.18,oe,ccsbBroad304_07029,TADA2A,-
4102,2.18,kd,CGS001-4665,NAB2,-
4103,2.18,oe,ccsbBroad304_02357,SSX3,-
4104,2.17,oe,ccsbBroad304_00841,IKBKB,IKK family
4105,2.16,kd,CGS001-7936,RDBP,-
4109,2.15,kd,CGS001-8879,SGPL1,Sphingosine 1-phosphate lyase
4112,2.13,oe,ccsbBroad304_02890,SYF2,-
4113,2.13,oe,ccsbBroad304_02319,PREB,WD repeat domain containing
4114,2.13,oe,ccsbBroad304_02688,MTF2,"Zinc fingers, PHD-type"
4115,2.13,oe,ccsbBroad304_01002,METTL1,-
4207,1.83,cp,BRD-A41722204,sulmazole,Adenosine receptor antagonist
4208,1.83,cp,BRD-K67445247,flurofamide,Urease inhibitor
4209,1.83,cp,BRD-K79131256,albendazole,Anthelmintic
4116,2.13,oe,ccsbBroad304_00570,FIGF,-
4117,2.13,kd,CGS001-861,RUNX1,-
4118,2.13,kd,CGS001-3251,HPRT1,-
4119,2.13,kd,CGS001-55632,G2E3,"Zinc fingers, PHD-type"
4120,2.13,kd,CGS001-1788,DNMT3A,Methyltransferases
4121,2.13,kd,CGS001-840,CASP7,Caspases
4122,2.13,oe,ccsbBroad304_08217,SCCPDH,-
4126,2.11,kd,CGS001-2066,ERBB4,Type I RTKs: ErbB (epidermal growth factor) receptor family
4127,2.08,oe,ccsbBroad304_11796,ULK3,Unc-51-like kinase (ULK) family
4128,2.08,oe,ccsbBroad304_02855,SPDEF,ETS Transcription Factors
4133,2.08,kd,CGS001-5361,PLXNA1,Plexins
4195,1.86,cp,BRD-K47631482,bromhexine,Mucolytic agent
4191,1.87,cp,BRD-A62434282,goserelin,Gonadotropin releasing factor hormone receptor agonist
4192,1.87,cp,BRD-K97330509,SRC-kinase-inhibitor-II,SRC inhibitor
4193,1.87,cp,BRD-K97863768,prothionamide,Mycobacterium tuberculosis enoyl-[acyl-carrier-protein] reductase [NADH] (inhA) inhibitor
4134,2.08,kd,CGS001-7099,TLR4,Toll-like receptor family
4135,2.08,kd,CGS001-1803,DPP4,Prolyl oligopeptidase
4136,2.08,kd,CGS001-54851,ANKRD49,Ankyrin repeat domain containing
4186,1.9,cp,BRD-K37130656,rivaroxaban,Coagulation inhibitor
4187,1.9,cp,BRD-A73605923,mocimycin,Protein synthesis inhibitor
4188,1.9,cp,BRD-A01643550,prednisolone,Glucocorticoid receptor agonist
4137,2.08,oe,ccsbBroad304_01234,POLB,DNA polymerases
4139,2.07,oe,ccsbBroad304_08605,PBK,TOPK family
4140,2.05,oe,ccsbBroad304_06870,RNH1,-
4141,2.05,oe,ccsbBroad304_07500,PJA2,RING-type (C3HC4) zinc fingers
4143,2.04,oe,ccsbBroad304_05180,ZNF626,"Zinc fingers, C2H2-type"
4173,1.94,cc,,EMSY complex LOF,-
4144,2.04,oe,ccsbBroad304_06235,G6PD,-
4145,2.04,oe,ccsbBroad304_00350,COX5B,Mitochondrial respiratory chain complex
4176,1.94,cp,BRD-A59174698,ritodrine,Adrenergic receptor agonist
4177,1.94,cp,BRD-K72024482,MRS-1754,Adenosine receptor antagonist
4178,1.94,cp,BRD-A41555725,chlortetracycline,Protein synthesis inhibitor
4146,2.04,oe,ccsbBroad304_00110,ASGR2,C-type lectin domain containing
4149,2.04,kd,CGS001-2762,GMDS,Short chain dehydrogenase/reductase superfamily / Extended SDR fold
4150,2.04,kd,CGS001-2288,FKBP4,Tetratricopeptide (TTC) repeat domain containing
4166,1.97,cp,BRD-K30563334,rifabutin,Protein synthesis inhibitor
4167,1.97,cp,BRD-K19309090,SR-95639A,Acetylcholine receptor agonist
4168,1.97,cp,BRD-K59273480,propentofylline,Adenosine reuptake inhibitor
4151,2.04,oe,ccsbBroad304_09358,MAPK1IP1L,-
4152,2.03,kd,CGS001-6776,STAT5A,SH2 domain containing
4171,1.97,cp,BRD-K86434416,selegiline,Monoamine oxidase inhibitor
4153,2.03,kd,CGS001-2287,FKBP3,-
4165,1.98,cp,BRD-K92049597,triamterene,Sodium channel blocker
4160,1.99,cc,,DNA dependent protein kinase inhibitor,-
4154,2.03,kd,CGS001-2078,ERG,ETS Transcription Factors
4155,2.01,oe,ccsbBroad304_02128,GPR55,GPCR / Class A : Orphans
4158,2,kd,CGS001-7035,TFPI,-
4159,2,kd,CGS001-3487,IGFBP4,insulin-like growth factor (IGF) binding proteins
4161,1.99,oe,ccsbBroad304_09934,MKX,Homeoboxes / TALE class
4162,1.99,oe,ccsbBroad304_00792,HSD17B2,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2
4156,2.01,cp,BRD-A15415227,GW-1929,PPAR receptor agonist
4157,2.01,cp,BRD-A18917088,estradiol,Contraceptive agent
4163,1.99,oe,ccsbBroad304_03314,HSD17B7,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2
4164,1.98,oe,ccsbBroad304_06260,GATA3,GATA zinc finger domain containing
4169,1.97,kd,CGS001-7905,REEP5,Receptor accessory proteins
4170,1.97,kd,CGS001-2954,GSTZ1,Glutathione S-transferases / Soluble
4172,1.96,kd,CGS001-3676,ITGA4,Integrins
4174,1.94,oe,ccsbBroad304_02626,PKIG,-
4175,1.94,oe,ccsbBroad304_06332,GSTM2,Glutathione S-transferases / Soluble
4147,2.04,cp,BRD-K79124250,ioxaglic-acid,Radiopaque medium
4148,2.04,cp,BRD-K31611373,fluprostenol,Prostanoid receptor agonist
4179,1.94,kd,CGS001-708,C1QBP,-
4180,1.94,oe,ccsbBroad304_00379,CSNK1E,Casein kinase 1 (CK1) family
4181,1.93,kd,CGS001-9801,MRPL19,Mitochondrial ribosomal proteins / large subunits
4182,1.92,kd,CGS001-5331,PLCB3,Phosphoinositide-specific phospholipase C
4183,1.91,oe,ccsbBroad304_01070,NDUFB3,Mitochondrial respiratory chain complex / Complex I
4142,2.05,cp,BRD-K02407574,parbendazole,Tubulin inhibitor
4184,1.91,kd,CGS001-9807,IP6K1,-
4185,1.9,oe,ccsbBroad304_00231,CBFB,-
4189,1.9,oe,ccsbBroad304_02458,STK25,YSK subfamily
4129,2.08,cp,BRD-K04710043,hexamethylenebisacetamide,AKT inhibitor
4130,2.08,cp,BRD-K59570838,homoveratrylamine,Dopamine analog
4131,2.08,cp,BRD-K12906962,dichlorobenzamil,Sodium/calcium exchange inhibitor
4132,2.08,cp,BRD-A72066420,mifobate,PPAR receptor antagonist
4190,1.89,kd,CGS001-6505,SLC1A1,Glutamate transporter subfamily
4194,1.87,kd,CGS001-64219,PJA1,RING-type (C3HC4) zinc fingers
4196,1.85,oe,ccsbBroad304_06320,FFAR1,Fatty acid receptors
4197,1.85,oe,ccsbBroad304_03006,OXGR1,"GPCR / Class A : Orphans, Oxoglutarate receptor"
4198,1.85,oe,ccsbBroad304_00817,IDH2,-
4138,2.08,cp,BRD-K20655524,mefexamide,Psychoactive drug
4123,2.11,cp,BRD-K00184207,GR-206,Aryl hydrocarbon receptor ligand
4124,2.11,cp,BRD-K82731415,olomoucine,CDK inhibitor
4125,2.11,cp,BRD-K09255212,clioquinol,Chelating agent
4199,1.85,kd,CGS001-3553,IL1B,Interleukins and interleukin receptors
4200,1.85,oe,ccsbBroad304_04801,ZNF543,"Zinc fingers, C2H2-type"
4201,1.85,oe,ccsbBroad304_04726,TAGAP,Rho GTPase activating proteins
4202,1.85,oe,ccsbBroad304_00690,GRN,-
4203,1.85,oe,ccsbBroad304_11324,RPS6KA4,MSK subfamily
4204,1.84,kd,CGS001-5860,QDPR,Short chain dehydrogenase/reductase superfamily / Atypical members
4205,1.84,kd,CGS001-7128,TNFAIP3,OTU domain containing
4206,1.84,kd,CGS001-4486,MST1R,Type X RTKs: HGF (hepatocyte growth factor) receptor family
4210,1.82,kd,CGS001-7048,TGFBR2,Type II receptor serine/threonine kinases
4211,1.82,kd,CGS001-8807,IL18RAP,CD molecules
4212,1.82,kd,CGS001-898,CCNE1,-
4213,1.82,kd,CGS001-9447,AIM2,-
4106,2.15,cp,BRD-U01690642,acetyl-geranyl-cysteine,Isoprenylated protein methylation inhibitor
4107,2.15,cp,BRD-A41833852,naloxone,Opioid receptor antagonist
4108,2.15,cp,BRD-K96119599,leucodin,Melanin inhibitor
4214,1.81,oe,ccsbBroad304_07961,RCHY1,RING-type (C3HC4) zinc fingers
4110,2.15,cp,BRD-A75479906,rimantadine,Antiviral
4111,2.15,cp,BRD-K42095107,daidzein,Estrogen receptor agonist
4215,1.81,oe,ccsbBroad304_09756,PAQR7,-
4216,1.81,oe,ccsbBroad304_06324,GPX7,-
4217,1.81,oe,ccsbBroad304_10207,ERLIN1,-
4099,2.18,cp,BRD-K49481516,galantamine,Acetylcholinesterase inhibitor
4100,2.18,cp,BRD-K11717138,benzbromarone,Chloride channel blocker
4101,2.18,cp,BRD-K14765469,vesamicol,Acetylcholinesterase inhibitor
4218,1.81,oe,ccsbBroad304_10806,ERBB3,Type I RTKs: ErbB (epidermal growth factor) receptor family
4219,1.81,oe,ccsbBroad304_01970,RFXANK,Ankyrin repeat domain containing
4220,1.8,oe,ccsbBroad304_04117,SLC25A22,Mitochondrial amino acid transporter subfamily
4222,1.79,kd,CGS001-2538,G6PC,-
4095,2.2,cp,BRD-A37052580,physostigmine,Acetylcholinesterase inhibitor
4088,2.21,cc,,Glucocorticoid receptor agonist,-
4223,1.79,kd,CGS001-112398,EGLN2,2-oxoglutarate oxygenases
4224,1.78,kd,CGS001-51290,ERGIC2,-
4225,1.77,oe,ccsbBroad304_07374,PTPLA,-
4228,1.76,kd,CGS001-55206,SBNO1,-
4229,1.76,oe,ccsbBroad304_00784,HRAS,RAS subfamily
4232,1.74,kd,CGS001-64750,SMURF2,-
4233,1.74,kd,CGS001-5440,POLR2K,RNA polymerase subunits
4234,1.74,kd,CGS001-2114,ETS2,ETS Transcription Factors
4235,1.74,kd,CGS001-329,BIRC2,Inhibitors of apoptosis (IAP) protein family
4236,1.74,kd,CGS001-208,AKT2,Akt (Protein kinase B)
4241,1.72,oe,ccsbBroad304_01310,PSMB2,Proteasome subunits
4242,1.71,oe,ccsbBroad304_06934,SFPQ,RNA binding motif (RRM) containing
4082,2.22,cp,BRD-K86930074,cediranib,KIT inhibitor
4083,2.22,cp,BRD-A49906757,scopolamine,Acetylcholine receptor antagonist
4084,2.22,cp,BRD-K89402695,L-655240,Thromboxane receptor antagonist
4085,2.22,cp,BRD-K07220430,cinnarizine,Calcium channel blocker
4086,2.22,cp,BRD-A71203467,l-stepholidine,Dopamine receptor antagonist
4243,1.71,oe,ccsbBroad304_06422,ID3,Basic helix-loop-helix proteins
4244,1.71,oe,ccsbBroad304_00728,HBE1,-
4072,2.26,cp,BRD-A09062839,amylocaine,Local anesthetic
4245,1.71,oe,ccsbBroad304_08645,BCCIP,-
4074,2.26,cp,BRD-A50764878,MDL-73005EF,Serotonin receptor antagonist
4246,1.71,kd,CGS001-29763,PACSIN3,-
4247,1.71,oe,ccsbBroad304_01825,SLC30A2,SLC30 zinc transporter family
4248,1.71,oe,ccsbBroad304_01615,SULT1A2,"Sulfotransferases, cytosolic"
4067,2.29,cp,BRD-K04196797,oxcarbazepine,Sodium channel blocker
4249,1.71,oe,ccsbBroad304_01684,TNF,Tumor necrosis factor (ligand) superfamily
4250,1.7,kd,CGS001-2588,GALNS,Arylsulfatase family
4255,1.68,kd,CGS001-5770,PTPN1,Protein tyrosine phosphatases
4062,2.32,cp,BRD-K90574421,ipsapirone,Serotonin receptor agonist
4256,1.68,kd,CGS001-165829,GPR156,GPCR / Class C : Orphans
4257,1.68,kd,CGS001-80150,ASRGL1,-
4059,2.33,cp,BRD-K14693417,cinchonine,P-glycoprotein inhibitor
4060,2.33,cp,BRD-K38197229,bumetanide,Solute carrier family member inhibitor
4061,2.33,cp,BRD-K15502390,nevirapine,Reverse transcriptase inhibitor
4258,1.67,oe,ccsbBroad304_02137,TRIP13,ATPases / AAA-type
4259,1.67,oe,ccsbBroad304_06907,S100A13,S100 calcium binding proteins
4260,1.67,oe,ccsbBroad304_00962,SMAD4,SMADs
4265,1.66,kd,CGS001-79727,LIN28A,"Zinc fingers, CCHC domain containing"
4266,1.65,kd,CGS001-3608,ILF2,-
4058,2.34,cp,BRD-K91699951,benzonatate,Local anesthetic
4052,2.35,cp,BRD-K48168960,propylthiouracil,Thyroid peroxidase inhibitor
4268,1.62,oe,ccsbBroad304_04257,SPRY4,-
4049,2.36,cp,BRD-K33106058,cytarabine,Ribonucleotide reductase inhibitor
4050,2.36,cp,BRD-K07237224,moclobemide,Monoamine oxidase inhibitor
4051,2.36,cp,BRD-K63430059,methoxsalen,DNA synthesis inhibitor
4043,2.37,cp,BRD-K99447003,enalaprilat,ACE inhibitor
4269,1.62,oe,ccsbBroad304_07590,WARS2,Aminoacyl tRNA synthetases / Class I
4270,1.62,oe,ccsbBroad304_02752,TRIM2,RING-type (C3HC4) zinc fingers
4271,1.62,oe,ccsbBroad304_08452,PIH1D1,-
4272,1.62,oe,ccsbBroad304_06528,FADS3,Fatty acid desaturases
4039,2.38,cp,BRD-K93645900,tadalafil,Phosphodiesterase inhibitor
4040,2.38,cp,BRD-A57382968,piroxicam,Cyclooxygenase inhibitor
4275,1.62,kd,CGS001-5827,PXMP2,-
4276,1.62,oe,ccsbBroad304_00094,ARF1,ADP-ribosylation factors
4277,1.62,oe,ccsbBroad304_00883,ISG20,-
4278,1.62,oe,ccsbBroad304_03945,AKTIP,Ubiquitin-conjugating enzymes E2
4279,1.62,oe,ccsbBroad304_01361,RAB27A,"RAB, member RAS oncogene"
4034,2.4,cp,BRD-K91442916,CAM-9-026,Membrane metalloendopeptidase inhibitor
4035,2.4,cp,BRD-A31227688,kynuramine,Aryl hydrocarbon receptor activator
4280,1.61,kd,CGS001-2534,FYN,Src family
4283,1.58,kd,CGS001-5805,PTS,-
4284,1.58,kd,CGS001-2512,FTL,-
4285,1.57,oe,ccsbBroad304_06985,SORD,-
4286,1.57,oe,ccsbBroad304_03640,CEP72,-
4029,2.43,cp,BRD-K83963101,MLN-8054,Aurora kinase inhibitor
4287,1.57,kd,CGS001-5498,PPOX,-
4288,1.57,oe,ccsbBroad304_05590,NOTCH2NL,-
4289,1.57,oe,ccsbBroad304_06340,GTF2H3,General transcription factors
4020,2.47,cp,BRD-A71657825,2-(biphenyl-4-ylsulfonamido)pentanedioic-acid,Matrix metalloprotease inhibitor
4021,2.47,cp,BRD-K74195153,irsogladine,Phosphodiesterase inhibitor
4022,2.47,cp,BRD-K67680372,CI-966,GAT inhibitor
4290,1.56,kd,CGS001-360023,ZBTB41,BTB/POZ domain containing
4293,1.55,kd,CGS001-4074,M6PR,-
4017,2.48,cc,,Baculoviral IAP repeat domain containing LOF,-
4018,2.48,cc,,Retinoid receptor agonist,-
4294,1.55,kd,CGS001-1287,COL4A5,Collagens
4295,1.54,kd,CGS001-22832,KIAA1009,-
4016,2.49,cp,BRD-K37865504,LY-2183240,FAAH inhibitor
4296,1.53,oe,ccsbBroad304_03391,PRKAG3,AMPK subfamily
4297,1.53,oe,ccsbBroad304_11277,HAT1,Histone acetyltransferases (HATs)
4005,2.5,cp,BRD-A67438293,treprostinil,Prostacyclin analog
4006,2.5,cp,BRD-K21283037,riluzole,Glutamate inhibitor
4298,1.53,kd,CGS001-9337,CNOT8,-
4299,1.53,oe,ccsbBroad304_06058,CSNK2B,Casein kinase 2 (CK2) family
4300,1.53,oe,ccsbBroad304_07012,STK3,MST subfamily
4306,1.48,oe,ccsbBroad304_03910,CCDC90A,-
4307,1.48,oe,ccsbBroad304_07491,IP6K1,-
4308,1.48,oe,ccsbBroad304_00066,ANG,"Ribonucleases, RNase A"
4313,1.48,oe,ccsbBroad304_01337,PTHLH,Endogenous ligands
4314,1.48,oe,ccsbBroad304_09983,ZNF454,"Zinc fingers, C2H2-type"
4002,2.52,cp,BRD-A60070924,alpha-estradiol,Estrogen receptor agonist
3997,2.53,cp,BRD-K93658967,aloisine,CDK inhibitor
3998,2.53,cp,BRD-A64125466,dehydrocholic-acid,choleretic agent
4315,1.48,oe,ccsbBroad304_02401,AKR1A1,Aldo-keto reductases
4316,1.47,kd,CGS001-9759,HDAC4,Histone deacetylases
4317,1.47,kd,CGS001-1036,CDO1,-
3995,2.54,cp,BRD-K76304753,phenazopyridine,Local anesthetic
3996,2.54,cp,BRD-K97056771,HY-11007,BCR-ABL kinase inhibitor
4319,1.46,oe,ccsbBroad304_08531,ZNF331,"Zinc fingers, C2H2-type"
4320,1.46,oe,ccsbBroad304_07137,WT1,"Zinc fingers, C2H2-type"
4323,1.45,kd,CGS001-2160,F11,Chymotrypsin
4328,1.44,kd,CGS001-84669,USP32,EF-hand domain containing
4329,1.44,kd,CGS001-375,ARF1,ADP-ribosylation factors
3988,2.56,cc,,X linked mental retardation group 1 LOF,-
3989,2.56,cp,BRD-K82143716,flucytosine,Antifungal
3984,2.57,cp,BRD-A56892734,esomeprazole,ATPase inhibitor
3985,2.57,cp,BRD-K28453807,nitrocaramiphen,Cholinergic receptor antagonist
3986,2.57,cp,BRD-K17110974,aristolochic-acid,Phospholipase inhibitor
3987,2.57,cp,BRD-K88741031,"methyl-2,5-dihydroxycinnamate",EGFR inhibitor
4330,1.43,kd,CGS001-133522,PPARGC1B,RNA binding motif (RRM) containing
4332,1.42,kd,CGS001-836,CASP3,Caspases
4333,1.42,oe,ccsbBroad304_02500,RRAGA,-
4338,1.4,oe,ccsbBroad304_01202,PIK3CB,Phosphatidylinositol kinases
3977,2.61,cp,BRD-K74765201,tomelukast,Leukotriene receptor antagonist
4339,1.39,oe,ccsbBroad304_03936,PJA1,RING-type (C3HC4) zinc fingers
4340,1.39,oe,ccsbBroad304_08128,ALG5,Glycosyltransferase family 2 domain containing
4341,1.39,kd,CGS001-55872,PBK,TOPK family
3974,2.64,cp,BRD-A68589262,troxipide,Glucosamine synthetase stimulant
3975,2.64,cp,BRD-K36965586,m-chlorophenylbiguanide,Serotonin receptor agonist
3976,2.64,cp,BRD-K85119730,tolbutamide,ATP channel blocker
3972,2.65,cp,BRD-K33204703,AG-370,PDGFR receptor inhibitor
4342,1.39,kd,CGS001-3558,IL2,Interleukins and interleukin receptors
4343,1.39,kd,CGS001-10146,G3BP1,RNA binding motif (RRM) containing
3967,2.68,cp,BRD-A49160188,donepezil,Acetylcholinesterase inhibitor
4344,1.39,kd,CGS001-1514,CTSL1,-
3969,2.68,cp,BRD-A66435872,HTMT,Histamine receptor agonist
4345,1.39,oe,ccsbBroad304_05763,ACTB,-
4346,1.39,oe,ccsbBroad304_04454,FBXL20,F-boxes / Leucine-rich repeats
3963,2.69,cp,BRD-A29426959,carbinoxamine,Histamine receptor antagonist
4347,1.39,oe,ccsbBroad304_02298,DNM1L,-
4348,1.39,oe,ccsbBroad304_03951,NARFL,-
4355,1.37,kd,CGS001-127396,ZNF684,"Zinc fingers, C2H2-type"
4356,1.37,kd,CGS001-165082,GPR113,Adhesion Class GPCRs
3956,2.71,cp,BRD-A28856712,tetryzoline,Adrenergic receptor agonist
4358,1.35,oe,ccsbBroad304_09095,PUS7L,-
4360,1.34,oe,ccsbBroad304_03175,MRPS16,Mitochondrial ribosomal proteins / small subunits
3959,2.71,cp,BRD-A60197193,amisulpride,Dopamine receptor antagonist
3952,2.73,cc,,Purinergic receptors P2Y GOF,-
4361,1.34,oe,ccsbBroad304_01484,SATB1,Homeoboxes / CUT class
4362,1.34,oe,ccsbBroad304_06685,PAH,Amino acid hydroxylases
4363,1.34,oe,ccsbBroad304_10971,MLLT6,"Zinc fingers, PHD-type"
4364,1.34,oe,ccsbBroad304_00800,HSPD1,Heat Shock Proteins / Chaperonins
4368,1.34,kd,CGS001-5580,PRKCD,Delta subfamily
4369,1.34,kd,CGS001-4439,MSH5,-
4370,1.34,oe,ccsbBroad304_06671,OPA1,-
4371,1.32,kd,CGS001-27430,MAT2B,Short chain dehydrogenase/reductase superfamily / Extended SDR fold
4372,1.32,kd,CGS001-4023,LPL,-
3943,2.75,cp,BRD-K67977190,eprosartan,Angiotensin receptor antagonist
3944,2.75,cp,BRD-K10670311,sulfasalazine,Antirheumatic
3945,2.75,cp,BRD-K53220666,trimetozine,Sedative
3942,2.77,cp,BRD-A39255369,DCPIB,Chloride channel blocker
3937,2.78,cp,BRD-K34154330,tracazolate,GABA receptor modulator
3938,2.78,cp,BRD-K45861246,azaperone,Dopamine receptor antagonist
4373,1.32,kd,CGS001-51564,HDAC7,Histone deacetylases
4374,1.32,kd,CGS001-2017,CTTN,-
4375,1.3,oe,ccsbBroad304_04613,HSPB9,Heat shock proteins / HSPB
4376,1.3,oe,ccsbBroad304_04767,SOCS4,SH2 domain containing
4377,1.3,oe,ccsbBroad304_03928,RRAGC,-
4378,1.3,oe,ccsbBroad304_00548,FDPS,Lanosterol biosynthesis pathway
4379,1.3,oe,ccsbBroad304_00034,AES,-
3931,2.83,cc,,Lipocalins GOF,-
4381,1.3,oe,ccsbBroad304_06206,FGA,Endogenous ligands
4382,1.3,oe,ccsbBroad304_08694,TBX20,T-boxes
4383,1.3,oe,ccsbBroad304_05213,ZNF449,"Zinc fingers, C2H2-type"
4384,1.29,kd,CGS001-622,BDH1,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2
3927,2.85,cp,BRD-K43797669,genistein,Tyrosine kinase inhibitor
4394,1.26,kd,CGS001-10093,ARPC4,Actin related protein 2/3 complex subunits
4395,1.25,oe,ccsbBroad304_11668,TBC1D9B,EF-hand domain containing
4396,1.25,oe,ccsbBroad304_05782,ADORA2A,GPCR / Class A : Adenosine receptors
4397,1.25,oe,ccsbBroad304_04261,RAB1B,"RAB, member RAS oncogene"
4398,1.25,oe,ccsbBroad304_02605,PAPD7,-
4399,1.25,oe,ccsbBroad304_01686,TNFAIP3,OTU domain containing
4400,1.25,oe,ccsbBroad304_01237,POLR2C,RNA polymerase subunits
4405,1.21,kd,CGS001-7335,UBE2V1,Ubiquitin-conjugating enzymes E2
4406,1.21,kd,CGS001-4193,MDM2,-
4407,1.21,kd,CGS001-55379,LRRC59,-
4408,1.21,kd,CGS001-3980,LIG3,-
3914,2.88,cp,BRD-A93424738,dexamethasone,Glucocorticoid receptor agonist
4409,1.2,oe,ccsbBroad304_01674,TIMP4,-
3907,2.89,cp,BRD-K96271548,coumaric-acid,Antioxidant
3908,2.89,cp,BRD-A02713983,dihydrodeoxygedunin,Growth factor receptor activator
4410,1.2,oe,ccsbBroad304_00101,RHOC,-
4411,1.2,oe,ccsbBroad304_04817,GABPB2,Ankyrin repeat domain containing
4420,1.2,oe,ccsbBroad304_11549,ZNF273,"Zinc fingers, C2H2-type"
4421,1.2,oe,ccsbBroad304_06797,PSMA5,Proteasome subunits
3913,2.89,cp,BRD-A73859745,glycodeoxycholic-acid,Apoptosis stimulant
3905,2.91,cp,BRD-A24122750,saclofen,GABA receptor antagonist
3906,2.91,cp,BRD-K76775527,nimesulide,Cyclooxygenase inhibitor
3898,2.92,cp,BRD-K39462424,dexchlorpheniramine,Histamine receptor antagonist
3899,2.92,cp,BRD-K40213712,SAL-1,Adenosine receptor antagonist
3900,2.92,cp,BRD-K15834839,lobendazole,Anthelmintic
3901,2.92,cp,BRD-K35377380,I-OMe-AG-538,IGF-1 inhibitor
4422,1.19,oe,ccsbBroad304_01423,RPL19,L ribosomal proteins
4427,1.16,kd,CGS001-2033,EP300,Chromatin-modifying enzymes / K-acetyltransferases
4428,1.16,oe,ccsbBroad304_00693,NR3C1,3-Ketosteroid receptors
4437,1.13,kd,CGS001-10196,PRMT3,Protein arginine N-methyltransferases
3894,2.95,cc,,SMAD family LOF,-
4438,1.13,kd,CGS001-2077,ERF,ETS Transcription Factors
4441,1.11,oe,ccsbBroad304_00709,GUK1,-
4442,1.11,oe,ccsbBroad304_01144,PAK1,PAKA subfamily
3890,2.96,cp,BRD-K42452249,EO-1428,p38 MAPK inhibitor
4443,1.11,oe,ccsbBroad304_02889,WWTR1,Hippo Signaling
4444,1.11,kd,CGS001-57149,LYRM1,LYR motif containing
3893,2.96,cp,BRD-K85133207,HDAC1-selective,HDAC inhibitor
4445,1.11,oe,ccsbBroad304_07322,SGPL1,Sphingosine 1-phosphate lyase
4446,1.11,oe,ccsbBroad304_03604,ENOSF1,-
4447,1.11,oe,ccsbBroad304_02822,ARFIP2,-
3885,2.98,cp,BRD-K61323504,SB-225002,CC chemokine receptor antagonist
3883,3,cc,,Gamma secretase inhibitor,-
4448,1.11,oe,ccsbBroad304_00863,IL15,Interleukins and interleukin receptors
4449,1.11,oe,ccsbBroad304_09910,BCL6B,BTB/POZ domain containing
4450,1.11,oe,ccsbBroad304_01372,RALB,-
4453,1.08,oe,ccsbBroad304_06374,HLA-DRA,Immunoglobulin superfamily / C1-set domain containing
3877,3.03,cp,BRD-K16485616,mocetinostat,HDAC inhibitor
3878,3.03,cp,BRD-K20287671,SU-4312,PDGFR receptor inhibitor
4454,1.08,kd,CGS001-595,CCND1,-
3872,3.05,cp,BRD-K40227168,vinburnine,Adrenergic receptor antagonist
4455,1.07,kd,CGS001-4012,LNPEP,Aminopeptidase N
4456,1.06,oe,ccsbBroad304_07520,USP15,Ubiquitin-specific peptidases
4457,1.06,oe,ccsbBroad304_08322,UFM1,-
4458,1.06,oe,ccsbBroad304_03850,TRIB3,Trbl family
3869,3.06,cp,BRD-K14643723,4-(2-Amino-ethyl)-benzenesulfonamide,carbonic anhydrase inhibitor
4459,1.06,oe,ccsbBroad304_08053,TAF5L,WD repeat domain containing
3871,3.06,cp,BRD-A46393198,tetramisole,Immunostimulant
3868,3.07,cp,BRD-K10843433,phenylbutazone,Cyclooxygenase inhibitor
4463,1.06,oe,ccsbBroad304_01955,CDK10,"Cyclin-dependent kinases, CDK10 subfamily"
3861,3.1,cc,,Akt Signaling LOF,-
4465,1.05,kd,CGS001-5603,MAPK13,MAPK:p38 subfamily
4467,1.03,kd,CGS001-5468,PPARG,Peroxisome proliferator-activated receptors
3864,3.1,cp,BRD-K72420232,WZ-4002,EGFR inhibitor
3865,3.1,cp,BRD-A09828896,SKF-81297,Dopamine receptor agonist
3866,3.1,cp,BRD-K37080523,isoreserpine,Vesicular monoamine transporter inhibitor
3860,3.11,cp,BRD-K78959463,FPL-64176,Calcium channel activator
3859,3.12,cp,BRD-K50938786,ropivacaine,Sodium channel blocker
4468,1.02,oe,ccsbBroad304_01373,RAN,-
3855,3.14,cp,BRD-A92630576,trimebutine,Opioid receptor agonist
3856,3.14,cp,BRD-K70778732,trazodone,Adrenergic receptor antagonist
3857,3.14,cp,BRD-K83302049,protopine,Histamine receptor antagonist
4469,1.02,oe,ccsbBroad304_06651,NOV,-
3851,3.16,cp,BRD-A34255068,rolipram,Phosphodiesterase inhibitor
4470,1.02,oe,ccsbBroad304_00796,DNAJB2,Heat shock proteins / DNAJ (HSP40)
4471,1.02,oe,ccsbBroad304_02391,BCKDK,Pyruvate dehydrogenase kinase (PDHK) family
3847,3.17,cp,BRD-K08640512,RS-100329,Adrenergic receptor antagonist
3848,3.17,cp,BRD-K77998258,ganglioside,SRC activator
3849,3.17,cp,BRD-A96456596,FPL-55712,Leukotriene receptor antagonist
3850,3.17,cp,BRD-K91336023,mesulergine,Dopamine receptor agonist
4472,1.02,oe,ccsbBroad304_07634,AGPAT2,1-acylglycerol-3-phosphate O-acyltransferases
4475,1.02,kd,CGS001-7018,TF,-
4477,1,kd,CGS001-353345,GPR141,GPCR / Class A : Orphans
3841,3.19,cp,BRD-A39290993,cyproterone,Androgen receptor antagonist
4485,0.97,oe,ccsbBroad304_08511,RFK,-
4486,0.97,oe,ccsbBroad304_06538,LSP1,-
3840,3.2,cp,BRD-K04146668,GW-441756,Growth factor receptor inhibitor
3834,3.21,cp,BRD-K79366068,PSB-069,NTPDase inhibitor
4487,0.97,kd,CGS001-55876,GSDMB,-
4488,0.97,oe,ccsbBroad304_06211,FGFR2,Type V RTKs: FGF (fibroblast growth factor) receptor family
4489,0.97,oe,ccsbBroad304_02197,VPS26A,-
3838,3.21,cp,BRD-K32836707,CAY-10577,Casein kinase inhibitor
3839,3.21,cp,BRD-K41410256,balsalazide,Cyclooxygenase inhibitor
3833,3.22,cp,BRD-K02637541,celecoxib,Cyclooxygenase inhibitor
4490,0.97,oe,ccsbBroad304_06229,FUS,RNA binding motif (RRM) containing
3828,3.24,cp,BRD-A35519318,benidipine,Calcium channel blocker
3829,3.24,cp,BRD-A81177136,KN-62,Calcium-calmodulin dependent protein kinase inhibitor
3830,3.24,cp,BRD-K88611939,aniracetam,Glutamate receptor agonist
4491,0.97,oe,ccsbBroad304_02738,RRS1,-
4492,0.96,oe,ccsbBroad304_02312,ARPC1B,Actin related protein 2/3 complex subunits
3826,3.25,cp,BRD-A32949107,MRS-1845,Calcium channel blocker
4496,0.95,kd,CGS001-11040,PIM2,PIM family
3823,3.28,cp,BRD-K08998509,fananserin,Dopamine receptor antagonist
3824,3.28,cp,BRD-A10903566,imiloxan,Adrenergic receptor antagonist
4500,0.93,oe,ccsbBroad304_03112,NENF,-
4501,0.93,oe,ccsbBroad304_04718,RPL39L,L ribosomal proteins
4502,0.93,oe,ccsbBroad304_06090,DDOST,-
4503,0.93,oe,ccsbBroad304_04294,ATG10,-
4504,0.93,oe,ccsbBroad304_09344,ZNF764,"Zinc fingers, C2H2-type"
3816,3.31,cp,BRD-K36395411,SB-206553,Serotonin receptor antagonist
3817,3.31,cp,BRD-K89839824,raltitrexed,Thymidylate synthase inhibitor
4505,0.93,oe,ccsbBroad304_04243,PLA2G12A,Phospholipase A2
4508,0.92,kd,CGS001-1861,TOR1A,-
4509,0.92,kd,CGS001-5532,PPP3CB,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
4510,0.92,kd,CGS001-11200,CHEK2,CHK1 subfamily
4518,0.88,oe,ccsbBroad304_01323,PSMD9,"Proteasome (prosome, macropain) subunits"
4519,0.88,oe,ccsbBroad304_00654,GNB1,WD repeat domain containing
3808,3.35,cp,BRD-A98378129,talniflumate,Cyclooxygenase inhibitor
3809,3.35,cp,BRD-K15601958,SEW-2871,Lysophospholipid receptor agonist
4520,0.88,oe,ccsbBroad304_06852,RBP4,Lipocalins
4521,0.87,oe,ccsbBroad304_05767,ACVR1,Type I receptor serine/threonine kinases
4522,0.87,kd,CGS001-7249,TSC2,-
4526,0.84,oe,ccsbBroad304_06617,NASP,Tetratricopeptide (TTC) repeat domain containing
4527,0.84,kd,CGS001-4683,NBN,-
4528,0.84,kd,CGS001-9690,UBE3C,-
3802,3.38,cp,BRD-K14880289,GW-501516,PPAR receptor agonist
4529,0.84,kd,CGS001-5986,RFNG,Beta 3-glycosyltransferases
4530,0.83,oe,ccsbBroad304_04728,TWIST2,Basic helix-loop-helix proteins
3791,3.39,cp,BRD-K52219182,BRD-K52219182,Phosphodiesterase inhibitor
4531,0.83,oe,ccsbBroad304_00238,CCNE1,-
4532,0.83,oe,ccsbBroad304_07118,UGDH,-
4533,0.83,oe,ccsbBroad304_09768,ZNF366,"Zinc fingers, C2H2-type"
4534,0.83,oe,ccsbBroad304_07178,ZFP112,-
4535,0.82,kd,CGS001-5202,PFDN2,-
4536,0.82,kd,CGS001-599,BCL2L2,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
3798,3.39,cp,BRD-K13571841,pepstatin,Aspartic protease inhibitor
3790,3.4,cc,,Aromatase inhibitor,-
4540,0.8,oe,ccsbBroad304_07843,FCHO1,-
3785,3.42,cp,BRD-K88759641,EMD-66684,Angiotensin receptor antagonist
4541,0.79,kd,CGS001-1184,CLCN5,Ion channels / Chloride channels : Voltage-sensitive
4542,0.78,oe,ccsbBroad304_02633,LSM6,-
4549,0.76,kd,CGS001-5590,PRKCZ,Iota subfamily
3784,3.43,cc,,Rho GTPase activating proteins LOF,-
4551,0.74,oe,ccsbBroad304_07861,COBL,-
3783,3.44,cp,BRD-K53523901,arctigenin,MEK inhibitor
4556,0.74,kd,CGS001-5979,RET,Type XIV RTKs: RET
3781,3.45,cp,BRD-A51714012,venlafaxine,Adrenergic inhibitor
4557,0.74,kd,CGS001-55718,POLR3E,RNA polymerase subunits
4558,0.74,kd,CGS001-80314,EPC1,-
3776,3.48,cc,,Reverse transcriptase inhibitor,-
3777,3.48,cp,BRD-K95899059,LY-344864,Serotonin receptor agonist
3775,3.49,cp,BRD-A41519720,ezetimibe,Niemann-Pick C1-like 1 protein antagonist
4559,0.74,oe,ccsbBroad304_01443,MRPL12,Mitochondrial ribosomal proteins / large subunits
4564,0.69,oe,ccsbBroad304_06226,FTL,-
4565,0.69,oe,ccsbBroad304_00312,CIRBP,RNA binding motif (RRM) containing
3770,3.52,cp,BRD-K75699339,rizatriptan,Serotonin receptor agonist
4566,0.69,oe,ccsbBroad304_02173,ATG5,-
4567,0.69,oe,ccsbBroad304_01536,SIM2,Basic helix-loop-helix proteins
4568,0.69,oe,ccsbBroad304_02506,EBP,-
4569,0.68,oe,ccsbBroad304_09497,ZNF57,"Zinc fingers, C2H2-type"
4579,0.65,oe,ccsbBroad304_06144,EFNB3,Ephrins
4580,0.65,oe,ccsbBroad304_09050,ZNF436,"Zinc fingers, C2H2-type"
4581,0.65,oe,ccsbBroad304_08536,PARL,-
4582,0.65,oe,ccsbBroad304_06204,FDFT1,Lanosterol biosynthesis pathway
4583,0.65,oe,ccsbBroad304_02438,FAM3C,-
4584,0.65,kd,CGS001-81034,SLC25A32,Mitochondrial nucleotide transporter subfamily
3763,3.56,cp,BRD-K96037667,norethindrone,Progesterone receptor agonist
4585,0.65,oe,ccsbBroad304_06727,PIK3CG,Phosphatidylinositol kinases
4586,0.65,oe,ccsbBroad304_01654,TCTA,-
4590,0.61,kd,CGS001-1459,CSNK2A2,Casein kinase 2 (CK2) family
3756,3.62,cp,BRD-K16977723,PP-3,EGFR inhibitor
4591,0.6,oe,ccsbBroad304_01709,NR2C1,Testicular receptors
4595,0.6,oe,ccsbBroad304_06663,OAS1,-
3752,3.64,cp,BRD-K64614248,salicin,Anti-inflammatory
4596,0.6,oe,ccsbBroad304_06431,IFNAR2,Interferon receptor family
4597,0.6,oe,ccsbBroad304_10507,SNX7,Sorting nexins
4598,0.6,oe,ccsbBroad304_02423,CD2BP2,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
4599,0.6,oe,ccsbBroad304_04649,ADC,-
3750,3.66,cp,BRD-A26384407,chlortalidone,Carbonic anhydrase inhibitor
4601,0.58,kd,CGS001-10383,TUBB2C,Tubulins
4602,0.56,oe,ccsbBroad304_00751,HMGB2,High-mobility group / Canonical
4606,0.56,oe,ccsbBroad304_07277,RTCD1,-
3745,3.7,cp,BRD-K28863208,PNU-282987,Cholinergic receptor agonist
4609,0.53,kd,CGS001-5286,PIK3C2A,Phosphatidylinositol-4-phosphate 3-kinase family
4612,0.51,oe,ccsbBroad304_05939,CBLB,RING-type (C3HC4) zinc fingers
4613,0.5,kd,CGS001-22891,ZNF365,"Zinc fingers, C2H2-type"
3739,3.74,cp,BRD-A64977602,mirtazapine,Adrenergic receptor antagonist
4622,0.46,oe,ccsbBroad304_03155,DHH,-
3736,3.75,cp,BRD-A89337244,PD-102807,Acetylcholine receptor antagonist
4623,0.46,oe,ccsbBroad304_04471,C5ORF62,-
4624,0.46,oe,ccsbBroad304_02582,UQCR11,Mitochondrial respiratory chain complex / Complex III
4627,0.42,oe,ccsbBroad304_00874,INS,-
4628,0.42,oe,ccsbBroad304_07663,IGF2BP3,RNA binding motif (RRM) containing
3733,3.78,cp,BRD-A58048407,nimodipine,Calcium channel blocker
4629,0.42,oe,ccsbBroad304_08137,HOOK2,-
4635,0.42,oe,ccsbBroad304_08660,SMARCAD1,-
4640,0.39,kd,CGS001-2065,ERBB3,Type I RTKs: ErbB (epidermal growth factor) receptor family
4643,0.37,oe,ccsbBroad304_09043,TSEN2,tRNA splicing endonuclease subunits
4644,0.37,oe,ccsbBroad304_06694,SERPINA5,Serine (or cysteine) peptidase inhibitors
3724,3.81,cp,BRD-K25186396,tangeritin,Cell cycle inhibitor
3725,3.81,cp,BRD-A43974499,reboxetine,Adrenergic receptor antagonist
3726,3.81,cp,BRD-K45296539,ZD-7114,Adrenergic receptor agonist
3727,3.81,cp,BRD-A92585442,RU-28318,Cytochrome P450 inhibitor
4645,0.37,kd,CGS001-7525,YES1,Src family
4646,0.37,oe,ccsbBroad304_00949,LRPAP1,-
4647,0.37,oe,ccsbBroad304_02553,BLCAP,-
4656,0.34,kd,CGS001-7771,ZFP112,-
4658,0.32,oe,ccsbBroad304_03652,EXOC2,-
3718,3.84,cp,BRD-K47761761,PD-168077,Dopamine receptor agonist
4666,0.28,oe,ccsbBroad304_00398,CTSL2,-
4677,0.23,oe,ccsbBroad304_03386,SPA17,-
4678,0.23,oe,ccsbBroad304_01265,PPP2R4,"Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits"
3714,3.87,cp,BRD-A80017228,bendroflumethiazide,Sodium/potassium/chloride transporter inhibitor
4688,0.19,oe,ccsbBroad304_04086,TCTN1,Tectonic proteins
4689,0.19,oe,ccsbBroad304_01239,POLR2E,RNA polymerase subunits
4690,0.19,oe,ccsbBroad304_00462,DR1,-
4692,0.16,oe,ccsbBroad304_06007,CISH,SH2 domain containing
4693,0.14,oe,ccsbBroad304_06035,CRABP1,Fatty acid-binding proteins
4694,0.14,oe,ccsbBroad304_00054,ALDOC,-
3707,3.9,cp,BRD-A65597028,RX-821002,Adrenergic receptor antagonist
3704,3.92,cc,,Akt Signaling GOF,-
4697,0.14,oe,ccsbBroad304_07219,CDC7,CDC7 family
3706,3.92,cp,BRD-K71512533,SNS-314,Aurora kinase inhibitor
3700,3.94,cp,BRD-K08252256,diclofenac,Cyclooxygenase inhibitor
4701,0.13,oe,ccsbBroad304_03658,DCP1A,-
4702,0.11,oe,ccsbBroad304_14291,GDPD5,-
4709,0.09,oe,ccsbBroad304_01258,PPP1CA,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
3697,3.95,cp,BRD-K55034111,pefloxacin,Bacterial DNA gyrase inhibitor
4715,0.05,oe,ccsbBroad304_05930,CAMK2D,CAMK2 family
3699,3.95,cp,BRD-K05977355,fluconazole,Sterol demethylase inhibitor
3692,3.97,cp,BRD-K65285700,BRD-K65285700,Cannabinoid receptor agonist
4723,0,oe,ccsbBroad304_07136,WNT9A,Wingless-type MMTV integration sites
4724,0,oe,ccsbBroad304_09993,VN1R4,"GPCR / Unclassified : Vomeronasal receptors, type 1"
4725,0,oe,ccsbBroad304_03594,TNFRSF19,Tumour necrosis factor (TNF) receptor family
4726,0,oe,ccsbBroad304_04544,RCCD1,-
3689,3.98,cp,BRD-K32710582,EI-247,IGF-1 inhibitor
3690,3.98,cp,BRD-K81225797,SCH-58261,Adenosine receptor antagonist
3691,3.98,cp,BRD-K87049188,fusaric-acid,Dopamine beta hydroxylase inhibitor
4727,0,oe,ccsbBroad304_01377,RARG,Retinoic acid receptors
4728,0,oe,ccsbBroad304_09708,PNLDC1,-
4729,0,oe,ccsbBroad304_06711,PFAS,-
3684,4.01,cp,BRD-K19227686,phenolphthalein,Indicator dye
4730,0,oe,ccsbBroad304_00736,NRG1,Immunoglobulin superfamily / I-set domain containing
3680,4.02,cp,BRD-A03216249,mepivacaine,Potassium channel blocker
3681,4.02,cp,BRD-K59456551,methotrexate,Dihydrofolate reductase inhibitor
3682,4.02,cp,BRD-K85383046,IAA-94,Chloride channel blocker
3683,4.02,cp,BRD-A62525898,prednisone,Glucocorticoid receptor agonist
4731,0,oe,ccsbBroad304_13991,NCOA3,Histone acetyltransferases
4732,0,oe,ccsbBroad304_00937,LGALS2,"Lectins, galactoside-binding"
4733,0,oe,ccsbBroad304_03934,LEPRE1,-
4734,0,oe,ccsbBroad304_03323,LARS,Aminoacyl tRNA synthetases / Class I
4735,0,oe,ccsbBroad304_00903,KCNQ1,Voltage-gated potassium channels
4736,0,oe,ccsbBroad304_04619,GNG8,-
4737,0,oe,ccsbBroad304_06234,G6PC,-
4738,0,oe,ccsbBroad304_00577,FOXO3,Forkhead boxes
3669,4.05,cc,,Toll like receptors LOF,-
3670,4.05,cp,BRD-K50325075,UCL-2077,Slow after hyperpolarization channel blocker
4739,0,oe,ccsbBroad304_00587,FOSL2,basic leucine zipper proteins
4740,0,oe,ccsbBroad304_06120,DRD1,Dopamine receptors
3665,4.07,cp,BRD-A62071884,siguazodan,Phosphodiesterase inhibitor
4741,0,oe,ccsbBroad304_00378,CSNK1D,Casein kinase 1 (CK1) family
3667,4.07,cp,BRD-K09778810,FGIN-1-27,Inositol monophosphatase inhibitor
4742,0,oe,ccsbBroad304_06041,CRYAA,Heat shock proteins / HSPB
4743,0,oe,ccsbBroad304_06649,CNOT4,RNA binding motif (RRM) containing
3661,4.09,cp,BRD-K54790157,trioxsalen,DNA synthesis inhibitor
3662,4.09,cp,BRD-A27554692,altrenogest,Progestogen hormone
4744,0,oe,ccsbBroad304_02801,CASP14,Caspases
3659,4.11,cp,BRD-K04993501,cefixime,Bacterial cell wall synthesis inhibitor
4745,0,oe,ccsbBroad304_03372,CAB39,-
3658,4.12,cp,BRD-K61192372,capecitabine,DNA synthesis inhibitor
3655,4.13,cp,BRD-K08890269,CO-102862,Sodium channel blocker
4746,0,oe,ccsbBroad304_00184,C2,Complement system
3652,4.14,cp,BRD-K92817986,BJM-CSC-19,MEK inhibitor
4747,0,oe,ccsbBroad304_11738,BRD4,Bromodomain kinase (BRDK) family
4748,0,oe,ccsbBroad304_11251,BRD3,Bromodomain kinase (BRDK) family
4749,0,oe,ccsbBroad304_05868,ATP5C1,ATPases / F-type
4750,0,oe,ccsbBroad304_05832,AIRE,"Zinc fingers, PHD-type"
3651,4.16,cp,BRD-K32164935,tolazamide,ATP channel blocker
4751,0,oe,ccsbBroad304_07709,AFG3L2,ATPases / AAA-type
4752,0,oe,ccsbBroad304_02108,AURKB,Aurora kinase
4753,0,oe,ccsbBroad304_10216,ZPBP2,Immunoglobulin superfamily / Immunoglobulin-like domain containing
4754,0,oe,ccsbBroad304_07158,ZNF74,"Zinc fingers, C2H2-type"
4755,0,oe,ccsbBroad304_09746,ZNF610,"Zinc fingers, C2H2-type"
4756,0,oe,ccsbBroad304_03461,ZNF562,"Zinc fingers, C2H2-type"
4757,0,oe,ccsbBroad304_05008,ZNF558,"Zinc fingers, C2H2-type"
3641,4.22,cc,,Bacterial 30S ribosomal subunit inhibitor,-
3638,4.25,cp,BRD-K34776109,glimepiride,Insulin secretagogue
3639,4.25,cp,BRD-A39268308,epibatidine,Acetylcholine receptor agonist
4758,0,oe,ccsbBroad304_10012,ZNF546,"Zinc fingers, C2H2-type"
4759,0,oe,ccsbBroad304_04732,ZNF488,"Zinc fingers, C2H2-type"
4760,0,oe,ccsbBroad304_07679,ZNF274,"Zinc fingers, C2H2-type"
4761,0,oe,ccsbBroad304_01795,ZNF22,"Zinc fingers, C2H2-type"
4762,0,oe,ccsbBroad304_07169,ZNF174,"Zinc fingers, C2H2-type"
3633,4.27,cp,BRD-K53263234,CITCO,CAR agonist
4763,0,oe,ccsbBroad304_01808,ZNF134,"Zinc fingers, C2H2-type"
4764,0,oe,ccsbBroad304_03308,YTHDF2,-
4765,0,oe,ccsbBroad304_01862,YEATS4,-
4766,0,oe,ccsbBroad304_01958,YARS,Aminoacyl tRNA synthetases / Class I
4767,0,oe,ccsbBroad304_07561,YAF2,-
3631,4.29,cp,BRD-K36862742,hydroflumethiazide,Sodium/potassium/chloride transporter inhibitor
3626,4.3,cp,BRD-K09471561,levofloxacin,Bacterial DNA gyrase inhibitor
4768,0,oe,ccsbBroad304_01781,WNT7B,Endogenous ligands
4769,0,oe,ccsbBroad304_09036,WDR61,WD repeat domain containing
3622,4.32,cp,BRD-K78838262,austricine,Hypolipidemic
4770,0,oe,ccsbBroad304_05422,VN1R5,"GPCR / Unclassified : Vomeronasal receptors, type 1"
3621,4.33,cp,BRD-K30649484,mafenide,Carbonic anhydrase inhibitor
3618,4.34,cp,BRD-K86958018,olvanil,TRPV agonist
4771,0,oe,ccsbBroad304_02231,USP6NL,-
4772,0,oe,ccsbBroad304_01760,USP1,Ubiquitin-specific peptidases
4773,0,oe,ccsbBroad304_01748,UFD1L,-
4774,0,oe,ccsbBroad304_00737,UBE2K,Ubiquitin-conjugating enzymes E2
4775,0,oe,ccsbBroad304_07506,UBAP2L,-
4776,0,oe,ccsbBroad304_03497,TXNL4B,-
4777,0,oe,ccsbBroad304_01723,TTK,TTK family
4778,0,oe,ccsbBroad304_07548,TSSC4,-
4779,0,oe,ccsbBroad304_02354,TRIM13,RING-type (C3HC4) zinc fingers
3610,4.39,cc,,PRD class homeoboxes and psudogenes LOF,-
4780,0,oe,ccsbBroad304_09281,TPD52L3,-
4781,0,oe,ccsbBroad304_04633,TP53RK,Bud32 family
4782,0,oe,ccsbBroad304_04457,TOX2,-
4783,0,oe,ccsbBroad304_02503,TNFSF13B,CD molecules
4784,0,oe,ccsbBroad304_02011,TNFRSF6B,Tumour necrosis factor (TNF) receptor family
4785,0,oe,ccsbBroad304_14122,TNFRSF21,Tumour necrosis factor (TNF) receptor family
3604,4.44,cp,BRD-K45252063,clofibrate,PPAR receptor agonist
4786,0,oe,ccsbBroad304_07080,TM7SF2,-
4787,0,oe,ccsbBroad304_07074,TLR2,Toll-like receptor family
4788,0,oe,ccsbBroad304_02278,THRAP3,-
4789,0,oe,ccsbBroad304_01663,TFF2,-
4790,0,oe,ccsbBroad304_01662,TFDP2,-
4791,0,oe,ccsbBroad304_08116,TBK1,IKK family
4792,0,oe,ccsbBroad304_01642,TAL2,Basic helix-loop-helix proteins
3599,4.47,cp,BRD-K44497846,enalapril,ACE inhibitor
3590,4.49,cp,BRD-A74907996,equol,Estrogen receptor agonist
4793,0,oe,ccsbBroad304_07337,TAF1B,-
3592,4.49,cp,BRD-K30743633,TCPOBOP,CAR agonist
4794,0,oe,ccsbBroad304_01623,SUPT4H1,-
4795,0,oe,ccsbBroad304_02485,STAMBP,-
4796,0,oe,ccsbBroad304_06993,SRD5A1,-
4797,0,oe,ccsbBroad304_01589,SQLE,Lanosterol biosynthesis pathway
4798,0,oe,ccsbBroad304_01588,SPP1,Endogenous ligands
4799,0,oe,ccsbBroad304_04754,SPIC,ETS Transcription Factors
3584,4.51,cp,BRD-K11634954,GBR-13069,Dopamine uptake inhibitor
4800,0,oe,ccsbBroad304_02195,SPAG7,-
3583,4.52,cp,BRD-A70649075,sulconazole,Sterol demethylase inhibitor
4801,0,oe,ccsbBroad304_01576,SOAT1,-
4802,0,oe,ccsbBroad304_03556,SMU1,WD repeat domain containing
4803,0,oe,ccsbBroad304_01545,SLC3A2,SLC3 family
4804,0,oe,ccsbBroad304_06952,SKP1,-
4805,0,oe,ccsbBroad304_02705,SIRT2,Histone deacetylases
4806,0,oe,ccsbBroad304_09665,SIK1,QIK subfamily
4807,0,oe,ccsbBroad304_01532,SIAH1,-
4808,0,oe,ccsbBroad304_01527,SGK1,SGK family
4809,0,oe,ccsbBroad304_06354,SERPIND1,Serine (or cysteine) peptidase inhibitors
3575,4.55,cp,BRD-K67261995,adipiodone,Contrast agent
4810,0,oe,ccsbBroad304_06687,SERPINB2,Serine (or cysteine) peptidase inhibitors
4811,0,oe,ccsbBroad304_04976,SERPINA12,Serine (or cysteine) peptidase inhibitors
4812,0,oe,ccsbBroad304_03878,SENP2,-
4813,0,oe,ccsbBroad304_01515,SDHD,Mitochondrial respiratory chain complex / Complex II
4814,0,oe,ccsbBroad304_06926,SDHA,Mitochondrial respiratory chain complex
3570,4.58,cp,BRD-K61951118,FG-7142,GABA benzodiazepine site receptor inverse agonist
4815,0,oe,ccsbBroad304_07490,SCRN1,-
4816,0,oe,ccsbBroad304_01475,S100A6,EF-hand domain containing
4817,0,oe,ccsbBroad304_06896,RPS6KA1,RSK subfamily
3561,4.62,cp,BRD-A56359832,zileuton,Leukotriene inhibitor
3562,4.62,cp,BRD-A51393488,noscapine,Bradykinin receptor antagonist
3563,4.62,cp,BRD-K99174507,cardiogenol-c,Cardiomyogenesis inducer
3564,4.62,cp,BRD-K68867920,quetiapine,Dopamine receptor antagonist
4818,0,oe,ccsbBroad304_01463,RPS27A,S ribosomal proteins
4819,0,oe,ccsbBroad304_06889,RPN2,-
4820,0,oe,ccsbBroad304_06888,RPN1,-
4821,0,oe,ccsbBroad304_03713,RNF20,RING-type (C3HC4) zinc fingers
3551,4.65,cp,BRD-K43164539,cholic-acid,Bile acid
3552,4.65,cp,BRD-K57926513,tyrphostin-AG-1295,PDGFR receptor inhibitor
3553,4.65,cp,BRD-K85030058,benactyzine,Acetylcholine receptor antagonist
4822,0,oe,ccsbBroad304_04256,RNF146,RING-type (C3HC4) zinc fingers
3555,4.65,cp,BRD-K68191783,ALW-II-38-3,Ephrin inhibitor
4823,0,oe,ccsbBroad304_01398,RHEB,-
4824,0,oe,ccsbBroad304_01396,RGS4,Regulators of G-protein signaling
3548,4.67,cc,,Apolipoproteins LOF,-
4825,0,oe,ccsbBroad304_03028,RBMX,RNA binding motif (RRM) containing
4826,0,oe,ccsbBroad304_03357,RASD1,-
4827,0,oe,ccsbBroad304_06845,RARRES3,-
4828,0,oe,ccsbBroad304_01374,RAP1A,-
3543,4.69,cc,,Benzodiazepine receptor agonist,-
4829,0,oe,ccsbBroad304_01363,RABGGTA,Prenyltransferase alpha subunit repeat containing
4830,0,oe,ccsbBroad304_06830,RAB5A,"RAB, member RAS oncogene"
4831,0,oe,ccsbBroad304_07889,QPRT,-
3538,4.73,cc,,Mediator complex LOF,-
4832,0,oe,ccsbBroad304_01321,PSMD5,"Proteasome (prosome, macropain) subunits"
4833,0,oe,ccsbBroad304_01313,PSMB9,"Proteasome (prosome, macropain) subunits"
4834,0,oe,ccsbBroad304_06800,PSMB7,Proteasome subunits
4835,0,oe,ccsbBroad304_01309,PSMB1,Proteasome subunits
3532,4.75,cp,BRD-K01555864,dibenzoylmethane,Antineoplastic
4836,0,oe,ccsbBroad304_11055,PRKCH,Eta subfamily
4837,0,oe,ccsbBroad304_01267,PPP4C,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
3530,4.76,cp,BRD-K19462402,buflomedil,Adrenergic receptor antagonist
3531,4.76,cp,BRD-K21667562,AM-404,Cyclooxygenase inhibitor
3529,4.77,cp,BRD-K08556791,ethoprop,Acetylcholinesterase inhibitor
4838,0,oe,ccsbBroad304_08453,PPP2R3C,"Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits"
4839,0,oe,ccsbBroad304_14081,PPP1R13B,Ankyrin repeat domain containing
4840,0,oe,ccsbBroad304_01259,PPP1CC,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
3525,4.79,cp,BRD-K15402119,huperzine-a,Acetylcholinesterase inhibitor
3524,4.8,cp,BRD-K31792052,pifithrin,Interleukin receptor antagonist
4841,0,oe,ccsbBroad304_01257,PPOX,-
4842,0,oe,ccsbBroad304_01255,PPM1B,"Serine/threonine phosphatases / Protein phosphatases, Mg2+/Mn2+ dependent"
4843,0,oe,ccsbBroad304_01252,PPIA,Cis-trans-isomerases
4844,0,oe,ccsbBroad304_02526,POP4,-
3517,4.83,cp,BRD-A67748489,K3644,Kinesin-like spindle protein inhibitor
3518,4.83,cp,BRD-K67017579,cilostazol,Phosphodiesterase inhibitor
4845,0,oe,ccsbBroad304_02783,POFUT1,Fucosyltransferases
3515,4.84,cc,,Targets of VEGFR inhibitors GOF,-
4846,0,oe,ccsbBroad304_01105,PNP,-
3514,4.85,cp,BRD-A35511923,L-803087,Somatostatin receptor agonist
4847,0,oe,ccsbBroad304_06736,PLCG2,Phosphoinositide-specific phospholipase C
4848,0,oe,ccsbBroad304_01208,PITPNA,-
4849,0,oe,ccsbBroad304_06720,PHYH,-
4850,0,oe,ccsbBroad304_01190,PHKG2,Phosphorylase kinase (PHK) family
4851,0,oe,ccsbBroad304_08228,PHF11,"Zinc fingers, PHD-type"
4852,0,oe,ccsbBroad304_01174,PEX13,-
3507,4.9,cp,BRD-A14208071,oxyphenonium,Cholinergic receptor antagonist
4853,0,oe,ccsbBroad304_13998,PDXK,-
4854,0,oe,ccsbBroad304_06704,PDE4D,Phosphodiesterases
3503,4.93,cp,BRD-K18757346,U-46619,Thromboxane receptor agonist
3504,4.93,cp,BRD-K94920105,DR-2313,PARP inhibitor
4855,0,oe,ccsbBroad304_01148,PCBD1,-
4856,0,oe,ccsbBroad304_01147,PC,Carboxylases
3502,4.95,cp,BRD-K51313569,palbociclib,CDK inhibitor
4857,0,oe,ccsbBroad304_04170,PANK2,-
4858,0,oe,ccsbBroad304_01137,P2RY6,"GPCR / Class A : Purinergic receptors, P2Y"
4859,0,oe,ccsbBroad304_01128,OTX2,Homeoboxes / PRD class
4860,0,oe,ccsbBroad304_02806,OPN3,GPCR / Class A : Opsin receptors
4861,0,oe,ccsbBroad304_06670,OGG1,-
4862,0,oe,ccsbBroad304_06660,NTRK3,Type VII RTKs: Neurotrophin receptor/Trk family
4863,0,oe,ccsbBroad304_07600,NSA2,-
3492,5.05,cp,BRD-K44899736,RO-16-6941,Monoamine oxidase inhibitor
3488,5.07,cp,BRD-A44133049,azasetron,Serotonin receptor antagonist
3489,5.07,cp,BRD-K45158365,valsartan,Angiotensin receptor antagonist
4864,0,oe,ccsbBroad304_02533,NOXA1,-
3491,5.07,cp,BRD-K29950728,clomifene,Estrogen receptor antagonist
3487,5.08,cp,BRD-K51671335,sulpiride,Dopamine receptor antagonist
4865,0,oe,ccsbBroad304_03191,NOSIP,-
4866,0,oe,ccsbBroad304_08663,NMUR2,GPCR / Class A : Neuromedin U receptors
4867,0,oe,ccsbBroad304_07362,NMI,-
4868,0,oe,ccsbBroad304_01084,NEU1,-
4869,0,oe,ccsbBroad304_01072,NDUFB6,Mitochondrial respiratory chain complex / Complex I
4870,0,oe,ccsbBroad304_13911,NDUFA9,Short chain dehydrogenase/reductase superfamily / Extended SDR fold
3480,5.12,cp,BRD-K06817181,BRD-K06817181,JAK inhibitor
4871,0,oe,ccsbBroad304_12226,NAGK,-
4872,0,oe,ccsbBroad304_04191,NAA50,N(alpha)-acetyltransferase subunits
3475,5.14,cp,BRD-K43290182,Ro-04-6790,Serotonin receptor antagonist
3476,5.14,cp,BRD-K60274257,dephostatin,Tyrosine phosphatase inhibitor
4873,0,oe,ccsbBroad304_02955,MYCBP,-
4874,0,oe,ccsbBroad304_14008,MPZL1,Immunoglobulin superfamily / V-set domain containing
3472,5.15,cp,BRD-A15131297,benazepril,ACE inhibitor
4875,0,oe,ccsbBroad304_01026,MNAT1,RING-type (C3HC4) zinc fingers
3468,5.17,cp,BRD-K16277217,piperacetazine,Dopamine receptor antagonist
4876,0,oe,ccsbBroad304_06590,MMP7,Matrix metallopeptidase
4877,0,oe,ccsbBroad304_01854,MLLT10,"Zinc fingers, PHD-type"
4878,0,oe,ccsbBroad304_08104,MED4,-
4879,0,oe,ccsbBroad304_00991,MDH1,-
4880,0,oe,ccsbBroad304_00986,MCM2,-
3466,5.19,cp,BRD-K06198550,isorotenone,Mitochondrial complex I inhibitor
4881,0,oe,ccsbBroad304_01836,MAPKAPK3,MAPKAPK subfamily
4882,0,oe,ccsbBroad304_01290,MAP2K5,MAPKK:STE7 family
4883,0,oe,ccsbBroad304_06558,MAOB,Catecholamine turnover
3460,5.22,cp,BRD-A70731303,avrainvillamide-analog-5,nucleophosmin inhibitor
4884,0,oe,ccsbBroad304_02175,MAGED1,-
4885,0,oe,ccsbBroad304_00957,M6PR,-
3457,5.23,cp,BRD-K67277431,picotamide,Thromboxane receptor antagonist
4886,0,oe,ccsbBroad304_06783,LGMN,Legumain
4887,0,oe,ccsbBroad304_08203,LAP3,Leucyl aminopeptidase
3453,5.24,cc,,CDK inhibitor,-
4888,0,oe,ccsbBroad304_02052,KYNU,-
4889,0,oe,ccsbBroad304_13499,KSR2,RAF family
3451,5.25,cp,BRD-K10870738,CDC,Lipoxygenase inhibitor
4890,0,oe,ccsbBroad304_09503,KLHDC9,-
3450,5.26,cp,BRD-A87606379,nadolol,Adrenergic receptor antagonist
4891,0,oe,ccsbBroad304_02318,KIF20A,Kinesins
3449,5.28,cp,BRD-K94689771,pinocembrin,CYP1B1 inhibitor
4892,0,oe,ccsbBroad304_07724,KDELR2,-
3444,5.32,cp,BRD-K85603128,resorcinol,Phosphodiesterase inhibitor
4893,0,oe,ccsbBroad304_03785,INTS12,"Zinc fingers, PHD-type"
4894,0,oe,ccsbBroad304_00854,IL8,-
4895,0,oe,ccsbBroad304_00843,IL1B,Interleukins and interleukin receptors
4896,0,oe,ccsbBroad304_01945,IKBKG,"Zinc fingers, C2HC-type containing"
4897,0,oe,ccsbBroad304_04752,IKBIP,-
4898,0,oe,ccsbBroad304_00838,IGFBP5,insulin-like growth factor (IGF) binding proteins
3439,5.38,cp,BRD-K08806317,timolol,Adrenergic receptor antagonist
4899,0,oe,ccsbBroad304_10901,IGF1R,Type II RTKs: Insulin receptor family
4900,0,oe,ccsbBroad304_07287,HYAL2,-
3434,5.42,cp,BRD-A97104540,fenoterol,Adrenergic receptor agonist
4901,0,oe,ccsbBroad304_07633,HTATIP2,Short chain dehydrogenase/reductase superfamily / Atypical members
4902,0,oe,ccsbBroad304_06410,HSPA8,Heat shock proteins / HSP70
4903,0,oe,ccsbBroad304_00797,HSPA2,Heat shock proteins / HSP70
4904,0,oe,ccsbBroad304_00793,HSD17B4,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3
4905,0,oe,ccsbBroad304_08239,HSD17B11,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3
4906,0,oe,ccsbBroad304_05038,HORMAD2,-
4907,0,oe,ccsbBroad304_07617,HMGN4,High-mobility group / Canonical
4908,0,oe,ccsbBroad304_09508,HMGB4,High-mobility group / Canonical
4909,0,oe,ccsbBroad304_10882,HLA-DRB1,Immunoglobulin superfamily / C1-set domain containing
3425,5.5,cp,BRD-K84639753,safinamide,Dopamine uptake inhibitor
3426,5.5,cp,BRD-K82091397,SB-239063,p38 MAPK inhibitor
3423,5.51,cp,BRD-K82865713,prostaglandin-b2,cAMP inhibitor
4910,0,oe,ccsbBroad304_06367,HK1,-
3420,5.52,cp,BRD-A95445494,maackiain,Sodium/glucose cotransporter inhibitor
4911,0,oe,ccsbBroad304_06348,HIST1H2BD,Histones / Replication-dependent
4912,0,oe,ccsbBroad304_02443,HAX1,-
3418,5.53,cp,BRD-K43880410,pregnenolone,glutamate receptor modulator
3419,5.53,cp,BRD-K28115081,apafant,Platelet activating factor receptor antagonist
3416,5.54,cc,,SRY LOF,-
3417,5.54,cp,BRD-K37194137,III606050,Cytochrome P450 inhibitor
4913,0,oe,ccsbBroad304_00725,HADHA,-
4914,0,oe,ccsbBroad304_03368,GPRC5B,GPCR / Class C : Orphans
4915,0,oe,ccsbBroad304_07244,GPR65,GPCR / Class A : Orphans
3411,5.57,cp,BRD-K64835161,BRD-K64835161,-666
3412,5.57,cp,BRD-K54210043,NS-1619,Calcium channel activator
4916,0,oe,ccsbBroad304_09761,GPR156,GPCR / Class C : Orphans
4917,0,oe,ccsbBroad304_04933,GPR119,GPCR / Class A : Orphans
4918,0,oe,ccsbBroad304_02287,GNPDA1,-
4919,0,oe,ccsbBroad304_00661,GNGT2,-
3406,5.62,cp,BRD-K20338176,cefaclor,Bacterial cell wall synthesis inhibitor
4920,0,oe,ccsbBroad304_06292,GNAI2,-
3405,5.63,cp,BRD-K80639402,SB-258585,Serotonin receptor antagonist
3403,5.64,cp,BRD-K03384561,roquinimex,Angiogenesis inhibitor
4921,0,oe,ccsbBroad304_06291,GNAI1,-
4922,0,oe,ccsbBroad304_03268,GMPR2,-
4923,0,oe,ccsbBroad304_00648,GLRX,-
3399,5.66,cp,BRD-A35033682,eriodictyol,Cytochrome P450 inhibitor
4924,0,oe,ccsbBroad304_03182,GLOD4,-
4925,0,oe,ccsbBroad304_00632,GGCX,Carboxylases
3398,5.67,cp,BRD-K10467831,tibolone,Androgen receptor agonist
4926,0,oe,ccsbBroad304_07834,GGA2,-
3394,5.69,cp,BRD-A38749782,fludrocortisone,Glucocorticoid receptor agonist
4927,0,oe,ccsbBroad304_03822,GATAD2B,GATA zinc finger domain containing
4928,0,oe,ccsbBroad304_00612,GALNS,Arylsulfatase family
4929,0,oe,ccsbBroad304_02330,G3BP1,RNA binding motif (RRM) containing
4930,0,oe,ccsbBroad304_00125,FXYD2,Ion transport regulator
4931,0,oe,ccsbBroad304_03161,FOXP3,Forkhead boxes
4932,0,oe,ccsbBroad304_00762,FOXA3,Forkhead boxes
4933,0,oe,ccsbBroad304_00552,FEN1,-
3387,5.75,cp,BRD-A14798026,mestranol,Estrogen receptor agonist
4934,0,oe,ccsbBroad304_07941,FBXO7,F-boxes / other
4935,0,oe,ccsbBroad304_00539,FANCG,"Fanconi anemia, complementation groups"
3381,5.78,cp,BRD-K96720755,relcovaptan,Vasopressin receptor antagonist
4936,0,oe,ccsbBroad304_02270,FAM20B,-
3383,5.78,cp,BRD-A31312900,montelukast,Leukotriene receptor antagonist
4937,0,oe,ccsbBroad304_06188,F10,Chymotrypsin
4938,0,oe,ccsbBroad304_03129,ERO1L,-
3378,5.8,cp,BRD-K65331431,retinyl,vitamin analog
4939,0,oe,ccsbBroad304_03266,ERGIC2,-
3375,5.81,cp,BRD-K38449220,seneciphylline,Cytochrome P450 inhibitor
3376,5.81,cp,BRD-A44448661,pentobarbital,Barbiturate antiepileptic
3374,5.82,cp,BRD-K72726508,arcyriaflavin-a,CDK inhibitor
3372,5.83,cp,BRD-K97158071,droperidol,Dopamine receptor antagonist
4940,0,oe,ccsbBroad304_00513,ERCC3,General transcription factors
4941,0,oe,ccsbBroad304_00498,ELK1,ETS Transcription Factors
4942,0,oe,ccsbBroad304_08802,ELAC2,-
3371,5.84,cp,BRD-K45117373,Y-26763,Potassium channel activator
4943,0,oe,ccsbBroad304_00492,EIF5A,-
3366,5.87,cp,BRD-K57569181,pentoxifylline,Phosphodiesterase inhibitor
4944,0,oe,ccsbBroad304_06136,ECHS1,-
4945,0,oe,ccsbBroad304_06134,ECH1,-
3363,5.9,cp,BRD-K08619838,tremorine,Acetylcholine receptor agonist
3364,5.9,cp,BRD-A81233518,glycopyrrolate,Acetylcholine receptor antagonist
4946,0,oe,ccsbBroad304_01655,DYNLT3,Cytoplasmic dyneins
4947,0,oe,ccsbBroad304_04947,DYNLL2,Cytoplasmic dyneins
4948,0,oe,ccsbBroad304_00469,DUT,-
3359,5.95,cp,BRD-A66199457,asiaticoside,Antineoplastic
4949,0,oe,ccsbBroad304_06130,DUSP4,Protein tyrosine phosphatases / Class I Cys-based PTPs : MAP kinase phosphatases
4950,0,oe,ccsbBroad304_07528,DMTF1,-
4951,0,oe,ccsbBroad304_06103,DMD,-
4952,0,oe,ccsbBroad304_10427,DHX8,DEAH-boxes
4953,0,oe,ccsbBroad304_08389,DHX29,DEAH-boxes
3352,5.99,cp,BRD-A95513702,"androsta-1,4-dien-3,17-dione",Aromatase inhibitor
3353,5.99,cp,BRD-A39390670,rabeprazole,ATPase inhibitor
4954,0,oe,ccsbBroad304_07379,DHRS3,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3
4955,0,oe,ccsbBroad304_00443,DHFR,Oxidoreductases
4956,0,oe,ccsbBroad304_06098,DHCR24,-
4957,0,oe,ccsbBroad304_06094,DFFA,-
4958,0,oe,ccsbBroad304_03437,DDX49,DEAD-boxes
4959,0,oe,ccsbBroad304_06087,DDB2,WD repeat domain containing
4960,0,oe,ccsbBroad304_03980,DCLRE1B,-
4961,0,oe,ccsbBroad304_00423,DAXX,-
4962,0,oe,ccsbBroad304_00402,CYB561,Cytochrome b genes
3340,6.06,cp,BRD-A55756846,H-7,PKA inhibitor
4963,0,oe,ccsbBroad304_06066,CTSL1,-
3342,6.06,cp,BRD-K47207162,zimelidine,Serotonin reuptake inhibitor
4964,0,oe,ccsbBroad304_00391,CTH,Hydrogen sulphide synthesis
4965,0,oe,ccsbBroad304_00382,CSNK2A2,Casein kinase 2 (CK2) family
4966,0,oe,ccsbBroad304_05012,CREB3L4,basic leucine zipper proteins
4967,0,oe,ccsbBroad304_03023,CRCP,-
4968,0,oe,ccsbBroad304_02154,COX5A,Mitochondrial respiratory chain complex
4969,0,oe,ccsbBroad304_08346,COQ3,-
4970,0,oe,ccsbBroad304_02143,CNOT8,-
3332,6.14,cp,BRD-K40530731,hyoscyamine,Acetylcholine receptor antagonist
4971,0,oe,ccsbBroad304_08339,CMPK1,-
3331,6.15,cp,BRD-K88742110,BRD-K88742110,HDAC inhibitor
3329,6.16,cp,BRD-K73982490,BI-78D3,JNK inhibitor
3326,6.17,cp,BRD-K69688083,mestinon,Cholinesterase inhibitor
3327,6.17,cp,BRD-A36318220,necrostatin-1,RIPK inhibitor
3328,6.17,cp,BRD-K06895174,cisapride,Serotonin receptor agonist
4972,0,oe,ccsbBroad304_00329,CLTA,-
4973,0,oe,ccsbBroad304_00316,CKS1B,-
3323,6.22,cc,,Nucleoside reverse transcriptase inhibitor,-
4974,0,oe,ccsbBroad304_06004,CKB,-
4975,0,oe,ccsbBroad304_03666,CISD1,CDGSH iron sulfur domain containing
3318,6.26,cp,BRD-K92870997,pterostilbene,Cyclooxygenase inhibitor
4976,0,oe,ccsbBroad304_02133,CD83,CD molecules
4977,0,oe,ccsbBroad304_00268,CD81,CD molecules
4978,0,oe,ccsbBroad304_00262,CD59,CD molecules
3316,6.28,cp,BRD-A97739905,ketoprofen,Cyclooxygenase inhibitor
4979,0,oe,ccsbBroad304_00249,CD14,CD molecules
4980,0,oe,ccsbBroad304_00240,CCNH,General transcription factor IIH complex subunits
3312,6.31,cp,BRD-K35240538,methylprednisolone,Glucocorticoid receptor agonist
3313,6.31,cp,BRD-K51018020,VAMA-37,DNA dependent protein kinase inhibitor
3310,6.32,cc,,PDGFR/KIT inhibitor,-
3311,6.32,cp,BRD-K68132782,terbinafine,Fungal squalene epoxidase inhibitor
4981,0,oe,ccsbBroad304_01495,CCL2,Chemokine ligands
3308,6.34,cp,BRD-A01593789,chlormadinone,5-alpha reductase inhibitor
4982,0,oe,ccsbBroad304_05942,CBS,Hydrogen sulphide synthesis
3306,6.36,cp,BRD-K09497549,kawain,Calcium channel modulator
4983,0,oe,ccsbBroad304_00223,CASP9,Caspases
4984,0,oe,ccsbBroad304_00221,CASP3,Caspases
4985,0,oe,ccsbBroad304_03047,BZW2,-
4986,0,oe,ccsbBroad304_02569,BTG3,-
4987,0,oe,ccsbBroad304_00170,BNIP1,-
4988,0,oe,ccsbBroad304_01951,BLZF1,-
3299,6.4,cp,BRD-K63979671,etifenin,Compound used in hepatobiliary scans of the liver
4989,0,oe,ccsbBroad304_05836,BIRC5,Inhibitors of apoptosis (IAP) protein family
3298,6.41,cp,BRD-K22096725,ALW-II-49-7,Ephrin inhibitor
3296,6.42,cp,BRD-K54256913,MK-1775,WEE1 kinase inhibitor
3295,6.43,cp,BRD-K97810537,beclometasone,Glucocorticoid receptor agonist
3290,6.44,cp,BRD-K73824630,skatole,Thrombin inhibitor
3291,6.44,cp,BRD-K60640630,mometasone,Glucocorticoid receptor agonist
4990,0,oe,ccsbBroad304_03599,BATF3,basic leucine zipper proteins
4991,0,oe,ccsbBroad304_00147,BAG1,-
4992,0,oe,ccsbBroad304_02604,B3GNT1,-
4993,0,oe,ccsbBroad304_00135,ATP6V0C,ATPases / V-type
4994,0,oe,ccsbBroad304_00138,ATP6V0B,ATPases / V-type
3289,6.48,cp,BRD-K20920669,cromoglicic-acid,Immunosuppressant
3286,6.49,cp,BRD-K96778649,tyrphostin-47,EGFR inhibitor
4995,0,oe,ccsbBroad304_07657,ATP5L,ATPases / F-type
3284,6.52,cp,BRD-K39621635,artemether,Antimalarial
4996,0,oe,ccsbBroad304_00129,ATP5D,ATPases / F-type
4997,0,oe,ccsbBroad304_00127,ATP5B,ATPases / F-type
4998,0,oe,ccsbBroad304_00120,ATOX1,-
3280,6.55,cp,BRD-K57304726,PRE-084,Sigma receptor agonist
3281,6.55,cp,BRD-K90543092,levonorgestrel,Estrogen receptor agonist
4999,0,oe,ccsbBroad304_00116,ASS1,-
5000,0,oe,ccsbBroad304_00113,ASNS,-
5001,0,oe,ccsbBroad304_07273,ASMTL,Pseudoautosomal regions / PAR1
5002,0,oe,ccsbBroad304_02466,ARPC1A,Actin related protein 2/3 complex subunits
5003,0,oe,ccsbBroad304_00084,APOH,Apolipoproteins
3274,6.58,cp,BRD-K63641886,cefuroxime,Bacterial cell wall synthesis inhibitor
3270,6.59,cp,BRD-K13566078,BMS-345541,IKK inhibitor
3271,6.59,cp,BRD-K12516989,zaprinast,Phosphodiesterase inhibitor
3272,6.59,cp,BRD-K55301415,abiraterone,"17,20 lyase inhibitor"
3268,6.61,cp,BRD-K81847782,scandenin,Plant compound with antimicrobial activity
5004,0,oe,ccsbBroad304_05838,APOC2,Apolipoproteins
5005,0,oe,ccsbBroad304_00077,APEX1,-
5006,0,oe,ccsbBroad304_06008,AP2M1,-
5007,0,oe,ccsbBroad304_03532,ANKZF1,Ankyrin repeat domain containing
5008,0,oe,ccsbBroad304_00052,ALDH3A2,Aldehyde dehydrogenases
5009,0,oe,ccsbBroad304_05801,ALDH3A1,Aldehyde dehydrogenases
5010,0,oe,ccsbBroad304_00046,AKT1,Akt (Protein kinase B)
5011,0,oe,ccsbBroad304_03565,ADI1,-
5012,0,oe,ccsbBroad304_00028,ADH5,Alcohol dehydrogenases
3258,6.68,cp,BRD-K72264770,QW-BI-011,Histone lysine methyltransferase inhibitor
5013,0,oe,ccsbBroad304_00024,ADCY3,Adenylyl cyclases
5014,0,oe,ccsbBroad304_02313,ACTR3,-
3255,6.69,cp,BRD-M45964048,verteporfin,Photosensitizing agent
5015,0,oe,ccsbBroad304_05759,ACAT2,Lanosterol biosynthesis pathway
3257,6.69,cp,BRD-K11742128,triprolidine,Histamine receptor antagonist
3252,6.7,cp,BRD-A15034104,bergenin,Interleukin inhibitor
5016,0,oe,ccsbBroad304_07542,ABCF2,ATP binding cassette transporters / subfamily F
5017,0,oe,ccsbBroad304_05471,ABCB5,ATP binding cassette transporters / subfamily B
5088,0,kd,CGS001-7695,ZNF136,"Zinc fingers, C2H2-type"
3248,6.72,cp,BRD-K82561139,ricinine,Casein kinase inhibitor
5089,0,kd,CGS001-8239,USP9X,Ubiquitin-specific peptidases
3246,6.73,cp,BRD-K88304388,dextrorphan,Glutamate receptor antagonist
3247,6.73,cp,BRD-K85266041,DNQX,Glutamate receptor antagonist
5090,0,kd,CGS001-51720,UIMC1,-
5091,0,kd,CGS001-54578,UGT1A6,UDP glucuronosyltransferases
5092,0,kd,CGS001-85480,TSLP,-
5093,0,kd,CGS001-7155,TOP2B,DNA Topoisomerases
5094,0,kd,CGS001-9967,THRAP3,-
5095,0,kd,CGS001-6827,SUPT4H1,-
5096,0,kd,CGS001-8464,SUPT3H,-
5097,0,kd,CGS001-29888,STRN4,WD repeat domain containing
5098,0,kd,CGS001-56731,SLC2A4RG,-
5099,0,kd,CGS001-6558,SLC12A2,SLC12 family of cation-coupled chloride transporters
3235,6.79,cp,BRD-K71289571,zafirlukast,Leukotriene receptor antagonist
3232,6.81,cp,BRD-A80383043,BRD-A80383043,Glutamate receptor agonist
5100,0,kd,CGS001-23678,SGK3,SGK family
5101,0,kd,CGS001-5269,SERPINB6,Serine (or cysteine) peptidase inhibitors
5102,0,kd,CGS001-222546,RFX6,-
3231,6.82,cp,BRD-A64297288,amlodipine,Calcium channel blocker
5103,0,kd,CGS001-54884,RETSAT,-
5104,0,kd,CGS001-25865,PRKD2,Pleckstrin homology (PH) domain containing
5105,0,kd,CGS001-25824,PRDX5,-
5106,0,kd,CGS001-5325,PLAGL1,"Zinc fingers, C2H2-type"
3221,6.87,cp,BRD-K59773493,benzohydroxamic-acid,Antifungal
3222,6.87,cp,BRD-K49668410,clarithromycin,Bacterial 50S ribosomal subunit inhibitor
3223,6.87,cp,BRD-K76617868,fasudil,Rho associated kinase inhibitor
5107,0,kd,CGS001-5194,PEX13,-
5108,0,kd,CGS001-7703,PCGF2,Polycomb group ring fingers
5109,0,kd,CGS001-10038,PARP2,Poly (ADP-ribose) polymerases
5110,0,kd,CGS001-4976,OPA1,-
5111,0,kd,CGS001-4905,NSF,ATPases / AAA-type
5112,0,kd,CGS001-57407,NMRAL1,Short chain dehydrogenase/reductase superfamily / Atypical members
5113,0,kd,CGS001-10783,NEK6,NIMA (never in mitosis gene a)- related kinase (NEK) family
5114,0,kd,CGS001-2475,MTOR,FRAP subfamily
5115,0,kd,CGS001-4488,MSX2,Homeoboxes / ANTP class : NKL subclass
5116,0,kd,CGS001-9412,MED21,-
5117,0,kd,CGS001-3643,INSR,Type II RTKs: Insulin receptor family
3211,6.97,cp,BRD-K70330367,amantadine,Glutamate receptor antagonist
5118,0,kd,CGS001-3551,IKBKB,IKK family
3208,7.01,cp,BRD-K74112339,acetohydroxamic-acid,Urease inhibitor
3209,7.01,cp,BRD-K53545112,CNQX,Glutamate receptor antagonist
5119,0,kd,CGS001-344561,GPR148,GPCR / Class A : Orphans
5120,0,kd,CGS001-266977,GPR110,Adhesion Class GPCRs
3205,7.04,cp,BRD-A13084692,troglitazone,Insulin sensitizer
5121,0,kd,CGS001-2558,GABRA5,GABA receptors
5122,0,kd,CGS001-64123,ELTD1,Adhesion Class GPCRs
3201,7.08,cp,BRD-K15567136,papaverine,Phosphodiesterase inhibitor
3202,7.08,cp,BRD-A07875874,cilnidipine,Calcium channel blocker
5123,0,kd,CGS001-2004,ELK3,ETS Transcription Factors
5124,0,kd,CGS001-22894,DIS3,-
5125,0,kd,CGS001-3579,CXCR2,Chemokine receptors
5126,0,kd,CGS001-9541,CIR1,-
5127,0,kd,CGS001-1119,CHKA,-
3192,7.18,cp,BRD-K49657628,tyrphostin-AG-18,EGFR inhibitor
5128,0,kd,CGS001-81620,CDT1,-
5129,0,kd,CGS001-805,CALM2,EF-hand domain containing
5130,0,kd,CGS001-8315,BRAP,RING-type (C3HC4) zinc fingers
3190,7.19,cp,BRD-K13927029,retinol,Retinoid receptor ligand
5131,0,kd,CGS001-283,ANG,"Ribonucleases, RNase A"
5132,0,kd,CGS001-9183,ZW10,-
5133,0,kd,CGS001-146050,ZSCAN29,"Zinc fingers, C2H2-type"
3188,7.23,cp,BRD-K53318339,vinpocetine,Phosphodiesterase inhibitor
5134,0,kd,CGS001-8233,ZRSR2,RNA binding motif (RRM) containing
5135,0,kd,CGS001-136051,ZNF786,"Zinc fingers, C2H2-type"
3181,7.26,cc,,DNA polymerase inhibitor,-
5136,0,kd,CGS001-58492,ZNF77,"Zinc fingers, C2H2-type"
3183,7.26,cp,BRD-K40919711,BAPTA-AM,Potassium channel blocker
5137,0,kd,CGS001-55657,ZNF692,"Zinc fingers, C2H2-type"
5138,0,kd,CGS001-342926,ZNF677,"Zinc fingers, C2H2-type"
3178,7.29,cp,BRD-K62736196,guanabenz,-666
5139,0,kd,CGS001-55634,ZNF673,-
5140,0,kd,CGS001-162963,ZNF610,"Zinc fingers, C2H2-type"
3177,7.31,cp,BRD-K81729199,AQ-RA741,Acetylcholine receptor antagonist
5141,0,kd,CGS001-84775,ZNF607,"Zinc fingers, C2H2-type"
5142,0,kd,CGS001-126295,ZNF57,"Zinc fingers, C2H2-type"
3171,7.35,cp,BRD-K24240364,GYKI-52466,Glutamate receptor antagonist
3172,7.35,cp,BRD-K79092138,nitrofural,Bacterial DNA inhibitor
5143,0,kd,CGS001-54811,ZNF562,"Zinc fingers, C2H2-type"
3170,7.36,cp,BRD-K10466330,AVA,Nucleophosmin inhibitor
5144,0,kd,CGS001-148156,ZNF558,"Zinc fingers, C2H2-type"
5145,0,kd,CGS001-57474,ZNF490,"Zinc fingers, C2H2-type"
5146,0,kd,CGS001-55311,ZNF444,"Zinc fingers, C2H2-type"
3166,7.44,cp,BRD-A11990600,lorazepam,Benzodiazepine receptor agonist
3165,7.47,cp,BRD-A94543220,bifonazole,Sterol demethylase inhibitor
5147,0,kd,CGS001-59348,ZNF350,"Zinc fingers, C2H2-type"
3164,7.49,cp,BRD-K55748775,SCH-28080,ATPase inhibitor
5148,0,kd,CGS001-162979,ZNF296,"Zinc fingers, C2H2-type"
5149,0,kd,CGS001-7988,ZNF212,"Zinc fingers, C2H2-type"
5150,0,kd,CGS001-57684,ZBTB26,BTB/POZ domain containing
5151,0,kd,CGS001-10652,YKT6,-
5152,0,kd,CGS001-25937,WWTR1,Hippo Signaling
5153,0,kd,CGS001-7481,WNT11,Wingless-type MMTV integration sites
5154,0,kd,CGS001-51231,VRK3,Vaccina related kinase (VRK) family
5155,0,kd,CGS001-6944,VPS72,-
3154,7.56,cp,BRD-K05977823,tenovins,SIRT inhibitor
3153,7.57,cp,BRD-A31007383,SDZ-WAG-994,Adenosine receptor agonist
3151,7.58,cp,BRD-A32349859,methyl-angolensate,Apoptosis inhibitor
5156,0,kd,CGS001-317703,VN1R4,"GPCR / Unclassified : Vomeronasal receptors, type 1"
3150,7.6,cp,BRD-K19220233,JNK-9L,JNK inhibitor
5157,0,kd,CGS001-7428,VHL,-
5158,0,kd,CGS001-6845,VAMP7,Pseudoautosomal regions / PAR2
5159,0,kd,CGS001-9958,USP15,Ubiquitin-specific peptidases
5160,0,kd,CGS001-7374,UNG,-
5161,0,kd,CGS001-55148,UBR7,Ubiquitin protein ligase E3 component n-recognins
5162,0,kd,CGS001-7337,UBE3A,-
5163,0,kd,CGS001-10477,UBE2E3,Ubiquitin-conjugating enzymes E2
3141,7.72,cc,,Aurora kinase inhibitor,-
5164,0,kd,CGS001-10628,TXNIP,-
3139,7.73,cp,BRD-A29731977,17-hydroxyprogesterone-caproate,progesterone receptor agonist
5165,0,kd,CGS001-10190,TXNDC9,-
3138,7.74,cp,BRD-A14985772,ascorbyl-palmitate,antioxidant
5166,0,kd,CGS001-7263,TST,-
5167,0,kd,CGS001-7106,TSPAN4,Tetraspanins
3135,7.78,cp,BRD-K31542390,mycophenolic-acid,Dehydrogenase inhibitor
3133,7.79,cp,BRD-K13800121,parecoxib,Cyclooxygenase inhibitor
5168,0,kd,CGS001-7247,TSN,-
3132,7.8,cp,BRD-K50384076,"7,4'-dihydroxyflavone",Opioid receptor antagonist
3130,7.82,cp,BRD-K64755930,etazolate,Phosphodiesterase inhibitor
5169,0,kd,CGS001-1831,TSC22D3,-
3128,7.83,cp,BRD-K02590140,O-2050,Cannabinoid receptor antagonist
3129,7.83,cp,BRD-A09539288,homatropine,Acetylcholine receptor antagonist
3126,7.84,cp,BRD-K76872913,benzanthrone,Aromatic hydrocarbon derivative
5170,0,kd,CGS001-7204,TRIO,Rho guanine nucleotide exchange factors
5171,0,kd,CGS001-10475,TRIM38,-
5172,0,kd,CGS001-79090,TRAPPC6A,Trafficking protein particle complex
3121,7.88,cp,BRD-K30697463,desoximetasone,Glucocorticoid receptor agonist
3122,7.88,cp,BRD-A45140972,meclocycline,Bacterial 30S ribosomal subunit inhibitor
5173,0,kd,CGS001-7185,TRAF1,-
5174,0,kd,CGS001-8741,TNFSF13,CD molecules
5175,0,kd,CGS001-8792,TNFRSF11A,Tumour necrosis factor (TNF) receptor family
5176,0,kd,CGS001-54732,TMED9,-
5177,0,kd,CGS001-51014,TMED7,-
5178,0,kd,CGS001-11011,TLK2,Tousled-like kinase (TLK) family
5179,0,kd,CGS001-114609,TIRAP,-
3114,7.96,cp,BRD-K55930204,phenytoin,Hydantoin antiepileptic
3115,7.96,cp,BRD-K21548250,moracizine,Sodium channel blocker
5180,0,kd,CGS001-25976,TIPARP,Poly (ADP-ribose) polymerases
3111,8.01,cp,BRD-K29653726,topiramate,Carbonic anhydrase inhibitor
5181,0,kd,CGS001-8914,TIMELESS,-
3109,8.02,cp,BRD-K23369905,oxiconazole,Bacterial cell wall synthesis inhibitor
5182,0,kd,CGS001-7046,TGFBR1,Type I receptor serine/threonine kinases
5183,0,kd,CGS001-6926,TBX3,T-boxes
5184,0,kd,CGS001-1155,TBCB,-
5185,0,kd,CGS001-6894,TARBP1,-
5186,0,kd,CGS001-27097,TAF5L,WD repeat domain containing
5187,0,kd,CGS001-6884,TAF13,-
3101,8.07,cp,BRD-K82484965,carmoxirole,Dopamine receptor agonist
5188,0,kd,CGS001-83551,TAAR8,GPCR / Class A : Trace amine associated receptors
5189,0,kd,CGS001-23075,SWAP70,EF-hand domain containing
3099,8.09,cp,BRD-K89046952,ciclacillin,Bacterial cell wall synthesis inhibitor
3097,8.1,cp,BRD-K66782112,BRD-K66782112,Histamine receptor antagonist
3098,8.1,cp,BRD-K57179821,crotamiton,Antipruritic
5190,0,kd,CGS001-56670,SUCNR1,GPCR / Class A : Orphans
3095,8.18,cp,BRD-A39415247,norethisterone,Progesterone receptor agonist
3093,8.2,cp,BRD-K46678324,RHO-kinase-inhibitor-II,Rho associated kinase inhibitor
5191,0,kd,CGS001-6813,STXBP2,-
5192,0,kd,CGS001-6812,STXBP1,-
5193,0,kd,CGS001-10273,STUB1,Tetratricopeptide (TTC) repeat domain containing
5194,0,kd,CGS001-27347,STK39,FRAY subfamily
5195,0,kd,CGS001-55620,STAP2,-
3088,8.24,cp,BRD-A75478957,PD-166793,Metalloproteinase inhibitor
5196,0,kd,CGS001-10610,ST6GALNAC2,Sialyltransferases
3086,8.28,cp,BRD-K34533029,tyrphostin-AG-494,EGFR inhibitor
5197,0,kd,CGS001-6732,SRPK1,SRPK family
5198,0,kd,CGS001-23380,SRGAP2,Rho GTPase activating proteins
5199,0,kd,CGS001-121599,SPIC,ETS Transcription Factors
3082,8.37,cp,BRD-A44780397,mifepristone,Glucocorticoid receptor antagonist
5200,0,kd,CGS001-9552,SPAG7,-
3079,8.39,cp,BRD-K83597974,pargyline,Monoamine oxidase inhibitor
5201,0,kd,CGS001-6670,SP3,Specificity protein transcription factors
5202,0,kd,CGS001-93349,SP140L,"Zinc fingers, PHD-type"
3077,8.4,cp,BRD-A75402480,desoxycorticosterone,Mineralocorticoid receptor agonist
5203,0,kd,CGS001-11262,SP140,"Zinc fingers, PHD-type"
3074,8.42,cp,BRD-K28849549,mesalazine,Cyclooxygenase inhibitor
5204,0,kd,CGS001-3431,SP110,Non-enzymatic BRD containing proteins
5205,0,kd,CGS001-9655,SOCS5,SH2 domain containing
5206,0,kd,CGS001-333929,SNAI3,Snail homologs
5207,0,kd,CGS001-64094,SMOC2,EF-hand domain containing
5208,0,kd,CGS001-10051,SMC4,Structural maintenance of chromosomes proteins
5209,0,kd,CGS001-6520,SLC3A2,SLC3 family
3068,8.49,cp,BRD-K76698671,HNHA,HDAC inhibitor
5210,0,kd,CGS001-206358,SLC36A1,SLC36 family of proton-coupled amino acid transporters
5211,0,kd,CGS001-6514,SLC2A2,Solute carriers
3064,8.54,cp,BRD-K26015241,ODQ,Guanylyl cyclase inhibitor
5212,0,kd,CGS001-29957,SLC25A24,Mitochondrial nucleotide transporter subfamily
5213,0,kd,CGS001-10165,SLC25A13,Mitochondrial amino acid transporter subfamily
5214,0,kd,CGS001-9121,SLC16A5,SLC16 family of monocarboxylate transporters
5215,0,kd,CGS001-9123,SLC16A3,SLC16 family of monocarboxylate transporters
3058,8.58,cp,BRD-A30815329,felodipine,Calcium channel blocker
5216,0,kd,CGS001-10723,SLC12A7,SLC12 family of cation-coupled chloride transporters
5217,0,kd,CGS001-51804,SIX4,Homeoboxes / SINE class
3053,8.6,cc,,Vitamin D receptor agonist,-
3054,8.6,cp,BRD-K02950022,BMS-299897,Gamma secretase inhibitor
3055,8.6,cp,BRD-A65449987,flunisolide,Cytochrome P450 inhibitor
3056,8.6,cp,BRD-K85090592,pilocarpine,Acetylcholine receptor agonist
3057,8.6,cp,BRD-A75368507,demeclocycline,Bacterial 30S ribosomal subunit inhibitor
5218,0,kd,CGS001-23411,SIRT1,Histone deacetylases
3050,8.63,cp,BRD-A56012032,thiorphan,Membrane metalloendopeptidase inhibitor
5219,0,kd,CGS001-10019,SH2B3,Pleckstrin homology (PH) domain containing
5220,0,kd,CGS001-29946,SERTAD3,-
5221,0,kd,CGS001-5345,SERPINF2,Serine (or cysteine) peptidase inhibitors
5222,0,kd,CGS001-205564,SENP5,-
5223,0,kd,CGS001-9632,SEC24C,-
3044,8.67,cp,BRD-K05658747,raltegravir,HIV integrase inhibitor
5224,0,kd,CGS001-10427,SEC24B,-
5225,0,kd,CGS001-6392,SDHD,Mitochondrial respiratory chain complex / Complex II
3042,8.71,cc,,Cyclin dependent kinases LOF,-
5226,0,kd,CGS001-6391,SDHC,Mitochondrial respiratory chain complex / Complex II
5227,0,kd,CGS001-6390,SDHB,Mitochondrial respiratory chain complex / Complex II
3037,8.74,cp,BRD-K97365803,PI-828,PI3K inhibitor
5228,0,kd,CGS001-80274,SCUBE1,-
3039,8.74,cp,BRD-K49519144,LY-2140023,Glutamate receptor agonist
5229,0,kd,CGS001-9805,SCRN1,-
5230,0,kd,CGS001-22908,SACM1L,-
5231,0,kd,CGS001-170591,S100Z,EF-hand domain containing
3033,8.78,cp,BRD-A74667430,etodolac,Cyclooxygenase inhibitor
5232,0,kd,CGS001-6195,RPS6KA1,RSK subfamily
3031,8.81,cp,BRD-A80928489,1-monopalmitin,P-glycoprotein inhibitor
5233,0,kd,CGS001-80135,RPF1,-
3029,8.84,cc,,PI3K inhibitor,-
5234,0,kd,CGS001-6048,RNF5,RING-type (C3HC4) zinc fingers
5235,0,kd,CGS001-5971,RELB,NFkappaB transcription factor family
5236,0,kd,CGS001-57665,RDH14,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2
5237,0,kd,CGS001-5933,RBL1,-
3024,8.86,cp,BRD-M64432851,sunitinib,FLT3 inhibitor
3023,8.87,cp,BRD-A74904029,EI-231,Casein kinase inhibitor
5238,0,kd,CGS001-5930,RBBP6,-
5239,0,kd,CGS001-5928,RBBP4,WD repeat domain containing
5240,0,kd,CGS001-5925,RB1,Endogenous ligands
5241,0,kd,CGS001-5915,RARB,Retinoic acid receptors
3021,8.89,cp,BRD-A94793051,gestrinone,Progesterone receptor antagonist
3017,8.91,cp,BRD-K69763916,LY-341495,Glutamate receptor antagonist
3016,8.92,cp,BRD-K51066026,aminoindazole,Ionophore
3015,8.93,cp,BRD-K99616396,motesanib,KIT inhibitor
5242,0,kd,CGS001-5906,RAP1A,-
5243,0,kd,CGS001-5900,RALGDS,-
5244,0,kd,CGS001-5889,RAD51C,"Fanconi anemia, complementation groups"
5245,0,kd,CGS001-7879,RAB7A,"RAB, member RAS oncogene"
5246,0,kd,CGS001-11031,RAB31,"RAB, member RAS oncogene"
5247,0,kd,CGS001-81876,RAB1B,"RAB, member RAS oncogene"
5248,0,kd,CGS001-65263,PYCRL,-
3007,9.03,cp,BRD-A24514565,warfarin,Vitamin K antagonist
5249,0,kd,CGS001-5829,PXN,-
5250,0,kd,CGS001-5819,PVRL2,Immunoglobulin superfamily / C2-set domain containing
5251,0,kd,CGS001-9232,PTTG1,-
5252,0,kd,CGS001-284119,PTRF,-
3002,9.07,cp,BRD-K63533170,AM-630,Cannabinoid receptor antagonist
5253,0,kd,CGS001-9200,PTPLA,-
5254,0,kd,CGS001-5743,PTGS2,Cyclooxygenase
5255,0,kd,CGS001-5714,PSMD8,"Proteasome (prosome, macropain) subunits"
5256,0,kd,CGS001-5699,PSMB10,"Proteasome (prosome, macropain) subunits"
5257,0,kd,CGS001-5660,PSAP,Endogenous ligands
5258,0,kd,CGS001-5621,PRNP,CD molecules
5259,0,kd,CGS001-5579,PRKCB,Alpha subfamily
5260,0,kd,CGS001-5571,PRKAG1,AMPK subfamily
2993,9.2,cp,BRD-A37817666,picrotoxin,GABA receptor antagonist
5261,0,kd,CGS001-11105,PRDM7,"Zinc fingers, C2H2-type"
5262,0,kd,CGS001-5538,PPT1,-
5263,0,kd,CGS001-5535,PPP3R2,EF-hand domain containing
5264,0,kd,CGS001-5530,PPP3CA,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
5265,0,kd,CGS001-5511,PPP1R8,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
5266,0,kd,CGS001-5495,PPM1B,"Serine/threonine phosphatases / Protein phosphatases, Mg2+/Mn2+ dependent"
5267,0,kd,CGS001-134187,POU5F2,Homeoboxes / POU class
5268,0,kd,CGS001-5450,POU2AF1,-
2984,9.29,cp,BRD-K96740444,itopride,Dopamine receptor antagonist
5269,0,kd,CGS001-51728,POLR3K,RNA polymerase subunits
2981,9.33,cp,BRD-K18678457,ZD-7288,HCN channel blocker
2982,9.33,cp,BRD-K19284129,salvinorin-a,Opioid receptor agonist
5270,0,kd,CGS001-5435,POLR2F,RNA polymerase subunits
5271,0,kd,CGS001-5432,POLR2C,RNA polymerase subunits
5272,0,kd,CGS001-5428,POLG,DNA polymerases
2976,9.37,cp,BRD-K21350491,phenamil,TRPV antagonist
5273,0,kd,CGS001-57048,PLSCR3,-
2974,9.38,cp,BRD-A79903587,tegafur,Thymidylate synthase inhibitor
5274,0,kd,CGS001-5352,PLOD2,-
2971,9.42,cp,BRD-K82147103,lofepramine,Norepinephrine reuptake inhibitor
2972,9.42,cp,BRD-K07117950,imperatorin,CDK inhibitor
5275,0,kd,CGS001-23659,PLA2G15,-
2970,9.43,cp,BRD-A63546914,RO-04-5595,Glutamate receptor antagonist
2968,9.44,cc,,Wnt family LOF,-
2969,9.44,cp,BRD-A54029483,IRL-2500,Endothelin receptor antagonist
5276,0,kd,CGS001-84647,PLA2G12B,-
5277,0,kd,CGS001-5586,PKN2,Protein kinase N (PKN) family
5278,0,kd,CGS001-5306,PITPNA,-
5279,0,kd,CGS001-5287,PIK3C2B,Phosphatidylinositol-4-phosphate 3-kinase family
2963,9.52,cp,BRD-A87479750,tenidap,Cyclooxygenase inhibitor
5280,0,kd,CGS001-5297,PI4KA,1-phosphatidylinositol 4-kinase family
5281,0,kd,CGS001-112885,PHF21B,"Zinc fingers, PHD-type"
2959,9.61,cc,,TGF beta receptor inhibitor,-
5282,0,kd,CGS001-55274,PHF10,"Zinc fingers, PHD-type"
5283,0,kd,CGS001-5193,PEX12,-
5284,0,kd,CGS001-3651,PDX1,Homeoboxes / ANTP class : HOXL subclass
5285,0,kd,CGS001-9601,PDIA4,Protein disulfide isomerases
5286,0,kd,CGS001-5162,PDHB,-
5287,0,kd,CGS001-11333,PDAP1,-
5288,0,kd,CGS001-5110,PCMT1,-
5289,0,kd,CGS001-5092,PCBD1,-
2951,9.68,cp,BRD-A25569250,KI-16425,Lysophosphatidic acid receptor antagonist
5290,0,kd,CGS001-55486,PARL,-
5291,0,kd,CGS001-8505,PARG,-
2950,9.69,cp,BRD-K63630713,etacrynic-acid,Sodium/potassium/chloride transporter inhibitor
5292,0,kd,CGS001-5048,PAFAH1B1,WD repeat domain containing
5293,0,kd,CGS001-5036,PA2G4,-
5294,0,kd,CGS001-5033,P4HA1,-
5295,0,kd,CGS001-27199,OXGR1,"GPCR / Class A : Orphans, Oxoglutarate receptor"
5296,0,kd,CGS001-5015,OTX2,Homeoboxes / PRD class
2941,9.76,cp,BRD-K23566484,nilutamide,Androgen receptor antagonist
5297,0,kd,CGS001-161725,OTUD7A,OTU domain containing
5298,0,kd,CGS001-130497,OSR1,"Zinc fingers, C2H2-type"
2936,9.83,cp,BRD-K94649603,taxifolin,Opioid receptor antagonist
2937,9.83,cp,BRD-K30189597,SYK-inhibitor,SYK inhibitor
5299,0,kd,CGS001-9180,OSMR,IL-6 receptor family
2939,9.83,cp,BRD-A21858158,praziquantel,Anthelmintic
2935,9.84,cp,BRD-K62929068,6-benzylaminopurine,Purinergic receptor activator
2934,9.85,cp,BRD-K40578143,GR-79236,Adenosine receptor agonist
5300,0,kd,CGS001-167826,OLIG3,Basic helix-loop-helix proteins
5301,0,kd,CGS001-4946,OAZ1,-
5302,0,kd,CGS001-64710,NUCKS1,-
5303,0,kd,CGS001-22978,NT5C2,Adenosine turnover
5304,0,kd,CGS001-56675,NRIP3,-
5305,0,kd,CGS001-3084,NRG1,Immunoglobulin superfamily / I-set domain containing
2927,9.91,cp,BRD-K37848908,ceforanide,Penicillin binding protein inhibitor
2926,9.93,cp,BRD-A40639672,ketorolac,Cyclooxygenase inhibitor
5306,0,kd,CGS001-4929,NR4A2,Nerve growth factor IB-like receptors
5307,0,kd,CGS001-7376,NR1H2,Liver X receptor-like receptors
5308,0,kd,CGS001-27020,NPTN,Immunoglobulin superfamily / Immunoglobulin-like domain containing
2923,9.97,cp,BRD-K00234327,RU-24969,Serotonin receptor agonist
2921,9.98,cp,BRD-K56301217,ABT-737,BCL inhibitor
5309,0,kd,CGS001-387129,NPSR1,GPCR / Class A : Neuropeptide receptors : S
5310,0,kd,CGS001-9520,NPEPPS,Aminopeptidase N
5311,0,kd,CGS001-10392,NOD1,Nucleotide-binding domain and leucine rich repeat containing
5312,0,kd,CGS001-8508,NIPSNAP1,-
5313,0,kd,CGS001-4811,NID1,-
2914,10.07,cp,BRD-K28667196,fillalbin,Increases arterial blood pressure
2915,10.07,cp,BRD-A34208323,VU-0404997-2,Glutamate receptor modulator
5314,0,kd,CGS001-4791,NFKB2,NFkappaB transcription factor family
2912,10.09,cp,BRD-A14966924,alaproclate,Serotonin receptor antagonist
5315,0,kd,CGS001-4783,NFIL3,basic leucine zipper proteins
5316,0,kd,CGS001-4781,NFIB,-
2910,10.12,cp,BRD-A24228527,ofloxacin,Bacterial DNA gyrase inhibitor
5317,0,kd,CGS001-4779,NFE2L1,basic leucine zipper proteins
5318,0,kd,CGS001-4775,NFATC3,Nuclear factor of activated T-cells
5319,0,kd,CGS001-10276,NET1,Rho guanine nucleotide exchange factors
5320,0,kd,CGS001-91754,NEK9,NIMA (never in mitosis gene a)- related kinase (NEK) family
5321,0,kd,CGS001-4720,NDUFS2,Mitochondrial respiratory chain complex / Complex I
5322,0,kd,CGS001-4708,NDUFB2,Mitochondrial respiratory chain complex / Complex I
2904,10.18,cp,BRD-A46179541,doxapram,Potassium channel blocker
5323,0,kd,CGS001-4678,NASP,Tetratricopeptide (TTC) repeat domain containing
2900,10.22,cp,BRD-K11163873,phenanthridone,PARP inhibitor
2899,10.24,cp,BRD-K81521265,dicyclohexylurea,Epoxide hydolase inhibitor
5324,0,kd,CGS001-55191,NADSYN1,-
5325,0,kd,CGS001-85366,MYLK2,Myosin Light Chain Kinase (MLCK) family
5326,0,kd,CGS001-4507,MTAP,-
5327,0,kd,CGS001-2956,MSH6,-
5328,0,kd,CGS001-117195,MRGPRX3,GPCR / Class A : Orphans
5329,0,kd,CGS001-4351,MPI,-
2891,10.34,cp,BRD-K86465814,HO-013,PPAR receptor agonist
5330,0,kd,CGS001-4286,MITF,Basic helix-loop-helix proteins
5331,0,kd,CGS001-4282,MIF,-
2889,10.36,cp,BRD-A35108200,dexamethasone,Glucocorticoid receptor agonist
5332,0,kd,CGS001-4255,MGMT,-
5333,0,kd,CGS001-11343,MGLL,Endocannabinoid turnover
5334,0,kd,CGS001-4223,MEOX2,Homeoboxes / ANTP class : HOXL subclass
5335,0,kd,CGS001-10001,MED6,-
5336,0,kd,CGS001-80306,MED28,-
2883,10.42,cp,BRD-K73293050,WZ-3146,EGFR inhibitor
5337,0,kd,CGS001-9441,MED26,-
2879,10.44,cp,BRD-K28075147,biochanin-a,Estrogen receptor agonist
5338,0,kd,CGS001-10873,ME3,-
5339,0,kd,CGS001-4171,MCM2,-
5340,0,kd,CGS001-84930,MASTL,MAST family
2875,10.47,cp,BRD-K64935403,ebelactone-b,Lipase inhibitor
2876,10.47,cp,BRD-A54845972,dihydroergotamine,Serotonin receptor agonist
5341,0,kd,CGS001-5606,MAP2K3,MAPKK:STE7 family
5342,0,kd,CGS001-4125,MAN2B1,-
5343,0,kd,CGS001-90678,LRSAM1,Sterile alpha motif (SAM) domain containing
5344,0,kd,CGS001-26020,LRP10,Low density lipoprotein receptors
5345,0,kd,CGS001-1902,LPAR1,GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid
2870,10.56,cp,BRD-A83431637,resmethrin,Cytochrome P450 inhibitor
2869,10.6,cp,BRD-K66876909,linezolid,Bacterial 50S ribosomal subunit inhibitor
5346,0,kd,CGS001-200879,LIPH,-
2866,10.62,cc,,CCK receptor antagonist,-
2867,10.62,cp,BRD-K62858456,lomerizine,Calcium channel blocker
5347,0,kd,CGS001-8549,LGR5,GPCR / Class A : Orphans
5348,0,kd,CGS001-55214,LEPREL1,-
2863,10.69,cp,BRD-K34441861,moexipril,ACE inhibitor
5349,0,kd,CGS001-3927,LASP1,-
5350,0,kd,CGS001-3827,KNG1,Endogenous ligands
5351,0,kd,CGS001-9903,KLHL21,BTB/POZ domain containing
2859,10.78,cp,BRD-K05673000,dicloxacillin,Bacterial cell wall synthesis inhibitor
5352,0,kd,CGS001-23588,KLHDC2,-
5353,0,kd,CGS001-8609,KLF7,Kruppel-like transcription factors
5354,0,kd,CGS001-51274,KLF3,Kruppel-like transcription factors
2855,10.91,cp,BRD-K38436528,imipramine,Norepinephrine reuptake inhibitor
2853,10.94,cp,BRD-K86727142,embelin,HCV inhibitor
2854,10.94,cp,BRD-K17823458,danoprevir,HCV inhibitor
2852,10.95,cp,BRD-A02176148,tubaic-acid,Mitochondrial complex I inhibitor
2849,10.96,cp,BRD-K12079898,PD-160170,Neuropeptide receptor antagonist
5355,0,kd,CGS001-136259,KLF14,Kruppel-like transcription factors
2851,10.96,cp,BRD-A45543382,metrizamide,Radiopaque medium
5356,0,kd,CGS001-23046,KIF21B,Kinesins
5357,0,kd,CGS001-26128,KIAA1279,-
5358,0,kd,CGS001-9703,KIAA0100,-
5359,0,kd,CGS001-10657,KHDRBS1,-
5360,0,kd,CGS001-11015,KDELR3,-
2843,11.04,cp,BRD-K34581968,BMS-536924,IGF-1 inhibitor
5361,0,kd,CGS001-54442,KCTD5,-
2839,11.06,cp,BRD-K21853356,RG-14620,EGFR inhibitor
5362,0,kd,CGS001-3755,KCNG1,Voltage-gated potassium channels
5363,0,kd,CGS001-3735,KARS,Aminoacyl tRNA synthetases / Class II
5364,0,kd,CGS001-83737,ITCH,-
2837,11.08,cp,BRD-K29173907,isoflupredone,Glucocorticoid receptor agonist
5365,0,kd,CGS001-345611,IRGM,-
5366,0,kd,CGS001-3559,IL2RA,IL-2 receptor family
5367,0,kd,CGS001-3596,IL13,Interleukins and interleukin receptors
5368,0,kd,CGS001-93185,IGSF8,CD molecules
2831,11.16,cp,BRD-A77050075,heraclenol,Vitamin K antagonist
2832,11.16,cp,BRD-A00100033,nifurtimox,DNA inhibitor
5369,0,kd,CGS001-10643,IGF2BP3,RNA binding motif (RRM) containing
2829,11.17,cp,BRD-K39983086,loteprednol,Glucocorticoid receptor agonist
5370,0,kd,CGS001-10642,IGF2BP1,RNA binding motif (RRM) containing
5371,0,kd,CGS001-3481,IGF2,-
5372,0,kd,CGS001-7866,IFRD2,-
5373,0,kd,CGS001-3458,IFNG,Interferons
5374,0,kd,CGS001-3456,IFNB1,Interferons
5375,0,kd,CGS001-8870,IER3,-
5376,0,kd,CGS001-3383,ICAM1,CD molecules
5377,0,kd,CGS001-3297,HSF1,-
5378,0,kd,CGS001-3295,HSD17B4,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3
5379,0,kd,CGS001-3281,HSBP1,-
5380,0,kd,CGS001-3269,HRH1,Histamine receptors
2816,11.33,cp,BRD-A94709349,metaxalone,Muscle relaxant
2817,11.33,cp,BRD-K64514229,toltrazuril,Antiprotozoal
5381,0,kd,CGS001-3248,HPGD,Prostaglandin synthases
5382,0,kd,CGS001-3215,HOXB5,Homeoboxes / ANTP class : HOXL subclass
5383,0,kd,CGS001-84525,HOPX,Homeoboxes / PRD class
2811,11.42,cp,BRD-K08973992,linoleic-acid,Oxidative stress inducer
5384,0,kd,CGS001-9455,HOMER2,-
5385,0,kd,CGS001-3157,HMGCS1,Lanosterol biosynthesis pathway
2810,11.45,cp,BRD-K26117720,gingerol,Nitric oxide synthase inhibitor
5386,0,kd,CGS001-127540,HMGB4,High-mobility group / Canonical
5387,0,kd,CGS001-3149,HMGB3,High-mobility group / Canonical
5388,0,kd,CGS001-3131,HLF,-
2804,11.51,cp,BRD-A55946879,BW-B70C,Lipoxygenase inhibitor
5389,0,kd,CGS001-3126,HLA-DRB4,Immunoglobulin superfamily / C1-set domain containing
2802,11.52,cp,BRD-K64800655,PHA-793887,CDK inhibitor
5390,0,kd,CGS001-3123,HLA-DRB1,Immunoglobulin superfamily / C1-set domain containing
5391,0,kd,CGS001-3115,HLA-DPB1,Immunoglobulin superfamily / C1-set domain containing
5392,0,kd,CGS001-8334,HIST1H2AC,Histones / Replication-dependent
5393,0,kd,CGS001-204851,HIPK1,HIPK subfamily
2798,11.56,cp,BRD-K37206356,rhamnetin,HDAC inhibitor
5394,0,kd,CGS001-3077,HFE,Immunoglobulin superfamily / C1-set domain containing
5395,0,kd,CGS001-3280,HES1,Basic helix-loop-helix proteins
2795,11.63,cp,BRD-K30097969,pitavastatin,HMGCR inhibitor
5396,0,kd,CGS001-50865,HEBP1,Endogenous ligands
2793,11.66,cp,BRD-K18905250,ST-91,Adrenergic receptor agonist
5397,0,kd,CGS001-27198,HCAR1,GPCR / Class A : Hydroxy-carboxylic acid receptors
5398,0,kd,CGS001-3035,HARS,Aminoacyl tRNA synthetases / Class II
2789,11.72,cp,BRD-K67439147,SIB-1893,Glutamate receptor antagonist
5399,0,kd,CGS001-2987,GUK1,-
5400,0,kd,CGS001-2967,GTF2H3,General transcription factors
5401,0,kd,CGS001-2963,GTF2F2,General transcription factors
2788,11.75,cp,BRD-K28183345,proguanil,Dihydrofolate reductase inhibitor
5402,0,kd,CGS001-2957,GTF2A1,General transcription factors
5403,0,kd,CGS001-2870,GRK6,GRK1/3 subfamily
2783,11.8,cp,BRD-K31553034,zibotentan,Endothelin receptor antagonist
5404,0,kd,CGS001-2886,GRB7,Pleckstrin homology (PH) domain containing
2781,11.82,cp,BRD-K16336526,capsaicin,TRPV agonist
2780,11.83,cp,BRD-K89626439,sirolimus,MTOR inhibitor
2778,11.84,cp,BRD-A78877355,nefopam,Cyclooxygenase inhibitor
5405,0,kd,CGS001-2885,GRB2,SH2 domain containing
5406,0,kd,CGS001-2876,GPX1,-
5407,0,kd,CGS001-9052,GPRC5A,GPCR / Class C : Orphans
5408,0,kd,CGS001-83873,GPR61,GPCR / Class A : Orphans
5409,0,kd,CGS001-2861,GPR37,GPCR / Class A : Orphans
2772,11.98,cc,,FOS transcription factor family GOF,-
5410,0,kd,CGS001-390212,GPR152,GPCR / Class A : Orphans
2771,12.02,cp,BRD-K76568384,PHTPP,Estrogen receptor antagonist
5411,0,kd,CGS001-124274,GPR139,GPCR / Class A : Orphans
5412,0,kd,CGS001-166647,GPR125,Adhesion Class GPCRs
5413,0,kd,CGS001-2805,GOT1,-
5414,0,kd,CGS001-2793,GNGT2,-
5415,0,kd,CGS001-2782,GNB1,WD repeat domain containing
5416,0,kd,CGS001-2752,GLUL,-
5417,0,kd,CGS001-2745,GLRX,-
5418,0,kd,CGS001-2710,GK,Glycerol kinases
5419,0,kd,CGS001-8836,GGH,Gamma-glutamyl hydrolase
5420,0,kd,CGS001-9945,GFPT2,-
2759,12.12,cp,BRD-K36627727,tamibarotene,Retinoid receptor agonist
2760,12.12,cp,BRD-K88358234,xaliproden,Serotonin receptor agonist
2761,12.12,cp,BRD-A17655518,ibuprofen,Cyclooxygenase inhibitor
5421,0,kd,CGS001-81544,GDPD5,-
5422,0,kd,CGS001-2639,GCDH,-
5423,0,kd,CGS001-26301,GBGT1,Glycosyltransferase family 6 domain containing
5424,0,kd,CGS001-2618,GART,Ribosyl transferases
2752,12.16,cp,BRD-K54411430,robustic-acid,cAMP inhibitor
5425,0,kd,CGS001-2592,GALT,-
5426,0,kd,CGS001-2568,GABRP,GABA receptors
5427,0,kd,CGS001-2562,GABRB3,GABA receptors
5428,0,kd,CGS001-79187,FSD1,Fibronectin type III domain containing
5429,0,kd,CGS001-2308,FOXO1,Forkhead boxes
2748,12.23,cp,BRD-A29901043,KIN001-127,ITK inhibitor
5430,0,kd,CGS001-1112,FOXN3,Forkhead boxes
2746,12.25,cp,BRD-K57886322,fluocinonide,Glucocorticoid receptor agonist
5431,0,kd,CGS001-2295,FOXF2,Forkhead boxes
2741,12.27,cp,BRD-K11107424,tiotidine,Histamine receptor antagonist
2742,12.27,cp,BRD-K37447567,hydrocotarnine,Opioid receptor antagonist
5432,0,kd,CGS001-3169,FOXA1,Forkhead boxes
5433,0,kd,CGS001-2348,FOLR1,-
5434,0,kd,CGS001-2335,FN1,Endogenous ligands
2737,12.31,cp,BRD-A27887842,prednisolone,Glucocorticoid receptor agonist
5435,0,kd,CGS001-2280,FKBP1A,Cis-trans-isomerases
5436,0,kd,CGS001-51024,FIS1,-
5437,0,kd,CGS001-2261,FGFR3,Type V RTKs: FGF (fibroblast growth factor) receptor family
5438,0,kd,CGS001-2263,FGFR2,Type V RTKs: FGF (fibroblast growth factor) receptor family
5439,0,kd,CGS001-2244,FGB,Endogenous ligands
2732,12.34,cp,BRD-A06784547,MRS-1334,Adenosine receptor antagonist
5440,0,kd,CGS001-2243,FGA,Endogenous ligands
2730,12.4,cp,BRD-K22947005,dexbrompheniramine,Histamine receptor antagonist
5441,0,kd,CGS001-2864,FFAR1,Fatty acid receptors
2727,12.43,cp,BRD-K94919853,10H-phenothiazin-10-yl)(p-tolyl)methanone,Butyrylcholinesterase inhibitor
5442,0,kd,CGS001-9638,FEZ1,-
5443,0,kd,CGS001-23291,FBXW11,F-boxes / WD-40 domains
5444,0,kd,CGS001-54620,FBXL19,F-boxes / Leucine-rich repeats
2723,12.46,cc,,Calcium channel blocker,-
2724,12.46,cp,BRD-K81473089,tacrine,Acetylcholinesterase inhibitor
2721,12.49,cp,BRD-K87024524,phenelzine,Monoamine oxidase inhibitor
5445,0,kd,CGS001-64319,FBRS,-
5446,0,kd,CGS001-2203,FBP1,-
2719,12.52,cp,BRD-K93880783,stavudine,DNA directed DNA polymerase inhibitor
5447,0,kd,CGS001-2197,FAU,S ribosomal proteins
5448,0,kd,CGS001-2150,F2RL1,GPCR / Class A : Protease activated receptors
2716,12.59,cp,BRD-A95696820,acadesine,AMPK activator
5449,0,kd,CGS001-2118,ETV4,ETS Transcription Factors
2714,12.62,cp,BRD-K41564320,purvalanol-b,Tyrosine kinase inhibitor
5450,0,kd,CGS001-2108,ETFA,-
2712,12.64,cc,,LIM class homeoboxes GOF,-
2710,12.65,cp,BRD-A61858259,CAY-10415,Insulin sensitizer
2711,12.65,cp,BRD-K51941867,LM-1685,Cyclooxygenase inhibitor
5451,0,kd,CGS001-2098,ESD,-
5452,0,kd,CGS001-2058,EPRS,Aminoacyl tRNA synthetases / Class I
5453,0,kd,CGS001-2056,EPO,Endogenous ligands
2706,12.71,cp,BRD-K41707108,ceramide,Phosphoenolpyruvate carboxylase activator
5454,0,kd,CGS001-4072,EPCAM,CD molecules
2703,12.74,cp,BRD-K69837166,trap-101,Nociceptin/orphanin FQ (NOP) receptor antagonist
5455,0,kd,CGS001-55556,ENOSF1,-
2702,12.76,cp,BRD-K11433652,aspirin,Cyclooxygenase inhibitor
2701,12.79,cp,BRD-K82164249,andarine,Androgen receptor modulator
5456,0,kd,CGS001-2023,ENO1,-
5457,0,kd,CGS001-79071,ELOVL6,-
2698,12.91,cp,BRD-A26095496,clobetasol,Glucocorticoid receptor agonist
5458,0,kd,CGS001-1977,EIF4E,Translation Initiation Factor 4E
2696,12.95,cp,BRD-K42221274,NNC-711,GAT inhibitor
5459,0,kd,CGS001-10289,EIF1B,-
5460,0,kd,CGS001-1958,EGR1,"Zinc fingers, C2H2-type"
5461,0,kd,CGS001-1910,EDNRB,Endothelin receptors
5462,0,kd,CGS001-1632,ECI1,-
5463,0,kd,CGS001-10969,EBNA1BP2,-
2690,13,cp,BRD-A03816571,CP-55940,Cannabinoid receptor agonist
2688,13.01,cp,BRD-K93080877,Ala-Ala-Phe-CMK,Tripeptidyl peptidase inhibitor
5464,0,kd,CGS001-1859,DYRK1A,Dyrk1 subfamily
5465,0,kd,CGS001-1856,DVL2,Dishevelled homologs
2686,13.04,cp,BRD-A63836183,PD-123319,Angiotensin receptor antagonist
2684,13.05,cp,BRD-A64227845,SKF-77434,Dopamine receptor agonist
5466,0,kd,CGS001-1849,DUSP7,Protein tyrosine phosphatases / Class I Cys-based PTPs : MAP kinase phosphatases
5467,0,kd,CGS001-1843,DUSP1,Protein tyrosine phosphatases / Class I Cys-based PTPs : MAP kinase phosphatases
2682,13.1,cp,BRD-A38913120,BH3I-1,BCL inhibitor
2680,13.11,cp,BRD-K64044582,linoleamide,ACAT inhibitor
5468,0,kd,CGS001-1840,DTX1,-
5469,0,kd,CGS001-10059,DNM1L,-
5470,0,kd,CGS001-1763,DNA2,-
5471,0,kd,CGS001-9787,DLGAP5,-
5472,0,kd,CGS001-1738,DLD,-
2675,13.17,cp,BRD-K06878038,deferiprone,Chelating agent
2671,13.19,cp,BRD-K60298136,ITE,Aryl hydrocarbon receptor agonist
2672,13.19,cp,BRD-K39733634,L-161982,Prostanoid receptor antagonist
5473,0,kd,CGS001-1659,DHX8,DEAH-boxes
5474,0,kd,CGS001-50846,DHH,-
5475,0,kd,CGS001-1717,DHCR7,-
5476,0,kd,CGS001-1676,DFFA,-
5477,0,kd,CGS001-79961,DENND2D,DENN/MADD domain containing
5478,0,kd,CGS001-23564,DDAH2,Dimethylarginine dimethylaminohydrolases
5479,0,kd,CGS001-55802,DCP1A,-
5480,0,kd,CGS001-1612,DAPK1,Death-associated kinase (DAPK) family
2664,13.33,cp,BRD-K87990216,piretanide,Glucocorticoid receptor agonist
5481,0,kd,CGS001-1537,CYC1,Mitochondrial respiratory chain complex / Complex III
5482,0,kd,CGS001-1495,CTNNA1,Catenins
2661,13.38,cp,BRD-K25906698,immepip,Histamine receptor agonist
5483,0,kd,CGS001-58190,CTDSP1,Serine/threonine phosphatases / CTD aspartate-based phosphatases
5484,0,kd,CGS001-10664,CTCF,"Zinc fingers, C2H2-type"
5485,0,kd,CGS001-1460,CSNK2B,Casein kinase 2 (CK2) family
5486,0,kd,CGS001-1440,CSF3,Endogenous ligands
2655,13.46,cp,BRD-K36258877,AZ-10417808,Caspase inhibitor
5487,0,kd,CGS001-1407,CRY1,-
5488,0,kd,CGS001-50813,COPS7A,-
2650,13.48,cp,BRD-K29905972,axitinib,PDGFR receptor inhibitor
2651,13.48,cp,BRD-A56020723,CA-074-Me,Cathepsin inhibitor
5489,0,kd,CGS001-1305,COL13A1,Collagens
5490,0,kd,CGS001-8192,CLPP,ATPases / AAA-type
5491,0,kd,CGS001-9575,CLOCK,Histone acetyltransferases
2647,13.5,cp,BRD-K66019333,oxantel,Anthelmintic
5492,0,kd,CGS001-23274,CLEC16A,C-type lectin domain containing
5493,0,kd,CGS001-1152,CKB,-
2644,13.55,cp,BRD-K15868788,SDZ-205-557,Serotonin receptor antagonist
5494,0,kd,CGS001-79145,CHCHD7,Coiled-coil-helix-coiled-coil-helix domain containing
5495,0,kd,CGS001-8208,CHAF1B,WD repeat domain containing
5496,0,kd,CGS001-1028,CDKN1C,-
2638,13.62,cp,BRD-K52459643,prostaglandin-e1,Prostanoid receptor agonist
2639,13.62,cp,BRD-K36737713,AG-957,Protein tyrosine kinase inhibitor
5497,0,kd,CGS001-983,CDK1,"Cyclin-dependent kinases, CDK1 subfamily"
5498,0,kd,CGS001-1009,CDH11,Cadherins / Major cadherins
5499,0,kd,CGS001-995,CDC25C,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
2635,13.64,cp,BRD-K06024458,n-arachidonyl-GABA,cannabinoid receptor agonist
5500,0,kd,CGS001-993,CDC25A,Protein tyrosine phosphatases / Class III Cys-based PTPs
2634,13.65,cp,BRD-K97181089,amiloride,Sodium channel blocker
5501,0,kd,CGS001-975,CD81,CD molecules
5502,0,kd,CGS001-51293,CD320,CD molecules
5503,0,kd,CGS001-902,CCNH,General transcription factor IIH complex subunits
5504,0,kd,CGS001-883,CCBL1,Hydrogen sulphide synthesis
5505,0,kd,CGS001-8535,CBX4,-
2627,13.71,cp,BRD-K10098805,rhapontin,Apoptosis stimulant
5506,0,kd,CGS001-826,CAPNS1,EF-hand domain containing
5507,0,kd,CGS001-821,CANX,-
2625,13.75,cp,BRD-K74514084,pazopanib,KIT inhibitor
2622,13.79,cp,BRD-A36471396,biperiden,Acetylcholine receptor antagonist
5508,0,kd,CGS001-775,CACNA1C,Calcium channel subunits
5509,0,kd,CGS001-718,C3,Endogenous ligands
2621,13.81,cp,BRD-K18523449,mestanolone,Androgenic steroid
5510,0,kd,CGS001-29105,C16ORF80,-
5511,0,kd,CGS001-28969,BZW2,-
2617,13.86,cp,BRD-K07212038,selinidin,Mast cell stabilizer
5512,0,kd,CGS001-8896,BUD31,-
5513,0,kd,CGS001-84811,BUD13,-
2615,13.9,cp,BRD-K82823076,RO-15-4513,GABA benzodiazepine site receptor inverse agonist
5514,0,kd,CGS001-23476,BRD4,Bromodomain kinase (BRDK) family
5515,0,kd,CGS001-662,BNIP1,-
5516,0,kd,CGS001-8548,BLZF1,-
5517,0,kd,CGS001-57448,BIRC6,Inhibitors of apoptosis (IAP) protein family
5518,0,kd,CGS001-255877,BCL6B,BTB/POZ domain containing
5519,0,kd,CGS001-10295,BCKDK,Pyruvate dehydrogenase kinase (PDHK) family
5520,0,kd,CGS001-573,BAG1,-
5521,0,kd,CGS001-26229,B3GAT3,"Beta-1,3-glucuronyltransferases"
2607,13.97,cp,BRD-K50938287,sumatriptan,Serotonin receptor agonist
5522,0,kd,CGS001-539,ATP5O,ATPases / F-type
5523,0,kd,CGS001-488,ATP2A2,Calcium-ATPases
5524,0,kd,CGS001-23300,ATMIN,"Zinc fingers, C2H2-type"
5525,0,kd,CGS001-10533,ATG7,Ubiquitin-like modifier activating enzymes
5526,0,kd,CGS001-22809,ATF5,basic leucine zipper proteins
5527,0,kd,CGS001-8623,ASMTL,Pseudoautosomal regions / PAR1
2598,14.06,cp,BRD-K44442813,pidotimod,Interferon receptor agonist
2599,14.06,cp,BRD-K27450477,EHNA,Adenosine deaminase inhibitor
5528,0,kd,CGS001-435,ASL,-
5529,0,kd,CGS001-433,ASGR2,C-type lectin domain containing
2595,14.09,cp,BRD-K63504947,semaxanib,VEGFR inhibitor
5530,0,kd,CGS001-408,ARRB1,-
5531,0,kd,CGS001-10094,ARPC3,Actin related protein 2/3 complex subunits
2591,14.11,cp,BRD-K03600606,catechin,Beta secretase inhibitor
5532,0,kd,CGS001-10552,ARPC1A,Actin related protein 2/3 complex subunits
5533,0,kd,CGS001-23365,ARHGEF12,Rho guanine nucleotide exchange factors
5534,0,kd,CGS001-397,ARHGDIB,Endogenous ligands
2587,14.2,cp,BRD-K30480208,torasemide,Electrolyte reabsorption inhibitor
5535,0,kd,CGS001-116985,ARAP1,Ankyrin repeat domain containing
2586,14.21,cp,BRD-K29359156,ebselen,H+/K+-ATPase inhibitor
2583,14.22,cp,BRD-A71009679,KUC103420N,-666
5536,0,kd,CGS001-369,ARAF,RAF family
5537,0,kd,CGS001-55937,APOM,Apolipoproteins
5538,0,kd,CGS001-345,APOC3,Apolipoproteins
5539,0,kd,CGS001-336,APOA2,Apolipoproteins
5540,0,kd,CGS001-335,APOA1,Apolipoproteins
5541,0,kd,CGS001-161,AP2A2,-
5542,0,kd,CGS001-302,ANXA2,Annexins
2577,14.4,cp,BRD-K66353228,zoxazolamine,Myorelaxant
5543,0,kd,CGS001-262,AMD1,Decarboxylases
5544,0,kd,CGS001-50808,AK3,-
5545,0,kd,CGS001-326,AIRE,"Zinc fingers, PHD-type"
5546,0,kd,CGS001-185,AGTR1,Angiotensin receptors
5547,0,kd,CGS001-10554,AGPAT1,1-acylglycerol-3-phosphate O-acyltransferases
2572,14.49,cp,BRD-K63068307,ZSTK-474,PI3K inhibitor
5548,0,kd,CGS001-166,AES,-
5549,0,kd,CGS001-135,ADORA2A,GPCR / Class A : Adenosine receptors
5550,0,kd,CGS001-27034,ACAD8,-
2566,14.58,cc,,Homeobox Gene GOF,-
2567,14.58,cp,BRD-K81209159,herniarin,Acetylcholinesterase inhibitor
5551,0,kd,CGS001-10058,ABCB6,ATP binding cassette transporters / subfamily B
5552,0,kd,CGS001-5244,ABCB4,ATP binding cassette transporters / subfamily B
5553,0,oe,ccsbBroad304_05005,ZNF582,"Zinc fingers, C2H2-type"
5554,0,oe,ccsbBroad304_07766,RASSF1,-
5555,0,oe,ccsbBroad304_02115,PTTG1,-
5556,0,oe,ccsbBroad304_04216,PBX4,Homeoboxes / TALE class
2559,14.67,cc,,Kinase anchoring proteins LOF,-
5557,0,oe,ccsbBroad304_02336,LPAR6,GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid
2558,14.69,cp,BRD-A81866333,CGS-21680,Adenosine receptor agonist
5558,0,oe,ccsbBroad304_00931,LCN2,Lipocalins
2554,14.72,cp,BRD-K59419204,AM-281,Cannabinoid receptor antagonist
5559,0,oe,ccsbBroad304_08613,KLHL9,BTB/POZ domain containing
5560,0,oe,ccsbBroad304_00392,CTLA4,CD molecules
5561,0,oe,ccsbBroad304_07345,CCRL2,Chemokine receptors
5562,0,oe,ccsbBroad304_05123,ZNF791,"Zinc fingers, C2H2-type"
5563,0,oe,ccsbBroad304_01754,UCK2,-
5564,0,oe,ccsbBroad304_01666,TGFBR1,Type I receptor serine/threonine kinases
2546,14.84,cp,BRD-K57222227,indometacin,Cyclooxygenase inhibitor
5565,0,oe,ccsbBroad304_08553,STAP2,-
5566,0,oe,ccsbBroad304_02372,SPRY1,-
5567,0,oe,ccsbBroad304_01556,SMARCB1,-
5568,0,oe,ccsbBroad304_00163,PRDM1,"Zinc fingers, C2H2-type"
5569,0,oe,ccsbBroad304_13939,MOK,RCK family
2542,14.93,cp,BRD-K35128472,2-aminopurine,Serine/threonine kinase inhibitor
5570,0,oe,ccsbBroad304_01010,MGST2,Glutathione S-transferases / Microsomal
5571,0,oe,ccsbBroad304_08878,METTL4,-
5572,0,oe,ccsbBroad304_06523,LIG1,-
5573,0,oe,ccsbBroad304_00859,IL12A,Interleukins and interleukin receptors
5574,0,oe,ccsbBroad304_06282,GLDC,-
5575,0,oe,ccsbBroad304_05420,EIF4E3,Translation Initiation Factor 4E
5576,0,oe,ccsbBroad304_02759,DICER1,-
5577,0,oe,ccsbBroad304_01658,PRDX2,-
5578,0,oe,ccsbBroad304_08424,SNRK,SNRK subfamily
5579,0,oe,ccsbBroad304_06739,PLOD1,-
2529,15.06,cp,BRD-K29582677,flunarizine,Calcium channel blocker
5580,0,oe,ccsbBroad304_08879,CASD1,-
5581,0,oe,ccsbBroad304_00183,C1S,Complement system
2528,15.07,cp,BRD-A56675431,altizide,Thiazide diuretic
5582,0,oe,ccsbBroad304_12885,ZFYVE19,"Zinc fingers, FYVE domain containing"
2525,15.09,cp,BRD-K64670467,JNJ-16259685,Glutamate receptor antagonist
5583,0,oe,ccsbBroad304_05192,SPRED2,-
5584,0,oe,ccsbBroad304_07820,SNW1,-
5585,0,oe,ccsbBroad304_08709,SCYL3,-
2522,15.12,cp,BRD-K60476892,YC-1,Guanylyl cyclase activator
5586,0,oe,ccsbBroad304_09425,RNF166,RING-type (C3HC4) zinc fingers
2521,15.16,cp,BRD-A45664787,iloprost,Platelet aggregation inhibitor
5587,0,oe,ccsbBroad304_09954,PTRF,-
2518,15.25,cp,BRD-K59851896,calycanthine,GABA release inhibitor
5588,0,oe,ccsbBroad304_06814,PTPN12,Protein tyrosine phosphatases / Class I Cys-based PTPs : Non-receptor
5589,0,oe,ccsbBroad304_02845,PRPF6,-
5590,0,oe,ccsbBroad304_07859,PLCB1,Phosphoinositide-specific phospholipase C
5591,0,oe,ccsbBroad304_01204,PIK3CD,Phosphatidylinositol kinases
2513,15.29,cp,BRD-A51382177,fosinopril,ACE inhibitor
5592,0,oe,ccsbBroad304_01141,PAFAH1B1,WD repeat domain containing
5593,0,oe,ccsbBroad304_05133,OXER1,GPCR / Class A : Leukotriene receptors
2510,15.32,cp,BRD-K00532621,midazolam,Benzodiazepine receptor agonist
2509,15.33,cp,BRD-K54316499,tolterodine,Acetylcholine receptor antagonist
5594,0,oe,ccsbBroad304_10994,NEK2,NIMA (never in mitosis gene a)- related kinase (NEK) family
5595,0,oe,ccsbBroad304_02496,MTX2,-
5596,0,oe,ccsbBroad304_06451,IMPDH1,Oxidoreductases
5597,0,oe,ccsbBroad304_00846,IL2,Interleukins and interleukin receptors
2504,15.4,cp,BRD-K32977963,eugenol,Androgen receptor antagonist
5598,0,oe,ccsbBroad304_06433,IGHMBP2,"Zinc fingers, AN1-type domain containing"
5599,0,oe,ccsbBroad304_00840,IGFBP7,insulin-like growth factor (IGF) binding proteins
5600,0,oe,ccsbBroad304_00597,FUT1,Fucosyltransferases
5601,0,oe,ccsbBroad304_07798,EXOC3,-
5602,0,oe,ccsbBroad304_06168,EPHA3,Type XIII RTKs: Ephrin receptor family
5603,0,oe,ccsbBroad304_00390,CTGF,-
5604,0,oe,ccsbBroad304_00180,BTK,Pleckstrin homology (PH) domain containing
2496,15.52,cp,BRD-A60294240,tribenoside,Anti-inflammatory
5605,0,oe,ccsbBroad304_07183,BRPF1,Non-enzymatic BRD containing proteins
5606,0,oe,ccsbBroad304_05882,BCL6,BTB/POZ domain containing
5607,0,oe,ccsbBroad304_07363,AIFM1,-
5608,0,oe,ccsbBroad304_04567,ZNF300,"Zinc fingers, C2H2-type"
5609,0,oe,ccsbBroad304_02579,YWHAQ,-
5610,0,oe,ccsbBroad304_04406,PLA2G12B,-
2488,15.68,cp,BRD-K56064827,EI-273,PKC inhibitor
5611,0,oe,ccsbBroad304_05527,GPR141,GPCR / Class A : Orphans
5612,0,oe,ccsbBroad304_03859,ENOPH1,-
5613,0,oe,ccsbBroad304_05817,ANPEP,Aminopeptidase N
2485,15.72,cp,BRD-K67537649,PQ-401,IGF-1 inhibitor
5614,0,oe,ccsbBroad304_02220,MTFR1,-
5615,0,oe,ccsbBroad304_00359,CPT1A,-
2481,15.76,cp,BRD-K01902415,pirinixic-acid,PPAR receptor agonist
5616,0,oe,ccsbBroad304_00278,CDK5,"Cyclin-dependent kinases, CDK5 subfamily"
2480,15.77,cp,BRD-A29437505,RWJ-21757,TLR agonist
5617,0,oe,ccsbBroad304_07412,ZRANB2,"Zinc fingers, RAN-binding domain containing"
2477,15.84,cp,BRD-K17415526,tyrphostin-AG-835,Protein tyrosine kinase inhibitor
5618,0,oe,ccsbBroad304_07119,UGP2,-
2475,15.85,cp,BRD-K28120222,parthenolide,NFkB pathway inhibitor
5619,0,oe,ccsbBroad304_07102,TSG101,-
2474,15.86,cp,BRD-K17294426,clebopride,Dopamine receptor antagonist
5620,0,oe,ccsbBroad304_01675,TK1,-
5621,0,oe,ccsbBroad304_01618,STXBP1,-
5622,0,oe,ccsbBroad304_00068,SLC25A6,Mitochondrial nucleotide transporter subfamily
5623,0,oe,ccsbBroad304_01445,RPS3,S ribosomal proteins
2469,15.96,cp,BRD-K18618618,cimetidine,Histamine receptor antagonist
2468,15.98,cp,BRD-K50398167,meclofenamic-acid,Cyclooxygenase inhibitor
2467,16,cp,BRD-A99833829,bethanechol,Acetylcholine receptor agonist
5624,0,oe,ccsbBroad304_01360,RAB4A,"RAB, member RAS oncogene"
5625,0,oe,ccsbBroad304_01282,PRKCB,Alpha subfamily
5626,0,oe,ccsbBroad304_02440,PPIE,RNA binding motif (RRM) containing
2463,16.09,cp,BRD-A82238138,budesonide,Glucocorticoid receptor agonist
2462,16.11,cp,BRD-K88679075,methandriol,Androgenic steroid
5627,0,oe,ccsbBroad304_01211,PKM2,-
5628,0,oe,ccsbBroad304_07598,PEMT,-
5629,0,oe,ccsbBroad304_01142,PAFAH1B2,-
5630,0,oe,ccsbBroad304_06525,LIPA,-
2457,16.18,cp,BRD-A54490543,pirlindole,Monoamine oxidase inhibitor
5631,0,oe,ccsbBroad304_02221,HS2ST1,"Sulfotransferases, membrane-bound"
5632,0,oe,ccsbBroad304_04534,HN1L,-
5633,0,oe,ccsbBroad304_00525,EZH1,Chromatin-modifying enzymes / K-methyltransferases
2453,16.21,cc,,Zinc fingers RanBP2 type LOF,-
5634,0,oe,ccsbBroad304_03239,DCXR,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
5635,0,oe,ccsbBroad304_01835,CXCR4,Chemokine receptors
2449,16.3,cp,BRD-K94080537,diethyltoluamide,DEET activator of fly antenna ionotropic receptor IR40a
2450,16.3,cp,BRD-A09722536,cyclophosphamide,DNA alkylating agent
5636,0,oe,ccsbBroad304_01735,UBE2D1,Ubiquitin-conjugating enzymes E2
2448,16.32,cp,BRD-K63550407,erythromycin,NFkB pathway inhibitor
5637,0,oe,ccsbBroad304_10116,SHC4,SH2 domain containing
2445,16.34,cp,BRD-K38003476,clocortolone,Glucocorticoid receptor agonist
2444,16.37,cp,BRD-A39172021,ampiroxicam,Cyclooxygenase inhibitor
5638,0,oe,ccsbBroad304_01326,PSME1,"Proteasome (prosome, macropain) subunits"
2443,16.39,cp,BRD-K90885812,propantheline,Acetylcholine receptor antagonist
5639,0,oe,ccsbBroad304_10491,PFKL,-
5640,0,oe,ccsbBroad304_01087,NF2,A-kinase anchor proteins
5641,0,oe,ccsbBroad304_13903,MTAP,-
5642,0,oe,ccsbBroad304_06140,EEF1D,-
5643,0,oe,ccsbBroad304_02499,CTCF,"Zinc fingers, C2H2-type"
5644,0,oe,ccsbBroad304_05963,CD44,CD molecules
5645,0,oe,ccsbBroad304_03580,ABCF3,ATP binding cassette transporters / subfamily F
5646,0,oe,ccsbBroad304_09689,ZNF595,"Zinc fingers, C2H2-type"
2432,16.56,cp,BRD-K96799727,pifithrin-mu,HSP inhibitor
5647,0,oe,ccsbBroad304_06754,PPARD,Nuclear hormone receptors
5648,0,oe,ccsbBroad304_01855,NCOA4,-
5649,0,oe,ccsbBroad304_08925,ZNF576,"Zinc fingers, C2H2-type"
5650,0,oe,ccsbBroad304_02405,TFG,-
5651,0,oe,ccsbBroad304_01661,TFCP2,-
5652,0,oe,ccsbBroad304_02378,STUB1,Tetratricopeptide (TTC) repeat domain containing
5653,0,oe,ccsbBroad304_06549,SMAD3,SMADs
5654,0,oe,ccsbBroad304_04788,OVCA2,-
5655,0,oe,ccsbBroad304_02716,NMNAT2,-
5656,0,oe,ccsbBroad304_13891,LCK,Src family
5657,0,oe,ccsbBroad304_00876,INSIG1,-
5658,0,oe,ccsbBroad304_00866,IMPA1,Inositol monophosphatase
5659,0,oe,ccsbBroad304_00837,IGFBP4,insulin-like growth factor (IGF) binding proteins
2419,16.8,cp,BRD-A23290232,westcort,Glucocorticoid receptor agonist
2417,16.81,cp,BRD-A28746609,paclitaxel,Tubulin inhibitor
5660,0,oe,ccsbBroad304_00799,HSP90AB1,Heat shock proteins / HSPC
5661,0,oe,ccsbBroad304_04072,HMGN5,High-mobility group / Canonical
5662,0,oe,ccsbBroad304_00524,EXT2,Exostosin glycosyltransferase family
5663,0,oe,ccsbBroad304_00499,ELK3,ETS Transcription Factors
5664,0,oe,ccsbBroad304_00424,DBI,-
2412,16.91,cp,BRD-A35623999,CGP-37157,L-type calcium channel blocker
5665,0,oe,ccsbBroad304_06018,COMT,Catecholamine turnover
2410,16.93,cp,BRD-K06388322,pramipexole,Dopamine receptor agonist
5666,0,oe,ccsbBroad304_05894,BLVRA,-
5667,0,oe,ccsbBroad304_00097,ARF6,ADP-ribosylation factors
5668,0,oe,ccsbBroad304_05833,APEH,Prolyl oligopeptidase
2406,16.98,cp,BRD-K98157055,SIB-1757,Glutamate receptor antagonist
5669,0,oe,ccsbBroad304_09774,ZNF92,"Zinc fingers, C2H2-type"
5670,0,oe,ccsbBroad304_04683,ZNF689,"Zinc fingers, C2H2-type"
5671,0,oe,ccsbBroad304_07372,ZBED1,Pseudoautosomal regions / PAR1
2402,17.09,cp,BRD-A51410489,yohimbine,Adrenergic receptor antagonist
2399,17.11,cc,,MCM family LOF,-
5672,0,oe,ccsbBroad304_01605,SSX2,-
2401,17.11,cp,BRD-K80396088,gliquidone,Sulfonylurea
2398,17.14,cp,BRD-K81783531,VX-222,HCV inhibitor
5673,0,oe,ccsbBroad304_06996,SRM,-
2396,17.26,cp,BRD-K09537769,NU-7026,DNA dependent protein kinase inhibitor
5674,0,oe,ccsbBroad304_02337,SLC25A13,Mitochondrial amino acid transporter subfamily
5675,0,oe,ccsbBroad304_06916,SCP2,-
5676,0,oe,ccsbBroad304_01413,RPA2,-
5677,0,oe,ccsbBroad304_00102,RND3,-
5678,0,oe,ccsbBroad304_02010,RIPK2,Receptor interacting protein kinase (RIPK) family
5679,0,oe,ccsbBroad304_01845,RDBP,-
5680,0,oe,ccsbBroad304_06801,PSMB10,"Proteasome (prosome, macropain) subunits"
5681,0,oe,ccsbBroad304_14389,PSMA8,"Proteasome (prosome, macropain) subunits"
5682,0,oe,ccsbBroad304_08340,POLR3K,RNA polymerase subunits
2386,17.54,cp,BRD-K04976539,aminogenistein,SRC inhibitor
5683,0,oe,ccsbBroad304_06734,PLAT,Chymotrypsin
5684,0,oe,ccsbBroad304_01189,PHF1,"Zinc fingers, PHD-type"
5685,0,oe,ccsbBroad304_09254,PAQR8,-
5686,0,oe,ccsbBroad304_01073,NDUFB8,Mitochondrial respiratory chain complex / Complex I
2381,17.64,cp,BRD-A17453586,MDL-72832,Serotonin receptor agonist
5687,0,oe,ccsbBroad304_04387,MKI67IP,-
2378,17.67,cp,BRD-K55044200,amoxicillin,Penicillin binding protein inhibitor
2379,17.67,cp,BRD-A91555231,norepinephrine,Adrenergic receptor agonist
2377,17.71,cp,BRD-K02953697,naringin,Cytochrome P450 inhibitor
2376,17.72,cp,BRD-K67013324,luzindole,Melatonin receptor antagonist
2374,17.73,cc,,Bile acid,-
2375,17.73,cp,BRD-K64157027,ZD-2079,Adrenergic receptor agonist
2373,17.75,cp,BRD-K97799481,theophylline,Adenosine receptor antagonist
5688,0,oe,ccsbBroad304_06583,MITF,Basic helix-loop-helix proteins
5689,0,oe,ccsbBroad304_06569,MCM5,-
2370,17.84,cp,BRD-K92991072,PAC-1,Caspase activator
5690,0,oe,ccsbBroad304_00371,MAPK14,MAPK:p38 subfamily
5691,0,oe,ccsbBroad304_06225,FTH1,-
5692,0,oe,ccsbBroad304_00523,EXT1,Exostosin glycosyltransferase family
5693,0,oe,ccsbBroad304_03428,EXOSC4,-
5694,0,oe,ccsbBroad304_06180,ESD,-
2363,17.92,cp,BRD-A84702196,penicillin,Bacterial cell wall synthesis inhibitor
5695,0,oe,ccsbBroad304_03728,DIABLO,-
5696,0,oe,ccsbBroad304_06040,CRY1,-
5697,0,oe,ccsbBroad304_00327,CLK2,CDC-like kinases
5698,0,oe,ccsbBroad304_08935,CERS4,Homeoboxes / CERS class
5699,0,oe,ccsbBroad304_00219,CARS,Aminoacyl tRNA synthetases / Class I
5700,0,oe,ccsbBroad304_02047,AP1S2,-
5701,0,oe,ccsbBroad304_01977,AOC3,Oxidoreductases
5702,0,oe,ccsbBroad304_07123,UQCRFS1,Mitochondrial respiratory chain complex / Complex III
5703,0,oe,ccsbBroad304_02345,TXNDC9,-
5704,0,oe,ccsbBroad304_07436,SPTLC2,Serine palmitoyltransferase
5705,0,oe,ccsbBroad304_01380,RBBP7,WD repeat domain containing
2354,18,cp,BRD-K15933101,ropinirole,Dopamine receptor agonist
5706,0,oe,ccsbBroad304_01198,PIGA,Glycosyltransferase group 1 domain containing
5707,0,oe,ccsbBroad304_06574,MDH2,-
5708,0,oe,ccsbBroad304_00658,GNG5,-
2348,18.09,cp,BRD-K46211610,tolazoline,Adrenergic receptor antagonist
5709,0,oe,ccsbBroad304_00085,APRT,-
5710,0,oe,ccsbBroad304_08594,PECR,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
5711,0,oe,ccsbBroad304_07557,NAMPT,-
5712,0,oe,ccsbBroad304_03119,C16ORF5,-
5713,0,oe,ccsbBroad304_02838,SDF2L1,-
2342,18.15,cp,BRD-K55703048,latrepirdine,Glutamate receptor antagonist
5714,0,oe,ccsbBroad304_02276,MVP,-
5715,0,oe,ccsbBroad304_05907,BUB1B,Bub family
2337,18.25,cp,BRD-A49172652,lansoprazole,ATPase inhibitor
5716,0,oe,ccsbBroad304_00361,ATF2,basic leucine zipper proteins
5717,0,oe,ccsbBroad304_09368,OPN4,GPCR / Class A : Opsin receptors
5718,0,oe,ccsbBroad304_00839,IGFBP6,insulin-like growth factor (IGF) binding proteins
5719,0,oe,ccsbBroad304_06974,SLC22A5,Organic zwitterions/cation transporters (OCTN)
5720,0,oe,ccsbBroad304_14044,PCGF3,Polycomb group ring fingers
2334,18.28,cp,BRD-A78322124,dobutamine,Adrenergic receptor agonist
5721,0,oe,ccsbBroad304_02452,NXF1,-
2331,18.31,cp,BRD-K83322645,L-693403,Sigma receptor agonist
2330,18.33,cp,BRD-K17497770,butein,EGFR inhibitor
5722,0,oe,ccsbBroad304_03637,DOK4,Pleckstrin homology (PH) domain containing
5723,0,oe,ccsbBroad304_13811,ALDH3B1,Aldehyde dehydrogenases
5724,0,oe,ccsbBroad304_05121,ZNF296,"Zinc fingers, C2H2-type"
5725,0,oe,ccsbBroad304_01660,TFAP4,Basic helix-loop-helix proteins
5726,0,oe,ccsbBroad304_00961,SMAD2,SMADs
2324,18.47,cp,BRD-K97061094,azacyclonol,Histamine receptor antagonist
5727,0,oe,ccsbBroad304_08715,SALL4,"Zinc fingers, C2H2-type"
5728,0,oe,ccsbBroad304_04715,MRGPRF,GPCR / Class A : Orphans
2321,18.5,cp,BRD-A64228451,terreic-acid,BTK inhibitor
5729,0,oe,ccsbBroad304_07945,GCA,EF-hand domain containing
5730,0,oe,ccsbBroad304_01890,FZD7,GPCR / Class F : Frizzled receptors
5731,0,oe,ccsbBroad304_00326,CLK1,CDC-like kinases
5732,0,oe,ccsbBroad304_05972,CDC25C,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
5733,0,oe,ccsbBroad304_01960,CASK,CASK family
2313,18.66,cp,BRD-K61177364,NBI-27914,CRF receptor antagonist
5734,0,oe,ccsbBroad304_00211,CALU,EF-hand domain containing
5735,0,oe,ccsbBroad304_00173,BRCA1,"Fanconi anemia, complementation groups"
5736,0,oe,ccsbBroad304_01394,RFX4,-
5737,0,oe,ccsbBroad304_06840,RAP1GDS1,Armadillo repeat containing
2310,18.74,cp,BRD-A67862938,naftidrofuryl,Adrenergic receptor antagonist
5738,0,oe,ccsbBroad304_01342,PTPN6,Protein tyrosine phosphatases
5739,0,oe,ccsbBroad304_06785,PRSS2,Serine peptidases
5740,0,oe,ccsbBroad304_01103,NONO,RNA binding motif (RRM) containing
2306,18.82,cp,BRD-K32795028,1-benzylimidazole,Thromboxane synthase inhibitor
2305,18.86,cp,BRD-K05181084,NGB-2904,Dopamine receptor antagonist
5741,0,oe,ccsbBroad304_00882,IRS1,Pleckstrin homology (PH) domain containing
5742,0,oe,ccsbBroad304_00810,HYAL1,-
2300,18.9,cp,BRD-K18316707,O-1918,Cannabinoid receptor antagonist
5743,0,oe,ccsbBroad304_03240,HSPA14,Heat shock proteins / HSP70
2302,18.9,cp,BRD-K07403598,CAY-10470,NFkB pathway inhibitor
5744,0,oe,ccsbBroad304_06393,HOXC4,Homeoboxes / ANTP class : HOXL subclass
5745,0,oe,ccsbBroad304_06350,HAL,-
2296,18.94,cp,BRD-K51302260,KU-C103871,GSP agonist
5746,0,oe,ccsbBroad304_00702,GSTM1,Glutathione S-transferases / Soluble
2295,18.95,cp,BRD-A13946108,sulindac,Cyclooxygenase inhibitor
5747,0,oe,ccsbBroad304_03394,GPR84,GPCR / Class A : Fatty acid receptors
5748,0,oe,ccsbBroad304_06264,GBP2,-
5749,0,oe,ccsbBroad304_06209,FGF9,Endogenous ligands
2291,19,cp,BRD-A43331270,niguldipine,Calcium channel blocker
2290,19.02,cp,BRD-K94841585,emodic-acid,Laxative
5750,0,oe,ccsbBroad304_00542,FBP1,-
5751,0,oe,ccsbBroad304_06185,EYA1,Protein tyrosine phosphatases / Asp-based PTPs
5752,0,oe,ccsbBroad304_06089,DDIT3,-
5753,0,oe,ccsbBroad304_06070,CYC1,Mitochondrial respiratory chain complex / Complex III
5754,0,oe,ccsbBroad304_07220,CDC45,-
2284,19.2,cp,BRD-A13188892,doxazosin,Adrenergic receptor antagonist
2283,19.21,cp,BRD-K83637872,SANT-1,Smoothened receptor antagonist
2282,19.25,cp,BRD-K46137903,prednicarbate,Phospholipase activator
5755,0,oe,ccsbBroad304_05745,CD24,CD molecules
5756,0,oe,ccsbBroad304_05948,CCND2,-
2279,19.33,cp,BRD-K14221570,benzopurpurin-4b,HIV entry inhibitor
5757,0,oe,ccsbBroad304_00155,CCND1,-
2277,19.35,cp,BRD-A37492983,iocetamic-acid,Radiopaque medium
5758,0,oe,ccsbBroad304_05823,ANXA2,Annexins
5759,0,oe,ccsbBroad304_05821,ANXA1,Annexins
2274,19.44,cp,BRD-K43764301,dexketoprofen,Cyclooxygenase inhibitor
5760,0,oe,ccsbBroad304_04478,ALG2,Glycosyltransferase group 1 domain containing
2272,19.5,cp,BRD-K67080878,milrinone,Phosphodiesterase inhibitor
2271,19.51,cp,BRD-K78294846,osthol,Calcium channel blocker
2269,19.55,cp,BRD-K46018455,bezafibrate,PPAR receptor agonist
5761,0,oe,ccsbBroad304_00047,AKT2,Akt (Protein kinase B)
5762,0,oe,ccsbBroad304_01979,AKR1C3,Prostaglandin synthases
5763,0,oe,ccsbBroad304_08681,ADCK3,ABC1-B subfamily
5764,0,oe,ccsbBroad304_03404,POLE3,DNA polymerases
5765,0,oe,ccsbBroad304_11714,ATMIN,"Zinc fingers, C2H2-type"
5766,0,oe,ccsbBroad304_02922,TES,-
5767,0,oe,ccsbBroad304_07018,SUPT5H,-
2262,19.63,cp,BRD-A08709697,heliotrine,Pyrrolizidine alkaloid
5768,0,oe,ccsbBroad304_00504,SLC29A1,SLC29 family
5769,0,oe,ccsbBroad304_06435,RBPJ,-
5770,0,oe,ccsbBroad304_08289,PRKAG2,AMPK subfamily
2258,19.7,cp,BRD-K56403959,ZK-756326,CC chemokine receptor ligand
5771,0,oe,ccsbBroad304_02208,PDIA4,Protein disulfide isomerases
5772,0,oe,ccsbBroad304_05564,NPSR1,GPCR / Class A : Neuropeptide receptors : S
5773,0,oe,ccsbBroad304_01092,NFIL3,basic leucine zipper proteins
2254,19.84,cp,BRD-K22010301,JLK-6,Gamma secretase inhibitor
2253,19.86,cp,BRD-K79353516,indolophenanthridine,CALY activator
2252,19.87,cp,BRD-A20126139,medrysone,Glucocorticoid receptor agonist
2251,19.88,cp,BRD-K93433262,alfacalcidol,Vitamin D receptor agonist
5774,0,oe,ccsbBroad304_04713,MAS1L,GPCR / Class A : Orphans
5775,0,oe,ccsbBroad304_00966,MAFG,-
5776,0,oe,ccsbBroad304_05194,LIPH,-
2247,19.96,cp,BRD-A23359898,sibutramine,Serotonin reuptake inhibitor
5777,0,oe,ccsbBroad304_07280,LAMTOR3,-
5778,0,oe,ccsbBroad304_00861,IL13RA1,IL-2 receptor family
5779,0,oe,ccsbBroad304_00770,HOXA2,Homeoboxes / ANTP class : HOXL subclass
5780,0,oe,ccsbBroad304_07800,EXOSC8,-
2242,20.06,cp,BRD-A04756508,norgestimate,Progesterone receptor agonist
5781,0,oe,ccsbBroad304_03808,ERGIC1,-
5782,0,oe,ccsbBroad304_06174,ERCC1,-
5783,0,oe,ccsbBroad304_00509,EPHX1,-
5784,0,oe,ccsbBroad304_03271,ECSIT,Mitochondrial respiratory chain complex assembly factors
2237,20.17,cp,BRD-K99063460,didanosine,Nucleoside reverse transcriptase inhibitor
2236,20.18,cp,BRD-K81855038,roxatidine,Histamine receptor antagonist
2234,20.19,cp,BRD-K01567962,pyrazolanthrone,JNK inhibitor
5785,0,oe,ccsbBroad304_07592,CEPT1,-
5786,0,oe,ccsbBroad304_00210,CALR,-
5787,0,oe,ccsbBroad304_02292,BCL2L11,-
2229,20.23,cp,BRD-K11911061,GR-127935,Serotonin receptor antagonist
5788,0,oe,ccsbBroad304_00098,ARG1,Arginase
5789,0,oe,ccsbBroad304_05000,ZNF524,"Zinc fingers, C2H2-type"
2227,20.24,cp,BRD-A15297126,fluocinonide,Glucocorticoid receptor agonist
5790,0,oe,ccsbBroad304_01741,UBE2V1,Ubiquitin-conjugating enzymes E2
5791,0,oe,ccsbBroad304_07015,SULT1A1,"Sulfotransferases, cytosolic"
5792,0,oe,ccsbBroad304_05148,SLC30A8,SLC30 zinc transporter family
5793,0,oe,ccsbBroad304_07880,SIRT5,Histone deacetylases
5794,0,oe,ccsbBroad304_09703,RNF145,RING-type (C3HC4) zinc fingers
2222,20.35,cp,BRD-A04668240,CGP-52432,GABA receptor antagonist
5795,0,oe,ccsbBroad304_01406,RNASE4,"Ribonucleases, RNase A"
5796,0,oe,ccsbBroad304_03122,RHOD,-
2218,20.43,cp,BRD-K01648091,LE-300,Dopamine receptor antagonist
5797,0,oe,ccsbBroad304_01375,RARA,Retinoic acid receptors
5798,0,oe,ccsbBroad304_07428,PSMF1,"Proteasome (prosome, macropain) subunits"
2216,20.47,cp,BRD-K34995470,SU-1498,VEGFR inhibitor
2215,20.48,cp,BRD-K79254416,decitabine,DNA methyltransferase inhibitor
2212,20.51,cp,BRD-A90799790,isradipine,Calcium channel blocker
5799,0,oe,ccsbBroad304_01307,PSMA1,Proteasome subunits
5800,0,oe,ccsbBroad304_06658,NT5E,Adenosine turnover
5801,0,oe,ccsbBroad304_02394,ZNF267,"Zinc fingers, C2H2-type"
5802,0,oe,ccsbBroad304_06253,GALT,-
5803,0,oe,ccsbBroad304_06722,SERPINB6,Serine (or cysteine) peptidase inhibitors
5804,0,oe,ccsbBroad304_07920,NUP62,-
5805,0,oe,ccsbBroad304_06619,NCF2,Tetratricopeptide (TTC) repeat domain containing
5806,0,oe,ccsbBroad304_07511,KIF14,Kinesins
5807,0,oe,ccsbBroad304_02249,KIAA0494,-
5808,0,oe,ccsbBroad304_08230,IRAK4,Interleukin-1 receptor-associated kinase (IRAK) family
5809,0,oe,ccsbBroad304_00818,IDH3A,-
2201,20.73,cc,,RAF inhibitor,-
5810,0,oe,ccsbBroad304_06336,GSTT1,Glutathione S-transferases / Soluble
2198,20.74,cp,BRD-K66206289,lobeline,Acetylcholine receptor antagonist
5811,0,oe,ccsbBroad304_00573,FKBP4,Tetratricopeptide (TTC) repeat domain containing
2200,20.74,cp,BRD-K93461745,buspirone,Serotonin receptor agonist
5812,0,oe,ccsbBroad304_02618,DIDO1,"Zinc fingers, PHD-type"
5813,0,oe,ccsbBroad304_03506,AURKAIP1,-
5814,0,oe,ccsbBroad304_13985,ZNF200,"Zinc fingers, C2H2-type"
5815,0,oe,ccsbBroad304_02709,SCMH1,Sterile alpha motif (SAM) domain containing
5816,0,oe,ccsbBroad304_01320,PSMD4,"Proteasome (prosome, macropain) subunits"
5817,0,oe,ccsbBroad304_07632,PROCR,CD molecules
2191,20.93,cp,BRD-K12357156,AG-490,EGFR inhibitor
5818,0,oe,ccsbBroad304_01067,NDUFA7,Mitochondrial respiratory chain complex / Complex I
5819,0,oe,ccsbBroad304_02332,MBNL2,"Zinc fingers, CCCH-type domain containing"
5820,0,oe,ccsbBroad304_07923,LSM5,-
5869,-0.18,oe,ccsbBroad304_09590,ZFP28,"Zinc fingers, C2H2-type"
5879,-0.28,oe,ccsbBroad304_01767,VDR,Vitamin D receptors
5889,-0.32,oe,ccsbBroad304_09831,CERS3,Homeoboxes / CERS class
5893,-0.32,kd,CGS001-7057,THBS1,-
5894,-0.32,oe,ccsbBroad304_03040,NKIRAS2,-
5895,-0.32,oe,ccsbBroad304_01155,CDK16,"Cyclin-dependent kinases, TAIRE subfamily"
2179,21.33,cp,BRD-K03981224,ethisterone,Progestogen hormone
5905,-0.37,oe,ccsbBroad304_03798,PHTF2,-
5906,-0.37,oe,ccsbBroad304_03439,GNB1L,WD repeat domain containing
5907,-0.37,oe,ccsbBroad304_08296,UBE2J1,Ubiquitin-conjugating enzymes E2
5908,-0.38,oe,ccsbBroad304_04903,ZNF786,"Zinc fingers, C2H2-type"
5915,-0.42,oe,ccsbBroad304_07802,TWF2,Twinfilin subfamily
5916,-0.42,oe,ccsbBroad304_04055,CHCHD7,Coiled-coil-helix-coiled-coil-helix domain containing
5917,-0.42,oe,ccsbBroad304_03933,CARD9,-
5921,-0.42,oe,ccsbBroad304_05560,AMIGO3,Immunoglobulin superfamily / Immunoglobulin-like domain containing
2172,21.47,cp,BRD-K86301799,dipyridamole,Phosphodiesterase inhibitor
2171,21.52,cp,BRD-K93188295,ARC-239,Adrenergic receptor antagonist
5924,-0.45,kd,CGS001-3066,HDAC2,Histone deacetylases
5933,-0.5,kd,CGS001-5295,PIK3R1,Phosphatidylinositol kinases
5934,-0.5,oe,ccsbBroad304_01261,PPP1R8,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
5935,-0.51,oe,ccsbBroad304_07759,PWP1,WD repeat domain containing
2166,21.63,cp,BRD-K67844266,MLN-4924,Nedd activating enzyme inhibitor
2165,21.64,cp,BRD-K25079130,avrainvillamide-analog-4,nucleophosmin inhibitor
5937,-0.51,oe,ccsbBroad304_09656,ZNF555,"Zinc fingers, C2H2-type"
5938,-0.51,oe,ccsbBroad304_05049,GPBAR1,Bile acid receptor
2163,21.7,cp,BRD-K96670504,lonidamine,Glucokinase inhibitor
5942,-0.56,oe,ccsbBroad304_01347,RAD1,-
2159,21.77,cp,BRD-K07736136,VX-702,p38 MAPK inhibitor
5943,-0.56,oe,ccsbBroad304_00489,EHHADH,-
2158,21.87,cp,BRD-A22684332,procaterol,Adrenergic receptor agonist
2157,21.9,cp,BRD-K82562631,tolmetin,Cyclooxygenase inhibitor
5949,-0.58,kd,CGS001-1432,MAPK14,MAPK:p38 subfamily
5950,-0.58,kd,CGS001-2990,GUSB,-
5951,-0.6,oe,ccsbBroad304_01164,PDHB,-
5952,-0.6,oe,ccsbBroad304_00688,GRB2,SH2 domain containing
5953,-0.6,oe,ccsbBroad304_02789,ADAT1,-
5959,-0.61,kd,CGS001-587,BCAT2,-
5960,-0.61,kd,CGS001-51382,ATP6V1D,ATPases / V-type
5969,-0.65,oe,ccsbBroad304_00756,HMGCS2,Lanosterol biosynthesis pathway
5970,-0.65,oe,ccsbBroad304_08849,ABCG8,ATP binding cassette transporters / subfamily G
5975,-0.68,kd,CGS001-4436,MSH2,-
2146,22.17,cp,BRD-K94270326,ecopipam,Dopamine receptor antagonist
5976,-0.69,oe,ccsbBroad304_06138,EDNRB,Endothelin receptors
2143,22.28,cp,BRD-K90524085,MY-5445,Phosphodiesterase inhibitor
5977,-0.69,oe,ccsbBroad304_02094,FIBP,-
5978,-0.69,oe,ccsbBroad304_07768,NISCH,-
2140,22.3,cp,BRD-K55991774,BAS-09104376,HIV integrase inhibitor
2141,22.3,cp,BRD-K02867583,minaprine,Serotonin reuptake inhibitor
2139,22.32,cp,BRD-K11373525,ZD-7155,Angiotensin receptor antagonist
5984,-0.74,oe,ccsbBroad304_05856,ASAH1,Acid ceramidase
5987,-0.74,oe,ccsbBroad304_00145,BACH1,BTB/POZ domain containing
5990,-0.76,kd,CGS001-3108,HLA-DMA,Immunoglobulin superfamily / C1-set domain containing
5991,-0.76,kd,CGS001-2932,GSK3B,GSK subfamily
5995,-0.79,oe,ccsbBroad304_02121,UBE2L6,Ubiquitin-conjugating enzymes E2
5996,-0.79,oe,ccsbBroad304_01238,POLR2D,RNA polymerase subunits
5997,-0.79,oe,ccsbBroad304_01168,PDPK1,PDK1 family
5998,-0.79,oe,ccsbBroad304_02131,ATP6V1F,ATPases / V-type
5999,-0.79,kd,CGS001-7029,TFDP2,-
6000,-0.8,oe,ccsbBroad304_04383,PCGF5,Polycomb group ring fingers
2128,22.7,cp,BRD-K17953061,staurosporine,PKC inhibitor
2127,22.71,cp,BRD-K96809896,SKF-86002,p38 MAPK inhibitor
6005,-0.82,kd,CGS001-6464,SHC1,SH2 domain containing
2125,22.81,cp,BRD-K63089472,farnesylthioacetic-acid,Inhibitor of methyl esterification of farnesylated proteins
6007,-0.83,oe,ccsbBroad304_02168,GGPS1,Lanosterol biosynthesis pathway
6008,-0.83,oe,ccsbBroad304_01269,PPP3R2,EF-hand domain containing
6009,-0.83,oe,ccsbBroad304_01218,PLK1,Polo-like kinase (PLK) family
2121,22.91,cp,BRD-A02180903,betamethasone,Glucocorticoid receptor agonist
6013,-0.87,kd,CGS001-7697,ZNF138,"Zinc fingers, C2H2-type"
6014,-0.88,oe,ccsbBroad304_00862,IL13RA2,IL-2 receptor family
2118,22.97,cp,BRD-K41731458,triclosan,Enoyl-[acyl-carrier-protein] reductase [NADH] inhibitor
2117,23.01,cp,BRD-K44094599,tacrolimus,Calcineurin inhibitor
2116,23.04,cp,BRD-K43068349,AMG-9810,TRPV antagonist
6017,-0.88,oe,ccsbBroad304_10437,STMN1,-
2114,23.11,cp,BRD-K15108141,gemcitabine,Ribonucleotide reductase inhibitor
6018,-0.88,oe,ccsbBroad304_01356,QDPR,Short chain dehydrogenase/reductase superfamily / Atypical members
6021,-0.9,kd,CGS001-3611,ILK,Ankyrin repeat domain containing
6024,-0.92,kd,CGS001-10587,TXNRD2,-
6028,-0.93,oe,ccsbBroad304_07662,NPRL2,-
6029,-0.93,oe,ccsbBroad304_06462,ITGAE,Integrins
6030,-0.93,oe,ccsbBroad304_09198,HOPX,Homeoboxes / PRD class
6036,-0.97,oe,ccsbBroad304_06625,NDUFS4,Mitochondrial respiratory chain complex / Complex I
6037,-0.97,kd,CGS001-7407,VARS,Aminoacyl tRNA synthetases / Class I
6038,-0.97,kd,CGS001-6469,SHH,-
6039,-0.97,oe,ccsbBroad304_08480,PNPO,-
6040,-0.97,oe,ccsbBroad304_08170,PIK3R4,Phosphatidylinositol kinases
6052,-1,kd,CGS001-5728,PTEN,Protein tyrosine phosphatases / Class I Cys-based PTPs : PTENs
2100,23.33,cp,BRD-M00539986,formoterol,Adrenergic receptor agonist
6053,-1.01,oe,ccsbBroad304_03842,ZNF317,"Zinc fingers, C2H2-type"
2099,23.35,cp,BRD-K20986251,lithocholic-acid,FXR antagonist
6054,-1.02,oe,ccsbBroad304_01034,MSH2,-
6056,-1.02,oe,ccsbBroad304_00670,GPR4,GPCR / Class A : Orphans
6057,-1.02,oe,ccsbBroad304_11910,RBM15B,RNA binding motif (RRM) containing
6058,-1.03,kd,CGS001-23510,KCTD2,-
2094,23.51,cp,BRD-K41868777,W-5,Calmodulin antagonist
2093,23.52,cp,BRD-A12560204,nitrendipine,Calcium channel blocker
6059,-1.03,kd,CGS001-55526,DHTKD1,-
2092,23.53,cp,BRD-A79237180,ascorbic-acid,Antioxidant
6062,-1.06,oe,ccsbBroad304_04194,ELL3,-
2089,23.57,cp,BRD-A09161221,nomilin,HSP inhibitor
6063,-1.08,oe,ccsbBroad304_00781,HPD,Oxidoreductases
6065,-1.08,kd,CGS001-116511,MAS1L,GPCR / Class A : Orphans
6071,-1.1,kd,CGS001-817,CAMK2D,CAMK2 family
6072,-1.11,oe,ccsbBroad304_04038,ELOVL6,-
6073,-1.11,oe,ccsbBroad304_02421,WFDC2,WAP four-disulfide core domain containing
6074,-1.11,oe,ccsbBroad304_04655,TRIM9,-
2082,23.79,cp,BRD-K56745457,azauridine,Antiviral
6077,-1.13,kd,CGS001-695,BTK,Pleckstrin homology (PH) domain containing
6083,-1.16,oe,ccsbBroad304_00222,CASP6,Caspases
6089,-1.16,oe,ccsbBroad304_00233,CBR1,Prostaglandin synthases
6090,-1.16,oe,ccsbBroad304_07275,PSMG1,-
2077,23.82,cp,BRD-K57930253,nitrazepam,Benzodiazepine receptor agonist
6091,-1.16,oe,ccsbBroad304_06856,RET,Type XIV RTKs: RET
6093,-1.18,kd,CGS001-51704,GPRC5B,GPCR / Class C : Orphans
2074,23.9,cp,BRD-K14767410,SC-560,Cyclooxygenase inhibitor
6094,-1.18,kd,CGS001-51021,MRPS16,Mitochondrial ribosomal proteins / small subunits
6095,-1.2,oe,ccsbBroad304_07459,SOCS5,SH2 domain containing
6096,-1.2,oe,ccsbBroad304_02668,PNKP,-
2070,24.03,cp,BRD-K13356952,methazolamide,Carbonic anhydrase inhibitor
2069,24.08,cp,BRD-K41445866,alfaxalone,Chloride channel agonist
6097,-1.21,oe,ccsbBroad304_01732,UBA52,L ribosomal proteins
6100,-1.23,kd,CGS001-23239,PHLPP1,Pleckstrin homology (PH) domain containing
6102,-1.25,oe,ccsbBroad304_00853,IL7R,IL-2 receptor family
6103,-1.25,oe,ccsbBroad304_00568,FHL2,-
2063,24.26,cp,BRD-A55416093,colforsin,Adenylyl cyclase activator
6104,-1.25,oe,ccsbBroad304_05803,ALDH3B2,Aldehyde dehydrogenases
6105,-1.25,oe,ccsbBroad304_02653,PRAF2,-
6106,-1.25,oe,ccsbBroad304_01035,MSH5,-
6107,-1.25,oe,ccsbBroad304_06365,HIF1A,Basic helix-loop-helix proteins
6114,-1.3,oe,ccsbBroad304_01519,SET,-
6115,-1.3,oe,ccsbBroad304_00394,CTSD,Cathepsins
6119,-1.3,oe,ccsbBroad304_01998,ABCC3,ATP binding cassette transporters / subfamily C
6120,-1.3,oe,ccsbBroad304_00256,TNFSF8,CD molecules
6121,-1.3,oe,ccsbBroad304_00239,CCNG1,-
6123,-1.32,oe,ccsbBroad304_02875,BRP44,-
6126,-1.33,kd,CGS001-91975,ZNF300,"Zinc fingers, C2H2-type"
6127,-1.34,oe,ccsbBroad304_07981,SENP6,Ulp1 endopeptidase
6128,-1.34,oe,ccsbBroad304_07128,VHL,-
2050,24.51,cp,BRD-A47633927,NPC-15199,ICAM1 antagonist
2049,24.52,cp,BRD-K23583188,lavendustin-a,EGFR inhibitor
6129,-1.34,oe,ccsbBroad304_02677,PDAP1,-
2047,24.56,cp,BRD-K18855837,varenicline,Acetylcholine receptor agonist
6130,-1.34,oe,ccsbBroad304_08365,CYCS,-
6136,-1.34,oe,ccsbBroad304_07564,SLC25A15,Mitochondrial amino acid transporter subfamily
2044,24.63,cc,,Histone deacetylases LOF,-
6137,-1.34,oe,ccsbBroad304_01872,DGCR14,-
6138,-1.34,oe,ccsbBroad304_14242,MCCC2,-
6141,-1.35,kd,CGS001-7332,UBE2L3,Ubiquitin-conjugating enzymes E2
2039,24.78,cp,BRD-A01346607,flumetasone,Glucocorticoid receptor agonist
6147,-1.39,oe,ccsbBroad304_01336,PTGS2,Cyclooxygenase
2038,24.79,cp,BRD-A71765365,mepireserpate,Catecholamine depleting sympatholytic
6148,-1.39,oe,ccsbBroad304_01001,MEST,-
2037,24.83,cp,BRD-A33447119,oxfendazole,Anthelmintic
6149,-1.39,kd,CGS001-727,C5,Endogenous ligands
2034,24.89,cp,BRD-K22662435,ganciclovir,DNA polymerase inhibitor
6150,-1.39,oe,ccsbBroad304_00512,EPO,Endogenous ligands
2031,24.96,cp,BRD-K97399794,quercetin,Polar auxin transport inhibitor
2032,24.96,cp,BRD-K71003802,hippeastrine,Plant alkaloid
6151,-1.39,oe,ccsbBroad304_07064,TH,Amino acid hydroxylases
6156,-1.41,kd,CGS001-23149,FCHO1,-
6157,-1.42,kd,CGS001-10221,TRIB1,Trbl family
2026,25.06,cc,,T-type calcium channel blocker,-
2027,25.06,cp,BRD-A00520476,otenzepad,Acetylcholine receptor antagonist
2024,25.08,cp,BRD-K48935217,epothilone,Microtubule inhibitor
2025,25.08,cp,BRD-A30205217,ethotoin,Hydantoin antiepileptic
6158,-1.42,oe,ccsbBroad304_06022,COX7B,Mitochondrial respiratory chain complex
2022,25.1,cp,BRD-K88789588,letrozole,Aromatase inhibitor
6159,-1.43,oe,ccsbBroad304_03767,TOMM22,-
6162,-1.44,oe,ccsbBroad304_10484,ZNF707,"Zinc fingers, C2H2-type"
6163,-1.44,oe,ccsbBroad304_07935,IFIT5,Tetratricopeptide (TTC) repeat domain containing
6164,-1.44,oe,ccsbBroad304_05348,FOXR1,Forkhead boxes
6165,-1.44,oe,ccsbBroad304_00144,B2M,Immunoglobulin superfamily / C1-set domain containing
6166,-1.44,oe,ccsbBroad304_01332,PTGER4,GPCR / Class A : Prostanoid receptors
6167,-1.44,oe,ccsbBroad304_02934,B3GAT3,"Beta-1,3-glucuronyltransferases"
6168,-1.44,oe,ccsbBroad304_04399,PGBD1,-
6170,-1.45,kd,CGS001-55437,STRADB,STLK subfamily
6171,-1.48,oe,ccsbBroad304_08313,ZNF581,"Zinc fingers, C2H2-type"
6172,-1.48,oe,ccsbBroad304_07077,TSPAN8,Tetraspanins
2011,25.37,cp,BRD-K57631554,aminolevulinic-acid,Oxidizing agent
2008,25.4,cp,BRD-K50422030,clomethiazole,GABA receptor antagonist
6173,-1.48,oe,ccsbBroad304_03570,QRSL1,-
6174,-1.48,oe,ccsbBroad304_02044,EIF2S2,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
2007,25.43,cp,BRD-K92758126,gibberellic-acid,NFkB pathway inhibitor
6179,-1.48,kd,CGS001-10247,HRSP12,-
6180,-1.48,oe,ccsbBroad304_01841,BAG6,-
6189,-1.55,kd,CGS001-29079,MED4,-
2002,25.51,cp,BRD-K14550461,doxercalciferol,Vitamin D receptor agonist
6190,-1.55,kd,CGS001-2961,GTF2E2,General transcription factors
6191,-1.57,oe,ccsbBroad304_08093,DCPS,-
6192,-1.57,oe,ccsbBroad304_01114,NUP88,-
6193,-1.57,oe,ccsbBroad304_02218,IKBKE,IKK family
1996,25.66,cp,BRD-K60160658,tiagabine,GABA uptake inhibitor
6194,-1.57,oe,ccsbBroad304_06680,P2RX4,"Ligand-gated ion channels / Purinergic receptors, ionotropic"
6195,-1.57,oe,ccsbBroad304_03441,UGT1A9,UDP glucuronosyltransferases
6196,-1.57,oe,ccsbBroad304_03923,LRRC4,Immunoglobulin superfamily / I-set domain containing
6197,-1.58,kd,CGS001-2277,FIGF,-
1992,25.77,cp,BRD-A13133631,fluorometholone,Glucocorticoid receptor agonist
6203,-1.62,oe,ccsbBroad304_07211,ZRSR2,RNA binding motif (RRM) containing
6208,-1.62,oe,ccsbBroad304_01889,FZD4,GPCR / Class F : Frizzled receptors
6209,-1.62,oe,ccsbBroad304_01984,EIF3G,RNA binding motif (RRM) containing
6210,-1.62,oe,ccsbBroad304_09413,ZNF554,"Zinc fingers, C2H2-type"
6211,-1.63,kd,CGS001-10227,MFSD10,-
6216,-1.66,kd,CGS001-399694,SHC4,SH2 domain containing
6217,-1.66,kd,CGS001-5601,MAPK9,MAPK:JNK subfamily
6218,-1.66,kd,CGS001-1869,E2F1,-
1983,26.03,cp,BRD-K40758068,efavirenz,HIV protease inhibitor
6219,-1.66,kd,CGS001-259,AMBP,Lipocalins
6220,-1.67,oe,ccsbBroad304_09445,MRGPRX3,GPCR / Class A : Orphans
6221,-1.67,oe,ccsbBroad304_03769,CTNNBIP1,Catenins
6222,-1.67,oe,ccsbBroad304_00322,CLCN5,Ion channels / Chloride channels : Voltage-sensitive
6224,-1.67,oe,ccsbBroad304_10026,ZNF517,"Zinc fingers, C2H2-type"
6225,-1.67,oe,ccsbBroad304_01184,PGK1,-
6226,-1.68,kd,CGS001-8321,FZD1,GPCR / Class F : Frizzled receptors
6231,-1.71,oe,ccsbBroad304_01480,S100P,EF-hand domain containing
6232,-1.71,oe,ccsbBroad304_01355,PYGL,Glycogen phosphorylases
6233,-1.71,oe,ccsbBroad304_06623,NDUFAB1,Mitochondrial respiratory chain complex / Complex I
1971,26.23,cp,BRD-K06712146,YM-90709,IL5 inhibitor
6234,-1.71,oe,ccsbBroad304_07727,LIAS,-
1970,26.24,cp,BRD-A16665823,butoconazole,Bacterial cell wall synthesis inhibitor
1969,26.33,cp,BRD-A30437061,camptothecin,Topoisomerase inhibitor
6235,-1.71,oe,ccsbBroad304_02831,SGK3,SGK family
6236,-1.71,oe,ccsbBroad304_01803,ZBTB25,BTB/POZ domain containing
1965,26.36,cc,,Interleukin receptors LOF,-
6237,-1.71,oe,ccsbBroad304_01391,RFC5,ATPases / AAA-type
6238,-1.71,oe,ccsbBroad304_01608,STAT2,SH2 domain containing
6244,-1.76,oe,ccsbBroad304_01215,PLAUR,CD molecules
6249,-1.76,kd,CGS001-5290,PIK3CA,Phosphatidylinositol kinases
6250,-1.76,kd,CGS001-5727,PTCH1,-
6251,-1.76,oe,ccsbBroad304_08183,NSDHL,Short chain dehydrogenase/reductase superfamily / Extended SDR fold
6252,-1.78,oe,ccsbBroad304_00009,ACLY,-
6253,-1.79,kd,CGS001-8803,SUCLA2,-
1957,26.54,cp,BRD-K73589401,corticosterone,mineralocorticoid receptor agonist
6254,-1.79,kd,CGS001-6303,SAT1,-
6255,-1.79,kd,CGS001-23028,KDM1A,Histone demethylase
6258,-1.81,oe,ccsbBroad304_07267,PDLIM4,-
6259,-1.82,kd,CGS001-81533,ITFG1,-
6260,-1.82,kd,CGS001-22903,BTBD3,BTB/POZ domain containing
6262,-1.84,kd,CGS001-1017,CDK2,"Cyclin-dependent kinases, CDK1 subfamily"
1950,26.61,cc,,Lysine acetyltransferases LOF,-
6263,-1.85,oe,ccsbBroad304_10230,STK19,G11 family
6264,-1.85,oe,ccsbBroad304_09881,RFX6,-
1947,26.71,cp,BRD-A55913614,primaquine,Antimalarial
1946,26.72,cp,BRD-A90131694,alclometasone,Glucocorticoid receptor agonist
6265,-1.85,oe,ccsbBroad304_08102,MRPL18,Mitochondrial ribosomal proteins / large subunits
1944,26.91,cp,BRD-K56429665,calcipotriol,Vitamin D receptor agonist
6266,-1.85,oe,ccsbBroad304_04018,VKORC1,Oxidoreductases
6268,-1.87,kd,CGS001-56938,ARNTL2,Basic helix-loop-helix proteins
6270,-1.9,oe,ccsbBroad304_01555,SNAI2,Snail homologs
6271,-1.9,oe,ccsbBroad304_05970,CDC20,WD repeat domain containing
6272,-1.9,oe,ccsbBroad304_00179,BTG1,-
6275,-1.92,oe,ccsbBroad304_02017,PEX11A,-
6276,-1.92,kd,CGS001-27297,CRCP,-
6277,-1.92,kd,CGS001-5156,PDGFRA,"Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family"
6278,-1.94,oe,ccsbBroad304_13936,PTPRF,Receptor tyrosine phosphatases (RTP)
1933,27.09,cp,BRD-K39520573,GW-5074,Leucine rich repeat kinase inhibitor
6280,-1.94,oe,ccsbBroad304_00849,IL4,Interleukins and interleukin receptors
6281,-1.94,oe,ccsbBroad304_09745,ZNF519,"Zinc fingers, C2H2-type"
1931,27.15,cp,BRD-A52326238,isogedunin,HSP inhibitor
6282,-1.94,oe,ccsbBroad304_03445,UGT1A1,UDP glucuronosyltransferases
6283,-1.94,oe,ccsbBroad304_00722,HSD17B10,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
6284,-1.95,kd,CGS001-6713,SQLE,Lanosterol biosynthesis pathway
6285,-1.95,kd,CGS001-7054,TH,Amino acid hydroxylases
6290,-1.99,oe,ccsbBroad304_04991,ZNF785,"Zinc fingers, C2H2-type"
6291,-1.99,oe,ccsbBroad304_00360,CREB1,basic leucine zipper proteins
6292,-1.99,oe,ccsbBroad304_00517,ESR1,Estrogen receptors
6293,-2,oe,ccsbBroad304_09206,ZGPAT,G patch domain containing
6294,-2,kd,CGS001-54584,GNB1L,WD repeat domain containing
1920,27.36,cp,BRD-K70358946,aripiprazole,Serotonin receptor agonist
6295,-2,kd,CGS001-1493,CTLA4,CD molecules
6300,-2.03,oe,ccsbBroad304_07197,PDHX,-
6301,-2.03,kd,CGS001-5583,PRKCH,Eta subfamily
6302,-2.03,kd,CGS001-27346,TMEM97,-
6303,-2.03,kd,CGS001-5931,RBBP7,WD repeat domain containing
1915,27.53,cp,BRD-K59637651,NSC-119889,Protein synthesis inhibitor
1914,27.61,cp,BRD-K84895041,BMY-45778,IP1 prostacyclin receptor agonist
6305,-2.04,oe,ccsbBroad304_01822,ZNF227,"Zinc fingers, C2H2-type"
6306,-2.05,kd,CGS001-6829,SUPT5H,-
6307,-2.05,kd,CGS001-163486,DENND1B,DENN/MADD domain containing
6308,-2.05,kd,CGS001-111,ADCY5,Adenylate cyclases
6313,-2.08,kd,CGS001-1072,CFL1,-
6314,-2.08,kd,CGS001-3155,HMGCL,-
1907,27.71,cp,BRD-K33864865,LY-225910,CCK receptor antagonist
6315,-2.08,oe,ccsbBroad304_02384,SMNDC1,Tudor domain containing
1905,27.78,cp,BRD-K80325895,eicosadienoic-acid,-666
1904,27.8,cp,BRD-K36377456,marmesin,Angiogenesis inhibitor
6316,-2.09,kd,CGS001-2643,GCH1,-
6318,-2.11,kd,CGS001-5645,PRSS2,Serine peptidases
1899,27.9,cp,BRD-K90733503,cefalexin,Bacterial cell wall synthesis inhibitor
6319,-2.13,oe,ccsbBroad304_08585,RIOK2,RIO2 subfamily
6320,-2.13,oe,ccsbBroad304_13633,PI4KAP2,-
6323,-2.16,kd,CGS001-23451,SF3B1,-
1896,27.97,cc,,AHSP Pathway LOF,-
6324,-2.16,kd,CGS001-9616,RNF7,RING-type (C3HC4) zinc fingers
6325,-2.17,kd,CGS001-1650,DDOST,-
6326,-2.18,oe,ccsbBroad304_02788,PRAME,-
6327,-2.18,oe,ccsbBroad304_00279,CDK6,"Cyclin-dependent kinases, CDK4 subfamily"
6331,-2.21,kd,CGS001-390148,OR5W2,GPCR / Class A : Olfactory receptors
6334,-2.22,oe,ccsbBroad304_00464,DTNA,-
6335,-2.22,oe,ccsbBroad304_07688,FAM114A2,-
1889,28.09,cp,BRD-K51223576,AG-99,Tyrosine kinase inhibitor
6336,-2.22,oe,ccsbBroad304_02041,SLC5A6,"Sodium iodide symporter, sodium-dependent multivitamin transporter and sodium-coupled monocarboxylate transporters"
6337,-2.24,kd,CGS001-5252,PHF1,"Zinc fingers, PHD-type"
6343,-2.26,kd,CGS001-8431,NR0B2,DAX-like receptors
1885,28.25,cp,BRD-K75478907,GS-39783,GABA receptor modulator
1884,28.34,cp,BRD-K84709232,caffeic-acid,Lipoxygenase inhibitor
6344,-2.26,kd,CGS001-966,CD59,CD molecules
6345,-2.27,oe,ccsbBroad304_08734,ZNF490,"Zinc fingers, C2H2-type"
6346,-2.27,oe,ccsbBroad304_00016,ACTN4,EF-hand domain containing
6347,-2.27,oe,ccsbBroad304_01447,RPS6KA3,RSK subfamily
6350,-2.29,kd,CGS001-130,ADH6,Alcohol dehydrogenases
1878,28.52,cp,BRD-K43796186,benzyl-quinazolin-4-yl-amine,EGFR inhibitor
6351,-2.31,oe,ccsbBroad304_06562,MAT1A,-
6352,-2.31,oe,ccsbBroad304_05792,AGTR1,Angiotensin receptors
6353,-2.31,oe,ccsbBroad304_09303,LRSAM1,Sterile alpha motif (SAM) domain containing
6355,-2.33,kd,CGS001-5927,KDM5A,Histone demethylases
6356,-2.34,kd,CGS001-5002,SLC22A18,Orphan or poorly characterized SLC22 family members
6357,-2.34,kd,CGS001-8732,RNGTT,Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases
1871,28.74,cp,BRD-K16478699,PLX-4720,RAF inhibitor
6358,-2.36,oe,ccsbBroad304_12518,STK33,CAMK-unique family
6361,-2.36,oe,ccsbBroad304_03037,TMEM97,-
6364,-2.37,kd,CGS001-5294,PIK3CG,Phosphatidylinositol kinases
6365,-2.37,kd,CGS001-84873,GPR128,Adhesion Class GPCRs
6366,-2.37,oe,ccsbBroad304_08014,GBGT1,Glycosyltransferase family 6 domain containing
6370,-2.4,kd,CGS001-64175,LEPRE1,-
6371,-2.41,oe,ccsbBroad304_14020,SH3BP5,-
1863,29.03,cp,BRD-K11636097,JNJ-7706621,CDK inhibitor
6372,-2.41,oe,ccsbBroad304_01852,ZNF212,"Zinc fingers, C2H2-type"
6373,-2.41,oe,ccsbBroad304_00678,GPR37,GPCR / Class A : Orphans
6374,-2.42,kd,CGS001-6199,RPS6KB2,p70 subfamily
6375,-2.42,kd,CGS001-11014,KDELR2,-
6376,-2.42,kd,CGS001-2172,FABP6,Fatty acid binding protein family
6378,-2.45,kd,CGS001-6009,RHEB,-
6379,-2.45,oe,ccsbBroad304_08952,E2F8,-
1855,29.2,cp,BRD-K87932577,CDK1-5-inhibitor,CDK inhibitor
6380,-2.46,kd,CGS001-55770,EXOC2,-
1853,29.26,cp,BRD-A39522003,OMDM-2,FAAH inhibitor
6383,-2.47,kd,CGS001-10252,SPRY1,-
1851,29.32,cp,BRD-K29313308,HDAC3-selective,HDAC inhibitor
6384,-2.49,kd,CGS001-4695,NDUFA2,Mitochondrial respiratory chain complex / Complex I
6385,-2.5,oe,ccsbBroad304_02230,HERPUD1,-
1847,29.4,cp,BRD-K51805276,temefos,Cholinesterase inhibitor
6389,-2.5,oe,ccsbBroad304_06998,SRPK1,SRPK family
6390,-2.5,oe,ccsbBroad304_14174,CDKAL1,-
1845,29.55,cp,BRD-K08589866,linsitinib,IGF-1 inhibitor
6391,-2.53,kd,CGS001-581,BAX,-
6394,-2.55,oe,ccsbBroad304_03874,UBL5,-
6395,-2.55,oe,ccsbBroad304_07056,TGFB1,Endogenous ligands
1840,29.65,cp,BRD-K81209512,AG-494,EGFR inhibitor
6396,-2.55,oe,ccsbBroad304_04082,SLC52A2,SLC52 family of riboflavin transporters
6397,-2.55,oe,ccsbBroad304_02502,GNA13,-
1837,29.67,cp,BRD-K62959606,sphingosine,Ceramidase inhibitor
6399,-2.55,kd,CGS001-28985,MCTS1,-
6400,-2.55,kd,CGS001-26292,MYCBP,-
6401,-2.55,kd,CGS001-2235,FECH,-
1833,29.9,cc,,Aldehyde dehydrogenases LOF,-
1834,29.9,cp,BRD-K73991644,isoquercetin,Aldose reductase inhibitor
6402,-2.55,oe,ccsbBroad304_02981,GPR160,GPCR / Class A : Orphans
6403,-2.56,oe,ccsbBroad304_02201,CLOCK,Histone acetyltransferases
6404,-2.57,oe,ccsbBroad304_03378,ERAP1,Aminopeptidase N
6405,-2.57,oe,ccsbBroad304_06789,PSEN2,Presenilin
1828,30.03,cp,BRD-A65767837,hydrocortisone,Glucocorticoid receptor agonist
1827,30.06,cp,BRD-K43978949,PIT,Purinergic receptor antagonist
1825,30.13,cp,BRD-A17411484,carprofen,Cyclooxygenase inhibitor
6408,-2.59,oe,ccsbBroad304_02741,PDS5A,-
6409,-2.59,oe,ccsbBroad304_01929,DYRK2,Dyrk2 subfamily
6410,-2.59,oe,ccsbBroad304_09592,CTCFL,"Zinc fingers, C2H2-type"
6411,-2.59,oe,ccsbBroad304_05927,CALM1,EF-hand domain containing
1820,30.22,cp,BRD-K53790871,triamcinolone,Glucocorticoid receptor agonist
1821,30.22,cp,BRD-K94353609,fluocinolone,Glucocorticoid receptor agonist
6415,-2.61,kd,CGS001-84838,ZNF496,"Zinc fingers, C2H2-type"
1818,30.25,cp,BRD-K18799075,BAY-59-3074,Cannabinoid receptor partial agonist
6416,-2.61,kd,CGS001-3592,IL12A,Interleukins and interleukin receptors
1816,30.29,cp,BRD-K67566344,KU-0063794,MTOR inhibitor
6422,-2.64,oe,ccsbBroad304_10487,BPHL,-
6423,-2.64,oe,ccsbBroad304_07760,KAT7,Histone acetyltransferases (HATs)
6424,-2.64,oe,ccsbBroad304_00795,HSF2,-
1812,30.45,cp,BRD-A41304429,practolol,Adrenergic receptor antagonist
6425,-2.64,oe,ccsbBroad304_02581,ASCC3,-
6429,-2.67,kd,CGS001-664,BNIP3,-
6431,-2.68,kd,CGS001-4302,MLLT6,"Zinc fingers, PHD-type"
6437,-2.73,oe,ccsbBroad304_02566,MORF4L1,-
1806,30.6,cp,BRD-A73741725,exemestane,Aromatase inhibitor
6438,-2.73,oe,ccsbBroad304_00845,IL1RAP,Immunoglobulin superfamily / Immunoglobulin-like domain containing
6439,-2.74,oe,ccsbBroad304_08532,SIRPG,Immunoglobulin superfamily / C1-set domain containing
6444,-2.78,oe,ccsbBroad304_01566,SNRPA,RNA binding motif (RRM) containing
6447,-2.78,kd,CGS001-6093,ROCK1,Pleckstrin homology (PH) domain containing
6448,-2.78,oe,ccsbBroad304_04490,RSPH1,-
6449,-2.78,oe,ccsbBroad304_01471,S100A1,EF-hand domain containing
1800,30.75,cp,BRD-A43849199,karakoline,Phytotoxin
6450,-2.79,kd,CGS001-9134,CCNE2,-
6451,-2.82,oe,ccsbBroad304_00652,GNAS,-
6453,-2.82,oe,ccsbBroad304_03089,PACSIN3,-
6455,-2.84,kd,CGS001-54925,ZNF434,-
6457,-2.87,oe,ccsbBroad304_06068,CXADR,Immunoglobulin superfamily / Immunoglobulin-like domain containing
6460,-2.89,kd,CGS001-9791,PTDSS1,-
6464,-2.91,kd,CGS001-3212,HOXB2,Homeoboxes / ANTP class : HOXL subclass
6465,-2.92,oe,ccsbBroad304_02826,SLC7A11,Solute carriers
6466,-2.92,oe,ccsbBroad304_10857,MKNK2,MKN subfamily
6467,-2.92,oe,ccsbBroad304_00370,CS,-
6468,-2.92,kd,CGS001-25836,NIPBL,-
6469,-2.92,oe,ccsbBroad304_07131,VRK1,Vaccina related kinase (VRK) family
6472,-2.96,oe,ccsbBroad304_02432,IFI30,-
6473,-2.96,oe,ccsbBroad304_00600,FYN,Src family
6475,-2.97,kd,CGS001-54499,TMCO1,-
6477,-2.98,kd,CGS001-8883,NAE1,Ubiquitin-like modifier activating enzymes
6478,-3,kd,CGS001-4702,NDUFA8,Mitochondrial respiratory chain complex / Complex I
6480,-3.01,oe,ccsbBroad304_07832,XPO7,Exportins
6481,-3.01,oe,ccsbBroad304_07761,CORO1A,Coronins
6484,-3.03,kd,CGS001-7982,ST7,-
6486,-3.06,oe,ccsbBroad304_00406,CYP1A1,Cytochrome P450s
6491,-3.08,kd,CGS001-9564,BCAR1,Cas scaffolding proteins
1777,31.46,cp,BRD-K71266197,PSB-06126,NTPDase inhibitor
6494,-3.1,kd,CGS001-84765,ZNF577,"Zinc fingers, C2H2-type"
1775,31.56,cp,BRD-A70514680,articaine,Local anesthetic
6495,-3.1,oe,ccsbBroad304_06683,FURIN,Subtilisin
6496,-3.11,kd,CGS001-64428,NARFL,-
6497,-3.11,kd,CGS001-162,AP1B1,-
1771,31.63,cp,BRD-K72783841,tyrphostin-AG-555,EGFR inhibitor
6501,-3.15,oe,ccsbBroad304_00006,ACADM,-
6502,-3.16,kd,CGS001-128,ADH5,Alcohol dehydrogenases
6503,-3.17,kd,CGS001-431707,LHX8,Homeoboxes / LIM class
6504,-3.19,oe,ccsbBroad304_07808,RAB11FIP2,-
6505,-3.19,oe,ccsbBroad304_06085,DCK,-
6506,-3.2,kd,CGS001-25949,SYF2,-
6508,-3.24,oe,ccsbBroad304_00418,CD55,CD molecules
6510,-3.24,kd,CGS001-944,TNFSF8,CD molecules
6511,-3.24,oe,ccsbBroad304_01143,PAFAH1B3,-
1760,31.88,cp,BRD-K46435977,valaciclovir,DNA polymerase inhibitor
6512,-3.24,oe,ccsbBroad304_01288,MAPK9,MAPK:JNK subfamily
6513,-3.26,kd,CGS001-7702,ZNF143,"Zinc fingers, C2H2-type"
6514,-3.26,kd,CGS001-26994,RNF11,RING-type (C3HC4) zinc fingers
1757,32.02,cp,BRD-K72703948,ZM-447439,Aurora kinase inhibitor
1755,32.13,cp,BRD-K34014345,naproxol,Anti-inflammatory
6515,-3.26,kd,CGS001-9815,GIT2,Ankyrin repeat domain containing
1754,32.19,cp,BRD-K31238592,devazepide,CCK receptor antagonist
6517,-3.28,oe,ccsbBroad304_08394,UGT1A6,UDP glucuronosyltransferases
6518,-3.29,oe,ccsbBroad304_01280,PRKAR1A,Protein kinase A
6519,-3.3,kd,CGS001-4711,NDUFB5,Mitochondrial respiratory chain complex / Complex I
6524,-3.32,kd,CGS001-29850,TRPM5,Transient Receptor Potential channels
6525,-3.33,oe,ccsbBroad304_00593,NR5A2,Fushi tarazu F1-like receptors
6526,-3.33,kd,CGS001-10473,HMGN4,High-mobility group / Canonical
1747,32.38,cp,BRD-K09668667,benzo(a)pyrene,Carcinogen
6527,-3.34,kd,CGS001-8576,STK16,NAK family
1745,32.4,cp,BRD-A98431941,ephedrine,Adrenergic receptor agonist
6534,-3.37,kd,CGS001-139378,GPR112,Adhesion Class GPCRs
6536,-3.38,oe,ccsbBroad304_03413,SLC38A2,System A-like transporters
6537,-3.38,oe,ccsbBroad304_03848,METTL14,-
1741,32.44,cc,,Mitochondrial complex IV LOF,-
6540,-3.39,kd,CGS001-4694,NDUFA1,Mitochondrial respiratory chain complex / Complex I
1739,32.49,cp,BRD-K05151076,ZK-164015,Estrogen receptor antagonist
6541,-3.39,kd,CGS001-8518,IKBKAP,Elongator acetyltransferase complex subunits
6543,-3.42,kd,CGS001-9131,AIFM1,-
1736,32.61,cp,BRD-K72816382,cinalukast,Leukotriene receptor antagonist
6545,-3.45,kd,CGS001-26147,PHF19,"Zinc fingers, PHD-type"
6547,-3.47,oe,ccsbBroad304_02837,BHMT2,-
6550,-3.53,oe,ccsbBroad304_05756,ACAA1,-
1732,32.79,cp,BRD-A07395371,esmolol,Adrenergic receptor antagonist
6551,-3.53,kd,CGS001-1374,CPT1A,-
6552,-3.56,oe,ccsbBroad304_03420,TOLLIP,-
1729,32.82,cp,BRD-A28318179,aminomethyltransferase,Nitric oxide synthase inhibitor
6555,-3.58,kd,CGS001-122809,SOCS4,SH2 domain containing
1727,32.87,cp,BRD-K16233984,eriochrome-black-t,Azo dye
6556,-3.58,kd,CGS001-6499,SKIV2L,-
6557,-3.58,kd,CGS001-115330,GPR146,GPCR / Class A : Orphans
1724,32.93,cp,BRD-A29082194,gitoxigenin,ATPase inhibitor
6558,-3.58,kd,CGS001-55715,DOK4,Pleckstrin homology (PH) domain containing
6559,-3.61,kd,CGS001-2747,GLUD2,-
6564,-3.63,kd,CGS001-9971,NR1H4,Liver X receptor-like receptors
6567,-3.66,kd,CGS001-114785,MBD6,-
1718,33.05,cp,BRD-A62182663,YK-4279,Apoptosis stimulant
6568,-3.66,oe,ccsbBroad304_02565,RALBP1,-
6570,-3.68,kd,CGS001-10617,STAMBP,-
6571,-3.68,kd,CGS001-672,BRCA1,"Fanconi anemia, complementation groups"
1715,33.32,cp,BRD-K08206212,entecavir,Reverse transcriptase inhibitor
6573,-3.7,kd,CGS001-6567,SLC16A2,SLC16 family of monocarboxylate transporters
6574,-3.7,oe,ccsbBroad304_13975,TYRO3,"Type XI RTKs: TAM (TYRO3-, AXL- and MER-TK) receptor family"
6575,-3.71,oe,ccsbBroad304_06309,UTS2R,Urotensin receptor
6576,-3.72,kd,CGS001-2068,ERCC2,General transcription factor IIH complex subunits
6578,-3.74,kd,CGS001-55825,PECR,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
6579,-3.74,kd,CGS001-55968,NSFL1C,UBX domain containing
6580,-3.74,kd,CGS001-2997,GYS1,Glycosyltransferase group 1 domain containing
6581,-3.75,oe,ccsbBroad304_03853,LSM2,-
6582,-3.75,oe,ccsbBroad304_06290,GNA15,-
1705,33.59,cp,BRD-K56001384,antimycin-a,ATP synthase inhibitor
6583,-3.75,kd,CGS001-4547,MTTP,-
6584,-3.76,kd,CGS001-7080,NKX2-1,Homeoboxes / ANTP class : NKL subclass
6585,-3.76,kd,CGS001-4794,NFKBIE,Ankyrin repeat domain containing
1701,33.7,cp,BRD-A52193669,withaferin-a,IKK inhibitor
6586,-3.76,kd,CGS001-51380,CSAD,-
6589,-3.79,oe,ccsbBroad304_03839,ZBTB26,BTB/POZ domain containing
6591,-3.8,oe,ccsbBroad304_03387,NUDT9,Nudix motif containing
6592,-3.8,oe,ccsbBroad304_14011,PAPSS1,-
6593,-3.8,oe,ccsbBroad304_01953,PIAS1,"Zinc fingers, MIZ-type"
6594,-3.8,oe,ccsbBroad304_06413,HSP90AA1,Heat shock proteins / HSPC
6597,-3.83,kd,CGS001-4313,MMP2,Matrix metallopeptidase
1693,34.01,cp,BRD-K43860855,iobenguane,Antineoplastic
6598,-3.83,oe,ccsbBroad304_01936,RAE1,WD repeat domain containing
6600,-3.84,kd,CGS001-1105,CHD1,-
6601,-3.85,kd,CGS001-7536,SF1,"Zinc fingers, CCHC domain containing"
6602,-3.86,oe,ccsbBroad304_00757,HMGA1,High-mobility group / Canonical
1688,34.17,cp,BRD-K49027941,PSB-1115,Adenosine receptor antagonist
6603,-3.86,oe,ccsbBroad304_00281,CDK8,"Cyclin-dependent kinases, CDK8 subfamily"
1686,34.24,cp,BRD-A07824748,flavanone,11-beta-HSD1 inhibitor
6604,-3.87,kd,CGS001-11143,KAT7,Histone acetyltransferases (HATs)
6605,-3.87,kd,CGS001-64921,CASD1,-
6606,-3.88,kd,CGS001-339500,ZNF678,"Zinc fingers, C2H2-type"
6607,-3.89,kd,CGS001-2185,PTK2B,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
6608,-3.89,kd,CGS001-79135,APOO,Apolipoproteins
6609,-3.89,oe,ccsbBroad304_00772,HOXA6,Homeoboxes / ANTP class : HOXL subclass
6610,-3.89,oe,ccsbBroad304_01408,RNF5,RING-type (C3HC4) zinc fingers
6611,-3.91,oe,ccsbBroad304_00644,GCLC,-
6614,-3.94,oe,ccsbBroad304_08255,ZNF219,"Zinc fingers, C2H2-type"
6616,-3.95,kd,CGS001-866,SERPINA6,Serine (or cysteine) peptidase inhibitors
6617,-3.96,kd,CGS001-3689,ITGB2,Integrins
6618,-3.98,oe,ccsbBroad304_06458,IRF3,-
6623,-4.03,kd,CGS001-57007,CXCR7,-
6624,-4.03,oe,ccsbBroad304_00276,CDK2,"Cyclin-dependent kinases, CDK1 subfamily"
6625,-4.05,kd,CGS001-192669,EIF2C3,-
6626,-4.07,oe,ccsbBroad304_06778,PROC,Endogenous ligands
6629,-4.09,oe,ccsbBroad304_01340,PTPN2,Protein tyrosine phosphatases
1667,34.62,cp,BRD-A59985574,topotecan,Topoisomerase inhibitor
6630,-4.11,kd,CGS001-7504,XK,Blood group antigens
6631,-4.11,kd,CGS001-837,CASP4,Caspases
6634,-4.17,oe,ccsbBroad304_04309,HDAC10,Histone deacetylases
6635,-4.18,kd,CGS001-154197,PNLDC1,-
6636,-4.18,kd,CGS001-9429,ABCG2,ATP binding cassette transporters / subfamily G
6637,-4.2,oe,ccsbBroad304_01392,TRIM27,-
6638,-4.21,oe,ccsbBroad304_03618,OSGEP,-
6643,-4.26,kd,CGS001-79109,MAPKAP1,-
6644,-4.26,kd,CGS001-9070,ASH2L,"Zinc fingers, PHD-type"
6645,-4.26,oe,ccsbBroad304_13933,PSME2,"Proteasome (prosome, macropain) subunits"
6646,-4.27,oe,ccsbBroad304_06908,S100B,EF-hand domain containing
1656,35,cp,BRD-A56245458,reichstein,Androgen receptor antagonist
6647,-4.29,kd,CGS001-8517,IKBKG,"Zinc fingers, C2HC-type containing"
6648,-4.31,oe,ccsbBroad304_01967,PPAP2A,Lipid phosphate phosphatases
6649,-4.31,oe,ccsbBroad304_01948,GAS7,-
6650,-4.31,oe,ccsbBroad304_07888,CBX6,-
1651,35.09,cp,BRD-K09132007,D-4476,TGF beta receptor inhibitor
6651,-4.31,oe,ccsbBroad304_00518,ETFA,-
6652,-4.37,kd,CGS001-6535,SLC6A8,GABA transporter subfamily
6654,-4.39,oe,ccsbBroad304_02974,HAVCR1,Immunoglobulin superfamily / V-set domain containing
6655,-4.39,kd,CGS001-286380,FOXD4L3,-
6657,-4.44,oe,ccsbBroad304_02416,TUBB4B,-
6661,-4.45,kd,CGS001-2781,GNAZ,-
6662,-4.45,kd,CGS001-23355,VPS8,-
6663,-4.45,kd,CGS001-5230,PGK1,-
6664,-4.45,kd,CGS001-1802,DPH2,-
6667,-4.47,kd,CGS001-51330,TNFRSF12A,Tumour necrosis factor (TNF) receptor family
1641,35.56,cp,BRD-K35629949,SR-27897,CCK receptor antagonist
6668,-4.47,kd,CGS001-9900,SV2A,Major facilitator superfamily (MFS) of transporters
1638,35.63,cp,BRD-A31204924,mitotane,Antineoplastic
6669,-4.47,kd,CGS001-54733,SLC35F2,SLC35 family of nucleotide sugar transporters
6675,-4.49,kd,CGS001-7027,TFDP1,-
6679,-4.51,kd,CGS001-7508,XPC,-
6680,-4.52,oe,ccsbBroad304_05818,SLC25A5,Mitochondrial nucleotide transporter subfamily
1634,35.87,cp,BRD-K63151507,MNITMT,Lymphocyte inhibitor
6681,-4.53,kd,CGS001-54536,EXOC6,-
6682,-4.53,kd,CGS001-90589,ZNF625,"Zinc fingers, C2H2-type"
1630,35.91,cp,BRD-K92760278,riboflavin,Vitamin B
6683,-4.53,kd,CGS001-8764,TNFRSF14,Tumour necrosis factor (TNF) receptor family
1628,35.96,cp,BRD-K37312348,kenpaullone,CDK inhibitor
6684,-4.54,oe,ccsbBroad304_02229,TRAM2,-
6689,-4.59,kd,CGS001-26086,GPSM1,Tetratricopeptide (TTC) repeat domain containing
6690,-4.61,kd,CGS001-6793,STK10,SLK subfamily
6693,-4.68,oe,ccsbBroad304_00650,GNA11,-
6695,-4.7,oe,ccsbBroad304_00851,IL6R,IL-6 receptor family
6696,-4.71,kd,CGS001-4610,MYCL1,-
1621,36.08,cp,BRD-K40624912,ZM-39923,JAK inhibitor
6699,-4.77,oe,ccsbBroad304_07763,NUDT6,Nudix motif containing
6700,-4.77,oe,ccsbBroad304_01401,RIT1,-
6701,-4.78,kd,CGS001-5277,PIGA,Glycosyltransferase group 1 domain containing
6702,-4.78,oe,ccsbBroad304_02295,PIGK,Phosphatidylinositol glycan anchor biosynthesis
6704,-4.79,kd,CGS001-2690,GHR,Prolactin receptor family
6705,-4.82,kd,CGS001-80818,ZNF436,"Zinc fingers, C2H2-type"
6706,-4.82,kd,CGS001-5211,PFKL,-
6707,-4.82,kd,CGS001-57019,CIAPIN1,-
1612,36.49,cp,BRD-K66956375,oleoylethanolamide,Cannabinoid receptor agonist
6711,-4.86,oe,ccsbBroad304_02040,NAE1,Ubiquitin-like modifier activating enzymes
6712,-4.87,kd,CGS001-6272,SORT1,-
6713,-4.91,oe,ccsbBroad304_01610,STAT4,SH2 domain containing
6714,-4.93,kd,CGS001-3685,ITGAV,Integrins
6715,-4.97,oe,ccsbBroad304_02538,RUVBL2,ATPases / AAA-type
6718,-4.97,kd,CGS001-2776,GNAQ,-
6719,-4.97,kd,CGS001-275,AMT,-
6720,-4.99,kd,CGS001-55366,LGR4,GPCR / Class A : Orphans
6721,-5,oe,ccsbBroad304_02109,XPR1,-
6723,-5.03,kd,CGS001-4923,NTSR1,GPCR / Class A : Neurotensin receptors
1601,36.92,cp,BRD-A54487287,cortisone,Glucocorticoid receptor agonist
6724,-5.05,kd,CGS001-51128,SAR1B,-
1599,36.99,cp,BRD-K86887724,dofetilide,Potassium channel blocker
6725,-5.05,oe,ccsbBroad304_02205,WTAP,-
6726,-5.08,kd,CGS001-5792,PTPRF,Receptor tyrosine phosphatases (RTP)
6727,-5.08,kd,CGS001-255738,PCSK9,Subtilisin
6728,-5.08,kd,CGS001-3202,HOXA5,Homeoboxes / ANTP class : HOXL subclass
6729,-5.08,kd,CGS001-2159,F10,Chymotrypsin
6731,-5.11,kd,CGS001-80762,NDFIP1,-
1592,37.29,cp,BRD-K92301463,"16,16-dimethylprostaglandin-e2",Prostanoid receptor agonist
6733,-5.13,kd,CGS001-7483,WNT9A,Wingless-type MMTV integration sites
1590,37.37,cp,BRD-K84955386,hyperoside,Glucosidase inhibitor
6735,-5.14,kd,CGS001-3417,IDH1,-
6736,-5.16,kd,CGS001-4300,MLLT3,-
6737,-5.16,kd,CGS001-8945,BTRC,F-boxes / WD-40 domains
6739,-5.18,kd,CGS001-8165,AKAP1,A-kinase anchor proteins
1585,37.78,cc,,Cell Cycle Inhibition GOF,-
1583,37.79,cp,BRD-K67868012,PI-103,MTOR inhibitor
1584,37.79,cp,BRD-K26664453,cytochalasin-b,Microtubule inhibitor
6744,-5.22,oe,ccsbBroad304_01094,NFKBIB,Ankyrin repeat domain containing
6745,-5.22,oe,ccsbBroad304_03574,FBXW7,F-boxes / WD-40 domains
6746,-5.24,kd,CGS001-2166,FAAH,Endocannabinoid turnover
6750,-5.28,kd,CGS001-3074,HEXB,-
6752,-5.32,oe,ccsbBroad304_00356,CPD,Carboxypeptidase A
6754,-5.34,oe,ccsbBroad304_06831,RAC1,Endogenous ligands
6755,-5.35,oe,ccsbBroad304_06238,GABBR1,GABA receptors
6756,-5.37,kd,CGS001-7733,ZNF180,"Zinc fingers, C2H2-type"
6759,-5.42,oe,ccsbBroad304_01453,RPS14,S ribosomal proteins
6761,-5.46,oe,ccsbBroad304_08534,STRADB,STLK subfamily
6763,-5.46,kd,CGS001-6342,SCP2,-
6764,-5.48,oe,ccsbBroad304_00815,ID2,Basic helix-loop-helix proteins
6766,-5.5,kd,CGS001-8731,RNMT,-
6767,-5.52,kd,CGS001-115201,ATG4A,-
6768,-5.53,kd,CGS001-54600,UGT1A9,UDP glucuronosyltransferases
6769,-5.53,kd,CGS001-57222,ERGIC1,-
1566,38.42,cp,BRD-A96107863,nisoldipine,Calcium channel blocker
6770,-5.53,kd,CGS001-8227,AKAP17A,A-kinase anchor proteins
6771,-5.55,kd,CGS001-8625,RFXANK,Ankyrin repeat domain containing
6774,-5.58,kd,CGS001-3304,HSPA1B,Heat shock proteins / HSP70
6775,-5.58,kd,CGS001-150280,HORMAD2,-
6778,-5.63,kd,CGS001-535,ATP6V0A1,ATPases / V-type
6779,-5.65,oe,ccsbBroad304_03861,ZNF77,"Zinc fingers, C2H2-type"
6782,-5.71,oe,ccsbBroad304_01578,SOS2,Rho guanine nucleotide exchange factors
6783,-5.72,kd,CGS001-10139,ARFRP1,ADP-ribosylation factors
6785,-5.77,kd,CGS001-4953,ODC1,Decarboxylases
1556,38.67,cp,BRD-K37720887,SB-525334,TGF beta receptor inhibitor
6787,-5.79,oe,ccsbBroad304_03479,YTHDF1,-
6788,-5.79,oe,ccsbBroad304_04271,MXD3,Basic helix-loop-helix proteins
1553,38.7,cc,,Ubiquitin-specific peptidases LOF,-
6789,-5.8,oe,ccsbBroad304_08426,TEX10,-
6791,-5.83,oe,ccsbBroad304_08023,EIF2C1,-
1550,38.78,cp,BRD-K33551950,radicicol,HSP inhibitor
6792,-5.83,oe,ccsbBroad304_01933,TEAD2,-
6794,-5.86,kd,CGS001-5646,PRSS3,Serine peptidases / Serine peptidases
1545,38.8,cc,,RNA Polymerase Enzymes LOF,-
6795,-5.87,oe,ccsbBroad304_01903,HIST2H2BE,Histones / Replication-dependent
1547,38.8,cp,BRD-A55815733,phylloquinone,Vitamin K
6797,-5.89,kd,CGS001-4837,NNMT,-
6798,-5.89,kd,CGS001-813,CALU,EF-hand domain containing
1542,38.91,cp,BRD-K92723993,imatinib,BCR-ABL kinase inhibitor
6799,-5.92,kd,CGS001-58478,ENOPH1,-
6800,-5.92,kd,CGS001-546,ATRX,-
1539,38.98,cp,BRD-A93477898,PETCM,Caspase activator
6801,-5.93,oe,ccsbBroad304_02681,MGLL,Endocannabinoid turnover
6802,-5.95,kd,CGS001-356,FASLG,Tumour necrosis factor (TNF) receptor family
6803,-5.95,kd,CGS001-158,ADSL,-
6805,-6,kd,CGS001-10513,APPBP2,-
6806,-6.01,kd,CGS001-2053,EPHX2,-
6808,-6.03,kd,CGS001-2887,GRB10,Pleckstrin homology (PH) domain containing
1532,39.44,cp,BRD-K46212057,voriconazole,Cytochrome P450 inhibitor
6809,-6.04,oe,ccsbBroad304_04405,KISS1R,GPCR / Class A : RF amide peptide receptors
6810,-6.05,kd,CGS001-4729,NDUFV2,Mitochondrial respiratory chain complex / Complex I
6811,-6.06,oe,ccsbBroad304_06496,KNG1,Endogenous ligands
6812,-6.06,oe,ccsbBroad304_00313,TBCB,-
6814,-6.11,oe,ccsbBroad304_08386,SMOX,-
6816,-6.12,oe,ccsbBroad304_01523,SRSF4,RNA binding motif (RRM) containing
1525,39.63,cp,BRD-K42573370,avrainvillamide-analog-2,nucleophosmin inhibitor
6817,-6.18,oe,ccsbBroad304_09225,BUD13,-
6818,-6.2,oe,ccsbBroad304_06824,PVR,Immunoglobulin superfamily / C2-set domain containing
6820,-6.2,kd,CGS001-5627,PROS1,-
6821,-6.2,kd,CGS001-4233,MET,Type X RTKs: HGF (hepatocyte growth factor) receptor family
6822,-6.2,oe,ccsbBroad304_01425,RPL22,L ribosomal proteins
6824,-6.23,kd,CGS001-2565,GABRG1,GABA receptors
1517,39.95,cp,BRD-K54529596,captopril,ACE inhibitor
6828,-6.28,kd,CGS001-2992,GYG1,Glycosyltransferase family 8 domain containing
6832,-6.35,kd,CGS001-9842,PLEKHM1,Pleckstrin homology (PH) domain containing
6834,-6.37,kd,CGS001-1513,CTSK,Cathepsins
6835,-6.38,oe,ccsbBroad304_06483,KCNK1,Two-P potassium channels
6836,-6.38,oe,ccsbBroad304_05124,ZNF114,"Zinc fingers, C2H2-type"
6839,-6.45,kd,CGS001-283383,GPR133,Adhesion Class GPCRs
6840,-6.47,kd,CGS001-57661,PHRF1,"Zinc fingers, PHD-type"
1510,40.23,cp,BRD-K07881437,danusertib,Aurora kinase inhibitor
6842,-6.53,kd,CGS001-5004,ORM1,Lipocalins
6843,-6.53,oe,ccsbBroad304_01216,PLD1,Phosphatidylcholine-specific phospholipase D
6845,-6.55,kd,CGS001-81579,PLA2G12A,Phospholipase A2
6846,-6.56,kd,CGS001-3949,LDLR,Low density lipoprotein receptors
6848,-6.61,oe,ccsbBroad304_02460,ATG7,Ubiquitin-like modifier activating enzymes
6849,-6.62,oe,ccsbBroad304_04990,ZNF597,"Zinc fingers, C2H2-type"
1504,40.43,cp,BRD-A07765530,epinephrine,carbonic anhydrase activator
6850,-6.64,kd,CGS001-22887,FOXJ3,Forkhead boxes
6853,-6.67,kd,CGS001-8569,MKNK1,MKN subfamily
6854,-6.67,oe,ccsbBroad304_01271,PPT1,-
6859,-6.79,kd,CGS001-140612,ZFP28,"Zinc fingers, C2H2-type"
6860,-6.79,kd,CGS001-134860,TAAR9,GPCR / Class A : Trace amine associated receptors
6861,-6.81,oe,ccsbBroad304_03173,TMED7,-
6862,-6.81,kd,CGS001-90233,ZNF551,"Zinc fingers, C2H2-type"
6863,-6.84,kd,CGS001-2553,GABPB1,Ankyrin repeat domain containing
1494,40.67,cc,,Topoisomerase inhibitor,-
6864,-6.85,oe,ccsbBroad304_04675,ATG4A,-
6865,-6.85,oe,ccsbBroad304_06708,PDGFRB,"Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family"
6866,-6.85,oe,ccsbBroad304_05142,OLIG3,Basic helix-loop-helix proteins
6868,-6.88,kd,CGS001-472,ATM,Other PIKK family kinases
6870,-6.92,kd,CGS001-6768,ST14,Serine peptidases / Transmembrane
6871,-6.92,kd,CGS001-1066,CES1,Carboxylesterases
6872,-6.93,oe,ccsbBroad304_07088,TP53,-
6873,-6.96,kd,CGS001-128368,OR10Z1,GPCR / Class A : Olfactory receptors
1485,40.96,cp,BRD-K61269089,daphnetin,Protein kinase inhibitor
6874,-6.96,kd,CGS001-4751,NEK2,NIMA (never in mitosis gene a)- related kinase (NEK) family
6875,-6.97,kd,CGS001-415116,PIM3,PIM family
6876,-6.98,oe,ccsbBroad304_02028,SOCS2,SH2 domain containing
1481,41.27,cp,BRD-K11696279,BU-239,Imidazoline receptor agonist
6877,-6.98,oe,ccsbBroad304_09833,SENP5,-
6879,-6.99,oe,ccsbBroad304_10035,ZKSCAN2,"Zinc fingers, C2H2-type"
6880,-6.99,oe,ccsbBroad304_02590,SLC27A3,SLC27 family of fatty acid transporters
6884,-7,kd,CGS001-5932,RBBP8,-
6885,-7.02,oe,ccsbBroad304_01166,PDK2,PDHK family
6887,-7.08,oe,ccsbBroad304_01075,NDUFV1,Mitochondrial respiratory chain complex / Complex I
6889,-7.08,kd,CGS001-9034,CCRL2,Chemokine receptors
1473,41.72,cp,BRD-K22227508,targinine,Nitric oxide synthase inhibitor
6890,-7.11,kd,CGS001-164832,LONRF2,RING-type (C3HC4) zinc fingers
1471,41.78,cp,BRD-K90864987,cobalt(II)-chloride,HSP inducer
6891,-7.11,kd,CGS001-1951,CELSR3,Cadherins / Major cadherins
6892,-7.13,kd,CGS001-10437,IFI30,-
6893,-7.13,oe,ccsbBroad304_03847,GPR107,GPCR / Unclassified : 7TM orphan receptors
6894,-7.15,kd,CGS001-7270,TTF1,-
6896,-7.16,kd,CGS001-4121,MAN1A1,-
6897,-7.17,kd,CGS001-10626,TRIM16,Tripartite motif containing
6899,-7.24,kd,CGS001-10623,POLR3C,RNA polymerase subunits
6900,-7.25,kd,CGS001-10451,VAV3,Rho guanine nucleotide exchange factors
6903,-7.27,oe,ccsbBroad304_02622,PRDM4,"Zinc fingers, C2H2-type"
6906,-7.29,oe,ccsbBroad304_13810,AHCY,Adenosine turnover
6907,-7.31,oe,ccsbBroad304_09354,IGSF8,CD molecules
6908,-7.32,kd,CGS001-330,BIRC3,Inhibitors of apoptosis (IAP) protein family
6911,-7.41,oe,ccsbBroad304_04541,ZNF502,"Zinc fingers, C2H2-type"
6913,-7.43,kd,CGS001-8575,PRKRA,-
6914,-7.46,kd,CGS001-125965,COX6B2,Mitochondrial respiratory chain complex / Complex IV
6916,-7.47,kd,CGS001-3638,INSIG1,-
6918,-7.49,oe,ccsbBroad304_07671,SIX2,Homeoboxes / SINE class
6919,-7.52,kd,CGS001-578,BAK1,-
6920,-7.55,kd,CGS001-4717,NDUFC1,Mitochondrial respiratory chain complex / Complex I
6921,-7.59,oe,ccsbBroad304_06597,MSX2,Homeoboxes / ANTP class : NKL subclass
6923,-7.6,oe,ccsbBroad304_03524,PLEKHJ1,Pleckstrin homology (PH) domain containing
6924,-7.61,kd,CGS001-350383,GPR142,GPCR / Class A : Orphans
1448,42.44,cp,BRD-K88625236,nonoxynol-9,Membrane integrity inhibitor
6925,-7.62,kd,CGS001-6720,SREBF1,Basic helix-loop-helix proteins
6926,-7.63,oe,ccsbBroad304_02580,TMED10,-
6927,-7.63,oe,ccsbBroad304_02373,SPRY2,-
6930,-7.69,oe,ccsbBroad304_01577,SOD1,-
6934,-7.78,oe,ccsbBroad304_08602,HDAC8,Histone deacetylases
6935,-7.79,kd,CGS001-6611,SMS,-
1440,42.71,cp,BRD-K53665955,MK-5108,Aurora kinase inhibitor
6936,-7.8,kd,CGS001-9767,PHF16,-
6937,-7.81,oe,ccsbBroad304_02737,JMJD6,-
1438,42.79,cp,BRD-K98763141,niflumic-acid,Cyclooxygenase inhibitor
1437,42.87,cc,,V type ATPases LOF,-
6938,-7.82,kd,CGS001-3600,IL15,Interleukins and interleukin receptors
6944,-7.92,kd,CGS001-5062,PAK2,PAKA subfamily
6945,-7.93,kd,CGS001-9870,KIAA0317,-
6947,-7.97,kd,CGS001-23624,CBLC,RING-type (C3HC4) zinc fingers
1431,43.03,cp,BRD-K81062487,taurocholic-acid,Bile acid
1432,43.03,cp,BRD-K62982419,cilomilast,Phosphodiesterase inhibitor
6948,-7.99,oe,ccsbBroad304_00175,ZFP36L1,RING-type (C3HC4) zinc fingers
6949,-8,kd,CGS001-23338,PHF15,-
6951,-8.05,kd,CGS001-7105,TSPAN6,Tetraspanins
6952,-8.05,kd,CGS001-24140,FTSJ1,-
6954,-8.08,oe,ccsbBroad304_04998,ZNF418,"Zinc fingers, C2H2-type"
1426,43.18,cp,BRD-K77008974,WYE-354,MTOR inhibitor
1424,43.2,cp,BRD-K93918653,quizartinib,FLT3 inhibitor
6956,-8.09,oe,ccsbBroad304_00782,HPGD,Prostaglandin synthases
6960,-8.13,oe,ccsbBroad304_01318,PSMD2,Proteasome subunits
6961,-8.16,kd,CGS001-55893,ZNF395,"Zinc fingers, C2H2-type"
6962,-8.17,kd,CGS001-285601,GPR150,GPCR / Class A : Orphans
1419,43.56,cp,BRD-A46186775,hydrocortisone,Glucocorticoid receptor agonist
6966,-8.19,kd,CGS001-2313,FLI1,ETS Transcription Factors
6967,-8.2,oe,ccsbBroad304_13952,SHMT2,-
1416,43.61,cp,BRD-K51662849,ilomastat,Matrix metalloprotease inhibitor
6968,-8.23,oe,ccsbBroad304_00491,EIF4EBP2,-
1414,43.64,cp,BRD-K00486786,RO-08-2750,NGF binding inhibitor
6970,-8.26,kd,CGS001-23192,ATG4B,Aut2 peptidase
6973,-8.34,kd,CGS001-3572,IL6ST,IL-6 receptor family
6974,-8.35,kd,CGS001-7760,ZNF213,"Zinc fingers, C2H2-type"
6975,-8.35,kd,CGS001-2937,GSS,-
6977,-8.36,kd,CGS001-4208,MEF2C,Myocyte enhancer factors
6979,-8.38,kd,CGS001-10048,RANBP9,-
6980,-8.38,kd,CGS001-3489,IGFBP6,insulin-like growth factor (IGF) binding proteins
6982,-8.4,kd,CGS001-7334,UBE2N,Ubiquitin-conjugating enzymes E2
6983,-8.41,oe,ccsbBroad304_01277,PRKAB2,AMPK subfamily
6985,-8.44,oe,ccsbBroad304_07764,SLC2A6,Solute carriers
6986,-8.45,kd,CGS001-1892,ECHS1,-
6990,-8.47,kd,CGS001-6652,SORD,-
1400,44.14,cp,BRD-K47943470,tyrphostin-51,EGFR inhibitor
6991,-8.55,kd,CGS001-2697,GJA1,Ion channels / Gap junction proteins (connexins)
1397,44.19,cp,BRD-A64933752,CV-1808,Adenosine receptor agonist
6992,-8.55,kd,CGS001-9710,KIAA0355,-
1399,44.19,cp,BRD-A61392169,eliprodil,Glutamate receptor antagonist
6993,-8.56,oe,ccsbBroad304_01187,SLC25A3,Mitochondrial phosphate transporters
1395,44.34,cp,BRD-A17535965,gelsemine,Acetylcholine receptor antagonist
6999,-8.63,kd,CGS001-256297,PTF1A,Basic helix-loop-helix proteins
7001,-8.64,kd,CGS001-4331,MNAT1,RING-type (C3HC4) zinc fingers
1392,44.46,cp,BRD-A91452556,estradiol-cypionate,Estrogen receptor agonist
7002,-8.65,kd,CGS001-4190,MDH1,-
7003,-8.67,oe,ccsbBroad304_00156,BCL2L1,"Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"
7004,-8.68,kd,CGS001-7025,NR2F1,COUP-TF-like receptors
7005,-8.7,oe,ccsbBroad304_01611,STAT6,SH2 domain containing
7006,-8.71,kd,CGS001-143471,PSMA8,"Proteasome (prosome, macropain) subunits"
7008,-8.79,kd,CGS001-2266,FGG,Endogenous ligands
7009,-8.82,kd,CGS001-1316,KLF6,Kruppel-like transcription factors
7010,-8.82,kd,CGS001-284,ANGPT1,Fibrinogen C domain containing
7011,-8.83,oe,ccsbBroad304_05923,DDR1,Type XVI RTKs: DDR (collagen receptor) family
7012,-8.84,kd,CGS001-152687,ZNF595,"Zinc fingers, C2H2-type"
7013,-8.84,kd,CGS001-11198,SUPT16H,-
7016,-8.85,kd,CGS001-3570,IL6R,IL-6 receptor family
7017,-8.87,oe,ccsbBroad304_00049,ALDH2,Aldehyde dehydrogenases
7018,-8.95,oe,ccsbBroad304_02676,PHB2,-
7019,-8.95,kd,CGS001-5533,PPP3CC,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
7020,-8.95,kd,CGS001-604,BCL6,BTB/POZ domain containing
7021,-9,kd,CGS001-7416,VDAC1,Voltage-dependent anion channels
7024,-9.03,oe,ccsbBroad304_08596,EAPP,-
7025,-9.05,kd,CGS001-2806,GOT2,-
7026,-9.05,kd,CGS001-1327,COX4I1,Mitochondrial respiratory chain complex
7027,-9.06,oe,ccsbBroad304_08742,ZNF398,"Zinc fingers, C2H2-type"
7029,-9.07,oe,ccsbBroad304_04472,HIST1H2BK,Histones / Replication-dependent
7030,-9.07,kd,CGS001-8243,SMC1A,Structural maintenance of chromosomes proteins
7032,-9.11,oe,ccsbBroad304_00162,BIK,-
7033,-9.16,kd,CGS001-201516,ZSCAN4,"Zinc fingers, C2H2-type"
7037,-9.26,oe,ccsbBroad304_01481,SARS,Aminoacyl tRNA synthetases / Class II
1365,45.21,cp,BRD-A65440446,cimaterol,Adrenergic receptor agonist
7040,-9.29,kd,CGS001-6284,S100A13,S100 calcium binding proteins
7043,-9.32,kd,CGS001-1737,DLAT,-
7044,-9.39,kd,CGS001-3672,ITGA1,Integrins
7046,-9.42,kd,CGS001-91392,ZNF502,"Zinc fingers, C2H2-type"
7047,-9.42,kd,CGS001-9604,RNF14,RING-type (C3HC4) zinc fingers
1359,45.5,cp,BRD-K35483542,alitretinoin,Retinoid receptor agonist
7049,-9.53,oe,ccsbBroad304_07292,TNFSF13,CD molecules
7053,-9.61,oe,ccsbBroad304_00769,HOXA1,Homeoboxes / ANTP class : HOXL subclass
1356,45.69,cp,BRD-K18036262,L-168049,Glucagon receptor antagonist
7055,-9.62,kd,CGS001-808,CALM3,EF-hand domain containing
7058,-9.67,kd,CGS001-1195,CLK1,CDC-like kinases
7059,-9.68,oe,ccsbBroad304_06287,GM2A,-
7060,-9.68,kd,CGS001-5698,PSMB9,"Proteasome (prosome, macropain) subunits"
7061,-9.71,kd,CGS001-9453,GGPS1,Lanosterol biosynthesis pathway
7062,-9.71,kd,CGS001-9140,ATG12,-
7063,-9.73,kd,CGS001-1069,CETN2,EF-hand domain containing
1348,45.88,cc,,IGF-1 inhibitor,-
7064,-9.74,oe,ccsbBroad304_01457,RPS19,S ribosomal proteins
7065,-9.76,kd,CGS001-55810,FOXJ2,Forkhead boxes
1345,45.95,cp,BRD-K73397362,purmorphamine,Smoothened receptor agonist
7066,-9.84,kd,CGS001-57547,ZNF624,"Zinc fingers, C2H2-type"
1343,46.03,cp,BRD-K92446736,zatebradine,HCN channel blocker
7067,-9.84,kd,CGS001-2,A2M,-
7068,-9.85,oe,ccsbBroad304_07173,ZNF202,"Zinc fingers, C2H2-type"
1340,46.08,cp,BRD-K19136521,indirubin,CDK inhibitor
1339,46.2,cp,BRD-A23683907,NAS-181,Serotonin receptor antagonist
7070,-9.87,kd,CGS001-1736,DKC1,-
7071,-9.88,oe,ccsbBroad304_04153,PHF17,-
7072,-9.93,oe,ccsbBroad304_08853,RGS18,Regulators of G-protein signaling
7074,-9.95,kd,CGS001-2521,FUS,RNA binding motif (RRM) containing
1334,46.4,cp,BRD-K78431006,crizotinib,ALK inhibitor
7075,-9.99,oe,ccsbBroad304_08971,ZNF669,"Zinc fingers, C2H2-type"
7076,-10.01,oe,ccsbBroad304_02268,G3BP2,RNA binding motif (RRM) containing
7077,-10.03,kd,CGS001-10241,CALCOCO2,-
7079,-10.05,oe,ccsbBroad304_01262,PPP2CB,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
7081,-10.11,oe,ccsbBroad304_06760,PPP2R3A,EF-hand domain containing
7085,-10.21,kd,CGS001-11254,SLC6A14,Glycine transporter subfamily
1327,46.49,cp,BRD-K13642330,cosmosiin,Cytochrome P450 inhibitor
7086,-10.21,oe,ccsbBroad304_04802,COX6B2,Mitochondrial respiratory chain complex / Complex IV
7087,-10.22,kd,CGS001-7692,ZNF133,"Zinc fingers, C2H2-type"
7089,-10.28,oe,ccsbBroad304_05253,GPR114,Adhesion Class GPCRs
7095,-10.32,kd,CGS001-25987,TSKU,-
7097,-10.33,kd,CGS001-9181,ARHGEF2,Rho guanine nucleotide exchange factors
1320,46.85,cp,BRD-U44700465,HG-5-88-01,Protein kinase inhibitor
7099,-10.38,oe,ccsbBroad304_01452,RPS13,S ribosomal proteins
1319,46.97,cp,BRD-A07000685,hydrocortisone,Glucocorticoid receptor agonist
7100,-10.41,kd,CGS001-26762,HAVCR1,Immunoglobulin superfamily / V-set domain containing
7101,-10.43,oe,ccsbBroad304_02285,MED6,-
7102,-10.44,kd,CGS001-84759,PCGF1,Polycomb group ring fingers
7105,-10.5,kd,CGS001-8467,SMARCA5,-
7107,-10.54,kd,CGS001-3480,IGF1R,Type II RTKs: Insulin receptor family
7108,-10.55,kd,CGS001-5817,PVR,Immunoglobulin superfamily / C2-set domain containing
1313,47.15,cp,BRD-K71823332,epothilone-a,Microtubule stabilizing agent
7112,-10.67,oe,ccsbBroad304_03555,PANK4,-
7113,-10.72,kd,CGS001-5715,PSMD9,"Proteasome (prosome, macropain) subunits"
1309,47.23,cp,BRD-K97752965,nicorandil,Nitric oxide donor
7116,-10.81,oe,ccsbBroad304_02349,MPHOSPH9,-
1307,47.34,cp,BRD-K56596464,QX-314,Sodium channel blocker
7121,-10.94,oe,ccsbBroad304_05749,A2M,-
7124,-11.02,kd,CGS001-6185,RPN2,-
1303,47.4,cp,BRD-K34437622,BRD-K34437622,Thymidylate synthase inhibitor
1304,47.4,cp,BRD-K08417745,SID-26681509,Cathepsin inhibitor
7125,-11.02,oe,ccsbBroad304_03415,GFOD1,-
7127,-11.05,kd,CGS001-788,SLC25A20,Mitochondrial amino acid transporter subfamily
7131,-11.13,kd,CGS001-4594,MUT,-
7133,-11.15,oe,ccsbBroad304_07026,SYT1,Synaptotagmins
7135,-11.16,oe,ccsbBroad304_08797,FASTKD5,-
7136,-11.19,oe,ccsbBroad304_02510,CNPY3,Trinucleotide (CAG) repeat containing
7137,-11.2,kd,CGS001-5831,PYCR1,-
7140,-11.24,kd,CGS001-80758,PRR7,-
1294,47.62,cp,BRD-K66766661,17-beta-estradiol,Estrogen receptor agonist
7142,-11.29,kd,CGS001-147949,ZNF583,"Zinc fingers, C2H2-type"
7143,-11.3,kd,CGS001-25948,KBTBD2,BTB/POZ domain containing
7144,-11.31,kd,CGS001-2787,GNG5,-
7145,-11.33,kd,CGS001-1390,CREM,basic leucine zipper proteins
7148,-11.34,kd,CGS001-80212,CCDC92,-
7149,-11.4,kd,CGS001-6932,TCF7,-
1287,47.85,cp,BRD-K67860401,AR-A014418,Glycogen synthase kinase inhibitor
1286,47.87,cp,BRD-A41450521,tosufloxacin,Bacterial DNA gyrase inhibitor
7151,-11.44,oe,ccsbBroad304_06773,PRKAR2B,Protein kinase A
7152,-11.51,kd,CGS001-5618,PRLR,Prolactin receptor family
7153,-11.53,oe,ccsbBroad304_01379,RBBP6,-
7155,-11.53,kd,CGS001-285267,ZNF619,"Zinc fingers, C2H2-type"
7159,-11.67,kd,CGS001-8019,BRD3,Bromodomain kinase (BRDK) family
7161,-11.69,kd,CGS001-85004,RERG,-
7163,-11.73,kd,CGS001-3957,LGALS2,"Lectins, galactoside-binding"
7164,-11.76,oe,ccsbBroad304_02469,SLC35A1,SLC35 family of nucleotide sugar transporters
7165,-11.78,kd,CGS001-7172,TPMT,-
7166,-11.78,oe,ccsbBroad304_04288,RPS6KL1,RSKL family
7167,-11.79,oe,ccsbBroad304_07147,ZNF8,"Zinc fingers, C2H2-type"
7168,-11.79,kd,CGS001-149428,BNIPL,-
7169,-11.79,oe,ccsbBroad304_00017,ACTN2,EF-hand domain containing
1272,48.23,cp,BRD-A26032986,zaldaride,Calmodulin antagonist
7171,-11.82,oe,ccsbBroad304_06806,PSMD3,"Proteasome (prosome, macropain) subunits"
7176,-11.94,kd,CGS001-7052,TGM2,Transglutaminases
7178,-11.98,kd,CGS001-51742,ARID4B,-
7179,-11.98,oe,ccsbBroad304_03305,ANAPC5,Anaphase promoting complex subunits
7180,-12,kd,CGS001-6541,SLC7A1,SLC7 family
7181,-12.04,oe,ccsbBroad304_08786,ZNF350,"Zinc fingers, C2H2-type"
1263,48.72,cp,BRD-A47706533,L-BSO,Glutathione transferase inhibitor
7182,-12.05,kd,CGS001-4891,SLC11A2,SLC11 family of proton-coupled metal ion transporters
1265,48.72,cp,BRD-K91601245,mercaptopurine,Immunosuppressant
7184,-12.21,kd,CGS001-9122,SLC16A4,SLC16 family of monocarboxylate transporters
7185,-12.23,kd,CGS001-23387,SIK3,QIK subfamily
7187,-12.28,kd,CGS001-22944,KIN,-
1259,48.79,cp,BRD-A29260609,acebutolol,Adrenergic receptor antagonist
7189,-12.3,kd,CGS001-960,CD44,CD molecules
7190,-12.3,oe,ccsbBroad304_01820,ZNF217,"Zinc fingers, C2H2-type"
7192,-12.33,oe,ccsbBroad304_00470,DVL2,Dishevelled homologs
7194,-12.39,oe,ccsbBroad304_03371,RAB23,"RAB, member RAS oncogene"
7195,-12.4,kd,CGS001-10423,CDIPT,-
7196,-12.44,kd,CGS001-3054,HCFC1,-
7198,-12.52,oe,ccsbBroad304_02815,SSBP2,-
7201,-12.59,oe,ccsbBroad304_02026,NRP1,CD molecules
7202,-12.6,oe,ccsbBroad304_01341,PTPN4,Protein tyrosine phosphatases
7203,-12.64,kd,CGS001-8463,TEAD2,-
1249,49.16,cp,BRD-K66412701,pazufloxacin,Topoisomerase inhibitor
1247,49.2,cp,BRD-K20755323,SA-792728,Sphingosine kinase inhibitor
1246,49.22,cp,BRD-K70577657,H-9,PKA inhibitor
7204,-12.65,kd,CGS001-9668,ZNF432,"Zinc fingers, C2H2-type"
7205,-12.66,kd,CGS001-537,ATP6AP1,-
7207,-12.68,kd,CGS001-1820,ARID3A,-
1242,49.49,cp,BRD-K47278471,diphenhydramine,Histamine receptor antagonist
7208,-12.75,oe,ccsbBroad304_02501,DCTN6,-
7210,-12.77,kd,CGS001-6197,RPS6KA3,RSK subfamily
7212,-12.79,kd,CGS001-10214,SSX3,-
7215,-12.82,kd,CGS001-5836,PYGL,Glycogen phosphorylases
7216,-12.82,kd,CGS001-2550,GABBR1,GABA receptors
7217,-12.82,oe,ccsbBroad304_05791,AGT,Endogenous ligands
7219,-12.85,kd,CGS001-3306,HSPA2,Heat shock proteins / HSP70
7221,-12.86,kd,CGS001-4548,MTR,-
7224,-12.91,kd,CGS001-117194,MRGPRX2,GPCR / Class A : Orphans
1232,49.84,cc,,IL4 Pathway LOF,-
7225,-12.97,kd,CGS001-8692,HYAL2,-
7226,-12.99,kd,CGS001-2131,EXT1,Exostosin glycosyltransferase family
7228,-13.02,oe,ccsbBroad304_02092,SYNGR3,-
7229,-13.04,oe,ccsbBroad304_07655,POLR3C,RNA polymerase subunits
7230,-13.04,oe,ccsbBroad304_03732,NPDC1,-
1225,50.07,cp,BRD-K64746805,MBCQ,Phosphodiesterase inhibitor
7232,-13.1,oe,ccsbBroad304_01088,NFATC3,Nuclear factor of activated T-cells
1224,50.11,cp,BRD-A42346008,metanephrine,Epinephrine metabolite
7234,-13.16,kd,CGS001-11179,ZNF277,-
7237,-13.21,kd,CGS001-771,CA12,Carbonic anhydrases
7241,-13.3,kd,CGS001-839,CASP6,Caspases
7242,-13.33,kd,CGS001-6347,CCL2,Chemokine ligands
7244,-13.45,kd,CGS001-5565,PRKAB2,AMPK subfamily
7245,-13.47,kd,CGS001-90,ACVR1,Type I receptor serine/threonine kinases
7246,-13.51,kd,CGS001-55644,OSGEP,-
7247,-13.56,kd,CGS001-25925,ZNF521,"Zinc fingers, C2H2-type"
7249,-13.6,kd,CGS001-11320,MGAT4A,-
7251,-13.63,kd,CGS001-5636,PRPSAP2,-
1213,50.48,cp,BRD-K14441456,tyrphostin-AG-556,EGFR inhibitor
7252,-13.66,oe,ccsbBroad304_06592,MMP14,Matrix metallopeptidase
7253,-13.68,oe,ccsbBroad304_00794,HSF1,-
7254,-13.72,kd,CGS001-3589,IL11,Endogenous ligands
7255,-13.73,oe,ccsbBroad304_03917,RBKS,-
7257,-13.79,kd,CGS001-5037,PEBP1,-
1207,50.78,cc,,C2 domain containing LOF,-
7258,-13.79,kd,CGS001-10379,IRF9,-
7260,-13.85,kd,CGS001-9826,ARHGEF11,Rho guanine nucleotide exchange factors
7262,-13.87,kd,CGS001-36,ACADSB,-
7264,-14.1,kd,CGS001-54556,ING3,"Zinc fingers, PHD-type"
1202,50.96,cp,BRD-K84566043,fenpiverinium,Acetylcholine receptor antagonist
7265,-14.12,kd,CGS001-10061,ABCF2,ATP binding cassette transporters / subfamily F
7266,-14.13,kd,CGS001-10915,TCERG1,-
1199,51.05,cp,BRD-K81709173,halcinonide,Glucocorticoid receptor agonist
1197,51.06,cp,BRD-U37049823,HG-6-64-01,RAF inhibitor
1198,51.06,cp,BRD-K04414442,SB-222200,Tachykinin antagonist
7267,-14.16,oe,ccsbBroad304_06294,GNAZ,-
7269,-14.25,kd,CGS001-16,AARS,Aminoacyl tRNA synthetases / Class II
7271,-14.3,kd,CGS001-842,CASP9,Caspases
7272,-14.31,oe,ccsbBroad304_03113,DSE,-
7273,-14.32,oe,ccsbBroad304_01454,RPS15A,S ribosomal proteins
7276,-14.39,kd,CGS001-51335,NGRN,-
7277,-14.42,oe,ccsbBroad304_05865,ATP1A3,ATPases / P-type
7279,-14.52,kd,CGS001-1376,CPT2,-
7280,-14.53,oe,ccsbBroad304_07411,LPXN,-
1187,51.58,cp,BRD-A04308630,genipin,Choleretic agent
7281,-14.53,kd,CGS001-10456,HAX1,-
7282,-14.56,kd,CGS001-9908,G3BP2,RNA binding motif (RRM) containing
7285,-14.58,kd,CGS001-3418,IDH2,-
7287,-14.62,kd,CGS001-54881,TEX10,-
7288,-14.62,oe,ccsbBroad304_00679,GPR39,GPCR / Class A : Orphans
7289,-14.64,kd,CGS001-4205,MEF2A,Myocyte enhancer factors
7290,-14.67,kd,CGS001-5664,PSEN2,Presenilin
7291,-14.8,kd,CGS001-9854,C2CD2L,-
1178,51.8,cp,BRD-K96471533,nitazoxanide,Pyruvate ferredoxin oxidoreductase inhibitor
7292,-14.83,oe,ccsbBroad304_06155,ELF1,ETS Transcription Factors
7294,-14.83,oe,ccsbBroad304_01446,RPS3A,S ribosomal proteins
1175,51.91,cp,BRD-K33882852,ZK-93423,Benzodiazepine receptor agonist
1174,51.98,cp,BRD-K34092021,arvanil,TRPV agonist
7295,-14.84,kd,CGS001-51548,SIRT6,Histone deacetylases (HDACs)
7298,-14.89,kd,CGS001-5914,RARA,Retinoic acid receptors
7299,-15,oe,ccsbBroad304_00487,EGR1,"Zinc fingers, C2H2-type"
7301,-15.01,kd,CGS001-1759,DNM1,Pleckstrin homology (PH) domain containing
7303,-15.09,oe,ccsbBroad304_01378,RASA1,Pleckstrin homology (PH) domain containing
1168,52.34,cp,BRD-K69328504,L-690488,Inositol monophosphatase inhibitor
7305,-15.09,kd,CGS001-1960,EGR3,"Zinc fingers, C2H2-type"
7306,-15.11,kd,CGS001-5653,KLK6,Chymotrypsin
7307,-15.2,kd,CGS001-9319,TRIP13,ATPases / AAA-type
7309,-15.32,oe,ccsbBroad304_00277,CDK4,"Cyclin-dependent kinases, CDK4 subfamily"
7310,-15.32,kd,CGS001-1455,CSNK1G2,Casein kinase 1 (CK1) family
7311,-15.33,kd,CGS001-23585,TMEM50A,-
7312,-15.34,oe,ccsbBroad304_02589,COPS5,-
7314,-15.41,kd,CGS001-4522,MTHFD1,-
7315,-15.43,kd,CGS001-50943,FOXP3,Forkhead boxes
7316,-15.46,kd,CGS001-59350,RXFP1,GPCR / Class A : Relaxin family peptide receptors
7318,-15.49,kd,CGS001-55111,PLEKHJ1,Pleckstrin homology (PH) domain containing
7320,-15.53,kd,CGS001-4232,MEST,-
1155,52.7,cp,BRD-K33312228,halometasone,Glucocorticoid receptor agonist
7321,-15.53,kd,CGS001-1622,DBI,-
7324,-15.58,kd,CGS001-10062,NR1H3,Liver X receptor-like receptors
1152,52.88,cp,BRD-K94294671,OSI-027,MTOR inhibitor
1151,52.98,cp,BRD-A88254928,salbutamol,Adrenergic receptor agonist
7325,-15.61,oe,ccsbBroad304_01064,NDUFA1,Mitochondrial respiratory chain complex / Complex I
7330,-15.72,kd,CGS001-3508,IGHMBP2,"Zinc fingers, AN1-type domain containing"
1148,53.07,cp,BRD-K37618799,MRS-1220,Adenosine receptor antagonist
7331,-15.75,kd,CGS001-7082,TJP1,-
7333,-15.86,oe,ccsbBroad304_00488,EGR3,"Zinc fingers, C2H2-type"
7334,-15.87,oe,ccsbBroad304_04128,ALG9,Dolichyl D-mannosyl phosphate dependent mannosyltransferases
7338,-15.97,kd,CGS001-9531,BAG3,-
7339,-16.06,oe,ccsbBroad304_02009,RAB11A,"RAB, member RAS oncogene"
1142,53.38,cp,BRD-K89708791,rifaximin,RNA synthesis inhibitor
7342,-16.08,oe,ccsbBroad304_00380,CSNK1G2,Casein kinase 1 (CK1) family
7343,-16.09,kd,CGS001-5937,RBMS1,RNA binding motif (RRM) containing
7345,-16.12,kd,CGS001-55765,C1ORF106,-
7347,-16.17,kd,CGS001-56956,LHX9,Homeoboxes / LIM class
1136,53.76,cp,BRD-A82096673,KU-C103428N,CDC inhibitor
7352,-16.29,kd,CGS001-306,ANXA3,Annexins
1135,53.77,cp,BRD-K11905747,spectinomycin,Bacterial 30S ribosomal subunit inhibitor
1134,53.78,cp,BRD-K88551539,CAY-10585,HIF modulator
1133,53.79,cp,BRD-K92726801,hydrastinine,Haemostatic agent
1132,53.81,cp,BRD-K50866992,tropisetron,Serotonin receptor antagonist
7353,-16.31,kd,CGS001-7124,TNF,Tumor necrosis factor (ligand) superfamily
7354,-16.32,kd,CGS001-51176,LEF1,-
1129,53.98,cp,BRD-A37837077,cyclazosin,Adrenergic receptor antagonist
7356,-16.35,oe,ccsbBroad304_06695,PCK2,-
1127,54.04,cp,BRD-A35989968,megestrol,Progesterone receptor agonist
7357,-16.37,kd,CGS001-25888,ZNF473,"Zinc fingers, C2H2-type"
7358,-16.44,oe,ccsbBroad304_01584,SPARC,-
1124,54.18,cc,,ATP synthase inhibitor,-
7359,-16.46,kd,CGS001-84231,TRAF7,RING-type (C3HC4) zinc fingers
7362,-16.55,oe,ccsbBroad304_02571,TOMM34,Tetratricopeptide (TTC) repeat domain containing
7363,-16.57,kd,CGS001-116039,OSR2,"Zinc fingers, C2H2-type"
7364,-16.57,kd,CGS001-55869,HDAC8,Histone deacetylases
7365,-16.61,kd,CGS001-83729,INHBE,-
7366,-16.63,oe,ccsbBroad304_10157,LHX8,Homeoboxes / LIM class
7367,-16.66,oe,ccsbBroad304_08840,KIF9,Kinesins
7368,-16.66,kd,CGS001-79088,ZNF426,"Zinc fingers, C2H2-type"
7370,-16.67,kd,CGS001-9989,PPP4R1,"Serine/threonine phosphatases / Protein phosphatase 4, regulatory subunits"
7371,-16.67,oe,ccsbBroad304_00811,ICAM1,CD molecules
7372,-16.7,kd,CGS001-3665,IRF7,-
7374,-16.81,kd,CGS001-5909,RAP1GAP,-
7375,-16.87,oe,ccsbBroad304_03118,NRBP1,NRBP family
7376,-16.87,kd,CGS001-2872,MKNK2,MKN subfamily
1109,54.7,cp,BRD-K37798499,etoposide,Topoisomerase inhibitor
1108,54.71,cp,BRD-K83289131,CAY-10618,NAMPT inhibitor
7377,-16.89,kd,CGS001-25797,QPCT,Aminopeptidase Y
7378,-16.9,kd,CGS001-51433,ANAPC5,Anaphase promoting complex subunits
7379,-16.92,oe,ccsbBroad304_00554,FGB,Endogenous ligands
7380,-16.93,kd,CGS001-10312,TCIRG1,ATPases / V-type
7382,-16.99,oe,ccsbBroad304_06370,HLA-DMB,Immunoglobulin superfamily / C1-set domain containing
1102,54.94,cp,BRD-K07265709,razoxane,Chelating agent
7383,-17.11,kd,CGS001-23463,ICMT,-
7384,-17.13,oe,ccsbBroad304_00856,CXCR2,Chemokine receptors
7388,-17.28,kd,CGS001-27197,GPR82,GPCR / Class A : Orphans
7389,-17.3,oe,ccsbBroad304_00734,HDAC1,Histone deacetylases
1097,55.07,cp,BRD-K85985071,ellipticine,Topoisomerase inhibitor
7390,-17.32,kd,CGS001-115196,ZNF554,"Zinc fingers, C2H2-type"
7391,-17.35,kd,CGS001-3385,ICAM3,CD molecules
7392,-17.42,kd,CGS001-5793,PTPRG,Receptor tyrosine phosphatases (RTP)
7393,-17.42,kd,CGS001-6513,SLC2A1,Solute carriers
7395,-17.44,oe,ccsbBroad304_01019,MLH1,-
7397,-17.52,kd,CGS001-1429,CRYZ,-
7399,-17.63,oe,ccsbBroad304_00995,MECP2,-
7402,-17.78,kd,CGS001-5465,PPARA,Peroxisome proliferator-activated receptors
1088,55.55,cc,,EIF Proteins LOF,-
7403,-17.83,kd,CGS001-2180,ACSL1,Acyl-CoA synthetase family
7405,-17.91,kd,CGS001-5881,RAC3,Endogenous ligands
7406,-17.93,oe,ccsbBroad304_01205,PIN1,-
7408,-18,oe,ccsbBroad304_01771,VIM,Intermediate filaments type III
1083,55.72,cp,BRD-K51730347,diphencyprone,Immunostimulant
7409,-18,oe,ccsbBroad304_01624,SUPV3L1,-
7411,-18,kd,CGS001-64127,NOD2,Nucleotide-binding domain and leucine rich repeat containing
7412,-18.01,kd,CGS001-156,ADRBK1,BARK/GRK2 subfamily
7413,-18.08,kd,CGS001-11214,AKAP13,A-kinase anchor proteins
1078,55.84,cp,BRD-K22878149,SB-205607,Delta 1 opioid receptor agonist
7416,-18.17,kd,CGS001-23761,PISD,Decarboxylases
1076,56.27,cp,BRD-K77286328,reversine,Aurora kinase inhibitor
7417,-18.17,kd,CGS001-9833,MELK,MELK subfamily
7418,-18.22,kd,CGS001-80347,COASY,-
7419,-18.27,kd,CGS001-6251,RSU1,-
7423,-18.33,oe,ccsbBroad304_06186,F2R,Protease activated receptors
1071,56.35,cp,BRD-K70511574,sunitinib,PLK inhibitor
7425,-18.37,kd,CGS001-11156,PTP4A3,Protein tyrosine phosphatases
7428,-18.46,kd,CGS001-5329,PLAUR,CD molecules
7430,-18.48,kd,CGS001-171017,ZNF384,"Zinc fingers, C2H2-type"
7431,-18.57,kd,CGS001-5696,PSMB8,"Proteasome (prosome, macropain) subunits"
1066,56.59,cp,BRD-A22143024,estropipate,Estrogen receptor agonist
1065,56.6,cp,BRD-K16664969,GTP-14564,FLT3 inhibitor
1064,56.62,cp,BRD-K66707493,lawsone,Coloring agent
7432,-18.58,kd,CGS001-2168,FABP1,Fatty acid-binding proteins
7433,-18.62,oe,ccsbBroad304_02632,PTP4A3,Protein tyrosine phosphatases
7434,-18.7,oe,ccsbBroad304_02702,MSRB2,-
7435,-18.71,oe,ccsbBroad304_00381,CSNK2A1,Casein kinase 2 (CK2) family
7436,-18.79,kd,CGS001-23621,BACE1,Pepsin
7438,-18.87,oe,ccsbBroad304_07890,CBX7,-
7439,-18.87,kd,CGS001-8574,AKR7A2,Aldo-keto reductases
7440,-18.89,kd,CGS001-344387,CDKL4,Cyclin-dependent kinases
1055,56.98,cp,BRD-K57011718,UK-356618,Metalloproteinase inhibitor
7441,-18.89,oe,ccsbBroad304_06420,ICAM3,CD molecules
1053,57.06,cp,BRD-K82577285,dipropyl-dopamine,Dopamine receptor agonist
1052,57.12,cp,BRD-A23637604,oxymetholone,Androgen receptor agonist
1051,57.15,cp,BRD-A87848830,bimatoprost,Prostanoid receptor agonist
1050,57.18,cp,BRD-K68392338,ZK-93426,Benzodiazepine receptor antagonist
7444,-19.05,oe,ccsbBroad304_06755,PPAT,Phosphoribosyl pyrophosphate amidotransferase
7445,-19.11,oe,ccsbBroad304_07050,TFAP2A,-
1046,57.26,cp,BRD-K42500029,CGP-57380,MAP kinase inhibitor
7446,-19.12,kd,CGS001-6511,SLC1A6,Glutamate transporter subfamily
1045,57.27,cp,BRD-K61480498,epoxycholesterol,LXR agonist
7449,-19.25,kd,CGS001-1948,EFNB2,Ephrins
7450,-19.35,kd,CGS001-1647,GADD45A,-
7451,-19.4,kd,CGS001-23067,SETD1B,Histone methyltransferases (HMTs)
7452,-19.45,oe,ccsbBroad304_04053,DERL1,-
7453,-19.49,kd,CGS001-7639,ZNF85,"Zinc fingers, C2H2-type"
7454,-19.51,oe,ccsbBroad304_02145,VAMP3,Vesicle-associated membrane proteins
7457,-19.72,kd,CGS001-169841,ZNF169,"Zinc fingers, C2H2-type"
7463,-19.9,oe,ccsbBroad304_02187,POLR1C,RNA polymerase subunits
7464,-19.92,kd,CGS001-3569,IL6,Interferons
7465,-19.94,oe,ccsbBroad304_07827,STK38L,NDR family
7466,-20.04,kd,CGS001-285676,ZNF454,"Zinc fingers, C2H2-type"
7469,-20.1,kd,CGS001-54681,P4HTM,-
7470,-20.13,kd,CGS001-6883,TAF12,-
1031,57.82,cp,BRD-K83063356,RS-102895,CCR antagonist
7471,-20.23,kd,CGS001-8821,INPP4B,Inositol polyphosphate phosphatases
7472,-20.23,kd,CGS001-163688,CALML6,EF-hand domain containing
7473,-20.24,kd,CGS001-55290,BRF2,-
7474,-20.35,kd,CGS001-999,CDH1,CD molecules
7475,-20.42,oe,ccsbBroad304_07153,ZNF24,"Zinc fingers, C2H2-type"
7477,-20.56,oe,ccsbBroad304_00514,ERF,ETS Transcription Factors
7478,-20.64,oe,ccsbBroad304_12059,ING3,"Zinc fingers, PHD-type"
7479,-20.74,kd,CGS001-80714,PBX4,Homeoboxes / TALE class
7483,-20.99,oe,ccsbBroad304_06274,GJA1,Ion channels / Gap junction proteins (connexins)
7484,-21.01,oe,ccsbBroad304_06131,DUSP6,Protein tyrosine phosphatases / Class I Cys-based PTPs : MAP kinase phosphatases
1020,58.43,cp,BRD-K77908580,entinostat,HDAC inhibitor
1019,58.51,cp,BRD-A84189516,baccatin-III,Paclitaxel precursor
7485,-21.04,kd,CGS001-1876,E2F6,-
7487,-21.14,kd,CGS001-84539,MCHR2,GPCR / Class A : MCH receptors
7488,-21.26,oe,ccsbBroad304_06237,GAA,Glycosidases
7489,-21.3,oe,ccsbBroad304_02271,LPGAT1,-
7490,-21.48,kd,CGS001-6822,SULT2A1,"Sulfotransferases, cytosolic"
7491,-21.5,oe,ccsbBroad304_13847,DUSP3,Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases
7493,-21.74,kd,CGS001-51311,TLR8,Toll-like receptor family
7494,-21.76,kd,CGS001-79177,ZNF576,"Zinc fingers, C2H2-type"
7495,-21.87,oe,ccsbBroad304_06349,HAGH,-
7496,-21.87,oe,ccsbBroad304_01294,PRKRIR,THAP (C2CH-type zinc finger) domain containing
7497,-21.89,oe,ccsbBroad304_07101,TSC2,-
7498,-21.91,oe,ccsbBroad304_00834,IFNGR1,Interferon receptor family
7500,-21.98,oe,ccsbBroad304_01966,RUVBL1,ATPases / AAA-type
7502,-22.02,kd,CGS001-84449,ZNF333,"Zinc fingers, C2H2-type"
7504,-22.04,kd,CGS001-1045,CDX2,Homeoboxes / ANTP class : HOXL subclass
7505,-22.08,kd,CGS001-31,ACACA,Carboxylases
7510,-22.19,oe,ccsbBroad304_00420,DAP,-
7513,-22.31,kd,CGS001-22905,EPN2,-
7514,-22.36,oe,ccsbBroad304_02534,UTP14A,-
7517,-22.45,kd,CGS001-6678,SPARC,-
7518,-22.49,kd,CGS001-81848,SPRY4,-
7519,-22.54,kd,CGS001-6906,SERPINA7,Serine (or cysteine) peptidase inhibitors
7521,-22.56,kd,CGS001-23344,ESYT1,Synaptotagmins
7522,-22.56,oe,ccsbBroad304_03032,HTATSF1,RNA binding motif (RRM) containing
7523,-22.59,kd,CGS001-7168,TPM1,Tropomyosins
7530,-22.93,kd,CGS001-382,ARF6,ADP-ribosylation factors
7531,-22.94,oe,ccsbBroad304_01786,XRCC4,XRCC DNA Repair
7536,-23.05,kd,CGS001-10668,CGRRF1,RING-type (C3HC4) zinc fingers
990,60.4,cp,BRD-A78391468,prednisolone,Glucocorticoid receptor agonist
7537,-23.07,kd,CGS001-3046,HBE1,-
7538,-23.2,kd,CGS001-79643,CHMP6,Charged multivesicular body proteins
7539,-23.27,oe,ccsbBroad304_00710,GUSB,-
7540,-23.28,oe,ccsbBroad304_08481,CEP55,-
7542,-23.33,kd,CGS001-8895,CPNE3,-
7543,-23.35,kd,CGS001-58528,RRAGD,-
7544,-23.35,kd,CGS001-57459,GATAD2B,GATA zinc finger domain containing
7545,-23.43,oe,ccsbBroad304_07008,STAT5A,SH2 domain containing
7546,-23.44,kd,CGS001-7153,TOP2A,DNA Topoisomerases
7547,-23.47,oe,ccsbBroad304_01546,SLC7A1,SLC7 family
7548,-23.55,kd,CGS001-3675,ITGA3,Integrins
978,61.07,cp,BRD-A33833419,TER-14687,Inhibitor of translocation of PKCq in T cells
7549,-23.64,oe,ccsbBroad304_04095,CHMP6,Charged multivesicular body proteins
7551,-23.72,kd,CGS001-22954,TRIM32,-
7553,-23.87,oe,ccsbBroad304_08993,DHDDS,-
7554,-23.89,oe,ccsbBroad304_06095,DFFB,-
7557,-23.98,kd,CGS001-25898,RCHY1,RING-type (C3HC4) zinc fingers
7558,-24.01,kd,CGS001-84109,QRFPR,GPCR / Class A : RF amide peptide receptors
970,61.31,cp,BRD-A17819071,gedunin,HSP inhibitor
7559,-24.06,oe,ccsbBroad304_01514,SDHC,Mitochondrial respiratory chain complex / Complex II
7561,-24.15,kd,CGS001-5999,RGS4,Regulators of G-protein signaling
968,61.4,cp,BRD-K49448285,bisindolylmaleimide,CDK inhibitor
7562,-24.22,kd,CGS001-5987,TRIM27,-
966,61.48,cc,,Serine proteases GOF,-
7563,-24.23,kd,CGS001-221391,OPN5,GPCR / Class A : Opsin receptors
7564,-24.23,kd,CGS001-4094,MAF,-
7565,-24.27,kd,CGS001-2857,GPR34,GPCR / Class A : Orphans
7566,-24.34,kd,CGS001-10957,PNRC1,-
7567,-24.5,oe,ccsbBroad304_10094,ZNF790,"Zinc fingers, C2H2-type"
7569,-24.57,kd,CGS001-55176,SEC61A2,-
7571,-24.66,kd,CGS001-65243,ZNF643,-
958,61.83,cp,BRD-K78122587,NNC-55-0396,T-type calcium channel blocker
957,61.85,cp,BRD-A85860691,chaetocin,Histone lysine methyltransferase inhibitor
7573,-24.68,kd,CGS001-475,ATOX1,-
7574,-24.68,kd,CGS001-1646,AKR1C2,Aldo-keto reductases
7576,-24.83,oe,ccsbBroad304_04227,SETD7,Histone methyltransferases (HMTs)
7577,-24.83,kd,CGS001-10813,UTP14A,-
7578,-24.85,kd,CGS001-5066,PAM,-
7580,-24.92,oe,ccsbBroad304_03554,NAT10,-
7581,-24.94,oe,ccsbBroad304_00819,IDH3B,-
949,62.36,cp,BRD-K10961822,latanoprost,Prostanoid receptor agonist
7582,-24.97,oe,ccsbBroad304_01312,PSMB8,"Proteasome (prosome, macropain) subunits"
7583,-25,kd,CGS001-10476,ATP5H,ATPases / F-type
7584,-25.05,oe,ccsbBroad304_07249,PIK3R3,Phosphatidylinositol kinases
7586,-25.06,oe,ccsbBroad304_01811,PCGF2,Polycomb group ring fingers
7588,-25.15,oe,ccsbBroad304_04114,SUV39H2,Histone methyltransferases (HMTs)
7589,-25.19,kd,CGS001-6658,SOX3,SRY (sex determining region Y)-boxes
7590,-25.22,oe,ccsbBroad304_01152,PCNA,-
941,62.8,cp,BRD-U25771771,WZ-4-145,EGFR inhibitor
7591,-25.29,oe,ccsbBroad304_07876,LARS2,Aminoacyl tRNA synthetases / Class I
939,62.86,cp,BRD-K77175907,calcifediol,Vitamin D receptor agonist
7592,-25.32,oe,ccsbBroad304_06317,GPR26,GPCR / Class A : Orphans
7593,-25.47,kd,CGS001-5588,PRKCQ,Delta subfamily
7596,-25.6,oe,ccsbBroad304_01483,SAT1,-
7597,-25.64,kd,CGS001-1022,CDK7,"Cyclin-dependent kinases, CDK7 subfamily"
7598,-25.76,kd,CGS001-1213,CLTC,-
7599,-25.85,kd,CGS001-80018,NAA25,N(alpha)-acetyltransferase subunits
7600,-26,kd,CGS001-440435,GPR179,GPCR / Class C : Orphans
7601,-26.02,oe,ccsbBroad304_00126,ATP5A1,ATPases / F-type
7602,-26.08,kd,CGS001-5460,POU5F1,Homeoboxes / POU class
928,63.43,cp,BRD-K02227374,milnacipran,Serotonin reuptake inhibitor
7603,-26.09,oe,ccsbBroad304_00303,CHN1,Rho GTPase activating proteins
7606,-26.22,kd,CGS001-9158,FIBP,-
7607,-26.28,oe,ccsbBroad304_06402,PRMT2,Protein arginine N-methyltransferases
7608,-26.35,kd,CGS001-113878,DTX2,RING-type (C3HC4) zinc fingers
7609,-26.36,kd,CGS001-3659,IRF1,-
7610,-26.42,kd,CGS001-64425,POLR1E,RNA polymerase subunits
7611,-26.45,kd,CGS001-1545,CYP1B1,Cytochrome P450s
7612,-26.47,oe,ccsbBroad304_00422,DARS,Aminoacyl tRNA synthetases / Class II
7614,-26.6,oe,ccsbBroad304_02879,ZNF473,"Zinc fingers, C2H2-type"
7616,-26.75,kd,CGS001-1591,CYP24A1,Cytochrome P450s
7618,-26.87,kd,CGS001-3490,IGFBP7,insulin-like growth factor (IGF) binding proteins
7619,-26.88,kd,CGS001-23081,KDM4C,Histone demethylases
916,63.94,cp,BRD-A48237631,mitomycin-c,DNA alkylating agent
7622,-27.03,kd,CGS001-23131,GPATCH8,G patch domain containing
7623,-27.06,kd,CGS001-80854,SETD7,Histone methyltransferases (HMTs)
7624,-27.09,kd,CGS001-55012,PPP2R3C,"Serine/threonine phosphatases / Protein phosphatase 2, regulatory subunits"
7625,-27.2,kd,CGS001-203,AK1,Adenylate kinases
7626,-27.24,kd,CGS001-3821,KLRC1,CD molecules
7629,-27.44,kd,CGS001-169026,SLC30A8,SLC30 zinc transporter family
7630,-27.46,kd,CGS001-63027,SLC22A23,Orphan or poorly characterized SLC22 family members
7631,-27.63,oe,ccsbBroad304_01672,TIMP2,-
7632,-27.68,kd,CGS001-10810,WASF3,-
7633,-27.69,kd,CGS001-652,BMP4,Bone morphogenetic proteins
7634,-27.73,kd,CGS001-25861,DFNB31,-
7638,-27.87,oe,ccsbBroad304_14047,TACC3,-
7639,-27.88,oe,ccsbBroad304_02310,ARPC4,Actin related protein 2/3 complex subunits
902,64.65,cp,BRD-K79425933,benperidol,Dopamine receptor antagonist
7641,-27.92,kd,CGS001-23314,SATB2,Homeoboxes / CUT class
7643,-28.11,kd,CGS001-3158,HMGCS2,Lanosterol biosynthesis pathway
7644,-28.15,kd,CGS001-10131,TRAP1,Heat shock proteins / HSPC
7645,-28.23,oe,ccsbBroad304_07381,MAPKAPK2,MAPKAPK subfamily
7646,-28.32,kd,CGS001-8092,ALX1,Homeoboxes / PRD class
7648,-28.5,oe,ccsbBroad304_07252,DGKZ,-
895,64.94,cp,BRD-K50836978,purvalanol-a,CDK inhibitor
7649,-28.52,kd,CGS001-10695,CNPY3,Trinucleotide (CAG) repeat containing
893,65.07,cc,,Poly ADP ribose polymerases LOF,-
7650,-28.57,kd,CGS001-10481,HOXB13,Homeoboxes / ANTP class : HOXL subclass
891,65.15,cp,BRD-K01815685,indole,aryl hydrocarbon receptor agonist
7652,-28.67,oe,ccsbBroad304_00775,HOXB5,Homeoboxes / ANTP class : HOXL subclass
7653,-28.71,oe,ccsbBroad304_08839,IFIH1,-
7654,-28.79,kd,CGS001-486,FXYD2,Ion transport regulator
887,65.31,cp,BRD-K62792802,LY-83583,Guanylyl cyclase inhibitor
7655,-28.8,kd,CGS001-2539,G6PD,-
7656,-28.81,kd,CGS001-55577,NAGK,-
7657,-28.82,kd,CGS001-7518,XRCC4,XRCC DNA Repair
882,65.41,cp,BRD-K52620403,STO-609,Calmodulin antagonist
7658,-28.83,kd,CGS001-26959,HBP1,-
7659,-28.84,oe,ccsbBroad304_01183,PGD,-
7661,-28.9,kd,CGS001-23076,RRP1B,-
7664,-29.02,kd,CGS001-9213,XPR1,-
7665,-29.03,oe,ccsbBroad304_00100,RHOA,-
7666,-29.03,kd,CGS001-2182,ACSL4,Acyl-CoA synthetase family
7667,-29.14,kd,CGS001-5268,SERPINB5,Serine (or cysteine) peptidase inhibitors
875,65.7,cp,BRD-K62363391,dapsone,Bacterial antifolate
7670,-29.24,kd,CGS001-388585,HES5,Basic helix-loop-helix proteins
7671,-29.26,kd,CGS001-8446,DUSP11,Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases
7672,-29.31,oe,ccsbBroad304_06286,GLUL,-
7673,-29.36,kd,CGS001-10973,ASCC3,-
870,65.9,cp,BRD-K15842202,eudesmic-acid,-666
7674,-29.41,kd,CGS001-5338,PLD2,Hydrolases
7675,-29.42,kd,CGS001-26298,EHF,-
7676,-29.49,kd,CGS001-94239,H2AFV,Histones / Replication-independent
866,66.13,cp,BRD-K03557653,sappanone-a,Tyrosinase inhibitor
7677,-29.55,oe,ccsbBroad304_08275,TLR8,Toll-like receptor family
7678,-29.58,oe,ccsbBroad304_02123,RPS6KA5,MSK subfamily
7679,-29.64,oe,ccsbBroad304_06954,SLC1A1,Glutamate transporter subfamily
7681,-29.81,kd,CGS001-26136,TES,-
7682,-29.84,kd,CGS001-4016,LOXL1,-
861,66.36,cp,BRD-K07303502,arachidonyl-trifluoro-methane,Cytosolic phospholipase inhibitor
859,66.44,cp,BRD-K56614220,clofazimine,GK0582 inhibitor
7685,-30.14,kd,CGS001-8453,CUL2,-
7686,-30.17,kd,CGS001-8624,PSMG1,-
855,66.6,cp,BRD-K31054881,BMY-7378,Adrenergic receptor antagonist
7687,-30.17,kd,CGS001-2495,FTH1,-
7689,-30.41,oe,ccsbBroad304_10929,JAK2,Janus kinase (JakA) family
7690,-30.47,kd,CGS001-23077,MYCBP2,-
7691,-30.5,kd,CGS001-1030,CDKN2B,-
851,66.93,cp,BRD-A83237092,fulvestrant,Estrogen receptor antagonist
850,66.97,cp,BRD-K49049886,CGS-15943,Adenosine receptor antagonist
7693,-30.67,kd,CGS001-7453,WARS,Aminoacyl tRNA synthetases / Class I
7694,-30.7,kd,CGS001-56848,SPHK2,Sphingosine kinase
7695,-30.71,oe,ccsbBroad304_01716,TSN,-
846,67.07,cp,BRD-K61401890,deguelin,NADH-ubiquinone oxidoreductase (Complex I) inhibitor
7696,-30.8,oe,ccsbBroad304_00682,GRK6,GRK1/3 subfamily
7697,-30.93,kd,CGS001-375449,MAST4,MAST family
7698,-30.94,kd,CGS001-10921,RNPS1,RNA binding motif (RRM) containing
842,67.16,cp,BRD-A11678676,wortmannin,PI3K inhibitor
7699,-31.23,oe,ccsbBroad304_02884,POT1,-
7700,-31.31,oe,ccsbBroad304_03451,SLC35F2,SLC35 family of nucleotide sugar transporters
840,67.22,cp,BRD-A70083328,secnidazole,Acetylcholinesterase inhibitor
7702,-31.35,kd,CGS001-84333,PCGF5,Polycomb group ring fingers
7703,-31.36,oe,ccsbBroad304_00707,GTF2E2,General transcription factors
7704,-31.37,oe,ccsbBroad304_00165,BMI1,Polycomb group ring fingers
7705,-31.41,kd,CGS001-1969,EPHA2,Type XIII RTKs: Ephrin receptor family
7706,-31.42,kd,CGS001-5576,PRKAR2A,Protein kinase A
7708,-31.5,kd,CGS001-5467,PPARD,Nuclear hormone receptors
7709,-31.52,oe,ccsbBroad304_01165,PDK1,-
7711,-31.59,kd,CGS001-571,BACH1,BTB/POZ domain containing
7717,-31.78,kd,CGS001-4212,MEIS2,Homeoboxes / TALE class
7718,-31.78,kd,CGS001-116832,RPL39L,L ribosomal proteins
7722,-31.96,kd,CGS001-79837,PIP4K2C,1-phosphatidylinositol-5-phosphate 4-kinase family
827,67.87,cc,,NFkB pathway inhibitor,-
7724,-32.01,kd,CGS001-1398,CRK,SH2 domain containing
7725,-32.04,kd,CGS001-10888,GPR83,GPCR / Class A : Orphans
7727,-32.12,kd,CGS001-6885,MAP3K7,MAPKKK:TAK1 subfamily
7730,-32.39,oe,ccsbBroad304_07204,TAF15,RNA binding motif (RRM) containing
7731,-32.39,kd,CGS001-4170,MCL1,-
7732,-32.48,kd,CGS001-5550,PREP,Prolyl oligopeptidase
7733,-32.52,kd,CGS001-445,ASS1,-
7734,-32.53,kd,CGS001-1387,CREBBP,Chromatin-modifying enzymes / K-acetyltransferases
7736,-32.58,oe,ccsbBroad304_07037,TCF12,Basic helix-loop-helix proteins
7737,-32.73,kd,CGS001-4129,MAOB,Catecholamine turnover
7742,-32.94,oe,ccsbBroad304_03444,PAF1,-
815,68.59,cp,BRD-K61829047,7b-cis,Exportin antagonist
7743,-32.98,kd,CGS001-9898,UBAP2L,-
813,68.76,cc,,DNA Replication LOF,-
811,68.82,cc,,Glycogen synthase kinase inhibitor,-
7744,-33.05,kd,CGS001-7086,TKT,-
810,68.85,cp,BRD-A72711497,lasalocid,Bacterial permeability inducer
7746,-33.11,oe,ccsbBroad304_09765,ZBTB49,BTB/POZ domain containing
7748,-33.23,oe,ccsbBroad304_02771,HEY1,Basic helix-loop-helix proteins
807,69.02,cp,BRD-K55454768,TAS-301,Calcium-calmodulin dependent protein kinase inhibitor
7751,-33.47,kd,CGS001-160851,DGKH,Pleckstrin homology (PH) domain containing
7752,-33.51,kd,CGS001-147837,ZNF563,"Zinc fingers, C2H2-type"
7754,-33.59,oe,ccsbBroad304_03806,MCOLN1,Voltage-gated ion channels / Transient receptor potential cation channels
7756,-33.61,kd,CGS001-10494,STK25,YSK subfamily
802,69.3,cp,BRD-K60460488,nelfinavir,HIV protease inhibitor
7759,-33.77,kd,CGS001-55328,RNLS,-
800,69.38,cp,BRD-K13725475,rhodomyrtoxin,Cytotoxic agent
799,69.39,cp,BRD-K62609077,scoulerine,Adrenergic receptor antagonist
7761,-34.07,kd,CGS001-6850,SYK,Syk family
7764,-34.38,kd,CGS001-9929,JOSD1,-
7765,-34.4,kd,CGS001-3148,HMGB2,High-mobility group / Canonical
7766,-34.43,oe,ccsbBroad304_02484,PAICS,-
7767,-34.44,kd,CGS001-256281,NUDT14,Nudix motif containing
7768,-34.52,oe,ccsbBroad304_04146,HDAC11,Histone deacetylases
7769,-34.56,kd,CGS001-9415,FADS2,Fatty acid desaturases
7770,-34.57,kd,CGS001-117608,ZNF354B,"Zinc fingers, C2H2-type"
7772,-34.73,kd,CGS001-3606,IL18,Interleukins and interleukin receptors
790,69.79,cp,BRD-K73978287,hydrocortisone,Glucocorticoid receptor agonist
7773,-34.78,kd,CGS001-255725,OR52B2,GPCR / Class A : Olfactory receptors
786,69.88,cp,BRD-K17674993,diflorasone,Corticosteroid agonist
7774,-34.8,kd,CGS001-2101,ESRRA,Estrogen-related receptors
7775,-34.85,kd,CGS001-7371,UCK2,-
784,70,cp,BRD-K72895815,SSR-69071,Leukocyte elastase inhibitor
7776,-34.85,kd,CGS001-1356,CP,-
782,70.1,cp,BRD-A39747742,estradiol-valerate,Estrogen receptor agonist
7777,-34.9,kd,CGS001-5228,PGF,-
7778,-34.93,kd,CGS001-23240,KIAA0922,-
778,70.14,cp,BRD-K32828673,chelidonine,Tubulin inhibitor
7780,-35.05,oe,ccsbBroad304_02778,TGDS,Short chain dehydrogenase/reductase superfamily / Extended SDR fold
7781,-35.06,kd,CGS001-151636,DTX3L,RING-type (C3HC4) zinc fingers
7782,-35.11,kd,CGS001-83933,HDAC10,Histone deacetylases
7783,-35.18,kd,CGS001-81611,ANP32E,ANP32 acidic nuclear phosphoproteins
7784,-35.22,oe,ccsbBroad304_08805,SLC22A23,Orphan or poorly characterized SLC22 family members
773,70.32,cp,BRD-A92439610,triamcinolone,Glucocorticoid receptor agonist
7785,-35.27,kd,CGS001-9061,PAPSS1,-
7786,-35.38,kd,CGS001-63874,ABHD4,Abhydrolase domain containing
7787,-35.47,oe,ccsbBroad304_08662,MCCC1,-
7789,-35.72,oe,ccsbBroad304_01644,TAP1,ATP binding cassette transporters / subfamily B
7790,-35.77,oe,ccsbBroad304_02766,GPR161,GPCR / Class A : Orphans
7791,-36.04,kd,CGS001-1385,CREB1,basic leucine zipper proteins
766,70.73,cc,,Protein phosphatase catalytic subunits LOF,-
7792,-36.2,kd,CGS001-7727,ZNF174,"Zinc fingers, C2H2-type"
7793,-36.2,kd,CGS001-6285,S100B,EF-hand domain containing
7794,-36.23,kd,CGS001-26205,GMEB2,-
762,70.79,cp,BRD-K07762753,aminopurvalanol-a,Tyrosine kinase inhibitor
7795,-36.23,oe,ccsbBroad304_08978,ZNF672,"Zinc fingers, C2H2-type"
7796,-36.23,oe,ccsbBroad304_02923,PHF19,"Zinc fingers, PHD-type"
7797,-36.26,kd,CGS001-83439,TCF7L1,-
7798,-36.3,kd,CGS001-1211,CLTA,-
7802,-36.75,kd,CGS001-4790,NFKB1,NFkappaB transcription factor family
7804,-36.77,oe,ccsbBroad304_02399,TNIP1,-
7805,-36.81,kd,CGS001-10929,SRSF8,Serine/arginine-rich splicing factors
7806,-36.83,kd,CGS001-29116,MYLIP,-
7807,-36.84,kd,CGS001-4217,MAP3K5,MAPKKK:STE11 family
7809,-36.89,oe,ccsbBroad304_01065,NDUFA3,Mitochondrial respiratory chain complex / Complex I
751,71.36,cc,,GATA Zinc finger domain containing LOF,-
7810,-36.93,oe,ccsbBroad304_03269,CD320,CD molecules
7811,-36.97,kd,CGS001-199704,ZNF585A,"Zinc fingers, C2H2-type"
7813,-37.01,kd,CGS001-319100,TAAR6,GPCR / Class A : Trace amine associated receptors
7815,-37.1,kd,CGS001-10672,GNA13,-
7816,-37.11,kd,CGS001-122402,TDRD9,Tudor domain containing
7818,-37.25,kd,CGS001-21,ABCA3,ATP binding cassette transporters / subfamily A
7819,-37.26,kd,CGS001-5479,PPIB,-
7822,-37.35,oe,ccsbBroad304_11580,TLK2,Tousled-like kinase (TLK) family
7823,-37.37,kd,CGS001-25913,POT1,-
7824,-37.55,kd,CGS001-509,ATP5C1,ATPases / F-type
7825,-37.63,oe,ccsbBroad304_03614,G2E3,"Zinc fingers, PHD-type"
739,71.96,cp,BRD-K06750613,GSK-1059615,PI3K inhibitor
7827,-37.74,oe,ccsbBroad304_01383,RBMS1,RNA binding motif (RRM) containing
7828,-37.77,kd,CGS001-9111,NMI,-
7829,-37.82,oe,ccsbBroad304_00429,AKR1C2,Aldo-keto reductases
735,72.08,cp,BRD-U82589721,HG-5-113-01,Protein kinase inhibitor
7831,-37.98,kd,CGS001-5336,PLCG2,Phosphoinositide-specific phospholipase C
7834,-38.05,kd,CGS001-7850,IL1R2,Immunoglobulin-like family of IL-1 receptors
7835,-38.06,kd,CGS001-353322,ANKRD37,Ankyrin repeat domain containing
7836,-38.14,oe,ccsbBroad304_01563,SNCA,Parkinson disease
7837,-38.16,kd,CGS001-2175,FANCA,"Fanconi anemia, complementation groups"
729,72.61,cp,BRD-K80970344,pyrrolidine-dithiocarbamate,NFkB pathway inhibitor
728,72.62,cp,BRD-K95435023,PHA-665752,c-Met inhibitor
7838,-38.2,kd,CGS001-8491,MAP4K3,MAPKKKK:KHS subfamily
7839,-38.23,kd,CGS001-9120,SLC16A6,SLC16 family of monocarboxylate transporters
7841,-38.29,kd,CGS001-29982,NRBF2,-
7842,-38.35,kd,CGS001-8905,AP1S2,-
7843,-38.36,kd,CGS001-6990,DYNLT3,Cytoplasmic dyneins
7846,-38.58,kd,CGS001-51109,RDH11,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2
7850,-38.84,kd,CGS001-51599,LSR,Immunoglobulin superfamily / Immunoglobulin-like domain containing
7851,-38.85,kd,CGS001-51056,LAP3,Leucyl aminopeptidase
7852,-38.93,oe,ccsbBroad304_04360,CAPNS2,EF-hand domain containing
7853,-38.97,kd,CGS001-949,SCARB1,-
717,73.11,cc,,Ribosomal 40s Subunit LOF,-
7855,-39.06,kd,CGS001-23325,KIAA1033,-
7856,-39.11,oe,ccsbBroad304_07240,DYRK3,Dyrk2 subfamily
7857,-39.23,kd,CGS001-57121,LPAR5,GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid
7858,-39.28,kd,CGS001-467,ATF3,basic leucine zipper proteins
7860,-39.34,oe,ccsbBroad304_09058,SLC25A32,Mitochondrial nucleotide transporter subfamily
7861,-39.37,kd,CGS001-11315,PARK7,Parkinson disease
7862,-39.41,kd,CGS001-3206,HOXA10,Homeoboxes / ANTP class : HOXL subclass
7863,-39.41,kd,CGS001-8751,ADAM15,ADAM metallopeptidase domain containing
7864,-39.47,kd,CGS001-2878,GPX3,-
7866,-39.74,kd,CGS001-8743,TNFSF10,CD molecules
7867,-39.79,oe,ccsbBroad304_04654,ZIM3,"Zinc fingers, C2H2-type"
7868,-40.04,oe,ccsbBroad304_07754,FGFR1OP,-
7870,-40.69,oe,ccsbBroad304_09195,MCM8,-
7871,-40.73,oe,ccsbBroad304_00080,APOA2,Apolipoproteins
7873,-40.92,oe,ccsbBroad304_01797,ZNF32,"Zinc fingers, C2H2-type"
7877,-41.29,kd,CGS001-1950,EGF,-
7878,-41.34,kd,CGS001-26996,GPR160,GPCR / Class A : Orphans
7879,-41.38,kd,CGS001-1903,S1PR3,GPCR / Class A : Lysophospholipid receptors : Sphingosine 1-phosphate
7880,-41.43,kd,CGS001-7756,ZNF207,"Zinc fingers, C2H2-type"
7883,-41.75,kd,CGS001-5480,PPIC,-
695,74.21,cp,BRD-A36066264,estradiol-benzoate,Estrogen receptor agonist
7884,-41.81,kd,CGS001-79733,E2F8,-
7885,-41.88,kd,CGS001-11154,AP4S1,-
7887,-42.03,oe,ccsbBroad304_07217,AXIN2,-
7890,-42.19,kd,CGS001-6895,TARBP2,-
7892,-42.36,kd,CGS001-9706,ULK2,Unc-51-like kinase (ULK) family
7893,-42.43,kd,CGS001-2153,F5,Blood coagulation components
7894,-42.55,oe,ccsbBroad304_07651,HEXIM1,-
7895,-42.57,kd,CGS001-79603,CERS4,Homeoboxes / CERS class
7896,-42.61,kd,CGS001-2842,GPR19,GPCR / Class A : Orphans
7897,-42.61,oe,ccsbBroad304_03147,IL20,Interleukins and interleukin receptors
684,74.76,cp,BRD-A77722753,hydralazine,Vasodilator
7898,-42.62,oe,ccsbBroad304_07993,ZBTB20,BTB/POZ domain containing
683,74.78,cp,BRD-A62025033,temsirolimus,MTOR inhibitor
7899,-42.63,kd,CGS001-8869,ST3GAL5,Sialyltransferases
7900,-42.68,kd,CGS001-25942,SIN3A,-
7901,-42.72,kd,CGS001-11329,STK38,NDR family
679,74.96,cc,,Proteasome Pathway LOF,-
678,74.97,cp,BRD-K39111395,BCL2-inhibitor,BCL inhibitor
7902,-42.75,kd,CGS001-10795,ZNF268,"Zinc fingers, C2H2-type"
7903,-42.79,oe,ccsbBroad304_07061,TGM2,Transglutaminases
7905,-42.85,kd,CGS001-3664,IRF6,-
7906,-42.86,kd,CGS001-5104,SERPINA5,Serine (or cysteine) peptidase inhibitors
7907,-42.86,kd,CGS001-136,ADORA2B,GPCR / Class A : Adenosine receptors
7908,-42.87,kd,CGS001-222545,GPRC6A,GPCR / Class C : Calcium-sensing receptors
7910,-42.89,oe,ccsbBroad304_01777,WNT1,Endogenous ligands
670,75.33,cp,BRD-A16934955,nalbuphine,Opioid receptor agonist
7911,-42.91,kd,CGS001-57117,INTS12,"Zinc fingers, PHD-type"
7912,-43.1,kd,CGS001-90993,CREB3L1,basic leucine zipper proteins
7914,-43.17,kd,CGS001-8270,LAGE3,-
666,75.7,cp,BRD-K44849676,capsazepine,TRPV agonist
7915,-43.21,kd,CGS001-5362,PLXNA2,Plexins
7916,-43.38,kd,CGS001-134391,GPR151,GPCR / Class A : Orphans
663,75.78,cp,BRD-K14618467,IKK-16,IKK inhibitor
7917,-43.54,kd,CGS001-5080,PAX6,Paired boxes
7918,-43.55,oe,ccsbBroad304_06081,DGKA,EF-hand domain containing
7919,-43.59,oe,ccsbBroad304_04525,TGIF2LY,Homeoboxes / TALE class
659,75.83,cc,,NKL subclass homeoboxes and pseudogenes LOF,-
7920,-43.68,kd,CGS001-10308,ZNF267,"Zinc fingers, C2H2-type"
7921,-43.85,kd,CGS001-10886,NPFFR2,GPCR / Class A : Neuropeptide receptors : FF/AF
7922,-43.92,kd,CGS001-4773,NFATC2,Nuclear factor of activated T-cells
7923,-43.93,oe,ccsbBroad304_02964,TIMM9,-
7924,-43.96,kd,CGS001-79921,TCEAL4,-
7926,-44.02,kd,CGS001-3630,INS,-
7927,-44.03,kd,CGS001-6583,SLC22A4,Organic zwitterions/cation transporters (OCTN)
7928,-44.05,kd,CGS001-1362,CPD,Carboxypeptidase A
7932,-44.25,kd,CGS001-5357,PLS1,EF-hand domain containing
7934,-44.56,kd,CGS001-51569,UFM1,-
7935,-44.68,oe,ccsbBroad304_07699,GPR83,GPCR / Class A : Orphans
647,76.46,cc,,MTOR inhibitor,-
7936,-44.8,kd,CGS001-23401,FRAT2,-
7938,-44.99,kd,CGS001-5782,PTPN12,Protein tyrosine phosphatases / Class I Cys-based PTPs : Non-receptor
644,76.61,cp,BRD-A06352418,terfenadine,Histamine receptor antagonist
7940,-45.14,kd,CGS001-164668,APOBEC3H,Apolipoprotein B mRNA editing enzymes
7942,-45.32,kd,CGS001-23196,FAM120A,-
7944,-45.47,kd,CGS001-843,CASP10,Caspases
7945,-45.62,kd,CGS001-5564,PRKAB1,AMPK subfamily
638,76.92,cp,BRD-K32501161,vanoxerine,Dopamine uptake inhibitor
639,76.92,cp,BRD-K50140147,NVP-TAE684,ALK inhibitor
7946,-45.71,kd,CGS001-10026,PIGK,Phosphatidylinositol glycan anchor biosynthesis
7947,-45.76,kd,CGS001-91433,RCCD1,-
7948,-45.79,kd,CGS001-5451,POU2F1,Homeoboxes / POU class
7949,-45.84,kd,CGS001-1381,CRABP1,Fatty acid-binding proteins
7950,-45.85,kd,CGS001-4704,NDUFA9,Short chain dehydrogenase/reductase superfamily / Extended SDR fold
7953,-45.98,oe,ccsbBroad304_06995,SREBF1,Basic helix-loop-helix proteins
7954,-45.98,kd,CGS001-8409,UXT,-
7955,-46.09,kd,CGS001-26036,ZNF451,"Zinc fingers, C2H2-type"
7956,-46.09,kd,CGS001-5501,PPP1CC,"Serine/threonine phosphatases / Protein phosphatase, catalytic subunits"
7957,-46.27,kd,CGS001-1051,CEBPB,basic leucine zipper proteins
7958,-46.47,kd,CGS001-10991,SLC38A3,System N-like transporters
626,77.61,cp,BRD-K98548675,parthenolide,NFkB pathway inhibitor
7962,-46.68,oe,ccsbBroad304_05786,ADRB2,GPCR / Class A : Adrenoceptors : beta
7963,-46.69,oe,ccsbBroad304_02869,ASF1A,-
623,77.77,cp,BRD-K94144010,cotinine,Nicotine metabolite
622,77.82,cp,BRD-K31627533,rimexolone,Glucocorticoid receptor agonist
7964,-46.77,kd,CGS001-90649,ZNF486,"Zinc fingers, C2H2-type"
7967,-47.03,kd,CGS001-4904,YBX1,-
7968,-47.05,kd,CGS001-8726,EED,Neutral sphingomyelinase coupling factors
618,77.9,cc,,BMP Signaling LOF,-
617,77.96,cp,BRD-K76840893,RS-17053,Adrenergic receptor antagonist
7970,-47.2,kd,CGS001-117196,MRGPRX4,GPCR / Class A : Orphans
7971,-47.35,kd,CGS001-218,ALDH3A1,Aldehyde dehydrogenases
7972,-47.4,kd,CGS001-5320,PLA2G2A,Hydrolases
7973,-47.56,kd,CGS001-3460,IFNGR2,Interferon receptor family
7974,-47.6,oe,ccsbBroad304_07164,ZNF133,"Zinc fingers, C2H2-type"
7975,-47.71,kd,CGS001-4292,MLH1,-
7977,-48.12,kd,CGS001-991,CDC20,WD repeat domain containing
7978,-48.25,kd,CGS001-9841,ZBTB24,BTB/POZ domain containing
7980,-48.4,kd,CGS001-648,BMI1,Polycomb group ring fingers
7981,-48.49,kd,CGS001-79850,FAM57A,-
7982,-48.7,oe,ccsbBroad304_01247,POU2AF1,-
7983,-48.76,oe,ccsbBroad304_02299,NR1H3,Liver X receptor-like receptors
7985,-48.97,kd,CGS001-387,RHOA,-
7986,-49.03,kd,CGS001-2356,FPGS,-
7987,-49.07,kd,CGS001-29899,GPSM2,Tetratricopeptide (TTC) repeat domain containing
601,78.78,cp,BRD-K64881305,ispinesib,Kinesin-like spindle protein inhibitor
600,78.89,cp,BRD-K13087974,"4,5-dianilinophthalimide",EGFR inhibitor
7988,-49.12,oe,ccsbBroad304_05135,PARP15,-
598,78.96,cp,BRD-K39987650,bisacodyl,Laxative
7991,-49.33,kd,CGS001-7343,UBTF,-
7992,-49.34,oe,ccsbBroad304_01240,POLR2F,RNA polymerase subunits
595,79.28,cp,BRD-A52282606,lacidipine,Calcium channel blocker
7993,-49.36,kd,CGS001-11072,DUSP14,Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases
7994,-49.63,oe,ccsbBroad304_08221,RDH11,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2
7995,-49.86,oe,ccsbBroad304_06381,HMGB1,High-mobility group / Canonical
7996,-50.07,kd,CGS001-3159,HMGA1,High-mobility group / Canonical
590,79.73,cp,BRD-K06426971,ryuvidine,Histone lysine methyltransferase inhibitor
7997,-50.41,kd,CGS001-4122,MAN2A2,-
7998,-50.45,kd,CGS001-6434,TRA2B,RNA binding motif (RRM) containing
587,79.94,cp,BRD-K69932463,AZD-8055,MTOR inhibitor
8000,-50.59,oe,ccsbBroad304_07478,CCP110,-
8001,-50.82,kd,CGS001-7752,ZNF200,"Zinc fingers, C2H2-type"
8004,-51.52,oe,ccsbBroad304_01304,PSEN1,Presenilin
8006,-51.58,oe,ccsbBroad304_06678,OTX1,Homeoboxes / PRD class
8008,-51.6,kd,CGS001-4312,MMP1,Matrix metallopeptidase
8009,-51.64,kd,CGS001-1349,COX7B,Mitochondrial respiratory chain complex
8012,-51.79,oe,ccsbBroad304_02548,PROKR1,GPCR / Class A : Prokineticin receptors
8013,-51.81,kd,CGS001-55892,MYNN,BTB/POZ domain containing
8014,-51.82,oe,ccsbBroad304_14143,NUSAP1,-
8015,-51.82,oe,ccsbBroad304_00944,LIMK2,LIMK subfamily
8016,-51.83,kd,CGS001-3998,LMAN1,-
575,80.57,cp,BRD-K28360340,TW-37,BCL inhibitor
8018,-52.02,kd,CGS001-10782,ZNF274,"Zinc fingers, C2H2-type"
8021,-52.45,kd,CGS001-8220,DGCR14,-
8022,-52.52,kd,CGS001-1031,CDKN2C,Ankyrin repeat domain containing
8023,-52.53,kd,CGS001-51601,LIPT1,-
8024,-52.56,kd,CGS001-6309,SC5DL,-
8026,-52.62,kd,CGS001-57404,CYP20A1,Cytochrome P450s
8027,-52.68,kd,CGS001-4091,SMAD6,SMADs
8028,-52.68,oe,ccsbBroad304_05899,BMP4,Bone morphogenetic proteins
8029,-52.74,kd,CGS001-5445,PON2,Paraoxonases
565,81.09,cp,BRD-A48570745,ivermectin,GABA receptor agonist
566,81.09,cp,BRD-K32292990,CGP-53353,EGFR inhibitor
8030,-52.8,kd,CGS001-23597,ACOT9,Acyl CoA thioesterases
8031,-52.81,kd,CGS001-10180,RBM6,G patch domain containing
8032,-52.82,oe,ccsbBroad304_00421,DAPK1,Death-associated kinase (DAPK) family
8033,-52.86,kd,CGS001-6277,S100A6,EF-hand domain containing
559,81.43,cc,,Tumor necrosis factor superfamily LOF,-
8034,-52.89,kd,CGS001-9702,CEP57,-
8036,-53.12,kd,CGS001-5159,PDGFRB,"Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family"
556,81.53,cp,BRD-K04923131,GSK-3-inhibitor-IX,Glycogen synthase kinase inhibitor
8040,-53.71,kd,CGS001-139135,PASD1,-
8041,-53.75,oe,ccsbBroad304_00044,AK2,Adenylate kinases
8042,-53.78,kd,CGS001-23043,TNIK,MSN subfamily
8043,-53.85,oe,ccsbBroad304_07683,ZNF268,"Zinc fingers, C2H2-type"
551,81.85,cp,BRD-K91623615,ABT-751,Tubulin inhibitor
8044,-53.97,kd,CGS001-115727,RASGRP4,EF-hand domain containing
8045,-53.99,oe,ccsbBroad304_13813,ARAF,RAF family
8048,-54.46,kd,CGS001-6908,TBP,General transcription factors
8049,-54.5,kd,CGS001-6478,SIAH2,-
8050,-54.59,kd,CGS001-55723,ASF1B,-
8051,-54.81,kd,CGS001-9126,SMC3,Structural maintenance of chromosomes proteins
8052,-54.82,kd,CGS001-51031,GLOD4,-
543,82.08,cp,BRD-K03842655,penitrem-a,Potassium channel blocker
8053,-54.83,kd,CGS001-2976,GTF3C2,General transcription factors
541,82.21,cp,BRD-K06593056,LE-135,Retinoid receptor agonist
540,82.23,cc,,Minor histocompatibility antigens LOF,-
539,82.32,cp,BRD-K28168037,fenretinide,Apoptosis stimulant
8054,-55.02,kd,CGS001-57192,MCOLN1,Voltage-gated ion channels / Transient receptor potential cation channels
536,82.4,cp,BRD-K67578145,GDC-0879,RAF inhibitor
8055,-55.11,kd,CGS001-5594,MAPK1,MAPK:ERK subfamily
8056,-55.14,kd,CGS001-3778,KCNMA1,Calcium-activated potassium channels
8059,-55.24,kd,CGS001-164091,PAQR7,-
8060,-55.25,kd,CGS001-9375,TM9SF2,-
8062,-55.54,kd,CGS001-8449,DHX16,DEAH-boxes
8064,-55.55,oe,ccsbBroad304_02097,LPAR2,GPCR / Class A : Lysophospholipid receptors : Lysophosphatidic acid
8065,-55.62,kd,CGS001-4942,OAT,-
529,82.81,cp,BRD-K53959060,indirubin,CDK inhibitor
8066,-55.77,kd,CGS001-151112,ZSWIM2,"Zinc fingers, SWIM-type"
8067,-55.99,kd,CGS001-1312,COMT,Catecholamine turnover
8069,-56.18,kd,CGS001-2237,FEN1,-
8071,-56.39,kd,CGS001-9344,TAOK2,TAO subfamily
8075,-56.63,kd,CGS001-22883,CLSTN1,Cadherins / Cadherin-related
523,82.98,cp,BRD-M30523314,vinorelbine,Tubulin inhibitor
8076,-56.63,kd,CGS001-6198,RPS6KB1,p70 subfamily
8077,-57.03,kd,CGS001-4714,NDUFB8,Mitochondrial respiratory chain complex / Complex I
8078,-57.37,kd,CGS001-1756,DMD,-
8079,-57.58,kd,CGS001-64805,P2RY12,"GPCR / Class A : Purinergic receptors, P2Y"
8080,-57.72,kd,CGS001-57018,CCNL1,-
8081,-57.74,kd,CGS001-58508,MLL3,-
8083,-58,kd,CGS001-8634,RTCD1,-
8084,-58.07,kd,CGS001-2597,GAPDH,-
8085,-58.27,kd,CGS001-162655,ZNF519,"Zinc fingers, C2H2-type"
8086,-58.3,kd,CGS001-6925,TCF4,Basic helix-loop-helix proteins
512,83.61,cp,BRD-K10705233,GW-405833,Cannabinoid receptor agonist
8087,-58.45,kd,CGS001-392,ARHGAP1,Rho GTPase activating proteins
8088,-58.53,kd,CGS001-55008,HERC6,-
8089,-58.57,kd,CGS001-10553,HTATIP2,Short chain dehydrogenase/reductase superfamily / Atypical members
8092,-58.92,kd,CGS001-79001,VKORC1,Oxidoreductases
8093,-59,oe,ccsbBroad304_13869,HLA-A,Immunoglobulin superfamily / C1-set domain containing
506,83.97,cp,BRD-A10420615,cyclopiazonic-acid,ATPase inhibitor
8095,-59.09,kd,CGS001-6271,S100A1,EF-hand domain containing
8096,-59.14,kd,CGS001-2615,LRRC32,-
8097,-59.14,kd,CGS001-64781,CERK,Ceramide kinase
502,84.22,cp,BRD-K15592317,CP466722,ATM kinase inhibitor
501,84.29,cp,BRD-K74133369,oligomycin-a,ATP synthase inhibitor
8100,-59.54,oe,ccsbBroad304_01077,NDUFS6,Mitochondrial respiratory chain complex / Complex I
8101,-59.6,oe,ccsbBroad304_00140,ATP6V0A1,ATPases / V-type
498,84.47,cp,BRD-K15916496,clotrimazole,Cytochrome P450 inhibitor
8103,-59.95,kd,CGS001-79862,ZNF669,"Zinc fingers, C2H2-type"
8104,-59.96,kd,CGS001-10904,BLCAP,-
496,84.56,cp,BRD-A80793822,pemoline,Dopamine receptor agonist
494,84.74,cc,,NADH ubiquinone oxidoreductase core subunits GOF,-
8106,-60.03,kd,CGS001-5825,ABCD3,ATP binding cassette transporters / subfamily D
8107,-60.12,kd,CGS001-55054,ATG16L1,WD repeat domain containing
8111,-60.24,kd,CGS001-7182,NR2C2,Testicular receptors
8113,-60.43,oe,ccsbBroad304_03746,CDC42SE1,-
8114,-60.5,oe,ccsbBroad304_02402,TMEM5,-
8115,-60.66,kd,CGS001-3909,LAMA3,Laminins
487,84.96,cp,BRD-K99749624,linifanib,PDGFR receptor inhibitor
8116,-60.68,kd,CGS001-4707,NDUFB1,Mitochondrial respiratory chain complex / Complex I
8117,-60.72,kd,CGS001-3995,FADS3,Fatty acid desaturases
8118,-60.75,kd,CGS001-5563,PRKAA2,AMPK subfamily
8119,-60.82,kd,CGS001-9517,SPTLC2,Serine palmitoyltransferase
482,85.31,cp,BRD-A20697603,thiostrepton,FOXM1 inhibitor
8123,-60.98,kd,CGS001-81856,ZNF611,"Zinc fingers, C2H2-type"
8124,-61.12,kd,CGS001-6887,TAL2,Basic helix-loop-helix proteins
8125,-61.16,kd,CGS001-11137,PWP1,WD repeat domain containing
8126,-61.25,kd,CGS001-4179,CD46,CD molecules
8127,-61.38,kd,CGS001-23534,TNPO3,Importins
476,85.63,cp,BRD-K13169950,NSC-3852,HDAC inhibitor
8128,-61.41,kd,CGS001-3958,LGALS3,Endogenous ligands
8129,-61.62,kd,CGS001-5442,POLRMT,-
8132,-61.65,kd,CGS001-3203,HOXA6,Homeoboxes / ANTP class : HOXL subclass
8133,-61.75,kd,CGS001-4938,OAS1,-
8134,-61.84,kd,CGS001-55907,CMAS,-
8137,-61.95,kd,CGS001-7251,TSG101,-
8138,-62.01,kd,CGS001-650,BMP2,Bone morphogenetic proteins
8140,-62.15,kd,CGS001-57720,GPR107,GPCR / Unclassified : 7TM orphan receptors
8141,-62.2,kd,CGS001-9917,FAM20B,-
467,86,cp,BRD-A42628519,iopanoic-acid,Radiopaque medium
465,86.12,cp,BRD-K31912990,CGP-71683,Neuropeptide receptor antagonist
8142,-62.29,kd,CGS001-3628,INPP1,Inositol polyphosphate phosphatases
463,86.16,cp,BRD-K77390737,xanthohumol,ATPase inhibitor
8143,-62.48,kd,CGS001-54901,CDKAL1,-
8144,-62.51,kd,CGS001-4316,MMP7,Matrix metallopeptidase
8145,-62.58,kd,CGS001-55608,ANKRD10,Ankyrin repeat domain containing
459,86.38,cp,BRD-K52075715,oxibendazole,Tubulin inhibitor
457,86.41,cp,BRD-K62289640,lylamine,Cannabinoid receptor agonist
8147,-62.64,kd,CGS001-56940,DUSP22,Protein tyrosine phosphatases / Class I Cys-based PTPs : Atypical dual specificity phosphatases
8149,-62.69,kd,CGS001-2322,FLT3,"Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family"
8150,-62.7,kd,CGS001-51530,ZC3HC1,"Zinc fingers, C3HC-type"
8151,-62.87,kd,CGS001-7175,TPR,-
8154,-63.2,kd,CGS001-10270,AKAP8,A-kinase anchor proteins
8155,-63.21,kd,CGS001-958,CD40,Tumour necrosis factor (TNF) receptor family
451,86.67,cp,BRD-A17065207,brefeldin-a,Protein synthesis inhibitor
449,86.76,cp,BRD-K55420858,mirin,MRE11A exonuclease inhibitor
8158,-63.24,kd,CGS001-55509,BATF3,basic leucine zipper proteins
8159,-63.49,kd,CGS001-5422,POLA1,DNA polymerases
8161,-63.78,kd,CGS001-11182,SLC2A6,Solute carriers
8162,-63.86,kd,CGS001-9926,LPGAT1,-
8163,-64.04,kd,CGS001-2309,FOXO3,Forkhead boxes
444,86.91,cp,BRD-A67605442,tetrahydrobiopterin,Nitric oxide stimulant
8164,-64.1,kd,CGS001-10401,PIAS3,"Zinc fingers, MIZ-type"
8165,-64.1,kd,CGS001-634,CEACAM1,CD molecules
8167,-64.56,oe,ccsbBroad304_07783,PMF1-BGLAP,-
440,87.17,cp,BRD-K68143200,SA-792541,CDC inhibitor
8168,-64.62,kd,CGS001-6046,BRD2,Bromodomain kinase (BRDK) family
8169,-64.66,oe,ccsbBroad304_00117,ATF4,basic leucine zipper proteins
438,87.33,cp,BRD-A71459254,cymarin,ATPase inhibitor
8170,-64.75,kd,CGS001-1848,DUSP6,Protein tyrosine phosphatases / Class I Cys-based PTPs : MAP kinase phosphatases
8171,-64.89,oe,ccsbBroad304_01008,KITLG,-
8172,-64.97,kd,CGS001-5918,RARRES1,-
8173,-65.01,kd,CGS001-30001,ERO1L,-
432,87.41,cp,BRD-K13049116,BMS-754807,IGF-1 inhibitor
431,87.44,cp,BRD-A78360835,cercosporin,Photoactivated toxin
8174,-65.12,oe,ccsbBroad304_07126,VARS,Aminoacyl tRNA synthetases / Class I
8175,-65.19,oe,ccsbBroad304_00816,IDE,Pitrilysin
8176,-65.39,kd,CGS001-23252,OTUD3,OTU domain containing
8177,-65.44,kd,CGS001-10887,PROKR1,GPCR / Class A : Prokineticin receptors
8178,-65.51,kd,CGS001-6286,S100P,EF-hand domain containing
8179,-65.53,kd,CGS001-5813,PURA,-
8180,-65.56,kd,CGS001-55423,SIRPG,Immunoglobulin superfamily / C1-set domain containing
8181,-65.64,kd,CGS001-2778,GNAS,-
8183,-65.69,oe,ccsbBroad304_01222,PLP2,-
8184,-65.79,oe,ccsbBroad304_02368,TIMM17B,-
8185,-65.83,kd,CGS001-253430,IPMK,-
419,88.05,cp,BRD-A36630025,SN-38,Topoisomerase inhibitor
8186,-65.91,kd,CGS001-1131,CHRM3,Cholinergic receptors
8187,-66.06,kd,CGS001-5796,PTPRK,Receptor tyrosine phosphatases (RTP)
8188,-66.09,kd,CGS001-629,CFB,Complement system
8189,-66.12,kd,CGS001-55958,KLHL9,BTB/POZ domain containing
8191,-66.2,kd,CGS001-222,ALDH3B2,Aldehyde dehydrogenases
8194,-66.46,kd,CGS001-717,C2,Complement system
8195,-66.5,kd,CGS001-338557,O3FAR1,-
8196,-66.64,kd,CGS001-10621,POLR3F,RNA polymerase subunits
8197,-66.72,oe,ccsbBroad304_06411,HSPA9,Heat shock proteins / HSP70
8199,-66.97,oe,ccsbBroad304_01470,RXRG,Retinoid X receptors
8200,-66.97,kd,CGS001-79796,ALG9,Dolichyl D-mannosyl phosphate dependent mannosyltransferases
8202,-67.18,oe,ccsbBroad304_04522,ZNF625,"Zinc fingers, C2H2-type"
8203,-67.27,kd,CGS001-1879,EBF1,-
8204,-67.28,kd,CGS001-23384,SPECC1L,-
8205,-67.28,oe,ccsbBroad304_06464,ITGB2,Integrins
403,88.6,cp,BRD-A49765801,fludroxycortide,Glucocorticoid receptor agonist
402,88.61,cp,BRD-K40175214,torin-1,MTOR inhibitor
401,88.63,cp,BRD-K75295174,alisertib,Aurora kinase inhibitor
8207,-67.37,kd,CGS001-3693,ITGB5,Integrins
400,88.75,cp,BRD-K90382497,GW-843682X,PLK inhibitor
8208,-67.4,oe,ccsbBroad304_04292,INHBE,-
8209,-67.41,kd,CGS001-53834,FGFRL1,Immunoglobulin superfamily / I-set domain containing
8210,-67.51,kd,CGS001-476,ATP1A1,ATPases / P-type
8211,-67.68,oe,ccsbBroad304_01411,RORC,Retinoic acid-related orphans
8212,-68.06,kd,CGS001-323,APBB2,-
8213,-68.12,oe,ccsbBroad304_01138,P4HB,Protein disulfide isomerases
8217,-68.6,kd,CGS001-54107,POLE3,DNA polymerases
8218,-68.83,kd,CGS001-10174,SORBS3,-
390,89.09,cp,BRD-K74402642,NSC-632839,Ubiquitin specific protease inhibitor
8219,-68.87,kd,CGS001-5734,PTGER4,GPCR / Class A : Prostanoid receptors
387,89.15,cc,,Nucleoporin LOF,-
8220,-68.91,kd,CGS001-11319,ECD,-
8222,-69,kd,CGS001-3028,HSD17B10,Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 1
8223,-69.03,kd,CGS001-29968,PSAT1,-
8225,-69.04,oe,ccsbBroad304_02784,SUZ12,"Zinc fingers, C2H2-type"
8226,-69.13,kd,CGS001-22850,ADNP2,"Zinc fingers, C2H2-type"
8227,-69.27,kd,CGS001-9314,KLF4,Kruppel-like transcription factors
8228,-69.56,kd,CGS001-90655,TGIF2LY,Homeoboxes / TALE class
381,89.46,cp,BRD-K88868628,iodoacetic-acid,Cysteine peptidase inhibitor
8229,-69.61,kd,CGS001-10198,MPHOSPH9,-
8230,-69.62,oe,ccsbBroad304_00549,FDX1,-
8231,-69.68,kd,CGS001-54805,CNNM2,-
376,89.69,cp,BRD-K24576554,AT-9283,JAK inhibitor
8234,-69.74,kd,CGS001-5366,PMAIP1,-
8235,-69.84,kd,CGS001-9263,STK17A,Death-associated kinase (DAPK) family
8236,-69.9,kd,CGS001-3988,LIPA,-
372,90.05,cp,BRD-K82823804,SA-792987,PKC inhibitor
371,90.21,cp,BRD-K47150025,KI-8751,VEGFR inhibitor
8237,-69.94,kd,CGS001-699,BUB1,Bub family
8238,-70,oe,ccsbBroad304_05313,NUDT14,Nudix motif containing
8239,-70.01,kd,CGS001-10018,BCL2L11,-
8240,-70.05,kd,CGS001-7132,TNFRSF1A,Tumour necrosis factor (TNF) receptor family
8246,-70.73,kd,CGS001-10269,ZMPSTE24,-
365,90.38,cp,BRD-K51816706,oxindole-I,VEGFR inhibitor
8247,-70.8,kd,CGS001-55703,POLR3B,RNA polymerase subunits
363,90.63,cp,BRD-A38030642,cyclosporin-a,Calcineurin inhibitor
361,90.68,cp,BRD-K62353524,DY-131,Estrogen receptor agonist
8249,-70.9,kd,CGS001-11257,TP53TG1,-
8250,-70.96,kd,CGS001-3105,HLA-A,Immunoglobulin superfamily / C1-set domain containing
8251,-71,oe,ccsbBroad304_02361,MFSD10,-
8253,-71.18,kd,CGS001-7345,UCHL1,Ubiquitin C-terminal hydrolase
8254,-71.25,kd,CGS001-51447,IP6K2,-
8255,-71.27,oe,ccsbBroad304_05485,ZNF677,"Zinc fingers, C2H2-type"
355,91.09,cp,BRD-K68336408,tyrphostin-AG-1478,EGFR inhibitor
354,91.12,cp,BRD-K78599730,manumycin-a,Farnesyltransferase inhibitor
8256,-71.36,kd,CGS001-55179,FAIM,-
352,91.17,cp,BRD-K16406336,methylene-blue,Guanylyl cyclase inhibitor
8258,-71.47,kd,CGS001-3586,IL10,Interleukins and interleukin receptors
8259,-71.78,kd,CGS001-7023,TFAP4,Basic helix-loop-helix proteins
8260,-71.78,kd,CGS001-79366,HMGN5,High-mobility group / Canonical
8262,-71.99,kd,CGS001-3614,IMPDH1,Oxidoreductases
8263,-72.03,kd,CGS001-27336,HTATSF1,RNA binding motif (RRM) containing
346,91.26,cp,BRD-K15616905,CCCP,Mitochondrial oxidative phosphorylation uncoupler
8267,-72.52,kd,CGS001-7424,VEGFC,-
345,91.29,cp,BRD-K37456065,VU-0365114-2,M5 modulator
8269,-72.78,kd,CGS001-7485,WRB,-
8270,-72.93,kd,CGS001-3688,ITGB1,Integrins
341,91.36,cp,BRD-K17075857,chloroxine,Opioid receptor antagonist
8271,-72.95,kd,CGS001-9189,ZBED1,Pseudoautosomal regions / PAR1
339,91.39,cp,BRD-A22713669,BVT-948,Tyrosine phosphatase inhibitor
8273,-73.12,oe,ccsbBroad304_10846,GGT1,CD molecules
8274,-73.37,kd,CGS001-6608,SMO,GPCR / Class F : Frizzled receptors
8276,-73.75,kd,CGS001-1201,CLN3,-
8278,-73.86,kd,CGS001-1635,DCTD,-
334,91.61,cp,BRD-K60230970,MG-132,Proteasome inhibitor
8280,-73.98,kd,CGS001-51805,COQ3,-
8281,-74.04,kd,CGS001-29103,DNAJC15,Heat shock proteins / DNAJ (HSP40)
331,91.79,cp,BRD-K38477985,malonoben,Protein tyrosine kinase inhibitor
330,91.83,cp,BRD-K62012036,acitretin,Retinoid receptor agonist
8283,-74.15,kd,CGS001-3199,HOXA2,Homeoboxes / ANTP class : HOXL subclass
8284,-74.23,kd,CGS001-84108,PCGF6,Polycomb group ring fingers
8285,-74.4,kd,CGS001-81539,SLC38A1,System A-like transporters
8286,-74.48,kd,CGS001-3098,HK1,-
8287,-74.57,kd,CGS001-1147,CHUK,IKK family
324,92,cp,BRD-K66896231,BRD-K66896231,Acetylcholinesterase inhibitor
323,92.05,cp,BRD-K73395020,SA-1478088,-666
322,92.06,cp,BRD-A11007541,BCI-hydrochloride,Protein phosphatase inhibitor
321,92.09,cc,,PKC inhibitor,-
320,92.14,cp,BRD-A75517195,thiazolopyrimidine,CDC inhibitor
8288,-74.65,oe,ccsbBroad304_00990,DNAJB9,Heat shock proteins / DNAJ (HSP40)
8289,-74.75,kd,CGS001-317705,VN1R5,"GPCR / Unclassified : Vomeronasal receptors, type 1"
8290,-75.03,kd,CGS001-10314,LANCL1,-
316,92.36,cp,BRD-K28907958,CD-437,Retinoid receptor agonist
315,92.37,cp,BRD-K15600710,obatoclax,BCL inhibitor
314,92.43,cp,BRD-K82135108,elesclomol,Oxidative stress inducer
8291,-75.06,kd,CGS001-10237,SLC35B1,SLC35 family of nucleotide sugar transporters
8293,-75.26,kd,CGS001-7032,TFF2,-
311,92.53,cp,BRD-K88677950,PD-198306,MAP kinase inhibitor
310,92.55,cp,BRD-K12184916,dactolisib,MTOR inhibitor
308,92.64,cp,BRD-K54233340,dorsomorphin,AMPK inhibitor
8294,-75.29,kd,CGS001-6675,UAP1,-
307,92.67,cp,BRD-K21806131,tegaserod,Serotonin receptor partial agonist
8295,-75.35,oe,ccsbBroad304_02505,GNB5,WD repeat domain containing
304,92.71,cp,BRD-K49810818,sorafenib,FLT3 inhibitor
305,92.71,cp,BRD-K77987382,mebendazole,Tubulin inhibitor
303,92.74,cp,BRD-A34205397,suloctidil,Adrenergic receptor antagonist
8296,-75.36,kd,CGS001-3170,FOXA2,Forkhead boxes
8297,-75.4,kd,CGS001-60468,BACH2,BTB/POZ domain containing
8300,-75.91,kd,CGS001-2072,ERCC4,-
299,92.87,cp,BRD-K54095730,CMPD-1,p38 MAPK inhibitor
298,92.88,cc,,FLT3 inhibitor,-
297,92.92,cp,BRD-A55484088,BNTX,Opioid receptor antagonist
296,92.94,cp,BRD-K39120595,bithionol,Autotaxin inhibitor
8302,-76.24,kd,CGS001-10150,MBNL2,"Zinc fingers, CCCH-type domain containing"
292,93.1,cp,BRD-A50737080,CGK-733,ATR kinase inhibitor
8303,-76.3,kd,CGS001-10434,LYPLA1,-
8304,-76.31,kd,CGS001-10721,POLQ,DNA polymerases
291,93.13,cp,BRD-A08003242,rhodomyrtoxin-b,sodium fluorescein uptake inhibitor
8307,-76.5,oe,ccsbBroad304_00048,ALDH1A1,Aldehyde dehydrogenases
8308,-76.63,oe,ccsbBroad304_07036,TCF4,Basic helix-loop-helix proteins
288,93.29,cp,BRD-K03816923,rottlerin,MAP kinase inhibitor
8310,-76.7,kd,CGS001-286530,P2RY8,"GPCR / Class A : Purinergic receptors, P2Y"
8311,-76.76,kd,CGS001-10128,LRPPRC,-
285,93.48,cp,BRD-K03109492,NSC-663284,CDC inhibitor
8313,-77.05,kd,CGS001-23462,HEY1,Basic helix-loop-helix proteins
284,93.49,cp,BRD-K35687265,ON-01910,PLK inhibitor
8314,-77.07,kd,CGS001-5875,RABGGTA,Prenyltransferase alpha subunit repeat containing
282,93.51,cp,BRD-K26863634,BIX-01338,Histone lysine methyltransferase inhibitor
280,93.57,cp,BRD-K41903098,diphenoxylate,Opioid receptor agonist
279,93.67,cp,BRD-K26669427,WR-216174,PFMRK inhibitor
278,93.69,cp,BRD-K13646352,midostaurin,FLT3 inhibitor
277,93.71,cp,BRD-K13514097,everolimus,MTOR inhibitor
8315,-77.08,kd,CGS001-5013,OTX1,Homeoboxes / PRD class
275,93.75,cp,BRD-A80775386,hyperforin,Cyclooxygenase inhibitor
273,93.87,cp,BRD-K15409150,penfluridol,T-type calcium channel blocker
274,93.87,cp,BRD-K14821540,FCCP,Mitochondrial oxidative phosphorylation uncoupler
8317,-77.32,kd,CGS001-3705,ITPK1,-
8318,-77.36,kd,CGS001-9459,ARHGEF6,Rho guanine nucleotide exchange factors
8319,-77.46,kd,CGS001-22828,SCAF8,RNA binding motif (RRM) containing
8320,-77.49,kd,CGS001-841,CASP8,Caspases
268,94.02,cp,BRD-K59753975,vindesine,Tubulin inhibitor
8322,-77.52,kd,CGS001-391013,PLA2G2C,-
266,94.06,cp,BRD-K83988098,alvespimycin,HSP inhibitor
8324,-77.71,kd,CGS001-9559,VPS26A,-
265,94.12,cp,BRD-K10573841,tunicamycin,GLCNAC phosphotransferase inhibitor
8325,-78.22,kd,CGS001-7580,ZNF32,"Zinc fingers, C2H2-type"
262,94.2,cp,BRD-A28105619,cucurbitacin-i,JAK inhibitor
261,94.22,cp,BRD-U08759356,EI-346-erlotinib-analog,EGFR inhibitor
8326,-78.32,kd,CGS001-116512,MRGPRD,GPCR / Class A : Orphans
8327,-78.43,kd,CGS001-635,BHMT,-
8328,-78.44,kd,CGS001-23142,DCUN1D4,-
257,94.48,cp,BRD-K78659596,MLN-2238,Proteasome inhibitor
256,94.5,cp,BRD-K08547377,irinotecan,Topoisomerase inhibitor
255,94.57,cp,BRD-K84595254,strophanthidin,ATPase inhibitor
8329,-78.57,kd,CGS001-25932,CLIC4,Ion channels / Chloride channels : Intracellular
8330,-78.67,kd,CGS001-147694,ZNF548,"Zinc fingers, C2H2-type"
252,94.67,cp,BRD-K43405658,tyrphostin-AG-527,Protein tyrosine kinase inhibitor
251,94.68,cp,BRD-A96799240,4-hydroxyretinoic-acid,Retinoid receptor binder
250,94.69,cp,BRD-K15935639,z-leu3-VS,Proteasome inhibitor
8331,-78.69,kd,CGS001-55226,NAT10,-
248,94.71,cp,BRD-K74305673,IKK-2-inhibitor-V,IKK inhibitor
8332,-78.7,kd,CGS001-54659,UGT1A3,UDP glucuronosyltransferases
8333,-78.75,kd,CGS001-9943,OXSR1,FRAY subfamily
245,94.89,cp,BRD-K64517075,heliomycin,ATP synthase inhibitor
8334,-78.83,kd,CGS001-9352,TXNL1,-
8335,-78.87,kd,CGS001-466,ATF1,basic leucine zipper proteins
8337,-79.09,kd,CGS001-3691,ITGB4,Integrins
8338,-79.18,kd,CGS001-1452,CSNK1A1,Casein kinase 1 (CK1) family
240,95.04,cp,BRD-K81528515,nilotinib,ABL inhibitor
8339,-79.36,kd,CGS001-150962,PUS10,-
8341,-79.6,kd,CGS001-10670,RRAGA,-
237,95.1,cp,BRD-K26818574,BIX-01294,Histone lysine methyltransferase inhibitor
236,95.16,cp,BRD-K76907295,VU-0418947-2,HIF modulator
234,95.18,cp,BRD-K51318897,fenbendazole,Tubulin inhibitor
8342,-79.75,oe,ccsbBroad304_07024,SYK,Syk family
8343,-80.05,oe,ccsbBroad304_06911,MAPK12,MAPK:p38 subfamily
8344,-80.06,kd,CGS001-440,ASNS,-
231,95.22,cp,BRD-A98283014,calmidazolium,Calcium channel blocker
230,95.24,cp,BRD-K44432556,VU-0418946-1,HIF modulator
229,95.27,cp,BRD-A82371568,clofarabine,Ribonucleoside reductase inhibitor
228,95.32,cc,,BCL inhibitor,-
226,95.35,cp,BRD-A45498368,WYE-125132,MTOR inhibitor
227,95.35,cp,BRD-K19295594,gossypol,BCL inhibitor
225,95.37,cp,BRD-K89930444,AG-592,Tyrosine kinase inhibitor
223,95.38,cp,BRD-K18518344,digitoxigenin,ATPase inhibitor
8345,-80.09,kd,CGS001-23236,PLCB1,Phosphoinositide-specific phospholipase C
8346,-80.15,kd,CGS001-28512,NKIRAS1,-
221,95.41,cp,BRD-K35960502,niclosamide,DNA replication inhibitor
8347,-80.18,oe,ccsbBroad304_01720,TSTA3,Short chain dehydrogenase/reductase superfamily / Extended SDR fold
219,95.44,cp,BRD-K40255344,tyrphostin-A9,Protein tyrosine kinase inhibitor
217,95.46,cp,BRD-K18619710,digoxigenin,Steroid
8348,-80.26,oe,ccsbBroad304_00899,KCNK2,Two-P potassium channels
8349,-80.33,oe,ccsbBroad304_07129,VIPR1,GPCR / Class B : VIP and PACAP (ADCYAP1) receptors
8350,-80.49,kd,CGS001-3029,HAGH,-
214,95.55,cp,BRD-K32744045,disulfiram,Aldehyde dehydrogenase inhibitor
213,95.57,cp,BRD-A35588707,teniposide,Topoisomerase inhibitor
212,95.62,cp,BRD-K95901403,XL-147,PI3K inhibitor
8351,-80.52,kd,CGS001-3964,LGALS8,"Lectins, galactoside-binding"
209,95.67,cp,BRD-K17705806,JTC-801,Opioid receptor antagonist
210,95.67,cp,BRD-A55594068,vinblastine,Microtubule inhibitor
8352,-80.63,kd,CGS001-23119,HIC2,BTB/POZ domain containing
208,95.71,cp,BRD-K25504083,cytochalasin-d,Actin polymerization inhibitor
8355,-81,kd,CGS001-4710,NDUFB4,Mitochondrial respiratory chain complex / Complex I
205,95.74,cp,BRD-K17140735,SCH-79797,Proteasome inhibitor
203,95.75,cp,BRD-K60623809,SU-11652,Tyrosine kinase inhibitor
8356,-81.14,kd,CGS001-2677,GGCX,Carboxylases
202,95.76,cp,BRD-K95655893,MAZ-51,VEGFR inhibitor
201,95.81,cp,BRD-K93331255,lypressin,Vasopressin receptor agonist
8357,-81.24,kd,CGS001-3717,JAK2,Janus kinase (JakA) family
199,95.84,cp,BRD-K78126613,menadione,Mitochondrial DNA polymerase inhibitor
8359,-81.39,kd,CGS001-3615,IMPDH2,Oxidoreductases
197,95.88,cp,BRD-A89434049,sarmentogenin,ATPase inhibitor
195,95.91,cp,BRD-A28970875,puromycin,Protein synthesis inhibitor
8360,-81.72,kd,CGS001-64087,MCCC2,-
194,95.95,cp,BRD-A02481876,importazole,Importin-beta transport receptor inhibitor
193,95.96,cp,BRD-K59469039,AG-879,Angiogenesis inhibitor
8361,-81.83,kd,CGS001-25885,POLR1A,RNA polymerase subunits
8362,-82,kd,CGS001-1409,CRYAA,Heat shock proteins / HSPB
190,96,cc,,Vesicular Transport LOF,-
189,96.04,cp,BRD-U68942961,JW-7-24-1,LCK Inhibitor
188,96.05,cp,BRD-A34806832,proscillaridin,ATPase inhibitor
8363,-82.12,oe,ccsbBroad304_01531,SHC1,SH2 domain containing
185,96.12,cp,BRD-A06352508,SB-218078,CHK inhibitor
186,96.12,cp,BRD-A93236127,digitoxin,ATPase inhibitor
8364,-82.19,kd,CGS001-55504,TNFRSF19,Tumour necrosis factor (TNF) receptor family
8365,-82.21,kd,CGS001-1891,ECH1,-
8366,-82.36,kd,CGS001-1001,CDH3,Cadherins / Major cadherins
8367,-82.44,kd,CGS001-51451,LCMT1,-
180,96.22,cp,BRD-K63265447,docetaxel,Tubulin inhibitor
8368,-82.45,kd,CGS001-8091,HMGA2,High-mobility group / Canonical
8369,-82.54,oe,ccsbBroad304_03148,IL21R,IL-2 receptor family
8370,-82.58,kd,CGS001-6253,RTN2,-
175,96.37,cp,BRD-U33728988,QL-X-138,MTOR inhibitor
176,96.37,cp,BRD-A94756469,digoxin,ATPase inhibitor
174,96.41,cp,BRD-K21672174,RO-28-1675,Glucokinase activator
8376,-83.28,kd,CGS001-5970,RELA,NFkappaB transcription factor family
8378,-83.66,oe,ccsbBroad304_00041,NR0B1,DAX-like receptors
171,96.44,cp,BRD-K63606607,bufalin,ATPase inhibitor
170,96.46,cp,BRD-K28296557,AKT-inhibitor-IV,AKT inhibitor
168,96.49,cp,BRD-A62809825,thapsigargin,ATPase inhibitor
8379,-83.7,oe,ccsbBroad304_05979,CDK9,"Cyclin-dependent kinases, CDK9 subfamily"
167,96.55,cp,BRD-K02526760,QS-11,ARFGAP inhibitor
166,96.58,cp,BRD-A68930007,ouabain,ATPase inhibitor
165,96.59,cc,,IKK inhibitor,-
8380,-84.04,kd,CGS001-25874,BRP44,-
8382,-84.09,kd,CGS001-4485,MST1,-
8383,-84.1,oe,ccsbBroad304_00020,ACY1,-
8384,-84.27,kd,CGS001-65217,PCDH15,Cadherins / Cadherin-related
8385,-84.35,kd,CGS001-134864,TAAR1,GPCR / Class A : Trace amine associated receptors
158,96.82,cp,BRD-K19894101,MST-312,Telomerase inhibitor
159,96.82,cp,BRD-K04546108,JAK3-inhibitor-VI,JAK inhibitor
8386,-84.52,kd,CGS001-10608,MXD4,Basic helix-loop-helix proteins
8387,-84.56,kd,CGS001-54807,ZNF586,"Zinc fingers, C2H2-type"
155,96.91,cc,,Proteasome inhibitor,-
152,96.93,cp,BRD-K09638361,SA-63133,-666
153,96.93,cp,BRD-K65814004,diphenyleneiodonium,Nitric oxide synthase inhibitor
8388,-84.57,kd,CGS001-7535,ZAP70,Syk family
151,96.98,cp,BRD-K66792149,quinoclamine,Algicide
8389,-84.57,kd,CGS001-9258,MFHAS1,-
149,97.03,cp,BRD-A45333398,periplocymarin,Apoptosis stimulant
148,97.04,cp,BRD-K26997899,SA-792574,Microtubule inhibitor
147,97.07,cp,BRD-A58564983,selamectin,Nematocide
8390,-84.64,kd,CGS001-79143,MBOAT7,-
8391,-84.7,kd,CGS001-4706,NDUFAB1,Mitochondrial respiratory chain complex / Complex I
144,97.15,cp,BRD-A80502530,cinobufagin,ATPase inhibitor
143,97.21,cp,BRD-M86331534,pyrvinium-pamoate,AKT inhibitor
141,97.22,cp,BRD-K12539581,nocodazole,Tubulin inhibitor
142,97.22,cp,BRD-K03406345,azacitidine,DNA methyltransferase inhibitor
140,97.29,cp,BRD-A47829399,artesunate,DNA synthesis inhibitor
8393,-85.05,kd,CGS001-64943,NT5DC2,-
8395,-85.11,kd,CGS001-3897,L1CAM,CD molecules
8396,-85.2,kd,CGS001-7108,TM7SF2,-
8398,-85.26,kd,CGS001-1810,DR1,-
135,97.39,cp,BRD-K67506692,tyrphostin-AG-126,ERK1 and ERK2 phosphorylation inhibitor
134,97.43,cp,BRD-K68174511,torin-2,MTOR inhibitor
8399,-85.3,kd,CGS001-51701,NLK,nmo subfamily
130,97.53,cp,BRD-K76805682,SB-415286,Glycogen synthase kinase inhibitor
8401,-85.6,kd,CGS001-1487,CTBP1,-
132,97.53,cp,BRD-K47869605,podophyllotoxin,Microtubule inhibitor
8402,-85.62,kd,CGS001-129685,TAF8,-
8405,-86.14,kd,CGS001-84961,FBXL20,F-boxes / Leucine-rich repeats
8407,-86.38,kd,CGS001-7158,TP53BP1,-
8408,-86.45,kd,CGS001-224,ALDH3A2,Aldehyde dehydrogenases
125,97.69,cc,,Heat shock 70kDa proteins LOF,-
8410,-86.6,kd,CGS001-4724,NDUFS4,Mitochondrial respiratory chain complex / Complex I
8411,-86.63,kd,CGS001-211,ALAS1,-
122,97.88,cp,BRD-K86003836,flubendazole,Tubulin inhibitor
8413,-86.69,kd,CGS001-114112,TXNRD3,-
119,97.92,cp,BRD-K24681473,YM-155,Survivin inhibitor
8414,-86.69,kd,CGS001-10950,BTG3,-
8416,-86.78,kd,CGS001-3613,IMPA2,Inositol monophosphatase
8418,-87.41,kd,CGS001-9975,NR1D2,Rev-Erb receptors
116,98.05,cp,BRD-A63998256,helveticoside,ATPase inhibitor
115,98.06,cp,BRD-K91370081,anisomycin,DNA synthesis inhibitor
8419,-87.45,kd,CGS001-317701,VN1R2,"GPCR / Unclassified : Vomeronasal receptors, type 1"
112,98.1,cp,BRD-K99498722,NPI-2358,Tubulin inhibitor
113,98.1,cp,BRD-A54927599,KF-38789,P-selectin inhibitor
8421,-87.82,kd,CGS001-169792,GLIS3,"Zinc fingers, C2H2-type"
8422,-87.85,kd,CGS001-2617,GARS,Aminoacyl tRNA synthetases / Class II
109,98.17,cp,BRD-K47983010,BX-795,IKK inhibitor
108,98.2,cp,BRD-A47513740,calyculin,Protein phosphatase inhibitor
8423,-87.86,kd,CGS001-8942,KYNU,-
8425,-88.13,kd,CGS001-11098,PRSS23,Serine peptidases / Serine peptidases
8431,-89.47,kd,CGS001-64754,SMYD3,Chromatin-modifying enzymes / K-methyltransferases
104,98.31,cp,BRD-A26002865,verrucarin-a,Protein synthesis inhibitor
102,98.34,cc,,HIF activator,-
8434,-89.65,kd,CGS001-10166,SLC25A15,Mitochondrial amino acid transporter subfamily
8435,-89.7,oe,ccsbBroad304_01613,STK11,LKB subfamily
8436,-89.72,kd,CGS001-3661,IRF3,-
8438,-89.99,oe,ccsbBroad304_01962,STK16,NAK family
98,98.41,cp,BRD-K56334280,amonafide,Topoisomerase inhibitor
97,98.45,cp,BRD-K82109576,vincristine,Tubulin inhibitor
96,98.47,cp,BRD-K98490050,amsacrine,Topoisomerase inhibitor
95,98.49,kd,CGS001-11331,PHB2,-
93,98.52,cc,,ATPase inhibitor,-
94,98.52,cp,BRD-A62184259,cycloheximide,Protein synthesis inhibitor
92,98.53,kd,CGS001-11057,ABHD2,Abhydrolase domain containing
91,98.56,cp,BRD-K53972329,ruxolitinib,JAK inhibitor
90,98.61,kd,CGS001-6461,SHB,SH2 domain containing
89,98.63,kd,CGS001-6909,TBX2,T-boxes
88,98.65,kd,CGS001-7311,UBA52,L ribosomal proteins
87,98.66,kd,CGS001-3309,HSPA5,Heat shock proteins / HSP70
86,98.68,kd,CGS001-4723,NDUFV1,Mitochondrial respiratory chain complex / Complex I
85,98.69,kd,CGS001-332,BIRC5,Inhibitors of apoptosis (IAP) protein family
83,98.7,cp,BRD-U86922168,QL-XII-47,BTK inhibitor
84,98.7,cp,BRD-K06792661,narciclasine,Coflilin signaling pathway activator
82,98.71,kd,CGS001-2879,GPX4,-
81,98.73,cp,BRD-K80348542,cephaeline,Protein synthesis inhibitor
80,98.77,cp,BRD-K92138166,mammea-a,other antibiotic
79,98.8,cp,BRD-K76674262,homoharringtonine,Protein synthesis inhibitor
77,98.82,kd,CGS001-6129,RPL7,L ribosomal proteins
78,98.82,kd,CGS001-9020,MAP3K14,MAPKKK:STE-unique family
76,98.83,kd,CGS001-4713,NDUFB7,Mitochondrial respiratory chain complex / Complex I
75,98.84,kd,CGS001-5050,PAFAH1B3,-
74,98.87,cp,BRD-A15010982,HU-211,Glutamate receptor antagonist
72,98.89,oe,ccsbBroad304_00606,GABPB1,Ankyrin repeat domain containing
73,98.89,oe,ccsbBroad304_11405,UBE3C,-
68,98.91,cc,,Tubulin inhibitor,-
69,98.91,cp,BRD-A36707673,hydroxycholesterol,LXR agonist
70,98.91,cp,BRD-K80431395,triciribine,AKT inhibitor
71,98.91,cp,BRD-A25687296,emetine,Protein synthesis inhibitor
67,98.92,kd,CGS001-64764,CREB3L2,basic leucine zipper proteins
66,98.94,oe,ccsbBroad304_02691,PUF60,RNA binding motif (RRM) containing
65,98.95,kd,CGS001-79080,CCDC86,-
64,99.01,cp,BRD-K28143534,cyproheptadine,Histamine receptor antagonist
62,99.03,kd,CGS001-51160,VPS28,-
63,99.03,kd,CGS001-100133941,CD24,CD molecules
61,99.05,oe,ccsbBroad304_05981,CDO1,-
59,99.11,kd,CGS001-79170,PRR15L,-
60,99.11,kd,CGS001-51053,GMNN,-
57,99.13,kd,CGS001-79724,ZNF768,"Zinc fingers, C2H2-type"
58,99.13,cp,BRD-K49669041,BX-912,Pyruvate dehydrogenase kinase inhibitor
55,99.17,kd,CGS001-9326,ZNHIT3,"Zinc fingers, HIT-type"
56,99.17,kd,CGS001-11004,KIF2C,Kinesins
54,99.18,kd,CGS001-11065,UBE2C,Ubiquitin-conjugating enzymes E2
53,99.19,cp,BRD-A15079084,phorbol-12-myristate-13-acetate,PKC activator
52,99.22,cp,BRD-K94325918,kinetin-riboside,Apoptosis stimulant
51,99.26,oe,ccsbBroad304_07097,TRAF1,-
50,99.3,cp,BRD-K04853698,LDN-193189,Serine/threonine kinase inhibitor
49,99.32,kd,CGS001-1212,CLTB,-
48,99.35,oe,ccsbBroad304_01090,NFE2L2,basic leucine zipper proteins
47,99.39,kd,CGS001-8767,RIPK2,Receptor interacting protein kinase (RIPK) family
46,99.41,kd,CGS001-11284,PNKP,-
45,99.44,oe,ccsbBroad304_01388,RELB,NFkappaB transcription factor family
44,99.45,kd,CGS001-221692,PHACTR1,Phosphatase and actin regulators
43,99.46,kd,CGS001-2021,ENDOG,-
39,99.47,kd,CGS001-291,SLC25A4,Mitochondrial nucleotide transporter subfamily
40,99.47,kd,CGS001-51116,MRPS2,Mitochondrial ribosomal proteins / small subunits
41,99.47,kd,CGS001-1182,CLCN3,Ion channels / Chloride channels : Voltage-sensitive
42,99.47,kd,CGS001-978,CDA,-
37,99.49,oe,ccsbBroad304_07304,TNFRSF10B,Tumour necrosis factor (TNF) receptor family
38,99.49,oe,ccsbBroad304_05098,MAGEB6,-
36,99.5,kd,CGS001-7480,WNT10B,Wingless-type MMTV integration sites
35,99.51,kd,CGS001-7187,TRAF3,-
33,99.53,kd,CGS001-4795,NFKBIL1,-
34,99.53,kd,CGS001-54566,EPB41L4B,-
31,99.54,cp,BRD-K91145395,prostratin,PKC activator
32,99.54,cp,BRD-A52650764,ingenol,PKC activator
30,99.55,cc,,Protein synthesis inhibitor,-
28,99.58,oe,ccsbBroad304_00832,IFNB1,Interferons
29,99.58,kd,CGS001-1677,DFFB,-
26,99.61,kd,CGS001-58477,SRPRB,-
27,99.61,kd,CGS001-51071,DERA,-
23,99.63,oe,ccsbBroad304_00259,CD40,Tumour necrosis factor (TNF) receptor family
24,99.63,kd,CGS001-7494,XBP1,basic leucine zipper proteins
25,99.63,kd,CGS001-8738,CRADD,-
22,99.68,oe,ccsbBroad304_07531,TANK,-
21,99.71,kd,CGS001-59286,UBL5,-
17,99.72,cc,,PKC activator,-
18,99.72,oe,ccsbBroad304_01710,TRAF2,RING-type (C3HC4) zinc fingers
19,99.72,oe,ccsbBroad304_01688,TNFRSF1A,Tumour necrosis factor (TNF) receptor family
20,99.72,oe,ccsbBroad304_09396,TIRAP,-
16,99.74,kd,CGS001-7184,HSP90B1,Heat shock proteins / HSPC
13,99.77,oe,ccsbBroad304_00833,IFNG,Interferons
14,99.77,oe,ccsbBroad304_02048,BCL10,-
15,99.77,oe,ccsbBroad304_06542,LTBR,Tumor necrosis factor receptor superfamily
11,99.79,kd,CGS001-4907,NT5E,Adenosine turnover
12,99.79,kd,CGS001-1054,CEBPG,basic leucine zipper proteins
10,99.81,oe,ccsbBroad304_00954,LYN,Src family
9,99.82,kd,CGS001-3516,RBPJ,-
7,99.84,kd,CGS001-4151,MB,-
8,99.84,kd,CGS001-383,ARG1,Arginase
6,99.86,oe,ccsbBroad304_07306,TNFRSF10A,Tumour necrosis factor (TNF) receptor family
4,99.89,kd,CGS001-22937,SCAP,WD repeat domain containing
5,99.89,kd,CGS001-83694,RPS6KL1,RSKL family
3,99.91,cc,,NFKB Activation GOF,-
2,99.92,kd,CGS001-694,BTG1,-
1,99.95,kd,CGS001-10113,PREB,WD repeat domain containing